1 00:00:05,889 --> 00:00:07,690 ALL RIGHT. GOOD MORNING, 2 00:00:07,690 --> 00:00:11,227 EVERYONE. WELCOME TO THE 6 3 00:00:11,227 --> 00:00:16,799 FIFTH MEETING FOR BIOMEDICAL 4 00:00:16,799 --> 00:00:20,737 IMAGINING AND BIOENGINEERING. 5 00:00:20,737 --> 00:00:23,006 THIS COUNCIL MEETING IS OPEN TO 6 00:00:23,006 --> 00:00:25,875 THE PUBLIC EXCEPT FOR REVIEW OF 7 00:00:25,875 --> 00:00:27,477 PENDING GRANT APPLICATIONS THAT 8 00:00:27,477 --> 00:00:30,380 TAKE PLACE LATER THIS AFTERNOON 9 00:00:30,380 --> 00:00:32,515 AND OPEN SESSION OF THIS MEETING 10 00:00:32,515 --> 00:00:34,984 IS LIVE BROADCAST ON THE NIH 11 00:00:34,984 --> 00:00:37,187 NETWORK AND RECORDED FOR NIH 12 00:00:37,187 --> 00:00:38,988 ARCHIVES AND COUNCIL MEMBERS IN 13 00:00:38,988 --> 00:00:41,424 THE ROOM, WE ASK THAT YOU PLEASE 14 00:00:41,424 --> 00:00:43,126 USE YOUR MICROPHONE WHEN YOU ARE 15 00:00:43,126 --> 00:00:44,460 SPEAKING AND FOR EVERYONE IN THE 16 00:00:44,460 --> 00:00:48,498 ROOM IF YOU TAKE A MOMENT TO 17 00:00:48,498 --> 00:00:50,433 PLEASE MUTE YOUR PHONES. 18 00:00:50,433 --> 00:00:53,036 I WILL FOLLOW MY OWN CRITIQUE 19 00:00:53,036 --> 00:00:57,173 AND SHUT OFF SOUND FROM YOUR 20 00:00:57,173 --> 00:00:58,441 LAPTOPS AND SO FORTH. 21 00:00:58,441 --> 00:01:01,844 THERE WE GO. WE WELCOME COUNCIL 22 00:01:01,844 --> 00:01:04,147 MEMBERS EX-OFFICIOS AND SPECIAL 23 00:01:04,147 --> 00:01:06,349 GUESTS AND THANKS TO ALL WHO ARE 24 00:01:06,349 --> 00:01:07,617 WATCHING ON VIDEO CAST. 25 00:01:07,617 --> 00:01:10,119 MEMBERS OF THE PUBLIC WISHING TO 26 00:01:10,119 --> 00:01:12,956 EXPRESS VIEWS REGARDING ITEMS 27 00:01:12,956 --> 00:01:14,190 DISCUSSED IN THIS MEETING MAY DO 28 00:01:14,190 --> 00:01:16,559 SO IN WRITING WITHIN THE NEXT 10 29 00:01:16,559 --> 00:01:23,233 DAYS BY E-MAILING ME AT INFO AT 30 00:01:23,233 --> 00:01:32,609 NIBIB.NIH.GOV. THAT IS 31 00:01:32,609 --> 00:01:33,042 NIFO@NIDID.NIH.GOV. 32 00:01:33,042 --> 00:01:35,245 PLEASE PUT NIV COUNCIL IN THE 33 00:01:35,245 --> 00:01:38,581 SUBJECT LINE OF THE E-MAIL. 34 00:01:38,581 --> 00:01:40,049 I WOULD LIKE TO NOTE FOR THE 35 00:01:40,049 --> 00:01:42,418 RECORD WE HAVE A QUORUM FOR 36 00:01:42,418 --> 00:01:46,522 TODAY'S MEETING AND THANK THE 37 00:01:46,522 --> 00:01:48,858 OFFICER PAM GLITSSON ON THE ZOOM 38 00:01:48,858 --> 00:01:53,296 TODAY NOT IN THE ROOM AND 39 00:01:53,296 --> 00:01:55,098 MANAGEMENT ALICIA WHO IS IN THE 40 00:01:55,098 --> 00:01:58,301 ROOM TODAY. THANK YOU FOR YOUR 41 00:01:58,301 --> 00:01:59,702 HELP ORGANIZING THE MEETING AND 42 00:01:59,702 --> 00:02:02,071 EXTRA EFFORTS TO SUCCESSFULLY 43 00:02:02,071 --> 00:02:06,075 GET EVERYONE ON CAMPUS VERY 44 00:02:06,075 --> 00:02:06,843 SMOOTHLY. 45 00:02:06,843 --> 00:02:14,951 THANKS SO MUCH. 46 00:02:14,951 --> 00:02:16,686 IR NEED TO NOTE THAT THESE 47 00:02:16,686 --> 00:02:20,156 PROCEEDINGS ARE GOVERNED BY 48 00:02:20,156 --> 00:02:21,024 FEDERAL ADVISORY COMMITTEE ACT 49 00:02:21,024 --> 00:02:22,792 IN ADDITION OF THE GOVERNMENT 50 00:02:22,792 --> 00:02:24,961 AND SUNSHINE ACT AND THAT MEANS 51 00:02:24,961 --> 00:02:27,497 MEETINGS ANNOUNCED TO PUBLIC IN 52 00:02:27,497 --> 00:02:31,534 FEDERAL REGISTER CONSISTS OF AN 53 00:02:31,534 --> 00:02:33,069 OPEN PORTION TO THE PUBLIC WE 54 00:02:33,069 --> 00:02:34,771 ARE IN, IN A MOMENT AND 55 00:02:34,771 --> 00:02:37,140 DISCUSSIONS OF APPLICATIONS 56 00:02:37,140 --> 00:02:40,143 LATER AND ANTICIPATE ADJOURNING 57 00:02:40,143 --> 00:02:41,844 PUBLISH SESSION AT 12:30. 58 00:02:41,844 --> 00:02:44,480 IN TERMS OF FUTURE COUNCIL DATES 59 00:02:44,480 --> 00:02:46,282 TAKING A MOMENT TO DRAW 60 00:02:46,282 --> 00:02:50,019 ATTENTION AT THE BOTTOM OF THE 61 00:02:50,019 --> 00:02:53,890 AGENDA AND COUNCIL MEMBERS. 62 00:02:53,890 --> 00:02:57,960 PLEASE DOUBLE CHECK THE DATES. 63 00:02:57,960 --> 00:03:00,496 ON A DATE THAT MIGHT CONFLICT 64 00:03:00,496 --> 00:03:02,432 WITH STUDENT COUNCIL MEMBERS AND 65 00:03:02,432 --> 00:03:05,802 NEXT MEETING IS SEPTEMBER 10TH 66 00:03:05,802 --> 00:03:09,372 2024 AND WILL BE AGAIN IN-PERSON 67 00:03:09,372 --> 00:03:11,107 MEETING IN [INDISCERNIBLE] 68 00:03:11,107 --> 00:03:12,842 CENTER AND FOES THOSE COUNCIL 69 00:03:12,842 --> 00:03:17,213 MEMBERS WANTING TO BE COOL KIDS 70 00:03:17,213 --> 00:03:19,549 ROBBING LITH 2. YOU ARE AMONG 71 00:03:19,549 --> 00:03:22,318 THE COOL KIDS AND NOTING THAT WE 72 00:03:22,318 --> 00:03:24,887 MENTIONED AT LAST COUNCIL WE 73 00:03:24,887 --> 00:03:27,523 RESCHEDULED MAY OF 20205 COUNCIL 74 00:03:27,523 --> 00:03:30,460 MEETING TO MAY 20TH SO IT 75 00:03:30,460 --> 00:03:33,796 DOESN'T CLASH WITH THE ISMRM 76 00:03:33,796 --> 00:03:35,898 MEETING AND COUNCIL MEMBERS AND 77 00:03:35,898 --> 00:03:37,100 COLLEAGUES WILL ATTEND AS WELL. 78 00:03:37,100 --> 00:03:39,235 WITH THAT I WOULD LIKE TO MOVE 79 00:03:39,235 --> 00:03:40,803 CONSIDERATION OF THE MINUTES 80 00:03:40,803 --> 00:03:42,472 FROM THE LAST COUNCIL MEETING 81 00:03:42,472 --> 00:03:44,607 MADE AVAILABLE TO YOU A FEW 82 00:03:44,607 --> 00:03:46,542 WEEKS AGO. ARE THERE ANY 83 00:03:46,542 --> 00:03:48,111 COMMENTS OR MODIFICATIONS THAT 84 00:03:48,111 --> 00:03:51,914 YOU WOULD LIKE TO MAKE TO THE 85 00:03:51,914 --> 00:03:52,749 MINUTES? 86 00:03:52,749 --> 00:03:55,051 HEARING NONE I WILL ENTERTAIN A 87 00:03:55,051 --> 00:03:56,819 MOTION TO APPROVE. 88 00:03:56,819 --> 00:03:59,389 IS THERE A SECOND? SECOND. ALL 89 00:03:59,389 --> 00:04:01,190 IN FAVOR, AYE. 90 00:04:01,190 --> 00:04:03,793 ALL OPPOSED, NAY. 91 00:04:03,793 --> 00:04:07,964 THANK YOU. THERE IS NO 92 00:04:07,964 --> 00:04:09,265 OPPOSITION AND MOTION PASSES AND 93 00:04:09,265 --> 00:04:12,468 WITH THAT INTRODUCTION, I WILL 94 00:04:12,468 --> 00:04:17,340 TURN THE PROCEEDING OVER TO DR. 95 00:04:17,340 --> 00:04:27,517 TROMBERG. 96 00:04:27,784 --> 00:04:30,920 >> OKAY. WE ARE BRINGING A 97 00:04:30,920 --> 00:04:36,926 SLIDE UP AND THANK YOU, DAVID 98 00:04:36,926 --> 00:04:38,161 FOR GETTING US STARTED AND GREAT 99 00:04:38,161 --> 00:04:40,263 TO SEE YOU IN PERSON. WE LOOK 100 00:04:40,263 --> 00:04:41,631 FORWARD TO MEETINGS TWICE A YEAR 101 00:04:41,631 --> 00:04:42,365 IN PERSON. 102 00:04:42,365 --> 00:04:45,301 IT IS AN ENERGY JOLT FOR ALL OF 103 00:04:45,301 --> 00:04:47,837 US AND GOOD TO HAVE YOU HERE. 104 00:04:47,837 --> 00:04:50,306 THIS IS A FAVORITE SITE. IT IS 105 00:04:50,306 --> 00:04:53,443 THE HOME COURT OF TO DR. PLAT 106 00:04:53,443 --> 00:04:55,278 WHO HAS LABORATORIES HERE AND 107 00:04:55,278 --> 00:04:57,313 HOPE YOU GET TO SEE THE NEW LAB. 108 00:04:57,313 --> 00:05:00,950 I'M VOLUNTEERING TOURS FOR YOU. 109 00:05:00,950 --> 00:05:02,685 IT IS A BEAUTIFUL SPACE. 110 00:05:02,685 --> 00:05:05,021 WE ARE PROUD OF MATRICES AND 111 00:05:05,021 --> 00:05:06,789 WHAT YOU ARE DOING HERE. I 112 00:05:06,789 --> 00:05:10,126 DON'T KNOW -- I THINK THIS IS A 113 00:05:10,126 --> 00:05:11,828 6 FIFTH COUNCIL. IS THAT WHAT 114 00:05:11,828 --> 00:05:14,263 YOU SAID, DAVE? I DON'T KNOW 115 00:05:14,263 --> 00:05:17,066 HOW OFTEN NIBIB COUNCIL HAS BEEN 116 00:05:17,066 --> 00:05:17,467 FLIPPED. 117 00:05:17,467 --> 00:05:19,702 THIS IS AN INVERSE COUNCIL 118 00:05:19,702 --> 00:05:22,238 MEETING AND NO DIRECTOR'S REPORT 119 00:05:22,238 --> 00:05:25,141 IN THE MORNING. WE DID IT FOR 120 00:05:25,141 --> 00:05:29,378 ONE SINGULAR REASON, TO HAVE OUR 121 00:05:29,378 --> 00:05:32,114 SPEAKER, OUR SPECIAL COUNCIL 122 00:05:32,114 --> 00:05:36,419 LECTURER THIS MORNING. WE ARE 123 00:05:36,419 --> 00:05:38,888 PLEASED I AM PLEASED TO HAVE 124 00:05:38,888 --> 00:05:40,923 SPEAKER DR. JANINE CLAYTON WHO 125 00:05:40,923 --> 00:05:42,492 IS ASSOCIATE DIRECTOR FOR 126 00:05:42,492 --> 00:05:44,994 RESEARCH ON WOMAN'S HEALTH AND 127 00:05:44,994 --> 00:05:46,829 DIRECTOR FOR OFFICE OF RESEARCH 128 00:05:46,829 --> 00:05:49,465 AND WOMEN'S HEAL THAJ IS SPECIAL 129 00:05:49,465 --> 00:05:52,368 NIH INSIDE BASEBALL TERMINOLOGY 130 00:05:52,368 --> 00:05:53,836 TWO TITLES FOR ONE SPECIFIC 131 00:05:53,836 --> 00:05:56,606 LEADERSHIP ROLE. THAT IS 132 00:05:56,606 --> 00:05:59,509 AWESOME. SHE IS CO-CHAIR FOR 133 00:05:59,509 --> 00:06:02,478 NIH WORKING GROUP FOR WOMEN THAT 134 00:06:02,478 --> 00:06:04,313 SHE CO-CHAIRS WITH DR. BER TAN 135 00:06:04,313 --> 00:06:09,051 OELI AND ELECTED MEMBER OF BOARD 136 00:06:09,051 --> 00:06:10,920 OF DIRECTORS TRIPLE AS AND A 137 00:06:10,920 --> 00:06:13,022 LITTLE MORE I WILL GO ON FOR A 138 00:06:13,022 --> 00:06:15,258 BIT MORE. I KNOW THAT JANINE 139 00:06:15,258 --> 00:06:17,126 HAS SO MANY THINGS TODAY. SHE 140 00:06:17,126 --> 00:06:18,461 WILL TELL YOU ABOUT THEM. 141 00:06:18,461 --> 00:06:20,563 THAT IS WHY WE FLIPPED THIS. 142 00:06:20,563 --> 00:06:23,432 SHE IS REALLY LEADING AN 143 00:06:23,432 --> 00:06:24,634 INCREDIBLY EXCITING 144 00:06:24,634 --> 00:06:26,269 INFORMATION-PACKED DAY THAT IS 145 00:06:26,269 --> 00:06:29,605 ANNOUNCING MANY INITIATIVES YOU 146 00:06:29,605 --> 00:06:31,107 WILL HEAR BEFORE THEY GO OUT 147 00:06:31,107 --> 00:06:32,775 INTO THE PUBLIC. 148 00:06:32,775 --> 00:06:36,045 SHE IS A BOARD-CERTIFIED 149 00:06:36,045 --> 00:06:38,514 OPHTHALMOLOGIST AND RESEARCH IS 150 00:06:38,514 --> 00:06:41,651 IN AUTO IMMUNE OCULAR DISEASES 151 00:06:41,651 --> 00:06:44,520 AND ROLE OF SEX AND GENDER AND 152 00:06:44,520 --> 00:06:46,656 HEALTH AND DISEASE AND HAS AN 153 00:06:46,656 --> 00:06:47,924 AMAZING BACKGROUND AND VERY 154 00:06:47,924 --> 00:06:49,959 STRONG INTEREST IN DISEASES 155 00:06:49,959 --> 00:06:53,262 ASSOCIATED WITH PREMATURE 156 00:06:53,262 --> 00:06:54,030 OVARIAN INSUFFICIENCY. 157 00:06:54,030 --> 00:06:58,901 THIS WORK REALLY INSPIRED HER 158 00:06:58,901 --> 00:07:01,671 UNDERSTANDING AND HER WORK ON 159 00:07:01,671 --> 00:07:03,839 DESCRIBING HOW SEX AND GENDER 160 00:07:03,839 --> 00:07:08,210 CAN INFLUENCE DISEASE AND HAS 161 00:07:08,210 --> 00:07:11,147 LED TO THIS PIONEERING WORK WITH 162 00:07:11,147 --> 00:07:12,648 DECLARATION OR UNDERSTANDING OF 163 00:07:12,648 --> 00:07:14,684 SEX IS A BIOLOGICAL VARIABLE 164 00:07:14,684 --> 00:07:16,586 ACROSS THE ENTIRE RESEARCH 165 00:07:16,586 --> 00:07:16,886 SPECTRUM. 166 00:07:16,886 --> 00:07:20,590 IT IS INSPIRED NOT ONLY WHAT IS 167 00:07:20,590 --> 00:07:22,091 GOING ON IN OP THAMOLOGY ABOUT 168 00:07:22,091 --> 00:07:24,860 YOU WHAT IS GOING ON IN 169 00:07:24,860 --> 00:07:27,563 BIOMEDICAL RESEARCH ACROSS 170 00:07:27,563 --> 00:07:29,098 BIOMEDICAL SPECTRUM AND RESEARCH 171 00:07:29,098 --> 00:07:32,001 AUTHOR OF 120 SCIENTIFIC 172 00:07:32,001 --> 00:07:34,437 PUBLICATIONS AND RESEARCH IS 173 00:07:34,437 --> 00:07:38,007 SPANNING FROM RANDOMIZED 174 00:07:38,007 --> 00:07:40,042 CLINICAL TRIALS IMMUNOTHERAPIES 175 00:07:40,042 --> 00:07:43,379 TO MY FAVORITE DIGITAL IMAGING 176 00:07:43,379 --> 00:07:45,214 INTERIOR SEGMENT OF THE EYE AND 177 00:07:45,214 --> 00:07:49,752 IS SHE IS A FELLOWSHIP TRAINED 178 00:07:49,752 --> 00:07:51,454 OPHTHALMOLOGIST AT WILL MER 179 00:07:51,454 --> 00:07:53,823 INSTITUTE AT JOHNS HOPKINS DOING 180 00:07:53,823 --> 00:07:57,126 WORK IN CORNEA AND INTERIOR 181 00:07:57,126 --> 00:08:02,264 SEGMENT AND NEI HERE FOCUSING ON 182 00:08:02,264 --> 00:08:02,965 IMMUNOOPHTHALMOLOGY AND 183 00:08:02,965 --> 00:08:03,799 INTERESTING BACKGROUND. 184 00:08:03,799 --> 00:08:06,802 SHE IS A NATIVE OF WASHINGTON, 185 00:08:06,802 --> 00:08:07,670 DC WHICH WE SHARE. 186 00:08:07,670 --> 00:08:09,872 WE HAVE BONDED A LOT OVER THAT 187 00:08:09,872 --> 00:08:11,874 OVER THE YEARS. 188 00:08:11,874 --> 00:08:14,143 AND SHE HAS RECEIVED SEVERAL 189 00:08:14,143 --> 00:08:16,012 AWARDS INCLUDING THE AMERICAN 190 00:08:16,012 --> 00:08:19,582 MEDICAL WOMEN'S ASSOCIATION LILA 191 00:08:19,582 --> 00:08:21,984 WALLACE WOMEN'S HEALTH AWARD AND 192 00:08:21,984 --> 00:08:24,687 WEN GER AWARD FOR EXCELLENCE IN 193 00:08:24,687 --> 00:08:28,324 PUBLIC SERVICE AND BERN ADEAN 194 00:08:28,324 --> 00:08:30,526 KEELEY AWARD IN WOMEN'S 195 00:08:30,526 --> 00:08:32,628 LEADERSHIP AND -- OUTSTANDING 196 00:08:32,628 --> 00:08:33,963 GOVERNMENT SERVICE AND SHE -- AS 197 00:08:33,963 --> 00:08:37,767 I MENTIONED BEFORE SHE IS AN 198 00:08:37,767 --> 00:08:40,936 ELECTED MEMBER OF AAA AND THIS 199 00:08:40,936 --> 00:08:41,404 BOARD. 200 00:08:41,404 --> 00:08:43,205 LET'S WELCOME DR. CLAYTON. WE 201 00:08:43,205 --> 00:08:51,914 ARE SO PLEASED TO HAVE YOU HERE. 202 00:08:51,914 --> 00:08:53,249 >> THANK YOU DR. TROMBERG FOR 203 00:08:53,249 --> 00:08:55,818 THAT REALLY LOVELY INTRODUCTION. 204 00:08:55,818 --> 00:08:58,087 IT IS NATIONAL WOMEN'S HEALTH 205 00:08:58,087 --> 00:09:00,089 WEEK 2024. IT IS WHY THERE IS 206 00:09:00,089 --> 00:09:01,991 SO MANY THINGS GOING ON TODAY. 207 00:09:01,991 --> 00:09:03,492 YOU WILL HEAR MORE ABOUT THEM. 208 00:09:03,492 --> 00:09:06,962 I'M REALLY HONORED TO BE HERE AT 209 00:09:06,962 --> 00:09:09,832 NIBIB'S COUNCIL AND TALK TO YOU 210 00:09:09,832 --> 00:09:11,534 A LITTLE ABOUT WOMEN'S HEALTH AT 211 00:09:11,534 --> 00:09:13,536 THIS PARTICULAR TIME AND HAD TO 212 00:09:13,536 --> 00:09:16,238 USE PHYSICS ANALOGIES FOR ALL OF 213 00:09:16,238 --> 00:09:16,706 YOU. 214 00:09:16,706 --> 00:09:24,513 IN TERMS OF FUL KRIM BEING IT IS 215 00:09:24,513 --> 00:09:26,949 A MEANS TO GETTING SOMETHING 216 00:09:26,949 --> 00:09:29,185 DONE AND THAT IS THE ANALOGY I'M 217 00:09:29,185 --> 00:09:31,554 USING TODAY AS I SELECTED THIS 218 00:09:31,554 --> 00:09:35,157 TITLE TECHNOLOGY AS A FULCRUM TO 219 00:09:35,157 --> 00:09:38,027 MAXIMIZE TRAJECTORY OF WOMEN'S 220 00:09:38,027 --> 00:09:38,260 HEALTH. 221 00:09:38,260 --> 00:09:42,698 SO HOW TECHNOLOGY INNOVATION AND 222 00:09:42,698 --> 00:09:44,200 HIGH-RETURN OPPORTUNITIES CAN 223 00:09:44,200 --> 00:09:46,368 ADVANCE WOMEN'S HEALTH CARE IS 224 00:09:46,368 --> 00:09:48,771 THIS STARTING POINT FOR MY TALK 225 00:09:48,771 --> 00:09:49,171 HERE. 226 00:09:49,171 --> 00:09:51,774 THERE ARE SO MANY WOMEN'S HEALTH 227 00:09:51,774 --> 00:09:54,477 TOPICS AND AREAS OF NEED AND 228 00:09:54,477 --> 00:09:57,113 ISSUES NEEDING TO BE ADDRESSED. 229 00:09:57,113 --> 00:09:59,081 THOSE REPRESENT RESEARCH 230 00:09:59,081 --> 00:10:01,150 OPPORTUNITIES FOR THE ENTIRE 231 00:10:01,150 --> 00:10:02,485 BIOMEDICAL RESEARCH ENTERPRISE 232 00:10:02,485 --> 00:10:04,220 AND IN PARTICULAR FOR THE 233 00:10:04,220 --> 00:10:06,088 MISSION AREAS OF NIBIB. 234 00:10:06,088 --> 00:10:08,257 I THINK WE ARE AT A TIPPING 235 00:10:08,257 --> 00:10:10,426 POINT WE CAN REALLY ACCELERATE 236 00:10:10,426 --> 00:10:13,295 PROGRESS BY APPLYING TECHNOLOGY, 237 00:10:13,295 --> 00:10:16,365 ENGINEERING, IMAGING AND OTHER 238 00:10:16,365 --> 00:10:17,299 ADVANCED STRATEGIES WHEN WE 239 00:10:17,299 --> 00:10:19,101 CONVERGE ON THE HEALTH OF WOMEN 240 00:10:19,101 --> 00:10:20,970 AND PUT ALL THAT SCIENCE AND 241 00:10:20,970 --> 00:10:22,404 TECHNOLOGY TO WORK FOR THE 242 00:10:22,404 --> 00:10:23,672 HEALTH OF WOMEN. 243 00:10:23,672 --> 00:10:25,374 WE CAN DEVELOP WHAT WE CALL 244 00:10:25,374 --> 00:10:28,144 SOLUTION STRATEGIES FOR THE 245 00:10:28,144 --> 00:10:29,278 PROBLEM STATEMENTS WE ARE SO 246 00:10:29,278 --> 00:10:30,379 FOND OF WRITING. 247 00:10:30,379 --> 00:10:36,252 I TOOK A LOOK AT NIBIB'S MISSION 248 00:10:36,252 --> 00:10:38,053 STATEMENT AND SAID THIS IS SO 249 00:10:38,053 --> 00:10:40,456 WELL WITH NIH SEX AS A 250 00:10:40,456 --> 00:10:42,324 BIOLOGICAL POLICY WHICH I WAS 251 00:10:42,324 --> 00:10:43,826 REALLY PLEASED TO WORK ON WITH 252 00:10:43,826 --> 00:10:45,795 MY COLLEAGUES HERE AT NIH. 253 00:10:45,795 --> 00:10:50,432 FIRST IN TERMS OF PREVENTION, WE 254 00:10:50,432 --> 00:10:52,935 KNOW THAT UNDER-REPRESENTED -- 255 00:10:52,935 --> 00:10:54,370 UNDERREPRESENTATION OF FEMALE 256 00:10:54,370 --> 00:10:56,305 PARTICIPANTS IN NIH AND CLINICAL 257 00:10:56,305 --> 00:10:58,874 RESEARCH OVER THE YEARS HAS LED 258 00:10:58,874 --> 00:11:01,577 TO A LACK OF SEX-BASED ANALYSIS 259 00:11:01,577 --> 00:11:04,413 OVER THE YEARS AND CREATED GAPS 260 00:11:04,413 --> 00:11:06,282 IN OUR KNOWLEDGE AND, 261 00:11:06,282 --> 00:11:07,950 UNFORTUNATELY, IT HAS LED TO THE 262 00:11:07,950 --> 00:11:09,785 SITUATION WE HAVE THERAPEUTICS 263 00:11:09,785 --> 00:11:11,620 THAT WERE NEVER TESTED IN 264 00:11:11,620 --> 00:11:14,123 PARTICULAR IN WOMEN BEFORE 265 00:11:14,123 --> 00:11:15,624 REVITALIZATION ACT AND 266 00:11:15,624 --> 00:11:17,426 REVITALIZATION OF 1993 THAT WILL 267 00:11:17,426 --> 00:11:18,828 REQUIRE THAT AND MEDICATIONS 268 00:11:18,828 --> 00:11:21,096 WERE NOT TESTED IN WOMEN BUT MEN 269 00:11:21,096 --> 00:11:23,432 AND FINDINGS WERE APPLIED MORE 270 00:11:23,432 --> 00:11:24,266 BROADLY TO EVERYONE. 271 00:11:24,266 --> 00:11:25,801 SOME OF THE MEDICATIONS HAVE 272 00:11:25,801 --> 00:11:27,937 BEEN FOUND TO HAVE LOWER 273 00:11:27,937 --> 00:11:29,772 EFFICACY IN WOMEN AND 274 00:11:29,772 --> 00:11:31,740 UNFORTUNATELY GREATER TOXICITY 275 00:11:31,740 --> 00:11:32,441 IN WOMEN. 276 00:11:32,441 --> 00:11:35,477 IN TERMS OF TREATMENTS, WE KNOW 277 00:11:35,477 --> 00:11:37,880 THAT SEX, A BIOLOGICAL VARIABLE 278 00:11:37,880 --> 00:11:40,015 OF SEX WHETHER YOU ARE 279 00:11:40,015 --> 00:11:41,650 SUSCEPTIBLE TO CERTAIN DISEASES 280 00:11:41,650 --> 00:11:43,786 WE SEE DIFFERENCES IN PREVALENCE 281 00:11:43,786 --> 00:11:45,588 OF DISEASE SEX AUTO IMMUNE 282 00:11:45,588 --> 00:11:48,157 DISEASE 80% OF PATIENTS ARE 283 00:11:48,157 --> 00:11:50,059 WOMEN AND WE SEE IT ALSO EFFECTS 284 00:11:50,059 --> 00:11:52,261 YOUR EXPERIENCE OF DISEASE AND 285 00:11:52,261 --> 00:11:54,997 YOUR RESPONSE TO TREATMENT AND 286 00:11:54,997 --> 00:11:55,965 BENEATH THAT TREATMENT STATEMENT 287 00:11:55,965 --> 00:11:59,335 IS ALL OF THAT UNDERLYING 288 00:11:59,335 --> 00:12:00,769 FOUNDATION THAT WE NEED TO 289 00:12:00,769 --> 00:12:01,036 CONSIDER. 290 00:12:01,036 --> 00:12:03,839 IN TERMS OF TOOLS AND 291 00:12:03,839 --> 00:12:05,241 TECHNOLOGIES THAT CAN HELP US 292 00:12:05,241 --> 00:12:08,110 IDENTIFY PATHWAYS AND PROCESSES 293 00:12:08,110 --> 00:12:09,478 TO IDENTIFY TARGETS CHARACTERIZE 294 00:12:09,478 --> 00:12:11,780 HOW THE BODY FIGHTS DISEASE SUCH 295 00:12:11,780 --> 00:12:14,350 AS THE IMMUNE SYSTEM AND 296 00:12:14,350 --> 00:12:15,718 SAME-SEX DIFFERENCES IN THE 297 00:12:15,718 --> 00:12:18,020 IMMUNE SYSTEM IF YOU DON'T KNOW 298 00:12:18,020 --> 00:12:20,823 BEFORE COVID YOU SEE NOW AND SEE 299 00:12:20,823 --> 00:12:23,125 HIGHER MORTALITY RATES IN MEN 300 00:12:23,125 --> 00:12:25,828 VERSUS WOMEN AND PROCESS PAIN 301 00:12:25,828 --> 00:12:26,829 AND LITERALLY DIFFERENT CELLS 302 00:12:26,829 --> 00:12:30,299 ARE INVOLVED IN PAIN PROCESSING 303 00:12:30,299 --> 00:12:32,201 AND MICROGLIA SEX AND HOW TO 304 00:12:32,201 --> 00:12:33,769 MAINTAIN HEALTH PREVENTION AND 305 00:12:33,769 --> 00:12:36,538 HEALTH PROMOTION AND IMPROVING 306 00:12:36,538 --> 00:12:39,341 HUMAN HEALTH, WE USE MODELS OF 307 00:12:39,341 --> 00:12:40,943 HUMAN DISEASE TO UNDERSTAND 308 00:12:40,943 --> 00:12:43,178 HUMAN HEALTH AND IN SOME CASES 309 00:12:43,178 --> 00:12:45,381 ANIMAL OR CELL-BASED MODELS ARE 310 00:12:45,381 --> 00:12:47,583 USED TO INFORM UNDERSTANDING OF 311 00:12:47,583 --> 00:12:49,585 HUMAN BIOLOGY AND DON'T 312 00:12:49,585 --> 00:12:53,088 NECESSARILY RECAPITULATE WITH 313 00:12:53,088 --> 00:12:54,857 FIDELITY IN TERMS WHAT WE SEE 314 00:12:54,857 --> 00:12:56,425 WITH SEX DISEASES AND HUMAN 315 00:12:56,425 --> 00:12:59,261 DISEASE AND HISTORICALLY WE 316 00:12:59,261 --> 00:13:01,931 OVERRELIED ON MALE ANIMALS AND 317 00:13:01,931 --> 00:13:03,832 MALE CELLS IN IN VITRO WORK. 318 00:13:03,832 --> 00:13:05,634 HERE ARE SOME WAYS IN ADDITION 319 00:13:05,634 --> 00:13:08,003 TO OUR EFFORTS TO PROMOTE 320 00:13:08,003 --> 00:13:09,705 TRAINING WHERE WE HAVE DEVELOPED 321 00:13:09,705 --> 00:13:13,008 ONLINE EDUCATIONAL RESOURCES 322 00:13:13,008 --> 00:13:16,979 RELATED TO SIBIB AND HOW NIBIB 323 00:13:16,979 --> 00:13:18,948 MISSION STATEMENT AND POLICY ARE 324 00:13:18,948 --> 00:13:19,848 TRULY COMPLEMENTARY. 325 00:13:19,848 --> 00:13:25,888 I WAS REAL EXCITED TO SEE YOU 326 00:13:25,888 --> 00:13:29,024 LIKE WE ARE THINKING ABOUT A NEW 327 00:13:29,024 --> 00:13:30,259 STRATEGIC PLAN AND GIVING A 328 00:13:30,259 --> 00:13:33,963 SNEAK PEEK WE ARE RELEASING NEW 329 00:13:33,963 --> 00:13:35,297 NIH-WIDE STRATEGIC PLAN ON 330 00:13:35,297 --> 00:13:36,865 RESEARCH OF HEALTH AND WOMEN 331 00:13:36,865 --> 00:13:38,300 TODAY. YOU ARE FIRST TO HEAR 332 00:13:38,300 --> 00:13:41,270 IT. IT IS ONLINE NOW AND DR. 333 00:13:41,270 --> 00:13:43,505 BER TAN OELI'S VIDEO TALKING 334 00:13:43,505 --> 00:13:45,941 ABOUT HER VISION AND HOW NIH CAN 335 00:13:45,941 --> 00:13:47,476 TURN DISCOVERY AND HEALTH FOR 336 00:13:47,476 --> 00:13:49,745 EVERYONE IS AVAILABLE ONLINE NOW 337 00:13:49,745 --> 00:13:52,748 AND NIBIB'S STRATEGIC PLAN IS 338 00:13:52,748 --> 00:13:54,416 THINKING ABOUT FIVE AREAS AS YOU 339 00:13:54,416 --> 00:13:57,252 GET INPUT. EACH AND EVERY ONE 340 00:13:57,252 --> 00:13:59,588 OF THEM ARE HIGHLY RELEVANT TO 341 00:13:59,588 --> 00:14:02,191 WOMEN'S HEALTH WHETHER ENGINEER 342 00:14:02,191 --> 00:14:05,260 BIOLOGIC SYSTEMS THAT MIMIC 343 00:14:05,260 --> 00:14:07,162 FEMALE REPRODUCTIVE TRACK OR 344 00:14:07,162 --> 00:14:09,031 CENSORS AND CARE DIAGNOSTICS AND 345 00:14:09,031 --> 00:14:11,800 FIRST WE COLLABORATED ON 346 00:14:11,800 --> 00:14:13,369 MATERNAL HEALTH CHALLENGE AND 347 00:14:13,369 --> 00:14:16,105 TRYING TO REALLY IDENTIFY, YOU 348 00:14:16,105 --> 00:14:19,808 KNOW, EARLY SIGNS OF LABOR 349 00:14:19,808 --> 00:14:22,478 PRETERM BIRTH DIAGNOSTICS 350 00:14:22,478 --> 00:14:24,213 BIOMEDICAL ENGINEERING AND GOOD 351 00:14:24,213 --> 00:14:27,483 FRIEND IS HERE AND A LOT OF THIS 352 00:14:27,483 --> 00:14:29,418 WORK IS RELEVANT TO WOMEN'S 353 00:14:29,418 --> 00:14:31,153 HEALTH AND LOTS OF WORK IS 354 00:14:31,153 --> 00:14:32,888 INCLUDING WOMEN'S HEALTH RIGHT 355 00:14:32,888 --> 00:14:34,857 NOW EVEN IF IT IS NOT CALLED 356 00:14:34,857 --> 00:14:36,658 WOMEN'S HEALTH RESEARCH AND WANT 357 00:14:36,658 --> 00:14:38,494 TO GIVE ALL THOSE TECHNOLOGISTS 358 00:14:38,494 --> 00:14:40,562 AND IMAGEERS AND SCIENTISTS IN 359 00:14:40,562 --> 00:14:42,297 THE AUDIENCE WORKING IN THAT 360 00:14:42,297 --> 00:14:45,934 SPACE A SHOUTOUT AND PUT YOU TO 361 00:14:45,934 --> 00:14:47,870 WOMEN'S HEALTH DATA SCIENCE 362 00:14:47,870 --> 00:14:50,139 MODELING AND COMPUTATION IS 363 00:14:50,139 --> 00:14:52,541 IMBEDDED IN NIH-WIDE STRATEGIC 364 00:14:52,541 --> 00:14:54,676 PLAN AS ONE OF THE GOALS AND WE 365 00:14:54,676 --> 00:14:57,112 ARE IN ALIGNMENT AND IN TERMS OF 366 00:14:57,112 --> 00:14:58,814 ADVANCED THERAPEUTICS, WE KNOW 367 00:14:58,814 --> 00:15:00,682 THAT WE ARE ON THE ROAD TO 368 00:15:00,682 --> 00:15:01,817 PRECISION MEDICINE. 369 00:15:01,817 --> 00:15:03,585 I WILL SAY ON THE ROAD. 370 00:15:03,585 --> 00:15:05,154 WE ARE NOT THERE FOR EVERYTHING, 371 00:15:05,154 --> 00:15:07,423 BUT WE HAVE MADE INCREDIBLE 372 00:15:07,423 --> 00:15:09,525 ADVANCES BY IDENTIFYING 373 00:15:09,525 --> 00:15:11,627 MOLECULAR TARGETS FOR LUNG 374 00:15:11,627 --> 00:15:13,295 CANCER WE CAN INTERVENE ON. 375 00:15:13,295 --> 00:15:16,031 LET ME PUT FORWARD TO YOU THAT 376 00:15:16,031 --> 00:15:17,299 CONSIDERING SEX SHOULD BE THE 377 00:15:17,299 --> 00:15:19,234 FIRST STEP ON THAT ROAD TO 378 00:15:19,234 --> 00:15:20,302 PRECISION MEDICINE. 379 00:15:20,302 --> 00:15:23,238 WE CAN'T REALLY BE PERSONALIZED. 380 00:15:23,238 --> 00:15:25,274 WE CAN'T REALLY BE 381 00:15:25,274 --> 00:15:26,708 INDIVIDUALIZED IF WE ARE NOT 382 00:15:26,708 --> 00:15:29,144 CONSIDERING SEX AS A BIOLOGICAL 383 00:15:29,144 --> 00:15:29,711 VARIABLE. 384 00:15:29,711 --> 00:15:33,182 WE NOW KNOW THAT SEX OPERATES AT 385 00:15:33,182 --> 00:15:34,817 EVERY LEVEL. GENE EXPRESSION 386 00:15:34,817 --> 00:15:37,219 LEVEL, TISSUE LEVEL, ORGAN LEVEL 387 00:15:37,219 --> 00:15:39,922 AND CERTAINLY AT ORGANISM LEVEL. 388 00:15:39,922 --> 00:15:42,458 SO ADVANCED THERAPEUTICS, SIBIB 389 00:15:42,458 --> 00:15:44,359 SHOULD BE PART OF THAT AND I'M 390 00:15:44,359 --> 00:15:45,561 SURE IT WILL BE. 391 00:15:45,561 --> 00:15:47,196 HOWEVER, WE DO KNOW THAT IF YOU 392 00:15:47,196 --> 00:15:49,832 LOOK ACROSS THE HEALTH 393 00:15:49,832 --> 00:15:51,633 ECOSYSTEM, WOMEN'S HEALTH IS NOT 394 00:15:51,633 --> 00:15:52,868 THE FIRST THING WILL YOU SEE. 395 00:15:52,868 --> 00:15:55,170 IF YOU LOOK AT WHERE INVESTMENTS 396 00:15:55,170 --> 00:15:57,840 ARE GOING IN COMPLEX ECOSYSTEMS 397 00:15:57,840 --> 00:16:00,909 AND MULTISECTOR ECOSYSTEM AND 398 00:16:00,909 --> 00:16:03,879 INVESTMENTS IN WOMEN'S HEALTH 399 00:16:03,879 --> 00:16:05,147 ARE NOT MOST ROBUST AS WELL. 400 00:16:05,147 --> 00:16:07,483 HERE IS WHY THAT IS AN ISSUE AND 401 00:16:07,483 --> 00:16:09,751 WHY I KNOW THAT EVERYONE IN THE 402 00:16:09,751 --> 00:16:11,687 ROOM AND EVERYONE HEARING THIS 403 00:16:11,687 --> 00:16:12,821 WILL DO SOMETHING DIFFERENT 404 00:16:12,821 --> 00:16:14,456 GOING FORWARD AND GLOBALLY WOMEN 405 00:16:14,456 --> 00:16:19,027 WITH DEMENTIA OUTNUMBER MEN WITH 406 00:16:19,027 --> 00:16:22,498 DEMENTIA 169 AND 2000 WOMEN IN 407 00:16:22,498 --> 00:16:24,166 THE UNITED STATES HAVE REPORTED 408 00:16:24,166 --> 00:16:26,235 ADVERSE EFFECTS FROM IMPROVED 409 00:16:26,235 --> 00:16:28,537 MEDICATION AND 2% MORE 410 00:16:28,537 --> 00:16:29,671 FREQUENTLY THAN MEN. 411 00:16:29,671 --> 00:16:33,308 SOME OF THEM HAVE INVOLVED FATAL 412 00:16:33,308 --> 00:16:34,143 [INDISCERNIBLE]. 413 00:16:34,143 --> 00:16:36,845 WOMEN ARE UNDER-REPRESENTED AND 414 00:16:36,845 --> 00:16:38,180 SURGICAL CLINICAL TRIALS FOR 415 00:16:38,180 --> 00:16:40,682 SPECIFIC CANCERS OF THE BLADDER 416 00:16:40,682 --> 00:16:43,952 HAD NEXT STOMACH AND ESOPHAGUS 417 00:16:43,952 --> 00:16:45,754 AND CANCER CAN EFFECT WOMEN AND 418 00:16:45,754 --> 00:16:48,323 MEN DIFFERENTLY AND SOME 419 00:16:48,323 --> 00:16:50,159 COUNTRIES, SWITZERLAND AND WOMEN 420 00:16:50,159 --> 00:16:52,561 PAID HIGHER INSURANCE PREMIUM 421 00:16:52,561 --> 00:16:54,563 THEN MEN DO THAT LIMITS ACCESS 422 00:16:54,563 --> 00:16:56,798 TO CARE AND THINK THIS AUDIENCE 423 00:16:56,798 --> 00:16:59,001 IS AWARE THAT COMPENSATION AND 424 00:16:59,001 --> 00:17:00,869 REMUNERATION FOR PHYSICIANS 425 00:17:00,869 --> 00:17:02,905 PERFORMING PROCEDURES DIFFERS 426 00:17:02,905 --> 00:17:05,641 FOR WOMEN AND MEN IF THEY ARE 427 00:17:05,641 --> 00:17:06,975 SIMILAR PROCEDURES EVEN. 428 00:17:06,975 --> 00:17:10,412 IN ADDITION, WE KNOW THAT THE 429 00:17:10,412 --> 00:17:11,280 EFFECTIVENESS OF SOME 430 00:17:11,280 --> 00:17:13,515 INTERVENTION IS LOWER FOR WOMEN. 431 00:17:13,515 --> 00:17:15,551 THE ACCESS TO SOME INTERVENTIONS 432 00:17:15,551 --> 00:17:17,386 IS LOWER. 433 00:17:17,386 --> 00:17:19,254 54% OF INTERVENTION STUDIES WERE 434 00:17:19,254 --> 00:17:21,323 FOUND TO PUT WOMEN AT A 435 00:17:21,323 --> 00:17:23,192 DISADVANTAGE BECAUSE OF LOWER 436 00:17:23,192 --> 00:17:26,161 EFFECTIVENESS AND LESS ACCESS OR 437 00:17:26,161 --> 00:17:28,897 BOTH FROM MACKENZIE REPORT THAT 438 00:17:28,897 --> 00:17:31,366 LOOKED ACROSS THE ENTIRE SECTOR 439 00:17:31,366 --> 00:17:34,503 AND HERE IS DATA THAT IS 440 00:17:34,503 --> 00:17:39,141 DEMONSTRATING THAT SINCE 1980, 441 00:17:39,141 --> 00:17:41,009 [INDISCERNIBLE] 3.5 TIMES MORE 442 00:17:41,009 --> 00:17:43,212 LIKELY TO BE REMOVED FROM THE 443 00:17:43,212 --> 00:17:44,580 MARKET BECAUSE OF SAFETY RISKS 444 00:17:44,580 --> 00:17:46,815 IN WOMEN COMPARED TO MEN AND 445 00:17:46,815 --> 00:17:49,151 WANT TO ALSO ADRAW YOUR 446 00:17:49,151 --> 00:17:50,485 ATTENTION TO THE GREY BAR THAT 447 00:17:50,485 --> 00:17:53,222 IS WHERE IT WAS UNKNOWN HERE. 448 00:17:53,222 --> 00:17:54,656 INSUFFICIENT DATA. 449 00:17:54,656 --> 00:17:56,525 BECAUSE THE DATA WAS PROBABLY 450 00:17:56,525 --> 00:17:58,994 NOT DISAGGREGATED BY SEX AND WE 451 00:17:58,994 --> 00:18:00,862 REALLY DON'T KNOW AND NEED TO 452 00:18:00,862 --> 00:18:02,464 REALLY KNOW THAT FOR EVERYONE'S 453 00:18:02,464 --> 00:18:02,698 HEALTH. 454 00:18:02,698 --> 00:18:05,067 IN TERMS OF THE ECONOMY, WE 455 00:18:05,067 --> 00:18:08,537 SEE, I THINK, LARGE UNMET NEEDS 456 00:18:08,537 --> 00:18:12,107 IN WOMEN'S HEALTH ARENA. 457 00:18:12,107 --> 00:18:13,442 THOSE REPRESENT OPPORTUNITIES 458 00:18:13,442 --> 00:18:15,477 AND TELLS GAPS IN MANY TOPICS. 459 00:18:15,477 --> 00:18:18,380 I WILL HIGHLIGHT A FEW OF THEM 460 00:18:18,380 --> 00:18:20,649 ENDOMETRIOSIS IN PARTICULAR THAT 461 00:18:20,649 --> 00:18:23,819 IS A $200 MILLION MARKET IN THE 462 00:18:23,819 --> 00:18:27,990 US UTERINE FIBROIDS HIGHLY 463 00:18:27,990 --> 00:18:28,924 PREVALENT CAUSED [INDISCERNIBLE] 464 00:18:28,924 --> 00:18:31,126 IN MEN AND WOMEN AND GREATER 465 00:18:31,126 --> 00:18:32,561 PREVALENCE IN AFRICAN AMERICAN 466 00:18:32,561 --> 00:18:33,729 WOMEN AND FURTHER RESEARCH 467 00:18:33,729 --> 00:18:35,931 NEEDED AND MENOPAUSE THAT WILL 468 00:18:35,931 --> 00:18:37,799 EFFECT EVERY FEMALE THAT LIVES 469 00:18:37,799 --> 00:18:39,067 LONG ENOUGH TO EXPERIENCE IT 470 00:18:39,067 --> 00:18:41,737 HIGH UNMET NEED AND ECONOMIC 471 00:18:41,737 --> 00:18:43,071 [INDISCERNIBLE] THERE AND IN 472 00:18:43,071 --> 00:18:45,774 TERMS OF DIGITAL HEALTH IS 473 00:18:45,774 --> 00:18:48,010 STRATEGY ADDRESSING FERTILITY 474 00:18:48,010 --> 00:18:49,578 AND INFERTILITY ISSUES SEEING 475 00:18:49,578 --> 00:18:52,481 WITH START-UPS AND MENSTRUAL 476 00:18:52,481 --> 00:18:54,883 PRODUCTS AND GYNECOLOGICAL 477 00:18:54,883 --> 00:18:58,020 DEVICES AND GREAT OPPORTUNITY TO 478 00:18:58,020 --> 00:18:59,588 ADDRESS THIS GENDER HEALTH GAP 479 00:18:59,588 --> 00:19:02,557 AND IN TERMS OF ECONOMIC BENEFIT 480 00:19:02,557 --> 00:19:03,625 WE KNOW THAT WOMEN PARTICIPATE 481 00:19:03,625 --> 00:19:05,627 IN THE ECONOMY IN VARIETY OF 482 00:19:05,627 --> 00:19:08,230 DIFFERENT WAYS IN ADDITION TO 483 00:19:08,230 --> 00:19:10,065 AMAZING THINGS WE DO TOGETHER AS 484 00:19:10,065 --> 00:19:12,034 COMMUNITY AND SOCIETY AND THEIR 485 00:19:12,034 --> 00:19:13,201 PARTICIPATION IN THE WORKFORCE 486 00:19:13,201 --> 00:19:15,304 IS A MAJOR DRIVER OF ECONOMIC 487 00:19:15,304 --> 00:19:16,638 GROWTH OF COUNTRIES. 488 00:19:16,638 --> 00:19:19,641 IF WE ADDRESS THE HEALTH GAP 489 00:19:19,641 --> 00:19:21,176 THAT WOMEN FACE IT COULD REACH 490 00:19:21,176 --> 00:19:24,413 THE GLOBAL ECONOMY BY ADDING 1 491 00:19:24,413 --> 00:19:28,216 TRILLION WITH A T TO THE GLOBAL 492 00:19:28,216 --> 00:19:29,818 ECONOMY BY 2040. 493 00:19:29,818 --> 00:19:32,220 IF YOU DON'T AGREE WOMEN'S 494 00:19:32,220 --> 00:19:35,090 HEALTH IS SOMETHING YOU SHOULD 495 00:19:35,090 --> 00:19:37,426 PRIORITIZE, FROM AN ECONOMIC 496 00:19:37,426 --> 00:19:38,694 PERSPECTIVE IT IS SOMETHING WE 497 00:19:38,694 --> 00:19:40,729 ALL NEED TO CONSIDER MOVING 498 00:19:40,729 --> 00:19:40,996 FORWARD. 499 00:19:40,996 --> 00:19:44,466 GLOBAL GENDER HEALTH INNOVATION 500 00:19:44,466 --> 00:19:46,568 GAP IS SOMETHING THAT ORWH IS 501 00:19:46,568 --> 00:19:49,471 CONCERNED OF AS OF LATE AND 502 00:19:49,471 --> 00:19:50,605 CO-AUTHORED THIS PIECE WITH 503 00:19:50,605 --> 00:19:52,908 JAMIE WHITE TO BRING ATTENTION 504 00:19:52,908 --> 00:19:55,377 TO GENDER HEALTH INNOVATION GAP 505 00:19:55,377 --> 00:19:57,913 AND COLLABORATED WITH BILL AND 506 00:19:57,913 --> 00:19:59,448 LINDA GATES FOUNDATION TO 507 00:19:59,448 --> 00:20:02,250 CONVENE INNOVATION EQUITY FORUM 508 00:20:02,250 --> 00:20:05,387 OR IES BRINGING TOGETHER 250 KEY 509 00:20:05,387 --> 00:20:07,656 INTERESTED PERSONS FROM OVER 50 510 00:20:07,656 --> 00:20:09,891 COUNTRIES WHO LOOK AT ONE OF THE 511 00:20:09,891 --> 00:20:12,861 MOST CRITICAL WOMEN'S HEALTH R & 512 00:20:12,861 --> 00:20:13,895 D GAPS. 513 00:20:13,895 --> 00:20:16,398 SO WHY IS THIS AN INNOVATION 514 00:20:16,398 --> 00:20:17,265 OPPORTUNITY? 515 00:20:17,265 --> 00:20:19,267 WOMEN'S HEALTH OF COURSE 516 00:20:19,267 --> 00:20:20,569 REPRESENTS AN UNTAPPED 517 00:20:20,569 --> 00:20:22,704 OPPORTUNITY TO IMPROVE 518 00:20:22,704 --> 00:20:23,105 WELLBEING. 519 00:20:23,105 --> 00:20:25,507 TO PROMOTE MORE RESILIENT 520 00:20:25,507 --> 00:20:27,976 HOUSEHOLDS AND COMMUNITIES AND 521 00:20:27,976 --> 00:20:29,811 STRONGER ECONOMIES AND INCREASED 522 00:20:29,811 --> 00:20:30,679 FINANCIAL DETOURENCE. 523 00:20:30,679 --> 00:20:33,615 I THINK THAT IS THE CASE FOR 524 00:20:33,615 --> 00:20:34,149 INNOVATION OPPORTUNITY. 525 00:20:34,149 --> 00:20:36,651 WE CREATED INNOVATION 526 00:20:36,651 --> 00:20:39,421 OPPORTUNITY MAP. HERE IS THE 527 00:20:39,421 --> 00:20:40,689 INDIVIDUAL SECTORS WE INCLUDED 528 00:20:40,689 --> 00:20:43,825 AND ENTIRE R & D ECOSYSTEM FROM 529 00:20:43,825 --> 00:20:45,994 A GLOBAL PERSPECTIVE AND SEVERAL 530 00:20:45,994 --> 00:20:48,063 CROSS-CUTTING TOPICS AND WILL 531 00:20:48,063 --> 00:20:49,664 FLAG A FEW FOR YOU ONE SECTION 532 00:20:49,664 --> 00:20:52,768 IS ON DATA AND MODELING AND ONE 533 00:20:52,768 --> 00:20:54,169 ON INNOVATION INTRODUCTION AND 534 00:20:54,169 --> 00:20:56,438 HERE IS THE US DATA. 535 00:20:56,438 --> 00:21:00,041 IN THE US THERE IS 300 MILLION 536 00:21:00,041 --> 00:21:02,411 DOLLAR INVESTMENT IN WOMEN'S 537 00:21:02,411 --> 00:21:04,546 HEALTH RESEARCH COULD GENERATE 538 00:21:04,546 --> 00:21:07,716 13 BILLION DOLLARS IN ECONOMIC 539 00:21:07,716 --> 00:21:10,085 RETURNS AND THIS IS THE 540 00:21:10,085 --> 00:21:12,521 FRAMEWORK FOR THE INNOVATION 541 00:21:12,521 --> 00:21:13,388 OPPORTUNITY MAP. 542 00:21:13,388 --> 00:21:16,658 WE LAID OUT 50 EQUITABLE 543 00:21:16,658 --> 00:21:17,626 HIGH-RETURN OPPORTUNITIES TO 544 00:21:17,626 --> 00:21:19,428 ADVANCE GLOBAL INNOVATION FOR 545 00:21:19,428 --> 00:21:22,297 WOMEN'S HEALTH AND USED CRITERIA 546 00:21:22,297 --> 00:21:24,332 AT THE TOP WHETHER POTENTIAL FOR 547 00:21:24,332 --> 00:21:25,767 IMPACT AND WHETHER THEY ARE 548 00:21:25,767 --> 00:21:27,536 READY FOR PROGRESS IN 5 TO 10 549 00:21:27,536 --> 00:21:29,271 YEARS AND HAD TO BE INNOVATIVE 550 00:21:29,271 --> 00:21:31,273 AND HAD TO MATTER TO WOMEN AND 551 00:21:31,273 --> 00:21:33,442 WANTED IT TO BE WOMEN-CENTRIC 552 00:21:33,442 --> 00:21:35,911 AND ADDRESS PROBLEMS WOMEN THINK 553 00:21:35,911 --> 00:21:37,946 NEED TO BE ADDRESSED AND HAD TO 554 00:21:37,946 --> 00:21:40,348 ADVANCE EQUITY. WE CALL THEM 555 00:21:40,348 --> 00:21:42,484 PRIME CRITERIA AND FILTERED ALL 556 00:21:42,484 --> 00:21:44,252 OF THE IDEAS AND SUGGESTIONS WE 557 00:21:44,252 --> 00:21:46,321 GOT FROM INNOVATION EQUITY FORUM 558 00:21:46,321 --> 00:21:48,690 FOR THE MONTHS ON THE CRITERIA 559 00:21:48,690 --> 00:21:50,459 AND DRILLED THEM DOWN TO THE 10 560 00:21:50,459 --> 00:21:51,993 MAJOR TOPIC AREAS. 561 00:21:51,993 --> 00:21:54,763 UNDER EACH OF THE AREAS, THERE 562 00:21:54,763 --> 00:21:57,732 ARE FIVE OR SIX SPECIFIC 563 00:21:57,732 --> 00:21:59,935 OBJECTIVES AND OPPORTUNITY. 564 00:21:59,935 --> 00:22:01,603 WHAT WE CONSIDER WOMEN'S HEALTH 565 00:22:01,603 --> 00:22:03,538 FOR THIS IS ANYTHING THAT 566 00:22:03,538 --> 00:22:07,209 EFFECTS WOMEN UNIQUELY. SO 567 00:22:07,209 --> 00:22:08,043 FEMALE-SPECIFIC. 568 00:22:08,043 --> 00:22:09,578 DIFFERENTLY LIKE AUTO IMMUNE 569 00:22:09,578 --> 00:22:11,413 DISEASE OR DISPROPORTIONATELY. 570 00:22:11,413 --> 00:22:13,248 I WANT TO JUST MAKE SURE YOU 571 00:22:13,248 --> 00:22:14,783 UNDERSTAND THE UNIVERSE HERE IS 572 00:22:14,783 --> 00:22:17,052 FAR BEYOND REPRODUCTIVE HEALTH 573 00:22:17,052 --> 00:22:19,020 AND WE CONSIDER WOMEN'S HEALTH 574 00:22:19,020 --> 00:22:20,388 EVERYTHING THAT EFFECTS WOMEN 575 00:22:20,388 --> 00:22:22,958 FROM HEAD TO TOE INSIDE AND OUT 576 00:22:22,958 --> 00:22:24,526 ACROSS THE ENTIRE LIFE COURSE. 577 00:22:24,526 --> 00:22:27,529 SO AS A RESULT OF THAT 578 00:22:27,529 --> 00:22:28,997 INNOVATION OPPORTUNITY MAP, WE 579 00:22:28,997 --> 00:22:32,734 WOULD LIKE TO IMPLEMENT A 580 00:22:32,734 --> 00:22:33,635 CROSS-SECTOR APPROACH TO ENGAGE 581 00:22:33,635 --> 00:22:36,137 GLOBAL KEY INTERESTED PERSONS 582 00:22:36,137 --> 00:22:37,205 PRIORITIZING WOMEN INCLUDING 583 00:22:37,205 --> 00:22:38,974 VOICES OF WOMEN THEMSELVES AND 584 00:22:38,974 --> 00:22:41,276 SOLVING PROBLEMS THAT WOMEN 585 00:22:41,276 --> 00:22:45,113 BELIEVE NEED TO BE SOLVED 586 00:22:45,113 --> 00:22:46,515 DEVELOPINO VATTIVE IDEAS AND 587 00:22:46,515 --> 00:22:47,816 WORKING THROUGH STEPPING STONES 588 00:22:47,816 --> 00:22:50,118 TO GET TO MILESTONES. WE KNOW 589 00:22:50,118 --> 00:22:51,520 THIS IS A COMPLEX AND 590 00:22:51,520 --> 00:22:52,854 CONSTRAINED ENVIRONMENT IN 591 00:22:52,854 --> 00:22:53,955 PARTICULAR RIGHT NOW. 592 00:22:53,955 --> 00:22:56,291 WHEN WOMEN'S HEALTH IMPROVES THE 593 00:22:56,291 --> 00:22:58,493 HEALTH OF COMMUNITIES AND 594 00:22:58,493 --> 00:22:59,361 SOCIETIES IMPROVE. 595 00:22:59,361 --> 00:23:01,530 SO THIS IS A SMART INVESTMENT 596 00:23:01,530 --> 00:23:02,397 FOR US ALL. 597 00:23:02,397 --> 00:23:05,433 WHAT ARE WAYS WE ARE DOING THAT 598 00:23:05,433 --> 00:23:08,203 THROUGH OUR PROGRAM AND OUR 599 00:23:08,203 --> 00:23:11,306 SCORE PROGRAM IS SEX DIFFERENCES 600 00:23:11,306 --> 00:23:12,407 CENTERS PROGRAM AND 601 00:23:12,407 --> 00:23:13,775 [INDISCERNIBLE] PROGRAM IS 602 00:23:13,775 --> 00:23:16,545 INSTITUTIONAL CAREER DEVELOPMENT 603 00:23:16,545 --> 00:23:20,415 PROGRAM AND WE HAVE BOIRJ BIRCH 604 00:23:20,415 --> 00:23:24,185 AND SCORE AND CREATING 605 00:23:24,185 --> 00:23:24,886 TRANSLA 606 00:23:24,886 --> 00:23:26,421 TRANSLATIONAL -- HERE THEY 607 00:23:26,421 --> 00:23:28,056 INCORPORATE DIFFERENT NEEDS OF 608 00:23:28,056 --> 00:23:30,492 WOMEN EXPLICITLY INTO THE WORLD 609 00:23:30,492 --> 00:23:33,228 OF ENTREPRENEURSHIP AND PRODUCT 610 00:23:33,228 --> 00:23:35,230 DEVELOPMENT TO PROMOTE 611 00:23:35,230 --> 00:23:37,032 SCIENTIFIC DISCOVERY AND 612 00:23:37,032 --> 00:23:39,267 OBJECTIVE IS TO FACILITATE 613 00:23:39,267 --> 00:23:40,635 SEAMLESS TRANSITION FROM BASIC 614 00:23:40,635 --> 00:23:42,571 RESEARCH TO CLINICAL APPLICATION 615 00:23:42,571 --> 00:23:43,972 AND COMMERCIALIZATION AND 616 00:23:43,972 --> 00:23:47,275 FOUNDATION OF THIS CONCEPT IS A 617 00:23:47,275 --> 00:23:49,811 SCIENTIFIC WORK FLOW TOIN 618 00:23:49,811 --> 00:23:50,579 EARTHIZE LABORATORY RESEARCH 619 00:23:50,579 --> 00:23:52,280 INTO COMMERCIAL OUTPUT IN THE 620 00:23:52,280 --> 00:23:54,749 FORM OF WORKFORCE AND WORK 621 00:23:54,749 --> 00:23:56,284 PRODUCT THROUGH SEX DIFFERENCES 622 00:23:56,284 --> 00:23:58,486 LENS AND WHAT IS THE DIFFERENCE 623 00:23:58,486 --> 00:23:59,621 AND LOOKING AT EVERYTHING TO 624 00:23:59,621 --> 00:24:00,956 [INDISCERNIBLE] LENS AND 625 00:24:00,956 --> 00:24:02,490 LEVERAGING TWO PROGRAMS WE 626 00:24:02,490 --> 00:24:04,492 SUPPORT ALONG WITH IC PARTNERS 627 00:24:04,492 --> 00:24:07,028 AND TRYING TO DEVELOP A 628 00:24:07,028 --> 00:24:08,630 DIAGNOSTIC ALGORITHM FOR SEX 629 00:24:08,630 --> 00:24:10,599 SELECT IMMUNE MARKERS FOR 630 00:24:10,599 --> 00:24:13,501 TARGETED TREATMENT AND TRYING TO 631 00:24:13,501 --> 00:24:15,503 CREATE SEX SELECTIVE 632 00:24:15,503 --> 00:24:17,172 NEUROMODULAR LATER PARAMETER 633 00:24:17,172 --> 00:24:21,409 DEVICE THAT IS A PAIN AND THEY 634 00:24:21,409 --> 00:24:25,113 ARE UTILIZING ULTRA IMAGING TO 635 00:24:25,113 --> 00:24:28,617 EXPLORE SEX DIFFERENCES IN BLOOD 636 00:24:28,617 --> 00:24:30,685 BRAIN BARRIER LEAKAGE FOR 637 00:24:30,685 --> 00:24:30,986 TARGETING. 638 00:24:30,986 --> 00:24:35,357 THAT WAS MY INTRO. 639 00:24:35,357 --> 00:24:37,292 TELLING YOU ABOUT ORWH AND 640 00:24:37,292 --> 00:24:40,495 EXCITED TO BE HERE AND TALK 641 00:24:40,495 --> 00:24:42,263 ABOUT INNOVATION AND THINGS THAT 642 00:24:42,263 --> 00:24:45,333 ARE IMPORTANT AND MISSION IS TO 643 00:24:45,333 --> 00:24:46,868 EXPAND WOMEN'S HEALTH RESEARCH 644 00:24:46,868 --> 00:24:48,536 AND WORK WITH ALL 27 INSTITUTES 645 00:24:48,536 --> 00:24:50,605 AND CENTERS TO DO THAT AND 646 00:24:50,605 --> 00:24:52,841 FOUNDED WHEN WOMEN WERE NOT 647 00:24:52,841 --> 00:24:54,976 INCLUDED AT NIH BECAUSE OF 648 00:24:54,976 --> 00:24:56,144 CONVENTION AND LACK OF 649 00:24:56,144 --> 00:24:57,812 UNDERSTANDING THAT SEX OPERATES 650 00:24:57,812 --> 00:24:59,748 AT A VERY BASIC LEVEL AND MOVE 651 00:24:59,748 --> 00:25:01,583 FORWARD THERE AND 652 00:25:01,583 --> 00:25:03,952 UNDER-REPRESENTED AND RACIAL AND 653 00:25:03,952 --> 00:25:06,488 ETHNIC POPULATIONS AS WELL MUST 654 00:25:06,488 --> 00:25:08,690 BE INCLUDED AND PROMOTE 655 00:25:08,690 --> 00:25:10,659 ADVANCEMENT FOR WOMEN IN 656 00:25:10,659 --> 00:25:10,925 CAREERS. 657 00:25:10,925 --> 00:25:12,894 FIRST TIME ANYONE IS SEEING THAT 658 00:25:12,894 --> 00:25:15,797 COVER AND NIBIB COUNCIL MEMBERS 659 00:25:15,797 --> 00:25:17,832 AND ATTENDEES WE IMAGINE A WORLD 660 00:25:17,832 --> 00:25:20,101 THAT SEX AND GENDER ARE 661 00:25:20,101 --> 00:25:23,405 INTEGRATE AD CROSS ENTIRE 662 00:25:23,405 --> 00:25:24,673 BIOMEDICAL RESEARCH SECTION FROM 663 00:25:24,673 --> 00:25:26,374 IDEA TO THE LAB TO TRANSLATION 664 00:25:26,374 --> 00:25:30,345 TO THE CLINIC TO THE APPLICATION 665 00:25:30,345 --> 00:25:35,283 TO THE PUBLICATION TO INFORMING 666 00:25:35,283 --> 00:25:43,058 NEXT HYPOTHESIS AND EXPERIMENT 667 00:25:43,058 --> 00:25:45,193 TAILORED TO OWN CIRCUMSTANCES 668 00:25:45,193 --> 00:25:48,530 GOALS AND NEEDS AND WORLD THAT 669 00:25:48,530 --> 00:25:51,166 WOMEN AND SCIENCE MEET FULL 670 00:25:51,166 --> 00:25:52,400 POTENTIAL AND CAN GET THEREIN 671 00:25:52,400 --> 00:25:55,170 COLLUSION IS PART OF DNA AND WHY 672 00:25:55,170 --> 00:25:58,707 WE WERE FOUNDED AND NIH 673 00:25:58,707 --> 00:26:02,143 REHABILITATION ACT OF 1993 IN 674 00:26:02,143 --> 00:26:03,712 THE UNITED STATES MUST BE 675 00:26:03,712 --> 00:26:05,613 INCLUDED IN NI SUPPORTED 676 00:26:05,613 --> 00:26:07,782 CLINICAL RESEARCH UNLESS 677 00:26:07,782 --> 00:26:10,285 SCIENTIFIC REASON NOT TO DO SO 678 00:26:10,285 --> 00:26:12,620 AND 21ST CENTURY MORE RECENTLY 679 00:26:12,620 --> 00:26:15,623 TOOK THAT FURTHER AND NOW MUST 680 00:26:15,623 --> 00:26:19,227 INCLUDE INDIVIDUALS OF ALL AGES 681 00:26:19,227 --> 00:26:29,771 IN RESEARCH-R- -- SO WE CAN MAKE 682 00:26:34,375 --> 00:26:36,444 TREATMENT DECISIONS TO TREAT 683 00:26:36,444 --> 00:26:39,714 WHAT THEY HAVE AND DELIVER 684 00:26:39,714 --> 00:26:42,450 EVIDENCE BASED CARE AND 21ST 685 00:26:42,450 --> 00:26:46,488 CENTURY CARES ACT REQUIRES 686 00:26:46,488 --> 00:26:56,931 TRIALS -- THAT IS A MAJOR 687 00:26:58,166 --> 00:27:01,302 ADVANCE SO WE CAN SEE THOSE 688 00:27:01,302 --> 00:27:11,746 RESULTS DISAGGREGATED IN. 689 00:27:27,095 --> 00:27:33,935 BECAUSE WE KNOW INSIGHTS 690 00:27:33,935 --> 00:27:35,436 GARNER + EXPANDED INCLUSION AND 691 00:27:35,436 --> 00:27:38,473 ENHANCES ARIGOR AND ENHANCES 692 00:27:38,473 --> 00:27:39,908 GENERALIZE NLT AND APPLICABILITY 693 00:27:39,908 --> 00:27:44,212 OF THE STUDIES AND FINDINGS AND 694 00:27:44,212 --> 00:27:45,847 BRUCE MENTIONING SEXING OF 695 00:27:45,847 --> 00:27:47,882 BIOLOGICAL POLICY AND POLICY IN 696 00:27:47,882 --> 00:27:49,350 A NUTSHELL AND EXPECT THAT SEX 697 00:27:49,350 --> 00:27:52,187 AS A BIOLOGICAL VARIABLE WILL BE 698 00:27:52,187 --> 00:27:54,055 FACTORED INTO RESEARCH DESIGN 699 00:27:54,055 --> 00:27:55,089 ANALYSIS AND REPORTING 700 00:27:55,089 --> 00:27:57,992 VERTEBRATE ANIMAL AND HUMAN 701 00:27:57,992 --> 00:27:59,360 STUDIES AND EXPECT STRONG 702 00:27:59,360 --> 00:28:01,596 JUSTIFICATION BE PROVIDED FOR 703 00:28:01,596 --> 00:28:03,531 SINGLE SEX STUDIES THAT COULD BE 704 00:28:03,531 --> 00:28:06,167 PERMITTED AND WE WANT STRONG 705 00:28:06,167 --> 00:28:07,702 JUSTIFICATION AND JUSTIFICATION 706 00:28:07,702 --> 00:28:11,439 THAT WE ALWAYS DO STUDIES IN 707 00:28:11,439 --> 00:28:14,142 MALE ANIMAL MODEL ARE NOT 708 00:28:14,142 --> 00:28:15,410 SUFFICIENT AND COLLABORATION IS 709 00:28:15,410 --> 00:28:17,579 KEY TO EXECUTING AND 710 00:28:17,579 --> 00:28:19,948 IMPLEMENTING NIH-WIDE STRATEGIC 711 00:28:19,948 --> 00:28:22,317 PLAN AND WORK WITH INSTITUTES 712 00:28:22,317 --> 00:28:24,352 AND CENTERS IN COORDINATING 713 00:28:24,352 --> 00:28:27,689 COMMITTEE AND PARTNERSHIP AND 714 00:28:27,689 --> 00:28:28,556 DRIVING SYNERGISTICALLY 715 00:28:28,556 --> 00:28:29,924 PRIORITIES WORKING TOGETHER TO 716 00:28:29,924 --> 00:28:32,260 DEVELOP PRIORITIES WORKING 717 00:28:32,260 --> 00:28:33,728 GROUPS AND WORKSHOPS AND 718 00:28:33,728 --> 00:28:36,030 PRIORITY SETTING AND WILL 719 00:28:36,030 --> 00:28:38,566 ACHIEVE THE VISION I MENTIONED 720 00:28:38,566 --> 00:28:41,302 FOR YOU AND WAY WE THINK ABOUT 721 00:28:41,302 --> 00:28:43,204 THIS ACROSS THE LIFE COURSE AND 722 00:28:43,204 --> 00:28:45,106 KNOW BIOLOGY MATTERS AND THAT WE 723 00:28:45,106 --> 00:28:47,475 DON'T HAVE TO DEBATE WITH ANYONE 724 00:28:47,475 --> 00:28:50,778 THAT HERE GENOME AND ANATOMY AND 725 00:28:50,778 --> 00:28:53,548 IMMUNOLOGY MATTERS AND MYCOBIOME 726 00:28:53,548 --> 00:28:57,352 MATTERS AND SOCIAL AND 727 00:28:57,352 --> 00:28:58,319 ENVIRONMENTAL EXPOSURES MATTER 728 00:28:58,319 --> 00:29:00,321 AND INTERACT WITH BIOLOGY ACROSS 729 00:29:00,321 --> 00:29:04,225 THE LIFE COURSE AND THIS IS A 730 00:29:04,225 --> 00:29:05,226 XREE HADDENCESIVE STRATEGY 731 00:29:05,226 --> 00:29:06,895 THINKING ABOUT HEALTH OF WOMEN 732 00:29:06,895 --> 00:29:09,364 AND ADDRESSING 1 OR 2 OF THESE 733 00:29:09,364 --> 00:29:10,732 OR THESE SEPARATELY WE DON'T 734 00:29:10,732 --> 00:29:14,168 HAVE SAME POWER IF WE INTEGRATE 735 00:29:14,168 --> 00:29:15,837 AND WORK TOGETHER IN 736 00:29:15,837 --> 00:29:17,505 INTERDISCIPLINARY MANNER TRYING 737 00:29:17,505 --> 00:29:19,574 TO SOLVE SPECIFIC PROBLEMS WHERE 738 00:29:19,574 --> 00:29:21,376 WE CONVERGE ON HEALTH OF WOMEN 739 00:29:21,376 --> 00:29:25,280 AND APPROACH FOR GOING FORWARD. 740 00:29:25,280 --> 00:29:31,753 I WAS REALLY HONORED TO BE IN 741 00:29:31,753 --> 00:29:33,855 OVAL OFFICE WITH [INDISCERNIBLE] 742 00:29:33,855 --> 00:29:39,794 AND SECRETARY BASERA PRESIDENT 743 00:29:39,794 --> 00:29:41,896 AND FIRST LADY AND OTHERS 744 00:29:41,896 --> 00:29:43,631 ANNOUNCING FIRST EVER WHITE 745 00:29:43,631 --> 00:29:44,799 HOUSE INITIATIVE ON WOMEN'S 746 00:29:44,799 --> 00:29:46,634 HEALTH AND RESEARCH WE SEE 747 00:29:46,634 --> 00:29:48,703 WOMEN'S HEALTH RESEARCH NOT 748 00:29:48,703 --> 00:29:50,405 WOMEN'S HEALTH BUT RESEARCH IS 749 00:29:50,405 --> 00:29:53,241 BEING PRIORITIZED AT HIGHEST 750 00:29:53,241 --> 00:29:54,442 LEVEL AND PRESIDENT AND FIRST 751 00:29:54,442 --> 00:29:59,247 LADY ANNOUNCED THIS IN NOVEMBER. 752 00:29:59,247 --> 00:30:01,282 PRESIDENT FOLLOWED UP WITH 753 00:30:01,282 --> 00:30:04,752 SIGNING OF EXECUTIVE ORDER 754 00:30:04,752 --> 00:30:06,254 EO14210 IN MARCH OF THIS YEAR 755 00:30:06,254 --> 00:30:09,357 AND DELIGHTED TO BE THERE WAS 756 00:30:09,357 --> 00:30:12,193 THE PRESIDENT AND FIRST LADY AND 757 00:30:12,193 --> 00:30:13,594 VICE PRESIDENT AND SECOND 758 00:30:13,594 --> 00:30:16,130 GENTLEMAN AND VARIETY OF LEADERS 759 00:30:16,130 --> 00:30:17,966 YOU CAN SEE THERE FOR SIGNING OF 760 00:30:17,966 --> 00:30:19,400 THIS HISTORIC EXECUTIVE ORDER 761 00:30:19,400 --> 00:30:21,436 THAT IS AN AMAZING SET OF 762 00:30:21,436 --> 00:30:24,439 STRATEGIES AND APPROACHES AND 763 00:30:24,439 --> 00:30:25,974 DIRECTIVES THAT TALKS ABOUT 764 00:30:25,974 --> 00:30:27,775 PRIORITIZING INVESTMENTS IN 765 00:30:27,775 --> 00:30:29,077 WOMEN'S HEALTH RESEARCH IN 766 00:30:29,077 --> 00:30:30,912 EVERYTHING WE DO INTEGRATING 767 00:30:30,912 --> 00:30:32,580 WOMEN'S HEALTH RESEARCH ACROSS 768 00:30:32,580 --> 00:30:35,283 THE FEDERAL RESEARCH PORTFOLIO 769 00:30:35,283 --> 00:30:37,885 MAKING SURE WE GALVANIZES NEW 770 00:30:37,885 --> 00:30:39,554 RESEARCH ON WOMEN'S MID-LIFE 771 00:30:39,554 --> 00:30:41,856 HEALTH ASSESSING UNMET NEEDS TO 772 00:30:41,856 --> 00:30:43,591 SUPPORT WOMEN'S HEALTH RESEARCH. 773 00:30:43,591 --> 00:30:45,660 SOME OF THE STEPS WE ALREADY 774 00:30:45,660 --> 00:30:47,996 HAVE COMMITTED TO TAKING HERE AT 775 00:30:47,996 --> 00:30:50,565 NIH ARE SUMMARIZED ON THIS 776 00:30:50,565 --> 00:30:50,798 SLIDE. 777 00:30:50,798 --> 00:30:53,401 THE FIRST IS WE PREPARED WITH 778 00:30:53,401 --> 00:30:55,570 EVERY SINGLE INSTITUTE AND 779 00:30:55,570 --> 00:30:58,606 CENTER AND MULTIPLE OFFICES 780 00:30:58,606 --> 00:31:00,708 NIH'S FIRST-EVER NOTICE OF 781 00:31:00,708 --> 00:31:01,743 SPECIAL INTEREST ON WOMEN'S 782 00:31:01,743 --> 00:31:03,811 HEALTH RESEARCH THAT IS LINKED 783 00:31:03,811 --> 00:31:06,347 TO EVERY SINGLE NIH PARENT 784 00:31:06,347 --> 00:31:07,448 FUNDING OPPORTUNITY AND WHAT IT 785 00:31:07,448 --> 00:31:09,951 SAYS IS NIH IS INTERESTED IN 786 00:31:09,951 --> 00:31:11,552 RECEIVING APPLICATIONS ON ALL OF 787 00:31:11,552 --> 00:31:13,588 THE WORK THAT WE DO ACROSS ALL 788 00:31:13,588 --> 00:31:15,189 OF THE FUNDING MECHANISMS ACROSS 789 00:31:15,189 --> 00:31:17,959 ALL OF THE TOPICS AND ALL OF THE 790 00:31:17,959 --> 00:31:18,292 DISCIPLINES. 791 00:31:18,292 --> 00:31:21,062 THIS IS ESSENTIALLY A DEDICATED 792 00:31:21,062 --> 00:31:23,264 FRONT DOOR FOR INVESTIGATORS TO 793 00:31:23,264 --> 00:31:25,900 SEEK NIH FUNDING FOR WOMEN'S 794 00:31:25,900 --> 00:31:27,969 HEALTH RESEARCH AND ARE WORKING 795 00:31:27,969 --> 00:31:29,237 TO IDENTIFY AND DEVELOP NEW 796 00:31:29,237 --> 00:31:31,572 COMMON DATA ELEMENTS RELATED TO 797 00:31:31,572 --> 00:31:33,641 WOMEN'S HEALTH LIKE ON 798 00:31:33,641 --> 00:31:35,877 MENOPAUSAL STATUS THAT WILL HELP 799 00:31:35,877 --> 00:31:37,812 RESEARCHER SHARES AND COMBINE 800 00:31:37,812 --> 00:31:40,448 DATA SETS AND WE WILL BE ABLE TO 801 00:31:40,448 --> 00:31:43,284 PROMOTE INTEROPERABILITY OF DATA 802 00:31:43,284 --> 00:31:45,620 SETS AND PROMOTE ACCURACY OF 803 00:31:45,620 --> 00:31:48,656 DATA SETS PARTICULARLY AROUND 804 00:31:48,656 --> 00:31:49,690 WOMEN AND ANNOUNCE INTENTION TO 805 00:31:49,690 --> 00:31:52,860 INCREASE BY 50% NIH INVESTMENT 806 00:31:52,860 --> 00:31:55,663 IN SBIR AND STT PROGRAMS RELATED 807 00:31:55,663 --> 00:31:57,665 TO HEALTH OF WOMEN AND NEW 808 00:31:57,665 --> 00:31:58,633 OPPORTUNITIES THERE. 809 00:31:58,633 --> 00:32:00,735 WE ALSO ANNOUNCE LED BY OFFICE 810 00:32:00,735 --> 00:32:02,670 OF DISEASE PREVENTION A PATHWAYS 811 00:32:02,670 --> 00:32:05,606 TO PREVENTION PROGRAM ON 812 00:32:05,606 --> 00:32:07,408 MENOPAUSE AND P TO P PROGRAM 813 00:32:07,408 --> 00:32:09,944 THAT IS A ROBUST AND RIGOROUS 814 00:32:09,944 --> 00:32:12,647 AND VERY PRESCRIPTIVE AND 815 00:32:12,647 --> 00:32:14,382 WELL-RESPECTED PROCESS THAT 816 00:32:14,382 --> 00:32:17,285 LOOKS CAREFULLY AT AN ISSUE 817 00:32:17,285 --> 00:32:18,653 BEGINNING WITH SYSTEMATIC 818 00:32:18,653 --> 00:32:20,588 EVIDENCE WORK WITH ARC AND 819 00:32:20,588 --> 00:32:22,590 WORKSHOPS AND OTHER MEETINGS AND 820 00:32:22,590 --> 00:32:25,660 WE ARE KICKING IT OFF TOMORROW 821 00:32:25,660 --> 00:32:27,095 AT MENOPAUSE ROUNDTABLE AND 822 00:32:27,095 --> 00:32:29,297 NATIONAL INSTITUTE OF CHILD'S 823 00:32:29,297 --> 00:32:31,232 HEALLE AND HUMAN DEVELOPMENT LED 824 00:32:31,232 --> 00:32:36,237 THE WAY ANNOUNCING NEW 825 00:32:36,237 --> 00:32:40,007 INITIATIVE ON BIOMARKER 826 00:32:40,007 --> 00:32:43,744 DISCOVERY AND PREVENT AND TREAT 827 00:32:43,744 --> 00:32:47,582 CONDITIONS ON PROGRAM FOCUSED ON 828 00:32:47,582 --> 00:32:49,951 ENDOMETRIOSIS AND THAT IS ON THE 829 00:32:49,951 --> 00:32:51,786 STREET NOW AND LOOKING FORWARD 830 00:32:51,786 --> 00:32:53,721 TO SEEING APPLICATIONS THERE AS 831 00:32:53,721 --> 00:32:55,857 WELL AS OTHER PROGRAMS IN THE 832 00:32:55,857 --> 00:32:57,325 CATEGORY AND A FEW OF THE THINGS 833 00:32:57,325 --> 00:33:00,495 WE STARTED TO ADDRESS THIS 834 00:33:00,495 --> 00:33:01,963 EXECUTIVE ORDER AND WANT TO MAKE 835 00:33:01,963 --> 00:33:05,032 SURE YOU KNOW THIS EO EXTENDS 836 00:33:05,032 --> 00:33:06,901 ACROSS US GOVERNMENT PARTNERS 837 00:33:06,901 --> 00:33:10,304 OMB TO DOD TO BA TO EPA AND 838 00:33:10,304 --> 00:33:14,275 USUAL COLLEAGUES IN HHS AND IN 839 00:33:14,275 --> 00:33:19,914 CMS THEY ARE ALL PART OF THE 840 00:33:19,914 --> 00:33:20,548 INTERDISCIPLINARY APPROACH AND 841 00:33:20,548 --> 00:33:24,051 PRESIDENT ALSO IN STATE OF THE 842 00:33:24,051 --> 00:33:26,254 UNION ADDRESS ACTS FOR 12 843 00:33:26,254 --> 00:33:29,624 BILLION DOLLARS TO SUPPORT NIH 844 00:33:29,624 --> 00:33:31,626 CENTRAL FUND ON WOMEN'S HEALTH 845 00:33:31,626 --> 00:33:34,462 AND RESEARCH AND THAT IS A BROAD 846 00:33:34,462 --> 00:33:35,363 ACT. 847 00:33:35,363 --> 00:33:38,266 I MENTIONED SEX HAS EFFECTS AT 848 00:33:38,266 --> 00:33:40,134 MULTIPLE LEVELS OF BIOLOGY AND 849 00:33:40,134 --> 00:33:41,702 GENE TISSUE EXPRESSION STUDY, WE 850 00:33:41,702 --> 00:33:43,738 KNOW THERE ARE MANY, MANY GENES 851 00:33:43,738 --> 00:33:45,072 THAT ARE EXPRESSED DIFFERENTLY 852 00:33:45,072 --> 00:33:47,241 IN MULTIPLE TISSUES IN THE BODY 853 00:33:47,241 --> 00:33:49,544 AND WE KNOW THAT THE IMMUNE 854 00:33:49,544 --> 00:33:51,179 SYSTEM AS ONE EXAMPLE DIFFER. 855 00:33:51,179 --> 00:33:54,582 WOMEN HAVE A ROBUST RESPONSE TO 856 00:33:54,582 --> 00:33:55,883 MICROORGANISMS GENERALLY THAN 857 00:33:55,883 --> 00:33:58,753 MEN DO AND THAT ROBUST RESPONSE 858 00:33:58,753 --> 00:34:00,688 TRANSLATES TO HIGHER RISKS FOR 859 00:34:00,688 --> 00:34:03,558 AUTO IMMUNITY AND AT THE 860 00:34:03,558 --> 00:34:04,659 ORGANISM OR PERSON LEVEL WE KNOW 861 00:34:04,659 --> 00:34:06,928 WE SEE DIFFERENCES IN HOW 862 00:34:06,928 --> 00:34:08,129 DISEASES SHOW UP AND HOW PEOPLE 863 00:34:08,129 --> 00:34:09,931 RESPOND TO TREATMENTS ACROSS THE 864 00:34:09,931 --> 00:34:11,966 LIFE COURSE AND WE NEED TO 865 00:34:11,966 --> 00:34:13,367 INTEGRATE THAT INFORMATION 866 00:34:13,367 --> 00:34:16,037 BECAUSE ALL OF THOSE LEVELS ARE 867 00:34:16,037 --> 00:34:18,172 INTERACTING SIMULTANEOUSLY AND 868 00:34:18,172 --> 00:34:19,273 WE ARE INTERACTING WITH THE 869 00:34:19,273 --> 00:34:22,476 ENVIRONMENT AND WHETHER IT IS A 870 00:34:22,476 --> 00:34:26,414 TOXIC EXPOSURE TO A TOX KANT OR 871 00:34:26,414 --> 00:34:28,749 TAXIC RELATIONSHIP. ALL THAT IS 872 00:34:28,749 --> 00:34:30,952 EFFECTING OUR HEALTH AND IT ALL 873 00:34:30,952 --> 00:34:32,153 APPLIES TO CLINICAL CARE, WHICH 874 00:34:32,153 --> 00:34:32,787 YOU KNOW. 875 00:34:32,787 --> 00:34:35,723 IF WE COULD INTEGRATE ALL OF THE 876 00:34:35,723 --> 00:34:37,191 DATA THAT WE ARE GATHERING 877 00:34:37,191 --> 00:34:41,295 WHETHER EPIGENETIC DATA OR GENE 878 00:34:41,295 --> 00:34:43,397 EXPRESSION DATA OR WHETHER 879 00:34:43,397 --> 00:34:45,333 TRANSCRIPTOMICS, IF WE COULD 880 00:34:45,333 --> 00:34:46,968 INTEGRATE ALL THAT INFORMATION 881 00:34:46,968 --> 00:34:49,870 TO A SEX-DIFFERENCES LENS, NOW 882 00:34:49,870 --> 00:34:51,272 THAT WE KNOW THERE ARE SEX 883 00:34:51,272 --> 00:34:53,608 DIFFERENCES IN EPIGENETICS AND 884 00:34:53,608 --> 00:34:57,878 SEX DIFFERENCES IN PROTEINS AND 885 00:34:57,878 --> 00:35:00,147 LOOKING AT IT THROUGH 886 00:35:00,147 --> 00:35:01,349 ENVIRONMENTAL INFLUENCES AGE AND 887 00:35:01,349 --> 00:35:05,286 SEX ACROSS LIFETIME AND LIVE 888 00:35:05,286 --> 00:35:06,887 COURSE PERSPECTIVE AND 889 00:35:06,887 --> 00:35:08,155 COMORBIDITY THINK WHAT WE COULD 890 00:35:08,155 --> 00:35:11,292 LEARN INSIGHTS WE COULD GARNER 891 00:35:11,292 --> 00:35:13,894 ARE ENUMERABLE AND WE ARE 892 00:35:13,894 --> 00:35:15,296 APPROACHING COMPUTATIONAL POWER 893 00:35:15,296 --> 00:35:17,131 AND ADVANCED ANALYTICS 894 00:35:17,131 --> 00:35:18,799 APPROACHES TO DO JUST THAT AND I 895 00:35:18,799 --> 00:35:21,068 CALL ON INVESTIGATORS TO THINK 896 00:35:21,068 --> 00:35:22,803 ABOUT WOMEN'S HEALTH WHEN THEY 897 00:35:22,803 --> 00:35:26,874 ARE DOING THAT AND DESIGNING 898 00:35:26,874 --> 00:35:28,609 ALGORITHMS AND ANALYTIC 899 00:35:28,609 --> 00:35:30,044 APPROACHES AND WILL GIVE AN 900 00:35:30,044 --> 00:35:33,714 EXAMPLE OF A PRESENTATION AT OUR 901 00:35:33,714 --> 00:35:35,316 ADVISORY COMMITTEE JUST LAST 902 00:35:35,316 --> 00:35:36,183 MONTH. 903 00:35:36,183 --> 00:35:39,587 ROBERTA DIAZ WORKS IN COGNITION 904 00:35:39,587 --> 00:35:43,658 AND ALZHEIMER'S IS PRIMARY AREA 905 00:35:43,658 --> 00:35:45,793 OF FOCUS DOING RETROSPECTIVE 906 00:35:45,793 --> 00:35:47,528 ANALYSIS AND DON'T HAVE TO DO 907 00:35:47,528 --> 00:35:51,766 THAT. SUMMARIZING QUICKLY FOR 908 00:35:51,766 --> 00:35:53,234 YOU AND RED DOT AND TO THE LEFT 909 00:35:53,234 --> 00:35:57,471 OF IT AND LOOKING AT 400,000 910 00:35:57,471 --> 00:35:59,173 INDIVIDUALS RECEIVING MENOPAUSAL 911 00:35:59,173 --> 00:36:02,843 THERAPY AND WAS INTERESTED IN 912 00:36:02,843 --> 00:36:06,514 NEURODEGENERATIVE DISEASE FROM 913 00:36:06,514 --> 00:36:12,620 ALZHEIMERS TO PARKINSON'S TO ALS 914 00:36:12,620 --> 00:36:13,554 AND [INDISCERNIBLE] IN ALL WOMEN 915 00:36:13,554 --> 00:36:22,863 AND SHE DECIDED TO FOCUS ON ER 916 00:36:22,863 --> 00:36:26,600 BETA AND DEVELOP PHYTOEST 917 00:36:26,600 --> 00:36:29,403 TROEJEN MADE WITH COMPOUNDS THAT 918 00:36:29,403 --> 00:36:32,773 ARE ALREADY SAFE WITH THE FDA. 919 00:36:32,773 --> 00:36:34,608 THIS IS SELECTIVE FOR THE BRAIN 920 00:36:34,608 --> 00:36:40,014 AND DOES NOT HAVE ACTIVITY IN 921 00:36:40,014 --> 00:36:41,749 REPRODUCTIVE TISSUES. 922 00:36:41,749 --> 00:36:44,085 HAS NOW MULTIPLE RO1S FROM THE 923 00:36:44,085 --> 00:36:46,354 AGING INSTITUTE DOING A PHASE 2 924 00:36:46,354 --> 00:36:48,422 CLINICAL TRIAL AND PROOF OF 925 00:36:48,422 --> 00:36:51,826 CONCEPT FOR THIS PARTICULAR ER 926 00:36:51,826 --> 00:36:54,462 BETA AGONIST TO DECLINE TO 927 00:36:54,462 --> 00:36:57,398 ADDRESS DELINE IN BRAIN 928 00:36:57,398 --> 00:36:59,867 METABOLISM AND COGNITION IN 929 00:36:59,867 --> 00:37:02,269 MENOPAUSAL TRANSITION AND SBR 930 00:37:02,269 --> 00:37:04,004 GRANT SHE HAS AND HIGHLIGHTING 931 00:37:04,004 --> 00:37:05,139 HOW TO BRING ALL THESE TOGETHER 932 00:37:05,139 --> 00:37:08,142 AND SHE IS ALSO LOOKING AT 933 00:37:08,142 --> 00:37:09,510 MENOPAUSAL HOT FLASHES ALL THE 934 00:37:09,510 --> 00:37:09,877 TIME. 935 00:37:09,877 --> 00:37:11,846 I WANTED TO HIGHLIGHT THESE AS 936 00:37:11,846 --> 00:37:14,482 AN EXAMPLE OF WAYS WE CAN BRING 937 00:37:14,482 --> 00:37:15,282 THIS ALL TOGETHER. 938 00:37:15,282 --> 00:37:17,284 TO PUT SCIENCE TO WORK FOR THE 939 00:37:17,284 --> 00:37:19,086 HEALTH OF WOMEN THAT IS OUR 940 00:37:19,086 --> 00:37:19,420 TIMELINE. 941 00:37:19,420 --> 00:37:21,222 IF WE ACCOUNT FOR SEX AT 942 00:37:21,222 --> 00:37:23,057 MULTIPLE LEVELS WHERE IT 943 00:37:23,057 --> 00:37:25,059 OPERATES, WE CAN PROVIDE NEW 944 00:37:25,059 --> 00:37:28,763 DIMENSIONS TO DATA AND GENERATE 945 00:37:28,763 --> 00:37:31,232 NEW [INDISCERNIBLE]. 946 00:37:31,232 --> 00:37:32,566 WHEN WE LEVERAGE THOSE LARGE 947 00:37:32,566 --> 00:37:34,435 DATA SETS CUTTING EDGE SCIENCE 948 00:37:34,435 --> 00:37:36,837 AND ANALYTIC TOOLS WE CAN SOLVE 949 00:37:36,837 --> 00:37:38,472 WOMEN'S HEALTH PROBLEMS 950 00:37:38,472 --> 00:37:40,074 CONSIDERING HEALTH OF WOMEN IN 951 00:37:40,074 --> 00:37:41,842 CLINICAL TRIALS WHEN DESIGNING 952 00:37:41,842 --> 00:37:44,645 THEM UP FRONT MAKING SURE 953 00:37:44,645 --> 00:37:45,746 INCLUSION CRITERIA ARE NOT 954 00:37:45,746 --> 00:37:48,482 BIASED AND MAKING SURE OUTCOME 955 00:37:48,482 --> 00:37:49,417 MEASURES WE SELECT ARE 956 00:37:49,417 --> 00:37:51,118 APPROPRIATE FOR MEN AND WOMEN WE 957 00:37:51,118 --> 00:37:54,088 CAN LEAD TO NEW TARGETS TO 958 00:37:54,088 --> 00:37:55,122 BETTER [INDISCERNIBLE] NEW 959 00:37:55,122 --> 00:37:57,224 TARGETS AND A GREATER 960 00:37:57,224 --> 00:37:59,493 UNDERSTANDING OF SEX-SPECIFIC 961 00:37:59,493 --> 00:37:59,760 EFFECTS. 962 00:37:59,760 --> 00:38:02,696 OUR GOAL IS TO CLOSE THE GAP IN 963 00:38:02,696 --> 00:38:05,299 WOMEN'S TECHNOLOGY BY APPLYING 964 00:38:05,299 --> 00:38:07,301 TECHNOLOGY ADVANCED ANALYTICS 965 00:38:07,301 --> 00:38:09,203 ENGINEERING IMAGING AND ANY 966 00:38:09,203 --> 00:38:10,738 OTHER TOOL OR STRATEGY WE CAN 967 00:38:10,738 --> 00:38:12,673 USE TO IMPROVE THE HEALTH OF 968 00:38:12,673 --> 00:38:15,443 WOMEN AND WE DO IT THROUGH OUR 969 00:38:15,443 --> 00:38:16,410 SIGNATURE PROGRAMS AND MENTIONED 970 00:38:16,410 --> 00:38:17,311 SEVERAL ALREADY. 971 00:38:17,311 --> 00:38:19,880 I WILL BRIEFLY MENTION MORE 972 00:38:19,880 --> 00:38:22,116 RECENT PROGRAMS THAT IS NIH'S 973 00:38:22,116 --> 00:38:25,252 FIRST-EVER RO1 AND LOOKING AT 974 00:38:25,252 --> 00:38:26,620 INTERSECTION OF SEX AND GENDER 975 00:38:26,620 --> 00:38:28,189 TOGETHER ON HEALTH AND DISEASE 976 00:38:28,189 --> 00:38:32,526 AND PARTNERING 11IOCS ON THAT 977 00:38:32,526 --> 00:38:35,596 AND FIRST EVERY R021 AND CHRONIC 978 00:38:35,596 --> 00:38:37,198 DISEASES AND WOMEN LIKELY TO BE 979 00:38:37,198 --> 00:38:39,099 EFFECTED BY CHRONIC DISEASE AND 980 00:38:39,099 --> 00:38:41,035 WOMEN LIVE LONGER THAN MEN DO 981 00:38:41,035 --> 00:38:43,237 AND MORE YEARS IN POOR HEALTH 982 00:38:43,237 --> 00:38:45,806 NOT JUST IMPORTANT TO LOOK AT 983 00:38:45,806 --> 00:38:48,309 LIFESPAN BUT HEALTH SPAN AND 984 00:38:48,309 --> 00:38:50,444 NEED TO ADDRESS THOSE 8 YEARS ON 985 00:38:50,444 --> 00:38:52,146 AVERAGE THAT WOMEN LIVE WITH 986 00:38:52,146 --> 00:38:54,048 POOR HEALTH AND TECHNOLOGIES 987 00:38:54,048 --> 00:38:56,450 WILL BE A WAY TO DO THAT AND 988 00:38:56,450 --> 00:38:58,252 CITING HERE NATIONAL INSTITUTE 989 00:38:58,252 --> 00:39:02,389 OF ENVIRONMENTAL HEALTH SCIENCES 990 00:39:02,389 --> 00:39:04,225 INTRAMURAL PROGRAM BASIC AI 991 00:39:04,225 --> 00:39:05,426 MACHINE LEARNING APPROACHES 992 00:39:05,426 --> 00:39:07,561 LOOKING AT BODY OF WORK AND 993 00:39:07,561 --> 00:39:09,230 MULTIPLE STUDIES THAT HAVE BEEN 994 00:39:09,230 --> 00:39:11,365 PUBLISHED AND ARE TRYING TO 995 00:39:11,365 --> 00:39:16,470 DIAGNOSE POLYCYSTIC OVARY SYSTEM 996 00:39:16,470 --> 00:39:19,607 MOST COMMONLY DIAGNOSED SYSTEM 997 00:39:19,607 --> 00:39:23,277 FOR WOMEN AND APPROACHED WITH 998 00:39:23,277 --> 00:39:25,446 SYSTEM -- WOMEN ARE DELAYED AND 999 00:39:25,446 --> 00:39:27,515 GET STREEMENT LATER AND AI AND 1000 00:39:27,515 --> 00:39:29,517 ML THIS APPROACH IS BASIC AND 1001 00:39:29,517 --> 00:39:31,619 WAS ABLE TO SUCCESSFULLY 1002 00:39:31,619 --> 00:39:33,554 DIAGNOSE PTOS FROM THIS LARGE 1003 00:39:33,554 --> 00:39:37,691 SET OF DATA THAT IS GENERATED 1004 00:39:37,691 --> 00:39:48,135 FROM MULTIPLE STUDIES IS 1005 00:39:48,536 --> 00:39:50,004 SOMETHING RELEVANT AND AVAILABLE 1006 00:39:50,004 --> 00:39:52,106 YOU CAN PUT WHAT TECHNOLOGY AND 1007 00:39:52,106 --> 00:39:54,141 TOOLS YOU HAVE AVAILABLE TO WORK 1008 00:39:54,141 --> 00:39:55,776 FOR THAT AND SMALL BUSINESS AND 1009 00:39:55,776 --> 00:39:58,078 EDUCATION AND ENTREPRENEURIAL 1010 00:39:58,078 --> 00:39:59,847 DEVELOPMENT PROGRAM IS A WAY 1011 00:39:59,847 --> 00:40:01,582 FUNDING CAN BE SECURED AND CORE 1012 00:40:01,582 --> 00:40:03,384 BUSINESS OBJECTIVES ARE LISTED 1013 00:40:03,384 --> 00:40:05,619 HERE AND THEY ARE LOOKING FOR 1014 00:40:05,619 --> 00:40:08,422 IMPACTFUL HEALTHCARE SOLUTIONS 1015 00:40:08,422 --> 00:40:11,325 SUPPORTING EARLY STAGE PRODUCT 1016 00:40:11,325 --> 00:40:13,694 DEVELOPMENTS FOR FUNDS AND 1017 00:40:13,694 --> 00:40:15,763 DIVERSE WORKFORCE AND IMPROVING 1018 00:40:15,763 --> 00:40:17,631 PATIENT CARE DRIVING ECONOMIC 1019 00:40:17,631 --> 00:40:19,366 GROWTH AND FUNDING OPPORTUNITIES 1020 00:40:19,366 --> 00:40:21,235 ARE LISTED HERE AND NOTICE OF 1021 00:40:21,235 --> 00:40:23,170 INFORMATION JUST WENT OUT 1022 00:40:23,170 --> 00:40:24,939 ANNOUNCING NIH'S INTENTION TO 1023 00:40:24,939 --> 00:40:26,473 PUT OUT NEW FUNDING 1024 00:40:26,473 --> 00:40:29,343 OPPORTUNITIES FOR SBIR AND TTR 1025 00:40:29,343 --> 00:40:34,582 AND HERE ARE ALL PARTICIPATING 1026 00:40:34,582 --> 00:40:38,519 ICOS AND NIBIB AND MENTIONED NEW 1027 00:40:38,519 --> 00:40:43,390 NO SEE NIH-WIDE RESEARCH LINKED 1028 00:40:43,390 --> 00:40:45,326 TO STT PARENT FUNDING 1029 00:40:45,326 --> 00:40:46,860 OPPORTUNITY AND THIS PROGRAM HAS 1030 00:40:46,860 --> 00:40:49,096 BEEN SUCCESSFUL ADVANCING 1031 00:40:49,096 --> 00:40:50,931 WOMEN'S HEALTH RESEARCH WITH 1032 00:40:50,931 --> 00:40:52,399 COMPANIES THAT I MENTIONED HERE 1033 00:40:52,399 --> 00:40:55,669 AND THEN ON THE RIGHT, THIS IS 1034 00:40:55,669 --> 00:40:57,905 AMERICA'S FUND THAT IS A ROAD 1035 00:40:57,905 --> 00:40:58,138 TOUR. 1036 00:40:58,138 --> 00:41:00,074 THEY ARE MOVING ACROSS THE 1037 00:41:00,074 --> 00:41:02,409 COUNTRY LITERALLY EVERY STATE BY 1038 00:41:02,409 --> 00:41:05,713 BUS OR TRAIN TO TALK ABOUT THIS 1039 00:41:05,713 --> 00:41:07,381 PROGRAM AND THE FOUR BILLION 1040 00:41:07,381 --> 00:41:09,450 DOLLARS IN FEDERAL FUNDS 1041 00:41:09,450 --> 00:41:11,685 AVAILABLE FOR EARLY STAGE 1042 00:41:11,685 --> 00:41:12,653 FUNDING OPPORTUNITIES SO PLEASE 1043 00:41:12,653 --> 00:41:14,755 CHECK IT OUT. 1044 00:41:14,755 --> 00:41:16,256 I MENTION GENE EXPRESSION BEING 1045 00:41:16,256 --> 00:41:18,225 DIFFERENT BY SEX AND HERE IS 1046 00:41:18,225 --> 00:41:20,961 DATA FROM COMMON FUND PROGRAM. 1047 00:41:20,961 --> 00:41:23,998 THIS IS SBIB IN ACTION AND 1048 00:41:23,998 --> 00:41:25,633 LOOKING AT MEN AND WOMEN 44 1049 00:41:25,633 --> 00:41:28,402 TISSUES ACROSS THE BODY COLOR 1050 00:41:28,402 --> 00:41:30,437 COATED WITH HISTOGRAM IN THE 1051 00:41:30,437 --> 00:41:33,173 MIDDLE AND FOUND 37% OF ALL 1052 00:41:33,173 --> 00:41:35,709 GENES EXHIBIT SEX BIASED 1053 00:41:35,709 --> 00:41:37,244 EXPRESSION AND LEAVES ONE TISSUE 1054 00:41:37,244 --> 00:41:40,214 AND I'M PRETTY SURE THERE IS A 1055 00:41:40,214 --> 00:41:41,115 CONSEQUENCE OF THAT GENE 1056 00:41:41,115 --> 00:41:42,516 EXPRESSION DIFFERENCE THAT YOU 1057 00:41:42,516 --> 00:41:45,219 CAN SEE HERE ON THE RIGHT THINGS 1058 00:41:45,219 --> 00:41:48,656 THAT YOU MIGHT RECOGNIZE PATTERN 1059 00:41:48,656 --> 00:41:51,992 BALDNESS HERE IN A BLUE DOT 1060 00:41:51,992 --> 00:41:53,360 MENTIONING SEX FOR MEN AND 1061 00:41:53,360 --> 00:41:56,030 [INDISCERNIBLE] I'M NOT SURE 1062 00:41:56,030 --> 00:41:58,499 WHAT YOU WOULD THINK OF THAT 1063 00:41:58,499 --> 00:42:01,068 PARAMETER AND JUST EVIDENCE OF 1064 00:42:01,068 --> 00:42:05,372 THE DIFFERENCES WE SEE AT MOST 1065 00:42:05,372 --> 00:42:08,075 BASIC LEVEL AND IN ANIMAL MODELS 1066 00:42:08,075 --> 00:42:10,277 ANIMAL MODELS MODELING HUMAN 1067 00:42:10,277 --> 00:42:11,412 DISEASE WE HAVE TO CONSIDER THIS 1068 00:42:11,412 --> 00:42:14,748 AS WELL AND WE KNOW THAT NO ONE 1069 00:42:14,748 --> 00:42:20,788 ANIMAL MODEL CAN RECAPITULATE 1070 00:42:20,788 --> 00:42:23,223 PATH OF FINDINGS YOU SEE IN 1071 00:42:23,223 --> 00:42:26,493 HUMAN DISEASE AND BIOLOGY GIVES 1072 00:42:26,493 --> 00:42:27,928 US NEW KNOWLEDGE TO EXPERIMENTS 1073 00:42:27,928 --> 00:42:30,497 AND STUDIES AND GENERATING 1074 00:42:30,497 --> 00:42:32,933 EXPERIMENTAL DATA AND USE 1075 00:42:32,933 --> 00:42:34,501 TECHNOLOGY FOR THAT AND 1076 00:42:34,501 --> 00:42:36,303 COMPUTATIONAL APPROACHES HELP US 1077 00:42:36,303 --> 00:42:39,073 GET NEW INSIGHTS THROUGH THIS 1078 00:42:39,073 --> 00:42:42,276 ENTIRE LIFE CYCLE WE DEVELOP NEW 1079 00:42:42,276 --> 00:42:43,911 UNDERSTANDINGS TO HEALTH OF 1080 00:42:43,911 --> 00:42:46,080 WOMEN AND BIOMEDICAL 1081 00:42:46,080 --> 00:42:47,314 TECHNOLOGIES BROADLY WHETHER 1082 00:42:47,314 --> 00:42:52,519 GENE EDITING OR AI OR USING 1083 00:42:52,519 --> 00:42:53,387 INDUCED PLURIPOTENT STEM CELLS 1084 00:42:53,387 --> 00:42:55,823 OR MICROANALYTICS IS WAYS TO PUT 1085 00:42:55,823 --> 00:42:58,459 SCIENCE TO WORK FOR HEALTH OF 1086 00:42:58,459 --> 00:43:01,228 WOMEN AND TO DIRECTOR RECENTLY 1087 00:43:01,228 --> 00:43:03,130 HAD [INDISCERNIBLE] PERFORMED ON 1088 00:43:03,130 --> 00:43:05,799 NOVEL ALTERNATIVE METHODS MOVING 1089 00:43:05,799 --> 00:43:07,735 BEYOND ANIMAL STUDIES GETTING 1090 00:43:07,735 --> 00:43:09,703 NEW INSIGHTS AND HERE 1091 00:43:09,703 --> 00:43:12,539 HIGHLIGHTED ON RIGHT POWER OF 1092 00:43:12,539 --> 00:43:14,141 INTEGRATED NOVEL ALTERNATIVES 1093 00:43:14,141 --> 00:43:16,844 METHODS ECOSYSTEM AND TRAINING 1094 00:43:16,844 --> 00:43:20,280 ON THAT MULTI-DISCIPLINARY TEAMS 1095 00:43:20,280 --> 00:43:20,948 ADDRESSING PARTIAL 1096 00:43:20,948 --> 00:43:23,484 RESPONSIBILITY AND COORDINATED 1097 00:43:23,484 --> 00:43:25,052 INFRASTRUCTURE AND INCREDIBLE 1098 00:43:25,052 --> 00:43:28,355 POTENTIAL HERE TO INCLUDE SEX AS 1099 00:43:28,355 --> 00:43:30,758 A BIOLOGICAL VARIABLE AND ONE 1100 00:43:30,758 --> 00:43:33,127 WAY THAT BIB HAS DONE IN PAST IS 1101 00:43:33,127 --> 00:43:35,429 THROUGH IMAGING RESEARCH AND 1102 00:43:35,429 --> 00:43:37,231 HIGHLIGHTING ONE EXAMPLE AND 1103 00:43:37,231 --> 00:43:39,433 SUPPORT FOR CARDIAC MRI IMAGING 1104 00:43:39,433 --> 00:43:41,702 AND IMAGING TECHNIQUES HAVE BEEN 1105 00:43:41,702 --> 00:43:43,604 HIGHLY RELEVANT TO WOMEN'S 1106 00:43:43,604 --> 00:43:48,008 HEALTH AND WOMEN TEND TO HAVE 1107 00:43:48,008 --> 00:43:48,308 N 1108 00:43:48,308 --> 00:43:52,279 NONOBSTRUCTIVE CORONARY PATTERN 1109 00:43:52,279 --> 00:43:54,915 NOT PICKED UP ON GOLD DIAGNOSTIC 1110 00:43:54,915 --> 00:44:00,020 STANDARD TEST THAT IS CORONARY 1111 00:44:00,020 --> 00:44:01,488 ANGIOGRAM AND WHY WOMEN WILL 1112 00:44:01,488 --> 00:44:03,757 PRESENT IN EMERGENCY ROOM AND 1113 00:44:03,757 --> 00:44:06,193 HAVE NORMAL CARDIO ANGIO GRAM 1114 00:44:06,193 --> 00:44:09,563 AND BE HAVING A HEART ATTACK AND 1115 00:44:09,563 --> 00:44:12,900 BE SENT HOME AND CHOLESTEROL 1116 00:44:12,900 --> 00:44:15,402 PLAQUE PATTERNS ARE DIFFERENT 1117 00:44:15,402 --> 00:44:18,172 AND CORONARY REMODELING AND 1118 00:44:18,172 --> 00:44:19,573 [INDISCERNIBLE] IS DIFFERENT AND 1119 00:44:19,573 --> 00:44:22,543 I WILL HIGHLIGHT THAT MICRO 1120 00:44:22,543 --> 00:44:23,944 VASCULAR DISEASE IS MORE COMMON 1121 00:44:23,944 --> 00:44:26,513 IN WOMEN THAN MEN AND MICRO 1122 00:44:26,513 --> 00:44:28,148 VASCULAR DISEASE IS NOT 1123 00:44:28,148 --> 00:44:30,017 NECESSARILY ALWAYS DETECTED BY 1124 00:44:30,017 --> 00:44:32,386 OUR GOLD STANDARD TEST BUT 1125 00:44:32,386 --> 00:44:35,322 CARDIAC MRI AND IMAGING 1126 00:44:35,322 --> 00:44:38,826 TECHNIQUES ARE SALIENT TO 1127 00:44:38,826 --> 00:44:39,726 DIAGNOSING [INDISCERNIBLE] AND 1128 00:44:39,726 --> 00:44:41,995 SEX AND GENDER IS ON OUR 1129 00:44:41,995 --> 00:44:44,364 NATIONAL RADAR. IT IS ALSO ON 1130 00:44:44,364 --> 00:44:47,701 THE INTERNATIONAL STAGE AS WELL. 1131 00:44:47,701 --> 00:44:50,237 THE WORLD HEALTH ORGANIZATION 1132 00:44:50,237 --> 00:44:51,905 RECENTLY ADOPTED SEX AND GENDER 1133 00:44:51,905 --> 00:44:54,007 EQUITY AND RESEARCH GUIDELINE 1134 00:44:54,007 --> 00:44:55,242 DEVELOPED TO PROMOTE SEX AND 1135 00:44:55,242 --> 00:44:57,945 GENDER EQUITY AND RESEARCH 1136 00:44:57,945 --> 00:44:59,112 ESPECIALLY AROUND PUBLICATION 1137 00:44:59,112 --> 00:45:01,748 AND JOURNALS AND PUBLISHERS 1138 00:45:01,748 --> 00:45:03,951 ADOPTED THE GUIDELINE AND I WAS 1139 00:45:03,951 --> 00:45:05,786 EXCITED TO BE ON A PANEL WHEN 1140 00:45:05,786 --> 00:45:08,121 WHO ANNOUNCED THAT ALONG WITH 1141 00:45:08,121 --> 00:45:11,592 THE CREATOR OF THE GUIDELINES. 1142 00:45:11,592 --> 00:45:15,395 WE HAVE RECENTLY A WEBINAR WHERE 1143 00:45:15,395 --> 00:45:17,497 WE TALKED ABOUT SIBIB AND SEX 1144 00:45:17,497 --> 00:45:20,267 AND RESEARCH AND I WAS REALLY 1145 00:45:20,267 --> 00:45:23,704 EXCITE TODAY BE AT PRECISION 1146 00:45:23,704 --> 00:45:26,006 MEDICINE WORLD CONFERENCE ON THE 1147 00:45:26,006 --> 00:45:27,908 STAGE RECEIVING AN AWARD WHERE 1148 00:45:27,908 --> 00:45:30,277 THEY TALKED ABOUT HOW ALL OF 1149 00:45:30,277 --> 00:45:32,045 PRECISION MEDICINE NEEDS TO 1150 00:45:32,045 --> 00:45:35,182 CONSIDER HEALTH OF WOMEN EARLIER 1151 00:45:35,182 --> 00:45:37,451 THIS YEAR AND WITH SOMETHING 1152 00:45:37,451 --> 00:45:39,052 ABOUT CAREERS AND HERE IS DATA 1153 00:45:39,052 --> 00:45:41,154 AND OVER TIME THE NUMBER OF 1154 00:45:41,154 --> 00:45:44,157 SUPPORTIVE PIS ON RESEARCH 1155 00:45:44,157 --> 00:45:46,593 PROJECT GRANTS BY SEX AND FISCAL 1156 00:45:46,593 --> 00:45:49,529 YEAR IN ORANGE AND MALES AND 1157 00:45:49,529 --> 00:45:52,199 GREY FEMALES AND SEE NO SLIGHT 1158 00:45:52,199 --> 00:45:53,467 UPTICK OR REAL CHANGE IN BLUE 1159 00:45:53,467 --> 00:45:55,135 THAT IS NOT REPORTED AND WE KNOW 1160 00:45:55,135 --> 00:45:58,438 THAT WOMEN AND MEN ARE EQUALLY 1161 00:45:58,438 --> 00:46:01,275 LIKELY TO BE FUNDED WHEN THEY 1162 00:46:01,275 --> 00:46:01,775 APPLY. 1163 00:46:01,775 --> 00:46:03,577 THAT HAS BEEN SHOWN MULTIPLE 1164 00:46:03,577 --> 00:46:06,213 TIMES FOR NIH GRANTS AND WOMEN 1165 00:46:06,213 --> 00:46:09,416 TEND TO NOT COME BACK IN FOR 1166 00:46:09,416 --> 00:46:11,618 SECOND RPGS AND WE ARE NOT 1167 00:46:11,618 --> 00:46:14,221 REALLY SEEING ANY MOVEMENTS 1168 00:46:14,221 --> 00:46:17,824 SUBSTANTIAL MOVEMENT ON THIS AND 1169 00:46:17,824 --> 00:46:20,727 NUMBERS OF WOMEN SEEKING 1170 00:46:20,727 --> 00:46:22,396 COMPUTER SCIENCE MAJORS WAS 1171 00:46:22,396 --> 00:46:24,197 GOING UP AND NOW IS GOING DOWN 1172 00:46:24,197 --> 00:46:26,199 AND WE CLEARLY HAVE WORK TO DO 1173 00:46:26,199 --> 00:46:30,404 IN THIS SPACE OF WHO IS IN THE 1174 00:46:30,404 --> 00:46:31,138 RESEARCH WORKFORCE AND WHOSE 1175 00:46:31,138 --> 00:46:32,806 IDEAS ARE WE CONSIDERING AND HOW 1176 00:46:32,806 --> 00:46:36,209 CAN WE GET ALL OF THE BRILLIANT 1177 00:46:36,209 --> 00:46:39,446 MINDS IN SCIENCE SO WE CAN 1178 00:46:39,446 --> 00:46:39,846 [INDISCERNIBLE]. 1179 00:46:39,846 --> 00:46:45,319 SO INSTEAD OF A PIPELINE WE ARE 1180 00:46:45,319 --> 00:46:46,687 TALKING ABOUT A BRAIDED RIVER 1181 00:46:46,687 --> 00:46:48,922 FOR ANALOGY FOR CAREERS TODAY 1182 00:46:48,922 --> 00:46:51,224 AND WE WANT INDIVIDUALS TO COME 1183 00:46:51,224 --> 00:46:52,893 INTO THIS FROM MULTIPLE ENTRIES 1184 00:46:52,893 --> 00:46:55,495 AND EXITS AND WANT THEM TO COME 1185 00:46:55,495 --> 00:46:56,563 FROM COMMUNITY COLLEGES AND WANT 1186 00:46:56,563 --> 00:47:00,233 THEM TO BE ABLE TO MOVE ACROSS 1187 00:47:00,233 --> 00:47:02,669 CREEKS AND ETES AND STREAMS HERE 1188 00:47:02,669 --> 00:47:04,838 TO MOVE FROM ONE SECTOR TO 1189 00:47:04,838 --> 00:47:05,939 ANOTHER AND LEAVE SCIENCE THAT 1190 00:47:05,939 --> 00:47:08,775 THEY NEED TO HAVE CAREGIVING 1191 00:47:08,775 --> 00:47:10,944 RESPONSIBILITIES AND HAVE A RAMP 1192 00:47:10,944 --> 00:47:12,546 TO GET BACK ON AND KNOW IF 1193 00:47:12,546 --> 00:47:14,181 INDIVIDUALS HAVE EXPERIENCES IN 1194 00:47:14,181 --> 00:47:16,883 MULTIPLE SECTORS THEY ARE LIKELY 1195 00:47:16,883 --> 00:47:18,385 TO BRING INTERDISCIPLINARY 1196 00:47:18,385 --> 00:47:19,486 SOLUTIONS TO SCIENCE AND THROUGH 1197 00:47:19,486 --> 00:47:21,288 CAREER PROGRAM WE ARE ADDRESSING 1198 00:47:21,288 --> 00:47:23,156 THESE ISSUES AND WON'T GO OVER 1199 00:47:23,156 --> 00:47:24,358 ALL THESE PROGRAMS. 1200 00:47:24,358 --> 00:47:27,928 THIS IS A PAPER THAT 1201 00:47:27,928 --> 00:47:29,930 CO-AUTHORED WITH MARIE BERNARD 1202 00:47:29,930 --> 00:47:33,333 CHIEF OFFICE OF SCIENTIFIC 1203 00:47:33,333 --> 00:47:35,235 WORKFORCE AND SCIENCE POLICY AND 1204 00:47:35,235 --> 00:47:37,971 KELLY FROM NIH INTRAMURAL 1205 00:47:37,971 --> 00:47:39,906 PROGRAM AND HERE WE TALKED ABOUT 1206 00:47:39,906 --> 00:47:42,509 HOW CRITICAL IT IS TO HAVE ALL 1207 00:47:42,509 --> 00:47:45,779 FIVE DOMAINS WORKING IN A 1208 00:47:45,779 --> 00:47:47,047 CONCERTED COORDINATED FASHION TO 1209 00:47:47,047 --> 00:47:49,249 BE ABLE TO FINALLY MAKE PROGRESS 1210 00:47:49,249 --> 00:47:51,885 AROUND EQUITY IN OUR WORKFORCE. 1211 00:47:51,885 --> 00:47:53,620 WE NEED TO HAVE FLEXIBILITY 1212 00:47:53,620 --> 00:47:55,522 OPTIONS AND MUST HAVE A CULTURE 1213 00:47:55,522 --> 00:47:57,624 OF INCLUSION AND HAVE TO 1214 00:47:57,624 --> 00:47:59,760 DEMONSTRATE LEADERSHIP SUPPORT 1215 00:47:59,760 --> 00:48:01,428 AND MUST INCLUDE ACTION 1216 00:48:01,428 --> 00:48:02,696 ORIENTING TO ACCOUNTABILITY 1217 00:48:02,696 --> 00:48:04,631 MEASURES AND AS ALWAYS WE DO 1218 00:48:04,631 --> 00:48:06,933 THIS IN AN EVIDENCE-BASE THE 1219 00:48:06,933 --> 00:48:08,235 SAME WAY WE DO ANYTHING. 1220 00:48:08,235 --> 00:48:10,670 WE NEED TO STUDY IT IN A 1221 00:48:10,670 --> 00:48:12,439 RIGOROUS WAY AND DO CLINICAL 1222 00:48:12,439 --> 00:48:15,075 TRIALS OF INTERVENTIONS WE ARE 1223 00:48:15,075 --> 00:48:17,344 PROPOSING THAT IS A 1224 00:48:17,344 --> 00:48:19,813 SUMMARIZATION IN THIS NATURE 1225 00:48:19,813 --> 00:48:20,047 PAPER. 1226 00:48:20,047 --> 00:48:21,648 WITH THAT I WANT TO THANK ALL OF 1227 00:48:21,648 --> 00:48:23,350 YOU FOR YOUR TIME THIS MORNING 1228 00:48:23,350 --> 00:48:24,851 AND BRUCE FOR CHANGING YOUR 1229 00:48:24,851 --> 00:48:27,187 AGENDA TO ALLOW ME TO BE HERE 1230 00:48:27,187 --> 00:48:30,490 FIRST TO GO TO THE NEXT STEP 1231 00:48:30,490 --> 00:48:32,726 LAUNCHING NIH-WIDE WOMEN'S 1232 00:48:32,726 --> 00:48:35,896 HEALTH RESEARCH AND LAUNCHING 1233 00:48:35,896 --> 00:48:37,998 FIRST EVER FAQ SHEET TALKING 1234 00:48:37,998 --> 00:48:40,133 ABOUT WOMEN'S HEALTH AND 1235 00:48:40,133 --> 00:48:42,836 INVESTMENT AND PUBLISHING 1236 00:48:42,836 --> 00:48:45,439 UNDERSTUDIED UNDERREPORTED 1237 00:48:45,439 --> 00:48:46,540 UNDER-REPRESENTED POPULATIONS OF 1238 00:48:46,540 --> 00:48:49,843 WOMEN'S HEALTH DATA BOOK. 1239 00:48:49,843 --> 00:48:52,345 WE PUBLISH IT EVERY 10 YEARS TO 1240 00:48:52,345 --> 00:48:53,980 SEE POPULATIONS OF WOMEN AND 1241 00:48:53,980 --> 00:48:55,148 HEALTH OUTCOMES. 1242 00:48:55,148 --> 00:48:57,517 CHECK IT OUT ONLINE TODAY AND IT 1243 00:48:57,517 --> 00:49:01,288 IS MY PLEASURE TO BE HERE WITH 1244 00:49:01,288 --> 00:49:02,289 YOU TODAY. 1245 00:49:02,289 --> 00:49:02,823 >> AUDIENCE: [APPLAUSE]. 1246 00:49:02,823 --> 00:49:12,232 >> THANK YOU SO MUCH, JANINE. 1247 00:49:12,232 --> 00:49:13,533 FANTASTIC PRESENTATION THAT IS A 1248 00:49:13,533 --> 00:49:15,202 LOT FOR US TO DIGEST. 1249 00:49:15,202 --> 00:49:17,337 I'M SURE THERE WILL BE MANY, 1250 00:49:17,337 --> 00:49:18,538 MANY QUESTIONS AND COUNCIL 1251 00:49:18,538 --> 00:49:20,874 MEMBERS, I GUESS DO WE HAVE A 1252 00:49:20,874 --> 00:49:23,276 PROTOCOL FOR THIS, DAVE? 1253 00:49:23,276 --> 00:49:26,012 MAYBE TURN YOUR CARD LIKE THAT 1254 00:49:26,012 --> 00:49:27,547 OR SOMETHING AS YOU GET IN A 1255 00:49:27,547 --> 00:49:32,752 LINE FOR YOUR QUESTIONS THAT 1256 00:49:32,752 --> 00:49:33,286 WILL HELP US INNOVATIVE 1257 00:49:33,286 --> 00:49:33,553 DIRECTOR. 1258 00:49:33,553 --> 00:49:37,424 >> I GOT THAT ENTIRELY FROM 1259 00:49:37,424 --> 00:49:39,459 SUSAN MARGO LEASE AT NSF THAT IS 1260 00:49:39,459 --> 00:49:41,661 WHAT SHE DOES AND HER CONVENTION 1261 00:49:41,661 --> 00:49:43,463 AND IT WORKS WELL. 1262 00:49:43,463 --> 00:49:45,365 >> I WANT TO MENTION I APOLOGIZE 1263 00:49:45,365 --> 00:49:47,167 I NEGLECTED TO MENTION THAT 1264 00:49:47,167 --> 00:49:48,201 [INDISCERNIBLE] COUNCIL MEMBER 1265 00:49:48,201 --> 00:49:52,939 IS ONLINE TODAY AND HE IS 1266 00:49:52,939 --> 00:49:53,907 PARTICIPATING ONLINE. 1267 00:49:53,907 --> 00:49:59,646 >> HOW WILL WE KNOW SHE HAS A 1268 00:49:59,646 --> 00:49:59,913 QUESTION. 1269 00:49:59,913 --> 00:50:01,615 >> WE SHOULD BE ABLE TO HEAR 1270 00:50:01,615 --> 00:50:01,815 HER. 1271 00:50:01,815 --> 00:50:04,050 >> OKAY. SHOUT OUT IF YOU HAVE 1272 00:50:04,050 --> 00:50:06,153 A VOICE. WE WANT TO HEAR IT. 1273 00:50:06,153 --> 00:50:08,989 >> I WILL. THANK YOU. 1274 00:50:08,989 --> 00:50:12,425 >> AWESOME. THANK YOU. 1275 00:50:12,425 --> 00:50:15,662 JOYCE? 1276 00:50:15,662 --> 00:50:19,432 >> THIS ONE, OKAY. 1277 00:50:19,432 --> 00:50:21,635 I THINK SO. THANK YOU SO MUCH. 1278 00:50:21,635 --> 00:50:25,906 THAT WAS WONDERFUL AND EXCITING 1279 00:50:25,906 --> 00:50:28,608 AND I'M EXCITED TO SEE THE 1280 00:50:28,608 --> 00:50:31,511 STRATEGIC PLAN AND HAVE A COUPLE 1281 00:50:31,511 --> 00:50:35,749 QUESTIONS LOGISTICALLY OF I LOVE 1282 00:50:35,749 --> 00:50:38,485 HOW YOU USE THE ARGUMENT 1 1283 00:50:38,485 --> 00:50:40,987 TRILLION DOLLARS IN 2040 AND 1284 00:50:40,987 --> 00:50:42,989 QUESTION IS I AGREE ALONE THAT 1285 00:50:42,989 --> 00:50:45,692 SHOULD BE AN ANSWER AND TRYING 1286 00:50:45,692 --> 00:50:46,560 TO INCENTIVIZE PEOPLE TO 1287 00:50:46,560 --> 00:50:47,861 UNDERSTAND HOW IMPORTANT IT IS 1288 00:50:47,861 --> 00:50:52,165 TO INVEST AND QUESTION IS 12 1289 00:50:52,165 --> 00:50:55,735 BILLION SHOWING THE REQUEST HOW 1290 00:50:55,735 --> 00:50:57,604 LIKELY OR WHAT CAN WE VIEW AS 1291 00:50:57,604 --> 00:50:59,372 COUNCIL MEMBERS AND OTHERS 1292 00:50:59,372 --> 00:51:01,208 WATCHING WHAT WE CAN DO TO MAKE 1293 00:51:01,208 --> 00:51:02,909 IT HAPPEN AND IS IT HAPPENING 1294 00:51:02,909 --> 00:51:05,212 AND THAT IS THE SECOND QUESTION. 1295 00:51:05,212 --> 00:51:05,478 >> SURE. 1296 00:51:05,478 --> 00:51:07,581 >> 12 BILLION DOLLARS IS NO. 1 1297 00:51:07,581 --> 00:51:09,583 QUESTION I'M GETTING RIGHT NOW 1298 00:51:09,583 --> 00:51:11,251 AND NOT SURPRISED IT IS FIRST 1299 00:51:11,251 --> 00:51:12,419 QUESTION AND REALLY IMPORTANT 1300 00:51:12,419 --> 00:51:12,786 ONE. 1301 00:51:12,786 --> 00:51:15,155 I THINK THAT IS A PRESIDENTIAL 1302 00:51:15,155 --> 00:51:16,122 REQUEST TO CONGRESS. 1303 00:51:16,122 --> 00:51:18,992 AND IT IS UP TO THE US CONGRESS 1304 00:51:18,992 --> 00:51:20,961 TO DECIDE HOW THEY WILL RESPOND 1305 00:51:20,961 --> 00:51:21,728 TO THAT REQUEST. 1306 00:51:21,728 --> 00:51:25,165 BY ASSIGNING THIS EXECUTIVE 1307 00:51:25,165 --> 00:51:27,701 ORDER IN LAYING OUT DIRECTIVES 1308 00:51:27,701 --> 00:51:29,836 THAT IS A ROADMAP TO WHAT COULD 1309 00:51:29,836 --> 00:51:30,837 BE DONE. 1310 00:51:30,837 --> 00:51:34,741 I THINK THAT THROUGH NIH EFFORTS 1311 00:51:34,741 --> 00:51:37,244 AND OTHERS WHERE WE TALK ABOUT 1312 00:51:37,244 --> 00:51:38,445 STRATEGIC PLAN AND OTHER 1313 00:51:38,445 --> 00:51:40,213 DOCUMENTS WHERE GAPS AND 1314 00:51:40,213 --> 00:51:41,615 OPPORTUNITIES ARE. 1315 00:51:41,615 --> 00:51:44,851 WE ARE DECLARING WHERE INCREASE 1316 00:51:44,851 --> 00:51:46,820 INVESTMENT MIGHT BE ABLE TO MAKE 1317 00:51:46,820 --> 00:51:48,989 A DIFFERENCE AND MUST GO THROUGH 1318 00:51:48,989 --> 00:51:51,524 THE USUAL BUSINESS PROCESSES 1319 00:51:51,524 --> 00:51:53,793 THAT BUDGET -- US GOVERNMENT 1320 00:51:53,793 --> 00:51:55,962 BUDGET GOES THROUGH AND AS 1321 00:51:55,962 --> 00:51:57,597 COUNCIL MEMBERS YOU ARE FEDERAL 1322 00:51:57,597 --> 00:52:00,500 GOVERNMENT EMPLOYEES RIGHT NOW 1323 00:52:00,500 --> 00:52:01,768 REMINDING YOU OF THAT. 1324 00:52:01,768 --> 00:52:04,638 THIS IS SOMETHING THAT ELEVATES 1325 00:52:04,638 --> 00:52:06,206 WOMEN'S HEALTH RESEARCH TO THE 1326 00:52:06,206 --> 00:52:08,341 HIGHEST LEVEL AND AS ALL 1327 00:52:08,341 --> 00:52:10,243 INSTITUTES AND CENTERS ARE -- 1328 00:52:10,243 --> 00:52:12,312 WILL FOLLOW CONGRESSIONAL 1329 00:52:12,312 --> 00:52:13,980 PROCESS FOR APROPRIATION AND 1330 00:52:13,980 --> 00:52:15,949 LOOK FORWARD TO SEEING WHAT 1331 00:52:15,949 --> 00:52:19,019 HAPPENS IN FISCAL YEAR '25. 1332 00:52:19,019 --> 00:52:20,120 >> GREAT. SECOND QUESTION HAS 1333 00:52:20,120 --> 00:52:23,456 TO DO WITH LOGISTICS IN NIH AND 1334 00:52:23,456 --> 00:52:25,458 LOVE HOW YOU SAY THE IDEA OF 1335 00:52:25,458 --> 00:52:28,728 REALLY INTEGRATING SEX AS A 1336 00:52:28,728 --> 00:52:31,998 BIOLOGICAL FACTOR AND GENDER 1337 00:52:31,998 --> 00:52:33,066 DIFFERENCES THROUGHOUT THE 1338 00:52:33,066 --> 00:52:34,634 ENTIRE RESEARCH TO CLINICAL 1339 00:52:34,634 --> 00:52:37,337 TRIALS AND QUESTION IS, IS THAT 1340 00:52:37,337 --> 00:52:39,105 BEING TRICKLED DOWN TO CENTER 1341 00:52:39,105 --> 00:52:41,541 FOR SCIENTIFIC REVIEW AND 1342 00:52:41,541 --> 00:52:44,811 ORIENTATION FOR STUDY SECTION 1343 00:52:44,811 --> 00:52:49,416 MEMBERS WHERE THEY SEE THIS AND 1344 00:52:49,416 --> 00:52:53,520 NO SEE SO IT GETS IMPLEMENTED 1345 00:52:53,520 --> 00:52:55,422 MAKING SURE THERE IS COMPLIANCE. 1346 00:52:55,422 --> 00:52:57,090 >> THANK YOU FOR THE GREAT 1347 00:52:57,090 --> 00:52:58,958 QUESTION. WENT INTO EFFECT IN 1348 00:52:58,958 --> 00:53:00,226 2016 AND KNOW THAT MAKING 1349 00:53:00,226 --> 00:53:03,496 CHANGES AT NIH IS SORT OF LIKE 1350 00:53:03,496 --> 00:53:07,233 TURNING AN AIRCRAFT CARRIER 1351 00:53:07,233 --> 00:53:09,035 TAKES A WHILE TO DO AND 1352 00:53:09,035 --> 00:53:09,869 DIFFERENT FIELDS AND DISCIPLINES 1353 00:53:09,869 --> 00:53:11,504 AT DIFFERENT PLACES IN THIS 1354 00:53:11,504 --> 00:53:14,507 STORY AND OVER YEARS DEVELOPED 1355 00:53:14,507 --> 00:53:21,514 VARIETY OF EDUCATIONAL MATERIALS 1356 00:53:21,514 --> 00:53:23,817 -- TALKING ABOUT HOW TO 1357 00:53:23,817 --> 00:53:29,189 IMPLEMENT SBIB AND TRAINING 1358 00:53:29,189 --> 00:53:30,790 TRAINER VIDEOS AND INTEGRATION 1359 00:53:30,790 --> 00:53:32,492 TEACHING GRAD STUDENTS AND THE 1360 00:53:32,492 --> 00:53:34,227 LIKE AND REGARDING CSR I HAVE 1361 00:53:34,227 --> 00:53:36,363 BEEN IN CONVERSATION WITH 1362 00:53:36,363 --> 00:53:39,866 MELANIE BURNS DIRECTOR OF CSR 1363 00:53:39,866 --> 00:53:43,370 AROUND CURRENT NEED TO FURTHER 1364 00:53:43,370 --> 00:53:46,272 ELEVATE -- AS A SIMPLIFIED 1365 00:53:46,272 --> 00:53:48,007 REVIEW FRAMEWORK GOING INTO 1366 00:53:48,007 --> 00:53:50,110 EFFECT AND IS ON AGENDA FOR 1367 00:53:50,110 --> 00:53:52,479 TODAY AND PART OF FACTOR 2 AND 1368 00:53:52,479 --> 00:53:54,481 YOU WILL SEE WHERE IT FITS AND 1369 00:53:54,481 --> 00:53:56,282 WILL CONTINUE TO ELEVATE ISSUE 1370 00:53:56,282 --> 00:54:00,186 THROUGH PEER REVIEW PROCESS AND 1371 00:54:00,186 --> 00:54:02,122 PROGRAMATIC OVERSIGHT LOOKING AT 1372 00:54:02,122 --> 00:54:04,557 PROGRESS REPORTS AND LIKE AND 1373 00:54:04,557 --> 00:54:06,192 ENCOURAGING IT BEST WE CAN 1374 00:54:06,192 --> 00:54:08,828 THROUGH PUBLICATIONS AND 1375 00:54:08,828 --> 00:54:12,732 MENTIONING THAT TTA.GOV 1376 00:54:12,732 --> 00:54:13,066 REQUIREMENTS. 1377 00:54:13,066 --> 00:54:15,034 THOSE CLINICAL TRIALS THAT ARE 1378 00:54:15,034 --> 00:54:17,337 PHASE 3 CLINICAL TRIALS OR 1379 00:54:17,337 --> 00:54:18,538 COVERING APPLICABLE PRODUCTS 1380 00:54:18,538 --> 00:54:21,775 WILL HAVE RESULTS BY SEX IN 1381 00:54:21,775 --> 00:54:23,743 CLINICAL TRIALS.GOV AND WANT TO 1382 00:54:23,743 --> 00:54:25,512 GIVE YOU GOOD NEWS WHEN WE LOOK 1383 00:54:25,512 --> 00:54:26,913 AT PUBLICATIONS. 1384 00:54:26,913 --> 00:54:29,783 RATE OF PUBLICATIONS AND OF 1385 00:54:29,783 --> 00:54:31,451 SEX-SPECIFIC OUTCOMES FROM PHASE 1386 00:54:31,451 --> 00:54:33,453 3 CLINICAL TRIALS HAS BEEN 1387 00:54:33,453 --> 00:54:35,188 SOLVED AT 25% OF THEM. 1388 00:54:35,188 --> 00:54:38,057 IT IS NOW UP TO NEARLY 50%. OF 1389 00:54:38,057 --> 00:54:40,760 COURSE, WE WANT IT TO BE 100%. 1390 00:54:40,760 --> 00:54:42,929 MORE WORK TO DO THERE AND ARE 1391 00:54:42,929 --> 00:54:45,465 WORKING AT PEER REVIEW PHASE AND 1392 00:54:45,465 --> 00:54:47,734 PROGRAMATIC OVERSIGHTS AND AT 1393 00:54:47,734 --> 00:54:54,474 PUBLICATION RESULTS REPORTING. 1394 00:54:54,474 --> 00:55:04,517 >> LOOKS LIKE KEN IS VERTICAL. 1395 00:55:04,517 --> 00:55:08,321 >> OKAY. WONDERFUL. THAT WAS 1396 00:55:08,321 --> 00:55:10,490 GREAT. SUCH A FABULOUS PROGRAM. 1397 00:55:10,490 --> 00:55:12,192 YOU KNOW, SO BROAD. 1398 00:55:12,192 --> 00:55:15,228 SOY WAS CURIOUS. I SIT ON A 1399 00:55:15,228 --> 00:55:17,897 FORUM FOR REGENERATIVE MEDICINE. 1400 00:55:17,897 --> 00:55:20,467 >> COW PUT YOUR MICROPHONE 1401 00:55:20,467 --> 00:55:20,700 CLOSER. 1402 00:55:20,700 --> 00:55:21,267 >> OKAY. 1403 00:55:21,267 --> 00:55:22,302 >> JUST DRAG IT. 1404 00:55:22,302 --> 00:55:25,605 >> CAN YOU HEAR ME NOW? OKAY. 1405 00:55:25,605 --> 00:55:26,172 >> [INDISCERNIBLE]. 1406 00:55:26,172 --> 00:55:28,575 >> YEAH. OKAY. GREAT. SORRY I 1407 00:55:28,575 --> 00:55:30,910 DON'T USUALLY HAVE TROUBLE BEING 1408 00:55:30,910 --> 00:55:32,479 HEARD. 1409 00:55:32,479 --> 00:55:33,012 >> AUDIENCE: [LAUGHING]. 1410 00:55:33,012 --> 00:55:36,149 >> ANYWAY, SO I SIT ON THE FORUM 1411 00:55:36,149 --> 00:55:39,719 NATIONAL CANDIDATES FORUM FOR 1412 00:55:39,719 --> 00:55:41,321 REGENERATIVE MEDICINE AND VERY 1413 00:55:41,321 --> 00:55:46,226 BROAD COALITION OF AGENCIES AND 1414 00:55:46,226 --> 00:55:47,727 PATIENT ADVOCATES AND ACADEMICS 1415 00:55:47,727 --> 00:55:50,563 AND INDUSTRY AND IS A TOP THAK 1416 00:55:50,563 --> 00:55:53,333 IS STARTING TO GET LENGTH IN 1417 00:55:53,333 --> 00:55:56,569 BEING TALKED ABOUT AND LINDA 1418 00:55:56,569 --> 00:55:58,104 GRIF EDGE GAVE TALK A COUPLE 1419 00:55:58,104 --> 00:56:02,075 YEARS AING TO FORUM THAT STARTED 1420 00:56:02,075 --> 00:56:04,577 TO JUMPSTART THIS IDEA AND IS 1421 00:56:04,577 --> 00:56:06,579 TIMELY AND IMPORTANT AND 1422 00:56:06,579 --> 00:56:08,214 WONDERING I DIDN'T SEE REFERENCE 1423 00:56:08,214 --> 00:56:10,483 EXPLICITLY TO REGENERATIVE 1424 00:56:10,483 --> 00:56:11,985 MEDICINE HERE AND WONDER IF 1425 00:56:11,985 --> 00:56:13,486 ELEMENTS OF PROGRAM TOUCH ON 1426 00:56:13,486 --> 00:56:13,686 THAT. 1427 00:56:13,686 --> 00:56:16,489 >> THANK YOU FOR THAT QUESTION. 1428 00:56:16,489 --> 00:56:21,361 VIVIAN DEPUTY DIRECTOR OF OWH IN 1429 00:56:21,361 --> 00:56:23,863 RECENT REGENERATIVE WORKSHOP 1430 00:56:23,863 --> 00:56:26,266 AFFILIATED WITH EFFORT IN 1431 00:56:26,266 --> 00:56:27,233 NATIONAL ACADEMIES TALKING ABOUT 1432 00:56:27,233 --> 00:56:30,036 SEX AS A BIOLOGICAL VARIABLE. 1433 00:56:30,036 --> 00:56:32,472 IT IS TRICKLING IN AND HASN'T 1434 00:56:32,472 --> 00:56:34,474 BEEN AT FOREFRONT AND KNOW IT 1435 00:56:34,474 --> 00:56:36,342 ABSOLUTELY NEEDS TO BE THERE. 1436 00:56:36,342 --> 00:56:38,278 THERE ARE VERY WELL-RECOGNIZED 1437 00:56:38,278 --> 00:56:40,813 SEX DIFFERENCES IN PROLIFERATIVE 1438 00:56:40,813 --> 00:56:42,682 CAPACITY AND SCARRING AND ARE 1439 00:56:42,682 --> 00:56:45,585 HIGHLY RELEVANT TO REGENERATIVE 1440 00:56:45,585 --> 00:56:46,953 MEDICINE AND FIELD THAT IS 1441 00:56:46,953 --> 00:56:49,222 FAIRLY NEW-ISH. YOU KNOW, IT IS 1442 00:56:49,222 --> 00:56:51,591 IMPORTANT TO IMBED THAT 1443 00:56:51,591 --> 00:56:52,225 CONSIDERATION FROM THE BEGINNING 1444 00:56:52,225 --> 00:56:54,027 AND WOULD LOVE TO HAVE YOU LEND 1445 00:56:54,027 --> 00:56:57,230 YOUR VOICE TO THAT AS YOU ARE IN 1446 00:56:57,230 --> 00:57:00,667 THOSE SECTORS AND CORNERS AND 1447 00:57:00,667 --> 00:57:00,900 VENUES. 1448 00:57:00,900 --> 00:57:03,202 >> WE WILL WANT YOU PROBABLY TO 1449 00:57:03,202 --> 00:57:05,004 LEND YOUR VOICE TO OUR GROUP AS 1450 00:57:05,004 --> 00:57:05,505 WELL. THANK YOU. 1451 00:57:05,505 --> 00:57:08,041 >> HAPPY TO DO THAT. 1452 00:57:08,041 --> 00:57:09,842 TRANSPLANTATION FOR EXAMPLE WE 1453 00:57:09,842 --> 00:57:14,080 KNOW SEX DIFFERENCES AND SEX 1454 00:57:14,080 --> 00:57:15,281 DISCORDANCE TRANCE PLANATION 1455 00:57:15,281 --> 00:57:17,450 BECAUSE OF PROLIFERATIVE 1456 00:57:17,450 --> 00:57:21,120 DIFFERENCES AS THOUGH REALLY 1457 00:57:21,120 --> 00:57:23,723 ABSOLUTELY NEED TO CONSIDER T 1458 00:57:23,723 --> 00:57:23,923 THAT. 1459 00:57:23,923 --> 00:57:27,193 >> CONGRATULATIONS ON THE 1460 00:57:27,193 --> 00:57:29,963 PHENOMENAL PROGRESS THAT ORWH 1461 00:57:29,963 --> 00:57:31,364 HAS MADE AND MY QUESTION IS 1462 00:57:31,364 --> 00:57:33,900 ABOUT YOU HAVE MADE IT CLEAR 1463 00:57:33,900 --> 00:57:35,301 AMONGST MANY THINGS SEX 1464 00:57:35,301 --> 00:57:36,903 DIFFERENCES THAT CAN LEAD TO 1465 00:57:36,903 --> 00:57:38,671 DIFFERENTIAL HEALTH OUTCOMES AND 1466 00:57:38,671 --> 00:57:40,473 WITHIN THAT AND FOR WOMEN IN 1467 00:57:40,473 --> 00:57:43,209 PARTICULAR, WHAT ABOUT 1468 00:57:43,209 --> 00:57:44,544 ADDRESSING THESE OTHER 1469 00:57:44,544 --> 00:57:45,411 DIFFERENTIAL EXPERIENCES THAT 1470 00:57:45,411 --> 00:57:48,948 ARE RELATED TO RACE, ETHNICITY 1471 00:57:48,948 --> 00:57:50,483 AND SOCIOECONOMIC? 1472 00:57:50,483 --> 00:57:52,518 WE KNOW THAT CERTAIN -- WOMEN 1473 00:57:52,518 --> 00:57:54,454 FROM CERTAIN UNDERSERVED CERTAIN 1474 00:57:54,454 --> 00:57:56,889 HEALTH DISPARITY POPULATIONS ARE 1475 00:57:56,889 --> 00:57:58,658 SEVERELY IMPACTED BY 1476 00:57:58,658 --> 00:58:00,860 DIFFERENTIAL FACTORS THAT LEAD 1477 00:58:00,860 --> 00:58:02,795 TO DIFFERENTIAL HEALTH OUTCOMES. 1478 00:58:02,795 --> 00:58:03,663 COULD YOU SPEAK. 1479 00:58:03,663 --> 00:58:03,930 >> SURE. 1480 00:58:03,930 --> 00:58:08,001 >> SPECIFICALLY TO THE SUBSET 1481 00:58:08,001 --> 00:58:10,269 AND HOW THAT EFFECTS THE HEALTH 1482 00:58:10,269 --> 00:58:10,536 OUTCOMES. 1483 00:58:10,536 --> 00:58:12,438 >> THANKS SO MUCH FOR THAT 1484 00:58:12,438 --> 00:58:13,206 QUESTION, GILDA. 1485 00:58:13,206 --> 00:58:17,343 YOU KNOW, AS I MENTIONED 1486 00:58:17,343 --> 00:58:17,977 UNDERSTUDIED UNDER-REPRESENTED 1487 00:58:17,977 --> 00:58:20,079 AND UNDERREPORTED POPULATION OF 1488 00:58:20,079 --> 00:58:21,781 WOMEN'S HEALTH DATA BOOK IS 1489 00:58:21,781 --> 00:58:22,682 COMING OUT TODAY. 1490 00:58:22,682 --> 00:58:24,550 IN THE DOCUMENT WE TALK ABOUT 1491 00:58:24,550 --> 00:58:26,486 THE HEALTH DISPARITIES WE SEE 1492 00:58:26,486 --> 00:58:28,154 ACROSS VARIOUS POPULATIONS OF 1493 00:58:28,154 --> 00:58:30,023 WOMEN AND KNOW ALL WOMEN ARE NOT 1494 00:58:30,023 --> 00:58:31,691 THE SAME AND MEN AND WOMEN ARE 1495 00:58:31,691 --> 00:58:33,526 DIFFERENT AND AGES AND FACTORS 1496 00:58:33,526 --> 00:58:36,829 AND OTHER FACTORS YOU MENTIONED 1497 00:58:36,829 --> 00:58:37,864 SEVERAL OF THEM AND IS IMPORTANT 1498 00:58:37,864 --> 00:58:39,432 FOR US TO THINK THROUGH AND NO 1499 00:58:39,432 --> 00:58:42,001 THE JUST GO TO DEFAULT THIS IS A 1500 00:58:42,001 --> 00:58:43,903 RACIAL AND ETHNIC DIFFERENCE IN 1501 00:58:43,903 --> 00:58:44,170 OUTCOME. 1502 00:58:44,170 --> 00:58:45,672 IT IS NOT NECESSARILY AND 1503 00:58:45,672 --> 00:58:48,307 USUALLY NOT RELATED TO RATES 1504 00:58:48,307 --> 00:58:50,410 PER-SE BUT SOMETHING ELSE THAT 1505 00:58:50,410 --> 00:58:53,813 IS HAPPENING LIKE DISCRIMINATION 1506 00:58:53,813 --> 00:58:58,217 OR LIKE SOCIOECONOMIC STATUS 1507 00:58:58,217 --> 00:58:59,919 FACTORS AND ACCESS TO CARE 1508 00:58:59,919 --> 00:59:02,055 ISSUES AND MIGHT BE GENETIC 1509 00:59:02,055 --> 00:59:04,190 ANCESTRY ISSUES TO SEPARATE FROM 1510 00:59:04,190 --> 00:59:05,491 RACE AS A SOCIAL CONSTRUCT. 1511 00:59:05,491 --> 00:59:07,093 IT IS REALLY IMPORTANT HOW WE 1512 00:59:07,093 --> 00:59:08,428 THINK ABOUT THIS AND TALK ABOUT 1513 00:59:08,428 --> 00:59:10,396 IT AND LOOK AT THE DATA. 1514 00:59:10,396 --> 00:59:13,332 THAT WE LOOK AT THE DATA. 1515 00:59:13,332 --> 00:59:16,769 SO WE INCLUDE LOW SOCIOECONOMIC 1516 00:59:16,769 --> 00:59:18,504 STATUS AND INCLUDE RURAL VERSUS 1517 00:59:18,504 --> 00:59:20,973 URBAN LOCATIONS AND ARE MANY 1518 00:59:20,973 --> 00:59:22,075 COUNTIES IN THE UNITED STATES 1519 00:59:22,075 --> 00:59:25,578 BOTH URBAN AND RURAL THAT ARE 1520 00:59:25,578 --> 00:59:27,513 MATERNITY CARE DESSERTS AND PART 1521 00:59:27,513 --> 00:59:30,650 OF WASHINGTON, DC NOW AND 1522 00:59:30,650 --> 00:59:31,951 DESERTS THAT WILL EFFECT HEALTH 1523 00:59:31,951 --> 00:59:33,419 OUTCOMES AND CLOSEST YOU CAN 1524 00:59:33,419 --> 00:59:35,321 DELIVER A BABY IS HOURS AWAY. 1525 00:59:35,321 --> 00:59:38,191 IT IS A VARIETY OF FACTORS AND 1526 00:59:38,191 --> 00:59:40,393 IF YOU RECALL THAT BLUE SLIDE I 1527 00:59:40,393 --> 00:59:42,295 SHOWED HAD ALL OF THE FACTORS IN 1528 00:59:42,295 --> 00:59:42,962 ONE SLIDE. 1529 00:59:42,962 --> 00:59:45,965 WE NEED TO CONSIDER MANY OF 1530 00:59:45,965 --> 00:59:46,999 THESE FACTORS TOGETHER AND NOT 1531 00:59:46,999 --> 00:59:48,701 ONLY LOOK AT ONE AT A TIME. 1532 00:59:48,701 --> 00:59:51,804 SO WE ARE CALLING ON OUR SOCIAL 1533 00:59:51,804 --> 00:59:54,474 SCIENCE COLLEAGUES AND OTHERS TO 1534 00:59:54,474 --> 00:59:57,810 HELP US FIND WAYS TO DO THAT 1535 00:59:57,810 --> 00:59:59,979 BECAUSE IT CAN BE OVERWHELMING 1536 00:59:59,979 --> 01:00:02,081 TO SAY ALL THESE FACTORS EFFECT 1537 01:00:02,081 --> 01:00:04,350 HEALTH AND IS EASIER TO LOOK AT 1538 01:00:04,350 --> 01:00:07,253 ONE GENE AND IS NOT ENOUGH AND 1539 01:00:07,253 --> 01:00:10,156 IF YOU TRY TO IMPROVE HEALTH OF 1540 01:00:10,156 --> 01:00:12,058 EVERYONE THAT DR. BER TAN OELI 1541 01:00:12,058 --> 01:00:14,393 HAS SAID OVER AND OVER OUR JOB 1542 01:00:14,393 --> 01:00:16,963 IS NOT DONE UNTIL ALL WOMEN'S 1543 01:00:16,963 --> 01:00:19,432 HEALTH IS BETTER WE HAVE TO FIND 1544 01:00:19,432 --> 01:00:21,801 ADDITIONAL APPROACHES AND REAL 1545 01:00:21,801 --> 01:00:23,302 WORLD EVIDENCE AND WHATEVER 1546 01:00:23,302 --> 01:00:25,104 TOOLS WE CAN TO UNDERSTAND WHAT 1547 01:00:25,104 --> 01:00:29,342 IS BETTER AND WHAT IS HAPPENING 1548 01:00:29,342 --> 01:00:29,842 AND WHY. 1549 01:00:29,842 --> 01:00:31,844 WHEN YOU CHARACTERIZE DATA LIKE 1550 01:00:31,844 --> 01:00:33,379 IN DATA BOOK IT TELLS YOU WHERE 1551 01:00:33,379 --> 01:00:35,281 NEEDS ARE AND OPENS QUESTIONS 1552 01:00:35,281 --> 01:00:36,616 FOR RESEARCH AND ARE PARTNERING 1553 01:00:36,616 --> 01:00:39,152 WITH INSTITUTES ON UNDERSTUDIED 1554 01:00:39,152 --> 01:00:41,821 AND UNDERREPORTED AND 1555 01:00:41,821 --> 01:00:43,055 UNDER-REPRESENTED POPULATIONS OF 1556 01:00:43,055 --> 01:00:44,891 WOMEN PROGRAM OR RESEARCH 1557 01:00:44,891 --> 01:00:47,026 PROGRAM THAT IS A SUPPLEMENT AND 1558 01:00:47,026 --> 01:00:49,295 ALLOW INVESTIGATORS TO SEEK 1559 01:00:49,295 --> 01:00:50,797 ADDITIONAL FUNDING TO DIG DEEPER 1560 01:00:50,797 --> 01:00:52,465 AND LOOK AT QUESTIONS AND THANKS 1561 01:00:52,465 --> 01:00:54,500 FOR BRINGING IT UP AS YOU KNOW 1562 01:00:54,500 --> 01:00:58,571 THE NOTION OF ADVANCING HEALTH 1563 01:00:58,571 --> 01:01:01,541 EQUITY IS CRITICAL FOR THE 1564 01:01:01,541 --> 01:01:02,875 HEALTH OF OUR COUNTRY AND NATION 1565 01:01:02,875 --> 01:01:05,178 AND ECONOMIES AND EVERYTHING 1566 01:01:05,178 --> 01:01:06,112 ELSE WE DO. 1567 01:01:06,112 --> 01:01:08,748 WE ARE EAGER TO PARTNER WITH ICO 1568 01:01:08,748 --> 01:01:11,117 COLLEAGUES ON WAYS TO DO THAT 1569 01:01:11,117 --> 01:01:13,219 AND THAT SPECIFICALLY ADDRESS 1570 01:01:13,219 --> 01:01:14,954 WOMEN'S HEALTH AND WILL GIVE YOU 1571 01:01:14,954 --> 01:01:19,091 ONE DATA POINT AS I END HERE. 1572 01:01:19,091 --> 01:01:20,993 MATERNAL MORTALITY IN THE 1573 01:01:20,993 --> 01:01:22,995 COUNTRY IS HIGHEST THAN IN ANY 1574 01:01:22,995 --> 01:01:24,997 INCOME COUNTRY AND IS INCREASING 1575 01:01:24,997 --> 01:01:28,301 AND HIGHER THAN SEVERAL MIDDLE 1576 01:01:28,301 --> 01:01:30,503 INCOME COUNTRIES AND 1577 01:01:30,503 --> 01:01:32,138 UNFORTUNATELY LIKE MANY HEALTH 1578 01:01:32,138 --> 01:01:33,840 DATA RACIAL AND ETHNIC 1579 01:01:33,840 --> 01:01:35,808 DIFFERENCE WE SEE HIGHEST 1580 01:01:35,808 --> 01:01:38,744 MORTALITY RATES IN INDIAN ALASKA 1581 01:01:38,744 --> 01:01:40,913 NATIVE AND AFRICAN AMERICAN 1582 01:01:40,913 --> 01:01:42,315 WOMEN THREE TIMES OTHERS AND 1583 01:01:42,315 --> 01:01:44,283 THAT IS A DIFFERENT -- IT IS NOT 1584 01:01:44,283 --> 01:01:47,253 DIFFERENT BY SOCIOECONOMIC 1585 01:01:47,253 --> 01:01:47,854 STATUS. 1586 01:01:47,854 --> 01:01:49,689 WHEREAS MANY HEALTH INDICATORS 1587 01:01:49,689 --> 01:01:53,693 ONCE YOU PUT IT ON SBS YOU SEE 1588 01:01:53,693 --> 01:01:55,494 DIFFERENCE IS A WAY AND IS 1589 01:01:55,494 --> 01:01:56,629 TELLING US SOMETHING ABOUT OUR 1590 01:01:56,629 --> 01:01:58,497 SYSTEM AND WE HAVE TO BETTER 1591 01:01:58,497 --> 01:01:59,732 UNDERSTAND THAT THROUGH RESEARCH 1592 01:01:59,732 --> 01:02:02,268 AND DATA TO INFORM POLICY 1593 01:02:02,268 --> 01:02:02,668 DECISIONS. 1594 01:02:02,668 --> 01:02:05,304 SO WE STILL HAVE WORK TO DO AND 1595 01:02:05,304 --> 01:02:07,039 THIS GROUP IS ASKING FANTASTIC 1596 01:02:07,039 --> 01:02:09,175 QUESTIONS AND I'M INSPIRED WE 1597 01:02:09,175 --> 01:02:11,744 WILL KEEP MOVING FORWARD IN THAT 1598 01:02:11,744 --> 01:02:12,278 REGARD. 1599 01:02:12,278 --> 01:02:13,946 >> JANINE IF I COULD FOLLOW UP 1600 01:02:13,946 --> 01:02:15,414 ON THAT QUESTION AND I THINK IT 1601 01:02:15,414 --> 01:02:18,484 IS A UNIQUE STRENGTH AND 1602 01:02:18,484 --> 01:02:19,485 RESOURCE WITHIN OUR COMMUNITY 1603 01:02:19,485 --> 01:02:22,922 AND WE PARTNERED WITH YOU ON RAD 1604 01:02:22,922 --> 01:02:25,691 X TECH FOR MATERNAL HEALTH AND 1605 01:02:25,691 --> 01:02:28,928 THERE IS BUILT INTO THE 1606 01:02:28,928 --> 01:02:31,864 EDUCATIONAL SYSTEM AND WAY THAT 1607 01:02:31,864 --> 01:02:34,500 OUR STUDENTS ARE PASSIONATE 1608 01:02:34,500 --> 01:02:36,869 ABOUT TECHNOLOGIES WITH DESIGN 1609 01:02:36,869 --> 01:02:37,603 PROJECTS AND EVERYONE GOES 1610 01:02:37,603 --> 01:02:39,038 THROUGH DESIGN PROJECTS AND MANY 1611 01:02:39,038 --> 01:02:41,641 DESIGN PROJECTS ARE ORIENTED 1612 01:02:41,641 --> 01:02:43,943 TOWARDS UNDERSERVED COMMUNITIES 1613 01:02:43,943 --> 01:02:45,344 AND THEY ARE CONSTRAINED 1614 01:02:45,344 --> 01:02:47,346 ACTUALLY IN COSTS BECAUSE 1615 01:02:47,346 --> 01:02:48,714 STUDENTS DON'T GET LOTS OF MONEY 1616 01:02:48,714 --> 01:02:50,917 TO DO DESIGNS AND THEY ARE VERY 1617 01:02:50,917 --> 01:02:53,052 CLEVER IN INTEGRATING AND OF 1618 01:02:53,052 --> 01:02:54,420 COURSE YOU WILL KNOW AS 1619 01:02:54,420 --> 01:02:57,957 PRESIDENT OF ENGINEERING COLLEGE 1620 01:02:57,957 --> 01:03:00,960 THAT REALLY DRIVES FORWARD THAT 1621 01:03:00,960 --> 01:03:02,595 WHOLE DESIGN EXPERIENCE AND 1622 01:03:02,595 --> 01:03:05,932 WORKED ON A NUMBER OF LEVELS 1623 01:03:05,932 --> 01:03:09,101 THAT IS WOVEN INTO OUR 1624 01:03:09,101 --> 01:03:10,136 CONSCIOUSNESS AND THOSE KIDS 1625 01:03:10,136 --> 01:03:11,938 THAT DO THE DESIGN AND GET 1626 01:03:11,938 --> 01:03:14,106 HOOKED ON PROJECTS IT STICKS 1627 01:03:14,106 --> 01:03:16,242 WITH THEM THEIR ENTIRE LIVES AND 1628 01:03:16,242 --> 01:03:18,945 MANY GO ON AND BEGIN TO 1629 01:03:18,945 --> 01:03:21,814 COMMERCIALIZE THOSE AND IS A 1630 01:03:21,814 --> 01:03:23,549 SECRET POWER IT IS NOT 1631 01:03:23,549 --> 01:03:25,384 NECESSARILY SO SECRET IN OUR 1632 01:03:25,384 --> 01:03:26,986 COMMUNITY AND NOT NECESSARILY 1633 01:03:26,986 --> 01:03:30,556 WIDELY KNOWN OUTSIDE OF OUR 1634 01:03:30,556 --> 01:03:30,856 COMMUNITY. 1635 01:03:30,856 --> 01:03:34,026 YOU HAVE SEEN EXPRESSION OF IT 1636 01:03:34,026 --> 01:03:35,094 IN INTERNAL HEAL WILLING AND 1637 01:03:35,094 --> 01:03:36,595 BEAUTIFUL TECHNOLOGIES MORE 1638 01:03:36,595 --> 01:03:40,800 COMING AND FROM OUR BIASED 1639 01:03:40,800 --> 01:03:43,202 PERSPECTIVE IT WOULD BE GREAT IF 1640 01:03:43,202 --> 01:03:45,338 THERE WERE MODEST AND COST 1641 01:03:45,338 --> 01:03:47,006 EFFECTIVE IF WE GET ANY OF 12 1642 01:03:47,006 --> 01:03:47,273 BILLION. 1643 01:03:47,273 --> 01:03:47,707 >> RIGHT. 1644 01:03:47,707 --> 01:03:49,976 >> GOING INTO INVESTING IN YOUNG 1645 01:03:49,976 --> 01:03:52,178 PEOPLE IN THE PIPELINE THERE IS 1646 01:03:52,178 --> 01:03:54,146 ENORMOUS DIVERSITY IN STUDENTS 1647 01:03:54,146 --> 01:03:57,350 AND THEN YOU KNOW IT IN TERMS OF 1648 01:03:57,350 --> 01:04:01,253 KAGSD AND LEADERSHIP BRINGING 1649 01:04:01,253 --> 01:04:03,022 WOMEN INTO THE FEMME TECH 1650 01:04:03,022 --> 01:04:04,423 BUSINESS EXPANSION THAT IS A 1651 01:04:04,423 --> 01:04:06,492 VERY COMPELLING ARGUMENT AND 1652 01:04:06,492 --> 01:04:08,160 STILL DON'T SEE THAT MANY C 1653 01:04:08,160 --> 01:04:10,029 SUITE WOMEN AND ENGINEERS AND SO 1654 01:04:10,029 --> 01:04:11,864 FORTH AND THIS IS ALL PART OF 1655 01:04:11,864 --> 01:04:15,735 THAT PIPELINE AND THINK YOU CAN 1656 01:04:15,735 --> 01:04:19,505 WITH MODEST ENCOURAGEMENT EXCEED 1657 01:04:19,505 --> 01:04:21,707 AND EXPAND ACTIVITIES WITH 1658 01:04:21,707 --> 01:04:24,176 CONNECTION HERE THAT IS WITH 1659 01:04:24,176 --> 01:04:26,512 COUNCIL AND OUR ENTIRE 1660 01:04:26,512 --> 01:04:26,812 COMMUNITY. 1661 01:04:26,812 --> 01:04:29,148 >> THANK YOU. I AGREE 1662 01:04:29,148 --> 01:04:30,483 WHOLEHEARTEDLY AND ONE REASON 1663 01:04:30,483 --> 01:04:32,685 WHEN I FIRST MET YOU TALKING 1664 01:04:32,685 --> 01:04:34,487 ABOUT GROWING UP IN DC JUST THE 1665 01:04:34,487 --> 01:04:36,856 WAY YOU TALK ABOUT THAT. 1666 01:04:36,856 --> 01:04:38,090 IN INCORPORATION OF DESIGN 1667 01:04:38,090 --> 01:04:40,393 THINKING INTO HOW SCIENTISTS 1668 01:04:40,393 --> 01:04:42,194 CONVERGE AND ARE NOT TRAINED 1669 01:04:42,194 --> 01:04:43,829 THAT WAY AS YOU KNOW. 1670 01:04:43,829 --> 01:04:45,831 IT IS A POWERFUL APPROACH AND 1671 01:04:45,831 --> 01:04:50,503 EVERY TIME I TALK TO SOME 1672 01:04:50,503 --> 01:04:52,304 YOUNGER INDIVIDUALS IN THIS 1673 01:04:52,304 --> 01:04:54,507 SPACE I'M INSPIRED AND HOPEFUL 1674 01:04:54,507 --> 01:04:56,442 FOR OUR FUTURE AT RISK OF MAKING 1675 01:04:56,442 --> 01:05:00,713 A GENERALIZATION AND I FIND THAT 1676 01:05:00,713 --> 01:05:02,515 ENGINEERING COLLEGE SKILLS ARE 1677 01:05:02,515 --> 01:05:03,449 [INDISCERNIBLE] AND IF YOU GIVE 1678 01:05:03,449 --> 01:05:05,684 THEM A PROBLEM THEY WILL TRY TO 1679 01:05:05,684 --> 01:05:08,554 SOLVE IT AND LOVE THAT ABOUT 1680 01:05:08,554 --> 01:05:10,056 THEM AND INTERDISCIPLINARY 1681 01:05:10,056 --> 01:05:11,657 APPROACHES BRINGS TEAMS TOGETHER 1682 01:05:11,657 --> 01:05:13,159 NOT SITTING AROUND TABLE SAYING 1683 01:05:13,159 --> 01:05:15,094 FROM MY PERSPECTIVE I SEE THIS 1684 01:05:15,094 --> 01:05:16,562 BUT TO COME TOGETHER AND MAKE 1685 01:05:16,562 --> 01:05:18,264 SOMETHING REALLY NEW IS WHAT WE 1686 01:05:18,264 --> 01:05:22,134 ARE AFTER AND THINK IT IS NOT A 1687 01:05:22,134 --> 01:05:26,505 SECRET POWER BRUCE BUT YOUR 1688 01:05:26,505 --> 01:05:27,073 SUPERPOWER. 1689 01:05:27,073 --> 01:05:28,841 >> I THINK IT IS. IF YOU HAVE A 1690 01:05:28,841 --> 01:05:31,210 FEW MORE MINUTES I WANT TO ASK 1691 01:05:31,210 --> 01:05:32,845 PROBABLY THE QUESTION THAT 1692 01:05:32,845 --> 01:05:35,648 EVERYONE IS ASKING MAYBE. 1693 01:05:35,648 --> 01:05:46,125 CYNTHIA, I WILL CPU. YES? 1694 01:05:47,326 --> 01:05:48,994 >> OKAY. I WILL TRY TO LOOK AT 1695 01:05:48,994 --> 01:05:50,930 YOU AND USE THE MIC HERE AND 1696 01:05:50,930 --> 01:05:53,232 THANKS FOR YOUR REALLY INSPIRING 1697 01:05:53,232 --> 01:05:53,599 PRESENTATIONS. 1698 01:05:53,599 --> 01:05:55,701 I WAS POPPING UP IDEAS IN MY 1699 01:05:55,701 --> 01:05:57,036 HEAD AS YOU WENT ALONG. 1700 01:05:57,036 --> 01:05:58,904 ONE THING I'M INTERESTED IF YOU 1701 01:05:58,904 --> 01:06:01,240 CAN SHARE YOUR DATA ON IS THE 1702 01:06:01,240 --> 01:06:02,675 RELATIONSHIP BETWEEN WOMEN'S 1703 01:06:02,675 --> 01:06:04,410 HEALTH AND CHILDREN'S HEALTH NO 1704 01:06:04,410 --> 01:06:07,947 THE JUST FOR MATERNAL HEALTH AND 1705 01:06:07,947 --> 01:06:10,382 PRENATAL AND POSTNATAL BUT IN 1706 01:06:10,382 --> 01:06:13,786 SINGLE MOTHER FAMILIES AND IF 1707 01:06:13,786 --> 01:06:16,555 MOM IS DOWN WITH SOME AGENCIES 1708 01:06:16,555 --> 01:06:18,090 FAMILY IS DOWN. 1709 01:06:18,090 --> 01:06:19,425 WHAT KIND OF COMMENT MIGHT YOU 1710 01:06:19,425 --> 01:06:22,928 HAVE ON THAT LINKAGE? 1711 01:06:22,928 --> 01:06:26,499 >> THANK YOU FOR THAT QUESTION 1712 01:06:26,499 --> 01:06:28,234 ABOUT HOW HEALTH OF WOMEN 1713 01:06:28,234 --> 01:06:30,503 EFFECTS FAMILIES AND CHILDREN 1714 01:06:30,503 --> 01:06:32,371 BEYOND PREGNANCY AND MATERNAL 1715 01:06:32,371 --> 01:06:34,206 HEALTH ANGLE THAT IS CRITICALLY 1716 01:06:34,206 --> 01:06:35,541 IMPORTANT AND WHAT WOMEN ARE 1717 01:06:35,541 --> 01:06:38,144 EXPOSED TO DURING PREGNANCY AND 1718 01:06:38,144 --> 01:06:39,979 HEALTH BEFORE PREGNANCY THAT HAS 1719 01:06:39,979 --> 01:06:42,114 A PROFOUND IMPACT ON THE HEALTH 1720 01:06:42,114 --> 01:06:44,416 OF THE CHILD THROUGH EPIGENETICS 1721 01:06:44,416 --> 01:06:46,252 EFFECTS AND OTHERS AND WE KNOW 1722 01:06:46,252 --> 01:06:49,688 THAT BIOLOGY AND KNOW THAT CAN 1723 01:06:49,688 --> 01:06:51,257 GENERATE INTERGENERATIONAL 1724 01:06:51,257 --> 01:06:51,524 OUTCOME. 1725 01:06:51,524 --> 01:06:54,493 YOU ARE ALSO ASKING ABOUT THE 1726 01:06:54,493 --> 01:06:55,294 SOCIAL CONTEXT. 1727 01:06:55,294 --> 01:06:58,497 I'M JUST KIND OF, YOU KNOW, SAD 1728 01:06:58,497 --> 01:07:00,332 TO SHARE WITH YOU THAT ONE 1729 01:07:00,332 --> 01:07:02,935 REALLY IMPORTANT CAUSE OF 1730 01:07:02,935 --> 01:07:04,970 MATERNAL HEALTH IN THIS COUNTRY 1731 01:07:04,970 --> 01:07:07,973 IS VIOLENCE, IS DEPRESSION, IS 1732 01:07:07,973 --> 01:07:10,176 SUICIDE, IS SUBSTANCE OVERDOSE. 1733 01:07:10,176 --> 01:07:12,144 THAT IS TELLING US SOMETHING 1734 01:07:12,144 --> 01:07:14,346 ABOUT WHAT WE ARE DOG OR NOT 1735 01:07:14,346 --> 01:07:16,282 DOING TO SUPPORT PREGNANT PEOPLE 1736 01:07:16,282 --> 01:07:19,652 AND PEOPLE AFTER THEY DELIVER. 1737 01:07:19,652 --> 01:07:22,454 AND SO I DON'T THINK THAT WE CAN 1738 01:07:22,454 --> 01:07:24,924 MINIMIZE THE MENTAL HEALTH 1739 01:07:24,924 --> 01:07:27,760 CONSEQUENCES OF THE SOCIAL 1740 01:07:27,760 --> 01:07:29,762 DRIVERS OF HEALTH WE ARE ALL 1741 01:07:29,762 --> 01:07:31,297 IMBEDDED IN AND WHAT YOU ARE 1742 01:07:31,297 --> 01:07:33,866 GETTING TO. 1743 01:07:33,866 --> 01:07:38,504 WE DO SEE THE EUNICE KENNEDY 1744 01:07:38,504 --> 01:07:40,039 SHRIVER NATIONAL HEALTH 1745 01:07:40,039 --> 01:07:41,707 INSTITUTE -- LEADING FOR 1746 01:07:41,707 --> 01:07:44,143 SUPPORTING MATERNAL HEALTH 1747 01:07:44,143 --> 01:07:45,211 RESEARCH AND CHILD HEALTH 1748 01:07:45,211 --> 01:07:46,712 RESEARCH AND ARE ADDRESSING SOME 1749 01:07:46,712 --> 01:07:51,183 THINGS ABOUT THE MATERNAL DIAD 1750 01:07:51,183 --> 01:07:53,185 AND LEAKING DATA SETS FROM 1751 01:07:53,185 --> 01:07:54,920 MOTHERS AND EHRS IN 1752 01:07:54,920 --> 01:07:57,256 COLLABORATION WITH OFFICE OF 1753 01:07:57,256 --> 01:07:58,357 NATIONAL COORDINATORS AND ONE 1754 01:07:58,357 --> 01:08:00,759 WAY THEY LINK DATA SETS TO DO 1755 01:08:00,759 --> 01:08:02,294 ANALYSIS TO LOOK AT OUTCOMES. 1756 01:08:02,294 --> 01:08:04,530 WE KNOW WHAT HAPPENS TO AN 1757 01:08:04,530 --> 01:08:07,132 INDIVIDUAL IS EMBODIED IN THAT 1758 01:08:07,132 --> 01:08:07,399 PERSON. 1759 01:08:07,399 --> 01:08:10,402 IT CAN BE MEASURED THROUGH 1760 01:08:10,402 --> 01:08:12,671 CORTISOL LEVELS AND MEASURED 1761 01:08:12,671 --> 01:08:14,506 THROUGH SHORTENING TELOMERES AND 1762 01:08:14,506 --> 01:08:16,875 HAS A CONSEQUENCE ON PARENTING 1763 01:08:16,875 --> 01:08:19,912 AND LAST DATA I ADDRESSED THAT 1764 01:08:19,912 --> 01:08:22,648 IS NICHD FUNDED INDIVIDUAL WOMEN 1765 01:08:22,648 --> 01:08:24,450 THAT EXPERIENCE DEPRESSION 1766 01:08:24,450 --> 01:08:26,418 DURING PREGNANCY OR POSTPARTUM 1767 01:08:26,418 --> 01:08:31,090 ARE MORE LIKELY TO HAVE A 1768 01:08:31,090 --> 01:08:33,525 CARDIOVASCULAR EVENT AFTER THE 1769 01:08:33,525 --> 01:08:35,494 DELIVERY UP TO A YEAR LATER AND 1770 01:08:35,494 --> 01:08:37,129 HAS TO HAVE AN EFFECT ON THE 1771 01:08:37,129 --> 01:08:39,565 FAMILY IF THE MOTHER IS NOT 1772 01:08:39,565 --> 01:08:41,066 AVAILABLE AND IS ILL. 1773 01:08:41,066 --> 01:08:43,535 THANKS FOR BRINGING UP THAT 1774 01:08:43,535 --> 01:08:45,004 REALLY SALIENT POINT NOT ABOUT 1775 01:08:45,004 --> 01:08:46,872 THE BIOLOGY AND HAVE TO CONSIDER 1776 01:08:46,872 --> 01:08:49,074 THAT AND ALSO IS ABOUT THE 1777 01:08:49,074 --> 01:08:50,476 SOCIAL FACTORS AND WHEN YOU 1778 01:08:50,476 --> 01:08:52,011 ADDRESS HEALTH OF WOMEN YOU 1779 01:08:52,011 --> 01:08:54,947 ADDRESS HEALTH OF FAMILIES AND 1780 01:08:54,947 --> 01:08:56,282 COMMUNITIES AND SOCIETIES 1781 01:08:56,282 --> 01:08:59,084 WHETHER ECONOMIC BENEFIT OR 1782 01:08:59,084 --> 01:09:00,252 STABILITY BENEFIT BECAUSE OF 1783 01:09:00,252 --> 01:09:02,054 CHILDREN IN FAMILY AND OTHER 1784 01:09:02,054 --> 01:09:05,024 INDIVIDUALS AND WOMEN ARE 1785 01:09:05,024 --> 01:09:06,492 PRIMARY CAREGIVERS OF ALL FAMILY 1786 01:09:06,492 --> 01:09:09,495 MEMBERS IN THE COUNTRY AND IS A 1787 01:09:09,495 --> 01:09:13,132 GENDERED BEHAVIOR AND ALSO HAS 1788 01:09:13,132 --> 01:09:18,170 CONSEQUENCES ON THOSE WOMEN TO 1789 01:09:18,170 --> 01:09:20,072 HELP THEMSELVES COMPLICATED 1790 01:09:20,072 --> 01:09:22,474 IMPORTANT TO ADDRESS AND 1791 01:09:22,474 --> 01:09:24,310 INSPIRED THAT YOUR COUNCIL ASKED 1792 01:09:24,310 --> 01:09:25,744 SO MANY GREAT QUESTIONS THINKING 1793 01:09:25,744 --> 01:09:28,480 ABOUT ISSUES FROM SO MANY 1794 01:09:28,480 --> 01:09:30,049 VANTAGE POINTS AND THAT IS WHAT 1795 01:09:30,049 --> 01:09:32,184 WE NEED AND BRUCE IS A GREAT 1796 01:09:32,184 --> 01:09:33,886 PARTNER AND LOOK FORWARD TO 1797 01:09:33,886 --> 01:09:36,221 WORKING WITH ALL INSTITUTES TO 1798 01:09:36,221 --> 01:09:37,990 BRING THEIR EXPERTISE TO THESE 1799 01:09:37,990 --> 01:09:38,757 ISSUES. 1800 01:09:38,757 --> 01:09:39,458 THANKS FOR THAT QUESTION. 1801 01:09:39,458 --> 01:09:41,694 >> THANK YOU. DO YOU HAVE TIME 1802 01:09:41,694 --> 01:09:42,294 FOR ONE MORE QUESTION. 1803 01:09:42,294 --> 01:09:42,961 >> ONE MORE. 1804 01:09:42,961 --> 01:09:45,130 >> I CAN ASK YOU QUESTIONS 1805 01:09:45,130 --> 01:09:45,397 ANYTIME. 1806 01:09:45,397 --> 01:09:47,099 >> THIS IS GREAT AND KNOW YOU 1807 01:09:47,099 --> 01:09:49,168 MENTIONED DATA IS A KEY PART OF 1808 01:09:49,168 --> 01:09:52,738 THIS LIKE YOU MENTIONED AI AND 1809 01:09:52,738 --> 01:09:54,973 MACHINE LEARNING AND ALSO WHEN 1810 01:09:54,973 --> 01:09:57,443 YOU MENTIONED RAD X I REMEMBER A 1811 01:09:57,443 --> 01:09:59,011 CHALLENGE YOU SAID WAS BRINGING 1812 01:09:59,011 --> 01:10:01,246 TOGETHER DATA SETS THEY TALK TO 1813 01:10:01,246 --> 01:10:03,649 EACH OTHER AND YOU MENTIONED 1814 01:10:03,649 --> 01:10:05,751 WORLDWIDE EFFORTS AND WONDER 1815 01:10:05,751 --> 01:10:08,287 WHAT EFFORTS AT NIH AND PARTNERS 1816 01:10:08,287 --> 01:10:10,489 AND IN TERMS OF BEING ABLE TO 1817 01:10:10,489 --> 01:10:12,458 MAKE THIS ACCESSIBLE I GUESS FOR 1818 01:10:12,458 --> 01:10:14,460 PRACTICAL ISSUES OF DATA AND 1819 01:10:14,460 --> 01:10:16,595 SHARING DATA THAT IS SIMILAR I 1820 01:10:16,595 --> 01:10:18,731 GUESS TO THE HUMAN GENOME 1821 01:10:18,731 --> 01:10:20,499 PROJECT AND YOU PROBABLY KNOW 1822 01:10:20,499 --> 01:10:22,668 THAT TOOK YEARS FOR THEM TO SET 1823 01:10:22,668 --> 01:10:25,104 UP ALL THAT AND WONDERING FROM 1824 01:10:25,104 --> 01:10:28,240 LOGISTICS STANDPOINT HOW THAT 1825 01:10:28,240 --> 01:10:30,376 DATA OR INFORMATION TO BE SHARED 1826 01:10:30,376 --> 01:10:32,177 OR WHAT CHALLENGES YOU MADE. 1827 01:10:32,177 --> 01:10:34,012 >> I WILL GIVE YOU THIS IN A 1828 01:10:34,012 --> 01:10:35,714 SECOND AND GIVING YOU A HEADS UP 1829 01:10:35,714 --> 01:10:39,284 AND IN TERMS OF WOMEN'S HEALTH, 1830 01:10:39,284 --> 01:10:42,755 DURING COVID WE DEMONSTRATED WE 1831 01:10:42,755 --> 01:10:45,991 COULD MOVE PAST AND MERGE DATA 1832 01:10:45,991 --> 01:10:48,660 SETS AND OTHER EFFORTS USING 1833 01:10:48,660 --> 01:10:50,496 ELECTRONIC HEALTH RECORDS DATA 1834 01:10:50,496 --> 01:10:52,731 AND WAY WE WERE ABLE TO SEE 1835 01:10:52,731 --> 01:10:54,233 PREGNANCY OUTCOMES WERE WORSE 1836 01:10:54,233 --> 01:10:55,000 WITH COVID. 1837 01:10:55,000 --> 01:10:57,236 WE HAVE TO DO THE SAME FOR 1838 01:10:57,236 --> 01:10:59,138 EVERYTHING IN A SAFE WAY THAT 1839 01:10:59,138 --> 01:11:01,340 EFFECTS OR PROTECTS PRIVACY. 1840 01:11:01,340 --> 01:11:05,310 WE HAVE NIH-WIDE DATA SHARING 1841 01:11:05,310 --> 01:11:06,478 POLICIES THAT HAVE BEEN RULED 1842 01:11:06,478 --> 01:11:09,047 OUT FAIRLY RECENTLY AND P SET IS 1843 01:11:09,047 --> 01:11:10,783 DIFFERENT FOR WOMEN'S HEALTH WE 1844 01:11:10,783 --> 01:11:12,317 NEED COMMON DATA ELEMENTS IN 1845 01:11:12,317 --> 01:11:17,089 DATA SETS SO DATA WILL BE 1846 01:11:17,089 --> 01:11:18,190 INTEROPERABLE AROUND AGE OF 1847 01:11:18,190 --> 01:11:20,959 MENSTRUATION AND MENOPAUSE 1848 01:11:20,959 --> 01:11:24,463 STATUS DID YOU HAVE PREECLAMPSIA 1849 01:11:24,463 --> 01:11:26,632 DURING PREGNANCY AND ASKING A 50 1850 01:11:26,632 --> 01:11:28,767 YEAR OLD WOMAN THAT IS SOMETHING 1851 01:11:28,767 --> 01:11:30,803 NOT THAT TYPICAL AND RELATED TO 1852 01:11:30,803 --> 01:11:32,938 HER RISK FOR CARDIOVASCULAR 1853 01:11:32,938 --> 01:11:34,139 DISEASE AND STROKE AND IF WE 1854 01:11:34,139 --> 01:11:36,341 DON'T HAVE QUESTIONS OF E HAD. 1855 01:11:36,341 --> 01:11:39,445 RS WE CAN'T ANALYZE DATA AND OUR 1856 01:11:39,445 --> 01:11:43,615 VANTAGE POINT IS IMBEDDING CDES 1857 01:11:43,615 --> 01:11:45,451 AND PERSPECTIVES INTO DATA SETS 1858 01:11:45,451 --> 01:11:49,054 SO THEY WILL BE IN FORMS AND 1859 01:11:49,054 --> 01:11:50,022 INTEROPERABLE AND WE CAN ANSWER 1860 01:11:50,022 --> 01:11:51,323 MORE QUESTIONS AND BRUCE HAVE 1861 01:11:51,323 --> 01:11:52,558 ANYTHING TO ADD FOR JOYCE FOR 1862 01:11:52,558 --> 01:11:52,858 THAT. 1863 01:11:52,858 --> 01:11:55,828 >> NO. THAT IS AN ENORMOUS 1864 01:11:55,828 --> 01:11:58,263 EFFORT AND INCREDIBLY VALUABLE 1865 01:11:58,263 --> 01:11:59,965 ONE THAT BEGINS TO INFORM HOW WE 1866 01:11:59,965 --> 01:12:02,901 USE EHS AND CRITICAL COMPONENTS 1867 01:12:02,901 --> 01:12:05,270 HOW WE WILL GET EHR AS AN 1868 01:12:05,270 --> 01:12:06,738 INFORMATION GENERATING 1869 01:12:06,738 --> 01:12:08,807 ULTIMATELY TO HELP FACILITATE 1870 01:12:08,807 --> 01:12:11,343 DECISIONS AND MY QUESTION IS A 1871 01:12:11,343 --> 01:12:13,412 LITTLE ABOUT THAT A LOT OF 1872 01:12:13,412 --> 01:12:15,013 EXCITEMENT AND CONFUSION IN 1873 01:12:15,013 --> 01:12:18,283 WOMEN'S HEALTH IS SURROUNDING 1874 01:12:18,283 --> 01:12:22,387 SORT OF THE HOFRM OWN RELACEMENT 1875 01:12:22,387 --> 01:12:25,390 THERAPY DISCUSSION AND OVER TIME 1876 01:12:25,390 --> 01:12:32,231 IF YOU TRACK IT CH. I'M INTERED 1877 01:12:32,231 --> 01:12:34,800 IN YOUR THOUGHTS ON THAT CLASSIC 1878 01:12:34,800 --> 01:12:36,368 CHALLENGE TO GET INFORMATION AND 1879 01:12:36,368 --> 01:12:39,438 FRUSTRATING WHEN YOU SEE YOU CAN 1880 01:12:39,438 --> 01:12:44,309 MAKE A DECISION WITH YOUR CARE 1881 01:12:44,309 --> 01:12:45,978 PROVIDER AND ASSESS RISKS AND 1882 01:12:45,978 --> 01:12:48,680 HOPE CARE PROVIDER HAS GUIDANCE 1883 01:12:48,680 --> 01:12:51,617 AND CANCER NATIONAL CONTROL 1884 01:12:51,617 --> 01:12:53,051 NETWORK AND THESE ARE GUIDELINES 1885 01:12:53,051 --> 01:12:54,486 AND CONDITION AND WHAT YOU 1886 01:12:54,486 --> 01:12:55,721 SHOULD DO FOR TREATMENT AND FEEL 1887 01:12:55,721 --> 01:12:58,490 THIS AREA IS CONFUSING AND 1888 01:12:58,490 --> 01:13:01,393 HAVING BEEN INVOLVED IN BREAST 1889 01:13:01,393 --> 01:13:03,395 CANCER RESEARCH FOR MANY YEARS I 1890 01:13:03,395 --> 01:13:05,330 THOUGHT I UNDERSTOOD IT AT ONE 1891 01:13:05,330 --> 01:13:06,498 POINT AND DIDN'T UNDERSTAND IT 1892 01:13:06,498 --> 01:13:10,469 AND THOUGHT I DID AND OSCILLATES 1893 01:13:10,469 --> 01:13:11,303 IT AND LIKEN TIRE DISCUSSION 1894 01:13:11,303 --> 01:13:13,372 TODAY WITH THE PUBLIC AND WHAT 1895 01:13:13,372 --> 01:13:14,673 ARE THOUGHTS ON THAT AND GETTING 1896 01:13:14,673 --> 01:13:16,608 TO GREATER CLARITY WITH 1897 01:13:16,608 --> 01:13:18,043 RECOMMENDATIONS FOR INDIVIDUALS 1898 01:13:18,043 --> 01:13:20,279 AND WHAT WE ACTUALLY NEED RATHER 1899 01:13:20,279 --> 01:13:22,414 THAN THAT SORT OF PHRASED MAKE A 1900 01:13:22,414 --> 01:13:23,916 DECISION WITH THE DISCUSSION 1901 01:13:23,916 --> 01:13:27,386 WITH YOUR PROVIDER. 1902 01:13:27,386 --> 01:13:32,224 >> RIGHT. BRUCE, THIS IS AN 1903 01:13:32,224 --> 01:13:33,926 IMPORTANT TOPIC AND TIMELY AND 1904 01:13:33,926 --> 01:13:37,362 OVER 30 YEARS AGO BERN ADEAN 1905 01:13:37,362 --> 01:13:39,398 HEELY CREATED WOMEN'S HEALTH 1906 01:13:39,398 --> 01:13:41,500 INITIATIVE THAT IS AN INCREDIBLE 1907 01:13:41,500 --> 01:13:44,102 INVESTMENT IN TIME AND MONEY AND 1908 01:13:44,102 --> 01:13:45,137 EFFORT AND INDIVIDUALS 1909 01:13:45,137 --> 01:13:46,405 PARTICIPATING AND CONTINUES WITH 1910 01:13:46,405 --> 01:13:48,640 A FOLLOW UP STUDY AND WAS 1911 01:13:48,640 --> 01:13:49,675 DESIGNED TO LOOK FOR VERY 1912 01:13:49,675 --> 01:13:53,378 SPECIFIC QUESTIONS ABOUT 1913 01:13:53,378 --> 01:13:54,212 CONJUGATED [INDISCERNIBLE] AND 1914 01:13:54,212 --> 01:13:56,114 WHICH IS WHAT WAS AVAILABLE AT 1915 01:13:56,114 --> 01:13:58,517 THE TIME TO INDIVIDUALS OVER 60 1916 01:13:58,517 --> 01:14:01,720 AND POST MENOPAUSAL IN TERMS OF 1917 01:14:01,720 --> 01:14:02,621 PREVENTION OF CHRONIC DISEASE 1918 01:14:02,621 --> 01:14:05,357 AND WAS A RANDOMIZE CHONDRTROLL 1919 01:14:05,357 --> 01:14:06,959 TRIAL WITH OTHER STUDIES AND 1920 01:14:06,959 --> 01:14:08,427 ANSWERS THOSE QUESTIONS AND LEFT 1921 01:14:08,427 --> 01:14:10,696 US ALSO WITH MORE QUESTIONS, 1922 01:14:10,696 --> 01:14:13,065 SOME OF WHICH HAVE NOT YET BEEN 1923 01:14:13,065 --> 01:14:15,167 ANSWERED AND OF COURSE SCIENCE 1924 01:14:15,167 --> 01:14:16,768 HAS CONTINUED AND WE NOW HAVE 1925 01:14:16,768 --> 01:14:20,405 HAD MORE FORMULATIONS WESTO 1926 01:14:20,405 --> 01:14:21,907 GENERALS AND PHYTOEST ROEJENS 1927 01:14:21,907 --> 01:14:24,376 AND FORMULATIONS OF PROGESTERONE 1928 01:14:24,376 --> 01:14:26,478 AND PERMUTATIONS AND WANT TO 1929 01:14:26,478 --> 01:14:28,413 UNDERSTAND BETTER WHEN TIMING 1930 01:14:28,413 --> 01:14:32,117 WHEN MENOPAUSAL HORMONE THERAPY 1931 01:14:32,117 --> 01:14:34,486 WHEN IT STARTED AND MIGHT BE 1932 01:14:34,486 --> 01:14:35,854 IMPORTANT AND UNDERSTAND BETTER 1933 01:14:35,854 --> 01:14:37,522 BRAIN EFFECTS AND AREA AND 1934 01:14:37,522 --> 01:14:40,592 READING PAPER AND HAVE QUESTIONS 1935 01:14:40,592 --> 01:14:42,027 LIKE I DID BEFORE AND WHAT I 1936 01:14:42,027 --> 01:14:44,262 WILL SAY IS THERE IS SO MANY 1937 01:14:44,262 --> 01:14:45,764 MORE QUESTIONS RIGHT NOW AND 1938 01:14:45,764 --> 01:14:47,099 SCIENCE HAS GIVEN US THOSE 1939 01:14:47,099 --> 01:14:47,933 QUESTIONS. 1940 01:14:47,933 --> 01:14:50,469 BUT WE NEED TO BE ABLE TO GIVE 1941 01:14:50,469 --> 01:14:54,172 WOMEN ANSWERS AS YOU SAID. 1942 01:14:54,172 --> 01:14:56,742 TO DO THAT WE NEED TO WORK 1943 01:14:56,742 --> 01:14:58,343 TOGETHER ACROSS INSTITUTES TO 1944 01:14:58,343 --> 01:15:00,312 DESIGN A COORDINATED STRATEGY 1945 01:15:00,312 --> 01:15:02,314 AROUND MENOPAUSE. 1946 01:15:02,314 --> 01:15:04,049 THIS PATHWAY TO PREVENTION 1947 01:15:04,049 --> 01:15:05,384 PROGRAM THAT WE ARE STARTING 1948 01:15:05,384 --> 01:15:09,287 WILL HELP US DO THAT IN A 1949 01:15:09,287 --> 01:15:11,890 THOUGHTFUL AND METHODICAL AND 1950 01:15:11,890 --> 01:15:13,258 DATA-DRIVEN WAY AND TAKES TIME 1951 01:15:13,258 --> 01:15:15,994 AND IS HARD TO WAIT FOR THAT 1952 01:15:15,994 --> 01:15:16,328 INFORMATION. 1953 01:15:16,328 --> 01:15:18,330 I THINK THAT WE ARE GOING TO 1954 01:15:18,330 --> 01:15:19,698 HAVE TO WORK TOGETHER IN 1955 01:15:19,698 --> 01:15:21,333 DIFFERENT WAYS AND APPLAUD THE 1956 01:15:21,333 --> 01:15:23,235 NATIONAL INSTITUTE ON AGING FOR 1957 01:15:23,235 --> 01:15:26,538 THE MANY STUDIES THAT THEY 1958 01:15:26,538 --> 01:15:27,806 SUPPORTED THUS FAR LIKE 1959 01:15:27,806 --> 01:15:29,808 MRS. FLASH AND THEY TESTED 1960 01:15:29,808 --> 01:15:32,144 INTERVENTIONS AND WE NOW HAVE 1961 01:15:32,144 --> 01:15:34,513 MULTIPLE INTERVENTIONS FOR MOTOR 1962 01:15:34,513 --> 01:15:37,716 SYSTEM AND BROUGHT MORE 1963 01:15:37,716 --> 01:15:39,785 QUESTIONS AS WOMEN THAT HAVE 1964 01:15:39,785 --> 01:15:42,788 PROMINENT BASED MOTOR SYSTEMS 1965 01:15:42,788 --> 01:15:43,989 CARDIOVASCULAR DISEASE WORSENING 1966 01:15:43,989 --> 01:15:45,857 AND HAVE MORE QUESTIONS AGAIN 1967 01:15:45,857 --> 01:15:47,926 AND THINK WE NEED A MENOPAUSE 1968 01:15:47,926 --> 01:15:49,761 ALE RESEARCH STRATEGY INVOLVING 1969 01:15:49,761 --> 01:15:52,597 MULTIPLE INSTITUTES AND CENTERS 1970 01:15:52,597 --> 01:15:54,499 THAT IS INTERDISCIPLINARY 1971 01:15:54,499 --> 01:15:56,835 COORDINATED AND LOOK FORWARD TO 1972 01:15:56,835 --> 01:15:58,170 PATHWAYS PREVENTION PROGRAM TO 1973 01:15:58,170 --> 01:16:00,005 HELP US MOVE IN THAT DIRECTION 1974 01:16:00,005 --> 01:16:02,874 AND WAS PARTICULARLY PLEASED TO 1975 01:16:02,874 --> 01:16:04,509 SEE MID LIFE HEALTH OF WOMEN 1976 01:16:04,509 --> 01:16:06,144 CALLED OUT IN THE EXECUTIVE 1977 01:16:06,144 --> 01:16:07,512 ORDER AND IMPORTANCE OF 1978 01:16:07,512 --> 01:16:09,948 UNDERSTANDING THAT THE 1979 01:16:09,948 --> 01:16:12,551 MENOPAUSAL TRANSITION IS A 1980 01:16:12,551 --> 01:16:14,486 HEALTH INFLECTION POINT THAT 1981 01:16:14,486 --> 01:16:18,056 MARKS A SUBSTANTIAL MOMENT WHERE 1982 01:16:18,056 --> 01:16:20,992 THE RISK FOR CHRONIC DISEASE 1983 01:16:20,992 --> 01:16:22,494 ACCELERATES MEANING IT IS A 1984 01:16:22,494 --> 01:16:27,699 POTENT OPPORTUNITY TO INTERVENE. 1985 01:16:27,699 --> 01:16:31,369 LIKE PREGNANCY IS A STRESS TEST 1986 01:16:31,369 --> 01:16:34,473 HEALTH INFLECTION POINT 1987 01:16:34,473 --> 01:16:36,308 MENOPAUSE TRANSITION IS A HEALTH 1988 01:16:36,308 --> 01:16:37,709 INFLECTION POINT AND WE HAVE TO 1989 01:16:37,709 --> 01:16:40,278 PAY MORE ATTENTION TO IT. 1990 01:16:40,278 --> 01:16:42,481 >> THANK YOU JANINE. YOU ARE 1991 01:16:42,481 --> 01:16:44,883 OFF THE HOOK AND WE ARE VERY, 1992 01:16:44,883 --> 01:16:46,885 VERY GRATEFUL FOR YOU COMING 1993 01:16:46,885 --> 01:16:47,085 HERE. 1994 01:16:47,085 --> 01:16:48,854 >> THANK YOU, BRUCE. 1995 01:16:48,854 --> 01:16:51,623 >> WE KNOW DAVE POINTED OUT 1996 01:16:51,623 --> 01:16:54,025 PRESS RELEASE CAME OUT AT 10:07. 1997 01:16:54,025 --> 01:16:55,193 >> PERFECT TIMING. 1998 01:16:55,193 --> 01:16:56,995 >> YOU ARE LIVE AND CAN GO 1999 01:16:56,995 --> 01:16:59,164 RESPOND TO THE ENTIRE COUNTRY. 2000 01:16:59,164 --> 01:17:00,799 WE ARE SO THANKFUL YOU CAN COME 2001 01:17:00,799 --> 01:17:02,868 HERE AND GIVE US A PREVIEW OF 2002 01:17:02,868 --> 01:17:04,703 THAT AND INSPIRE LOTS OF 2003 01:17:04,703 --> 01:17:06,104 THINKING AND WE LOOK FORWARD TO 2004 01:17:06,104 --> 01:17:07,773 EXPANDING OUR COLLABORATIONS 2005 01:17:07,773 --> 01:17:11,877 WITH YOU AND OUR COMMUNITY IS, 2006 01:17:11,877 --> 01:17:13,779 YOU KNOW, A RESOURCE THAT WE ARE 2007 01:17:13,779 --> 01:17:15,413 HOPING YOU CAN CONTINUE TO RAI 2008 01:17:15,413 --> 01:17:16,381 LIE ON. 2009 01:17:16,381 --> 01:17:18,483 >> THANK YOU BRUCE AND JILL AND 2010 01:17:18,483 --> 01:17:20,986 DAVID FOR LEADERSHIP AND 2011 01:17:20,986 --> 01:17:22,621 INSTITUTE THAT HAS BEEN FROM THE 2012 01:17:22,621 --> 01:17:24,222 BEGINNING SINCE YOU CAME, BRUCE, 2013 01:17:24,222 --> 01:17:28,827 OPEN TO THE CONVERSATIONS AND 2014 01:17:28,827 --> 01:17:31,930 EXCITED ABOUT HEARING FROM NIWHS 2015 01:17:31,930 --> 01:17:34,432 IDEAS PUTTING SCIENCE AND 2016 01:17:34,432 --> 01:17:36,434 TECHNOLOGY AND ENGINEERING AND 2017 01:17:36,434 --> 01:17:38,904 IMAGING AND TOOLS TO WORK WITH 2018 01:17:38,904 --> 01:17:39,704 [INDISCERNIBLE] AND PLEASURE BE 2019 01:17:39,704 --> 01:17:41,039 WITH ALL OF YOU AND LOOK FORWARD 2020 01:17:41,039 --> 01:17:43,275 TO WORKING WITH ALL OF NEW 2021 01:17:43,275 --> 01:17:46,311 CAPACITY AND THRILLED NEW 2022 01:17:46,311 --> 01:17:48,780 NIH-WIDE RESEARCH FOR HEALTH OF 2023 01:17:48,780 --> 01:17:53,718 WOMEN 2024 TO 2028 IS NOW LIVE. 2024 01:17:53,718 --> 01:17:58,990 THANKS SO MUCH. 2025 01:17:58,990 --> 01:18:07,265 >> AUDIENCE: [APPLAUSE]. 2026 01:18:07,265 --> 01:18:12,370 >> THANK YOU SO MUCH, JANINE AND 2027 01:18:12,370 --> 01:18:14,639 TO JOYCE AND JANINE AND STAFF 2028 01:18:14,639 --> 01:18:23,048 AND QUESTION ABOUT PEER REVIEW. 2029 01:18:23,048 --> 01:18:33,592 >> GOOD TO GO, RYAN? THANKS. 2030 01:18:38,263 --> 01:18:40,532 THANK YOU, RYAN. I WOULD LIKE 2031 01:18:40,532 --> 01:18:45,937 TO INTRODUCE DIRECTOR OF NIBIB'S 2032 01:18:45,937 --> 01:18:49,574 SCIENTIFIC REVIEW SHARING 2033 01:18:49,574 --> 01:18:53,378 INFORMATION ON PROJECT BRANDS 2034 01:18:53,378 --> 01:19:01,753 AND CONDIT REVISIONS TO FELLOWS 2035 01:19:01,753 --> 01:19:02,220 APPLICATIONS. 2036 01:19:02,220 --> 01:19:05,657 >> THANK YOU. I'M DIRECTOR OF 2037 01:19:05,657 --> 01:19:06,625 SCIENTIFIC OFFICE AND I WOULD 2038 01:19:06,625 --> 01:19:09,094 BEFORE I GO TO MY TOPIC WOULD 2039 01:19:09,094 --> 01:19:10,228 LIKE TO TAKE THIS OPPORTUNITY. 2040 01:19:10,228 --> 01:19:14,366 >> COULD YOU GET CLOSER TO THE 2041 01:19:14,366 --> 01:19:14,666 MICROPHONE. 2042 01:19:14,666 --> 01:19:16,001 >> IS THAT BETTER. 2043 01:19:16,001 --> 01:19:16,368 >> THANK YOU. 2044 01:19:16,368 --> 01:19:18,236 >> SO I WOULD LIKE TO TAKE THIS 2045 01:19:18,236 --> 01:19:21,006 OPPORTUNITY TO INTRODUCE THE 2046 01:19:21,006 --> 01:19:23,508 OFFICE OF SCIENTIFIC REVIEW. 2047 01:19:23,508 --> 01:19:27,212 SO MANY OF YOU KNOW OR IF YOU 2048 01:19:27,212 --> 01:19:33,051 DON'T KNOW WE HAVE IN HOUSE AT 2049 01:19:33,051 --> 01:19:35,120 NIBIB OWN OFFICE OF SCIENTIFIC 2050 01:19:35,120 --> 01:19:38,590 REVIEW AND APPLIED AS OUR OWN 2051 01:19:38,590 --> 01:19:40,358 AND SOME ARE HERE. 2052 01:19:40,358 --> 01:19:44,896 SOME ARE ON THE LINE ON ZOOM. 2053 01:19:44,896 --> 01:19:47,632 DR. JOAN HAYES. IF YOU ARE 2054 01:19:47,632 --> 01:19:53,371 HERE, STAND UP AND SHOW 2055 01:19:53,371 --> 01:19:53,638 YOURSELF. 2056 01:19:53,638 --> 01:19:56,808 DR. YOUNG JONES AND 2057 01:19:56,808 --> 01:19:58,343 [INDISCERNIBLE] AND DR. 2058 01:19:58,343 --> 01:20:00,712 [INDISCERNIBLE] IN OUR 2059 01:20:00,712 --> 01:20:03,815 INDISPENSABLE SUPPORTS. 2060 01:20:03,815 --> 01:20:05,817 SO WE ARE [INDISCERNIBLE] AND 2061 01:20:05,817 --> 01:20:08,787 ONLY 5SROS AND WE ARE BUSY AND 2062 01:20:08,787 --> 01:20:11,489 WHAT DO WE DO HERE? CONTINUOUS 2063 01:20:11,489 --> 01:20:13,325 PROGRAMS WE MANAGE ARE CAREER 2064 01:20:13,325 --> 01:20:15,260 DEVELOPMENT AWARDS AND NIH 2065 01:20:15,260 --> 01:20:17,929 RESEARCH TRAINING PROGRAMS TO 32 2066 01:20:17,929 --> 01:20:21,333 AND 35 AND NIH SUPPORTS RESEARCH 2067 01:20:21,333 --> 01:20:23,401 EDUCATION THAT INCLUDES 2068 01:20:23,401 --> 01:20:26,471 TEAM-BASED DESIGN FOR BIOMEDICAL 2069 01:20:26,471 --> 01:20:28,640 OR BIOENGINEERING PRODUCTS AND 2070 01:20:28,640 --> 01:20:29,908 RESEARCH EDUCATION EXPERIENCE 2071 01:20:29,908 --> 01:20:35,180 AND RESEARCH SUPPORT AND NIHLIP 2072 01:20:35,180 --> 01:20:37,449 PAYMENT PROGRAMS AND WE ARE 2073 01:20:37,449 --> 01:20:39,884 DOING SPECIAL PROGRAMS WITH 2074 01:20:39,884 --> 01:20:40,785 MULTIPLE [INDISCERNIBLE] DATE 2075 01:20:40,785 --> 01:20:44,522 AND ONE IS NIBIB SIGNATURE 2076 01:20:44,522 --> 01:20:47,859 PROGRAM FOR P41 NATIONAL CENTERS 2077 01:20:47,859 --> 01:20:50,261 OF BIOMEDICAL ENGINEERING. 2078 01:20:50,261 --> 01:20:53,398 WE ARE PART OF THE REVIEW TEAM 2079 01:20:53,398 --> 01:20:56,001 FOR BRAIN INITIATIVE RFAS AND 2080 01:20:56,001 --> 01:20:57,202 CURRENTLY HAVE THREE OF THEM AND 2081 01:20:57,202 --> 01:20:59,404 ARE EXCITED TO DO 2082 01:20:59,404 --> 01:21:00,472 NON-TRADITIONAL PROGRAMS ALWAYS 2083 01:21:00,472 --> 01:21:05,276 AND ONE IS DURING NSF AND NIH 2084 01:21:05,276 --> 01:21:06,511 INITIATIVE AND WE 2085 01:21:06,511 --> 01:21:07,746 [INDISCERNIBLE] WITH CYBER 2086 01:21:07,746 --> 01:21:10,148 PHYSICAL SYSTEMS AND NATIONAL 2087 01:21:10,148 --> 01:21:11,316 BODY INITIATIVES AND SOME COMING 2088 01:21:11,316 --> 01:21:12,817 UP IN THE PIPELINE. 2089 01:21:12,817 --> 01:21:19,190 SO IN 2024 AND 2025 WE HAD AND 2090 01:21:19,190 --> 01:21:20,458 REVIEWED ALREADY AND WILL REVIEW 2091 01:21:20,458 --> 01:21:25,897 NEW RFAS AND THE REST IS HERE 2092 01:21:25,897 --> 01:21:28,299 BIOMEDICAL NETWORKS USED 2093 01:21:28,299 --> 01:21:29,701 TECHNOLOGY DEVELOPMENT TO USE 2094 01:21:29,701 --> 01:21:32,037 HEALTH DISPARITIES AND ENHANCE 2095 01:21:32,037 --> 01:21:33,772 DATA AND HISTORICALLY BLACK 2096 01:21:33,772 --> 01:21:36,674 COLLEGES AND UNIVERSITIES AND 2097 01:21:36,674 --> 01:21:39,044 RESEARCH AND BIOETHICAL ISSUES 2098 01:21:39,044 --> 01:21:42,714 RELATED TO BIONICS AND ROBOTIC 2099 01:21:42,714 --> 01:21:44,249 DEVICE DEVELOPMENT AND 2100 01:21:44,249 --> 01:21:44,716 [INDISCERNIBLE]. 2101 01:21:44,716 --> 01:21:49,387 SO YOU SEE WE ARE BUSY HERE AND 2102 01:21:49,387 --> 01:21:52,190 MUST SAY WE DON'T HAVE STUDY 2103 01:21:52,190 --> 01:21:54,859 SECTIONS AND REVIEW PANELS ARE 2104 01:21:54,859 --> 01:21:58,229 SPECIAL EMPHASIS PANELS AND SROS 2105 01:21:58,229 --> 01:22:00,098 ARE RECRUITING EVERY SINGLE 2106 01:22:00,098 --> 01:22:03,268 REVIEWER AND WE REALLY 2107 01:22:03,268 --> 01:22:04,836 APPRECIATE WHEN PEOPLE ARE 2108 01:22:04,836 --> 01:22:06,237 RESPONDING TO INVITATION AND I 2109 01:22:06,237 --> 01:22:09,941 WOULD BE HAPPY TO HELP YOU. 2110 01:22:09,941 --> 01:22:14,479 AND WE DON'T HAVE SPECIALLY 2111 01:22:14,479 --> 01:22:16,514 ESTABLISHED PROGRAM SPSR HAS. 2112 01:22:16,514 --> 01:22:19,584 WE HAVE A SEPARATE E-MAIL. 2113 01:22:19,584 --> 01:22:22,821 WE REALLY APPRECIATE WHEN PEOPLE 2114 01:22:22,821 --> 01:22:28,259 ARE SENDING US REQUESTS AND 2115 01:22:28,259 --> 01:22:29,394 INTERESTS AND SHARING WITH 2116 01:22:29,394 --> 01:22:31,429 COLLEAGUES AND INSTITUTIONS AND 2117 01:22:31,429 --> 01:22:34,165 IS ESPECIALLY VERY HELPFUL AND 2118 01:22:34,165 --> 01:22:38,470 BENEFICIAL TO PEOPLE IN THEIR 2119 01:22:38,470 --> 01:22:40,672 EARLY-STAGE CAREER. 2120 01:22:40,672 --> 01:22:44,542 NOW LET'S GO TO MY TOPIC TODAY. 2121 01:22:44,542 --> 01:22:49,280 NIH RE-CORRECTLY PLANNED FOR 2122 01:22:49,280 --> 01:22:52,984 IMPLEMENTATION AND SIMPLIFYING 2123 01:22:52,984 --> 01:22:55,019 REVIEW FRAMEWORK FOR RESEARCH 2124 01:22:55,019 --> 01:22:56,321 PROJECT GRANT AND ALSO AT SAME 2125 01:22:56,321 --> 01:22:58,056 TIME WE ARE DOING REVISIONS TO 2126 01:22:58,056 --> 01:23:01,526 THE NIH FELLOWSHIP APPLICATION. 2127 01:23:01,526 --> 01:23:04,462 AND REVIEW PROCESS. 2128 01:23:04,462 --> 01:23:06,998 AND THAT I WILL COVER THOSE TO 2129 01:23:06,998 --> 01:23:11,002 IMMEMENTATION PLANS TO -- IN MY 2130 01:23:11,002 --> 01:23:13,705 TALK TODAY. 2131 01:23:13,705 --> 01:23:15,974 WHAT WAS MOTIVATION FOR 2132 01:23:15,974 --> 01:23:17,408 EXAMINING APPLICATION REVIEW? 2133 01:23:17,408 --> 01:23:19,377 ORGANIZATION OF PEER REVIEW 2134 01:23:19,377 --> 01:23:21,279 CRITERIA HAS BECOME TOO COMPLEX 2135 01:23:21,279 --> 01:23:23,414 AND HEARD PERSISTENCY FEEDBACK 2136 01:23:23,414 --> 01:23:26,084 FROM REVIEWERS AND ALSO ABSORBED 2137 01:23:26,084 --> 01:23:27,252 BY NIH STAFF. 2138 01:23:27,252 --> 01:23:30,488 THERE WAS ALSO IN PAST DECADE 2139 01:23:30,488 --> 01:23:33,558 EXPANSION OF ADMINISTRATIVE AND 2140 01:23:33,558 --> 01:23:35,660 QUALITY COMPLIANCE REVIEWS TO 2141 01:23:35,660 --> 01:23:38,496 ADDRESS COMPLIANCE AND ALL THIS 2142 01:23:38,496 --> 01:23:41,799 DETRACTED ATTENTION AND WENT FOR 2143 01:23:41,799 --> 01:23:45,603 CRITICAL ROLE OF PEER REVIEW TO 2144 01:23:45,603 --> 01:23:47,005 EVALUATE SCIENTIFIC AND 2145 01:23:47,005 --> 01:23:49,107 TECHNICAL MERIT OF THE PROJECT 2146 01:23:49,107 --> 01:23:52,977 AND WAS ALSO APPEARANCE OF UNDUE 2147 01:23:52,977 --> 01:23:54,979 INFLUENCE OF REPUTATION IN NIH 2148 01:23:54,979 --> 01:23:57,448 PEER REVIEW AND CONCERNS RAISED 2149 01:23:57,448 --> 01:23:59,484 BY COMMUNITY AND OBSERVED BY NIH 2150 01:23:59,484 --> 01:24:02,487 STAFFING LEADERSHIP AND ALL THIS 2151 01:24:02,487 --> 01:24:04,556 EFFECTS JUDGMENT OF MERIT WHEN 2152 01:24:04,556 --> 01:24:08,126 WELL-KNOWN RESEARCHERS OR PLACES 2153 01:24:08,126 --> 01:24:12,564 ARE GIVEN A PATH AND LESS KNOWN 2154 01:24:12,564 --> 01:24:15,600 ARE TREATED WITH MORE SCRUTINY 2155 01:24:15,600 --> 01:24:17,202 AND ADDRESSING CHALLENGES AND 2156 01:24:17,202 --> 01:24:19,537 NIH HAS DECIDED TO SIMPLIFY 2157 01:24:19,537 --> 01:24:23,575 REVIEW FRAMEWORK FOR RPGS AND 2158 01:24:23,575 --> 01:24:28,146 RESEARCH PROJECT APPLICATIONS. 2159 01:24:28,146 --> 01:24:30,882 AND GOALS OF THESE CHANGES, 2160 01:24:30,882 --> 01:24:32,317 THERE ARE THREE GOALS. 2161 01:24:32,317 --> 01:24:34,986 FIRST, ENABLE REVIEWERS TO 2162 01:24:34,986 --> 01:24:38,223 BETTER FOCUS ON ANSWERING THE 2163 01:24:38,223 --> 01:24:39,958 KEY QUESTIONS. 2164 01:24:39,958 --> 01:24:41,793 SCIENTIFIC AND TECHNICAL MERIT 2165 01:24:41,793 --> 01:24:43,795 AND SHOULD PROPOSED RESEARCH 2166 01:24:43,795 --> 01:24:47,165 PROJECT BE CONDUCTED AND CAN 2167 01:24:47,165 --> 01:24:49,567 PROPOSED RESEARCH PROJECT BE 2168 01:24:49,567 --> 01:24:50,001 CONDUCTED? 2169 01:24:50,001 --> 01:24:52,971 THE SECOND GOAL IS TO MITIGATE 2170 01:24:52,971 --> 01:24:54,939 THE EFFECT OF REPUTATIONAL BIAS 2171 01:24:54,939 --> 01:24:59,077 AND THIRD GOAL IS REDUCING 2172 01:24:59,077 --> 01:25:02,547 REVIEWER'S BURDEN AND FIRST 2173 01:25:02,547 --> 01:25:05,783 INTENTION OF ACTIONS WERE 2174 01:25:05,783 --> 01:25:08,519 PUBLISHED IN OCTOBER OF 20203. 2175 01:25:08,519 --> 01:25:11,055 THIS IS HYPERLINK YOU CAN CHECK 2176 01:25:11,055 --> 01:25:12,657 DETAILS AND CHANGES ARE COMING 2177 01:25:12,657 --> 01:25:15,493 AT END AND WHAT IS CHANGES? IT 2178 01:25:15,493 --> 01:25:22,867 EFFECTS ALL RPGS WITH R ACTIVITY 2179 01:25:22,867 --> 01:25:25,103 CODE AND ALSO CORPORATE 2180 01:25:25,103 --> 01:25:30,742 AGREEMENTS AND R01 AND R03, R15, 2181 01:25:30,742 --> 01:25:33,845 R21, ET CETERA AND BIPHASIC 2182 01:25:33,845 --> 01:25:37,081 AWARDS AND MUST SAY THAT THESE 2183 01:25:37,081 --> 01:25:40,251 EFFECTS OR CHANGES ARE IMPACTING 2184 01:25:40,251 --> 01:25:42,153 ONLY SINGLE COMPONENT 2185 01:25:42,153 --> 01:25:44,589 APPLICATIONS AND MULTICOMPONENT 2186 01:25:44,589 --> 01:25:46,257 APPLICATIONS EVEN THOUGH THEY 2187 01:25:46,257 --> 01:25:49,193 MIGHT USE STRUCTURE OF R01 IN 2188 01:25:49,193 --> 01:25:52,030 APPLICATIONS AND WOULD BE STILL 2189 01:25:52,030 --> 01:25:54,699 REVIEWED UNDER THE OLD CRITERIA. 2190 01:25:54,699 --> 01:25:57,935 WHEN WILL THIS BE COMING? 2191 01:25:57,935 --> 01:26:00,204 IT WOULD EFFECT ALL APPLICATIONS 2192 01:26:00,204 --> 01:26:04,609 COMING FOR DUE DATE ON JANUARY 2193 01:26:04,609 --> 01:26:06,511 252025 AND AFTER. IT WILL 2194 01:26:06,511 --> 01:26:11,082 EFFECT SOME PEER REVIEW 20205. 2195 01:26:11,082 --> 01:26:14,485 YOU WILL SEE THE RESULTS IN 2196 01:26:14,485 --> 01:26:20,992 OCTOBER OF 2025. 2197 01:26:20,992 --> 01:26:22,727 SIMPLIFIED FRAMEWORK IMPACTS 2198 01:26:22,727 --> 01:26:26,698 REVIEW PROCESS AND WILL HELP AND 2199 01:26:26,698 --> 01:26:29,400 IMPROVE THE EXPECTATION IS THAT 2200 01:26:29,400 --> 01:26:33,071 IT WILL IMPROVE A REVIEW FOCUS 2201 01:26:33,071 --> 01:26:35,740 EXISTING FIVE REVIEW CRITERIA TO 2202 01:26:35,740 --> 01:26:37,709 BE REORGANIZED INTO THREE 2203 01:26:37,709 --> 01:26:41,212 FACTORS AND SOME ADDITIONAL 2204 01:26:41,212 --> 01:26:45,216 REVIEW CRITERIA WILL BE 2 OR ONE 2205 01:26:45,216 --> 01:26:48,219 FACTOR AND FACTOR 2 AND I WILL 2206 01:26:48,219 --> 01:26:52,123 IN A MINUTE EXACTLY WHICH ONE. 2207 01:26:52,123 --> 01:26:54,659 REDUCE THE SECOND EXPECTATION TO 2208 01:26:54,659 --> 01:26:57,695 THAT IT WILL REDUCE REPUTATIONAL 2209 01:26:57,695 --> 01:27:00,098 BIAS AND BY INVESTIGATIVE 2210 01:27:00,098 --> 01:27:02,934 ENVIRONMENT THAT WILL BE 2211 01:27:02,934 --> 01:27:05,737 EVALUATED IN SUCCESSION OR GAPS 2212 01:27:05,737 --> 01:27:08,172 IDENTIFIED AND THIS FACTOR WILL 2213 01:27:08,172 --> 01:27:10,441 NOT RECEIVE INDIVIDUAL SCORE BUT 2214 01:27:10,441 --> 01:27:13,378 WILL EFFECT SCORE. 2215 01:27:13,378 --> 01:27:16,748 AND THE SECOND WAS MENTIONED IN 2216 01:27:16,748 --> 01:27:20,418 THE GOAL IS IT SHOULD REDUCE 2217 01:27:20,418 --> 01:27:22,553 BURDEN AND MOST ADDITIONAL 2218 01:27:22,553 --> 01:27:24,789 REVIEW CONSIDERATION WILL BE 2219 01:27:24,789 --> 01:27:29,093 SHIFTED FROM REVIEWER TO NIH 2220 01:27:29,093 --> 01:27:29,327 STAFF. 2221 01:27:29,327 --> 01:27:31,896 ALL THIS SHOULD IMPROVE 2222 01:27:31,896 --> 01:27:34,265 IDENTIFICATION OF STRONGEST AND 2223 01:27:34,265 --> 01:27:36,701 POTENTIALLY HIGH-IMPACT 2224 01:27:36,701 --> 01:27:37,668 RESEARCH. 2225 01:27:37,668 --> 01:27:41,939 HOW IT WILL BE FOR REVIEWERS 2226 01:27:41,939 --> 01:27:45,076 WHEN THEY COME THROUGH AROUND 2227 01:27:45,076 --> 01:27:49,680 TIME TO REVIEW APPLICATION. 2228 01:27:49,680 --> 01:27:53,284 SO FIVE REVIEW CORE CRITERIA 2229 01:27:53,284 --> 01:27:55,253 WILL BE GOOD IN THREE FACTORS AS 2230 01:27:55,253 --> 01:27:57,355 I SAID. 2231 01:27:57,355 --> 01:27:59,390 FIRST FACTOR WILL ADDRESS 2232 01:27:59,390 --> 01:28:01,626 IMPORTANCE OF THE RESEARCH. 2233 01:28:01,626 --> 01:28:04,328 BY EVALUATION OF [INDISCERNIBLE] 2234 01:28:04,328 --> 01:28:06,998 INNOVATION AND IT WILL RECEIVE A 2235 01:28:06,998 --> 01:28:08,099 SEPARATE SCORE FROM 2236 01:28:08,099 --> 01:28:08,499 [INDISCERNIBLE]. 2237 01:28:08,499 --> 01:28:13,371 SECOND FACTOR, FACTOR TO ADDRESS 2238 01:28:13,371 --> 01:28:19,644 RIGOR AND FEASIBILITY AND BY 2239 01:28:19,644 --> 01:28:20,945 EVALUATING APPROACH WHICH WILL 2240 01:28:20,945 --> 01:28:24,449 INCLUDE INCLUSION OF HUMAN 2241 01:28:24,449 --> 01:28:26,451 SUBJECT STUDY GROUP AND STUDY 2242 01:28:26,451 --> 01:28:28,186 TIMELINE FOR CLINICAL TRIAL. 2243 01:28:28,186 --> 01:28:32,657 IT WILL ALSO RECEIVE A SEPARATE 2244 01:28:32,657 --> 01:28:33,191 SCORE. 2245 01:28:33,191 --> 01:28:36,828 FACTOR 3, IT WILL ASSESS 2246 01:28:36,828 --> 01:28:39,497 EXPERTISE AND RESOURCES BY 2247 01:28:39,497 --> 01:28:42,467 EVALUATING INVESTIGATORS AND 2248 01:28:42,467 --> 01:28:42,800 ENVIRONMENT. 2249 01:28:42,800 --> 01:28:45,703 IT WILL BE EVALUATED APPROPRIATE 2250 01:28:45,703 --> 01:28:48,739 OR GAPS IDENTIFIED. 2251 01:28:48,739 --> 01:28:51,242 IF GAPS, ARE AN EXPLANATION THAT 2252 01:28:51,242 --> 01:28:54,412 WILL BE NEEDED. 2253 01:28:54,412 --> 01:28:56,581 FACTOR 3 WILL NOT RECEIVE A 2254 01:28:56,581 --> 01:28:57,815 SEPARATE SCORE BUT WILL BE 2255 01:28:57,815 --> 01:28:59,584 CONSIDERED FOR OVERALL IMPACT 2256 01:28:59,584 --> 01:28:59,851 SCORING. 2257 01:28:59,851 --> 01:29:03,254 SO IF YOU GO TO ADDITIONAL 2258 01:29:03,254 --> 01:29:05,256 REVIEW CRITERIA THAT ARE 2259 01:29:05,256 --> 01:29:07,859 CURRENTLY NOT SCORED BUT CAN 2260 01:29:07,859 --> 01:29:09,660 EFFECT OVERALL SCORE. 2261 01:29:09,660 --> 01:29:13,231 AS I ALREADY SAID, STUDY 2262 01:29:13,231 --> 01:29:15,666 TIMELINE WILL BE MOVED TO FACTOR 2263 01:29:15,666 --> 01:29:18,970 2 AND REVIEWS SHOULD ADDRESS 2264 01:29:18,970 --> 01:29:25,510 AWARD INCLUSION GROUPS THAT ARE 2265 01:29:25,510 --> 01:29:28,980 IN PLAN FOR RECRUITMENT. 2266 01:29:28,980 --> 01:29:33,017 ALSO, STUDY TIMELINE FOR 2267 01:29:33,017 --> 01:29:37,088 CLINICAL TRIALS WILL BE 2268 01:29:37,088 --> 01:29:39,891 CONSIDERED AND REVIEWED 2269 01:29:39,891 --> 01:29:42,960 EVALUATING FACTOR 2. 2270 01:29:42,960 --> 01:29:45,730 WHAT WILL REMAIN HERE IS HUMAN 2271 01:29:45,730 --> 01:29:48,199 SUBJECT PROTECTION SECTION AND 2272 01:29:48,199 --> 01:29:50,301 BIOHAZARDS AND SUBMISSIONS RENEW 2273 01:29:50,301 --> 01:29:53,571 AND REVISIONS AND ALL THIS WILL 2274 01:29:53,571 --> 01:29:56,207 REMAIN FOR ADDITIONAL REVIEW 2275 01:29:56,207 --> 01:29:59,210 CRITERIA THAT WILL EFFECT 2276 01:29:59,210 --> 01:30:06,751 OVERALL IMPACT SCORE ADDITIONAL 2277 01:30:06,751 --> 01:30:08,052 REVIEW CONSIDERATION THAT DON'T 2278 01:30:08,052 --> 01:30:11,155 RECEIVE A SEPARATE SCORE OR 2279 01:30:11,155 --> 01:30:14,458 IMPACT OVERALL SCORE, THEY WILL 2280 01:30:14,458 --> 01:30:19,130 BE TRAINED SIGNIFICANTLY. 2281 01:30:19,130 --> 01:30:22,166 [INDISCERNIBLE] WILL BE REMOVED 2282 01:30:22,166 --> 01:30:26,070 AND WILL SHIFT TO PROGRAM STAFF 2283 01:30:26,070 --> 01:30:29,240 AND WILL EVALUATE POST REVIEW 2284 01:30:29,240 --> 01:30:30,808 SELECTION AND AGENTS AND 2285 01:30:30,808 --> 01:30:33,644 RESOURCE SHARING PLAN AND REVIEW 2286 01:30:33,644 --> 01:30:36,647 TO ADDRESS INDICATION OF 2287 01:30:36,647 --> 01:30:37,448 BIOCHEMICAL [INDISCERNIBLE] AND 2288 01:30:37,448 --> 01:30:40,751 PERIOD OF SUPPORT AND THIS IS 2289 01:30:40,751 --> 01:30:42,820 ONE-STOP SHOP THAT IS JUST A 2290 01:30:42,820 --> 01:30:46,057 BUSINESS LIFE AND TO GIVE YOU A 2291 01:30:46,057 --> 01:30:47,625 COMPARISON AND LEFT SIDE YOU SEE 2292 01:30:47,625 --> 01:30:53,431 CRITERIA REVIEW CRITERIA REVIEW 2293 01:30:53,431 --> 01:30:55,633 CONSIDERATION FOR BEFORE JANUARY 2294 01:30:55,633 --> 01:30:57,969 2025 THAT WE HAVE CURRENTLY AND 2295 01:30:57,969 --> 01:31:00,471 ON THE RIGHT SIDE THESE ARE ONES 2296 01:31:00,471 --> 01:31:03,774 THAT ARE HOW THEY WILL BE 2297 01:31:03,774 --> 01:31:06,110 ORGANIZED AND WILL SEE AFTER 2298 01:31:06,110 --> 01:31:08,846 JANUARY 2025. 2299 01:31:08,846 --> 01:31:09,880 NIH DEVELOPED COMPREHENSIVE 2300 01:31:09,880 --> 01:31:12,617 WEBSITE HAVING A LOT OF 2301 01:31:12,617 --> 01:31:12,950 INFORMATION. 2302 01:31:12,950 --> 01:31:17,254 IT IS UPDATED ON A DAILY BASIS 2303 01:31:17,254 --> 01:31:21,993 AND WE -- THEY -- WE OFFERED 2304 01:31:21,993 --> 01:31:25,796 WEBINARS THAT ARE ALL RECORDED 2305 01:31:25,796 --> 01:31:29,934 AND AVAILABLE ONLINE TO WATCH 2306 01:31:29,934 --> 01:31:30,201 LATER. 2307 01:31:30,201 --> 01:31:36,707 HERE ARE SOME LINKS TO THE BLOG 2308 01:31:36,707 --> 01:31:37,742 OF OFFICE OF [INDISCERNIBLE] 2309 01:31:37,742 --> 01:31:45,216 RESEARCH AND LINKS TO THE PO 2310 01:31:45,216 --> 01:31:45,449 POLICY. 2311 01:31:45,449 --> 01:31:47,585 SO LET'S MOVE TO NEXT TOPIC 2312 01:31:47,585 --> 01:31:51,022 REVISIONS OF NIH FELLOWSHIP 2313 01:31:51,022 --> 01:31:52,423 APPLICATIONS AND REVIEW 2314 01:31:52,423 --> 01:31:52,957 CRITERIA. 2315 01:31:52,957 --> 01:31:56,927 AS I SAID, IT IS DONE IN 2316 01:31:56,927 --> 01:31:57,328 PARALLEL. 2317 01:31:57,328 --> 01:32:00,264 IT IS HAPPENING AT THE SAME 2318 01:32:00,264 --> 01:32:01,198 TIME. 2319 01:32:01,198 --> 01:32:04,068 RPGS CHANGES EFFECTS ALL THIS 2320 01:32:04,068 --> 01:32:06,003 REVIEW CRITERIA. 2321 01:32:06,003 --> 01:32:08,773 NOTHING CHANGES WHEN APPLICANTS 2322 01:32:08,773 --> 01:32:09,440 -- RESEARCHERS ARE PREPARING 2323 01:32:09,440 --> 01:32:12,543 THEIR APPLICATIONS. 2324 01:32:12,543 --> 01:32:13,377 FELLOWSHIPS, THERE ARE MORE 2325 01:32:13,377 --> 01:32:16,514 SIGNIFICANT CHANGES. 2326 01:32:16,514 --> 01:32:20,584 BECAUSE IT EFFECTS APPLICATION 2327 01:32:20,584 --> 01:32:22,687 CELLS AND REVIEW CRITERIA AND 2328 01:32:22,687 --> 01:32:24,755 THEY ARE BASICALLY SAME AND 2329 01:32:24,755 --> 01:32:27,391 BETTER FOCUS REVIEWERS ATTENTION 2330 01:32:27,391 --> 01:32:29,994 ON THREE KEY ASSESSMENT 2331 01:32:29,994 --> 01:32:31,629 FELLOWSHIP CANDIDATES 2332 01:32:31,629 --> 01:32:33,264 PREPAREDNESS AND POTENTIAL AND 2333 01:32:33,264 --> 01:32:34,999 RESEARCH TRAINING PLAN AND 2334 01:32:34,999 --> 01:32:36,567 COMMITMENT TO CANDIDATES AND 2335 01:32:36,567 --> 01:32:38,602 SECOND IS TO ENSURE THAT A BROAD 2336 01:32:38,602 --> 01:32:42,973 RANGE OF CANDIDATES AND RESEARCH 2337 01:32:42,973 --> 01:32:46,077 TRAINING COULD BE RECOGNIZED AS 2338 01:32:46,077 --> 01:32:48,179 MERITORIOUS BY CLARIFYING 2339 01:32:48,179 --> 01:32:49,213 SIMPLIFYING LANGUAGE IN 2340 01:32:49,213 --> 01:32:52,450 APPLICATION AND IN REVIEW 2341 01:32:52,450 --> 01:32:53,417 CRITERIA. 2342 01:32:53,417 --> 01:32:55,920 AND, AGAIN, REVIEWS BIAS IN 2343 01:32:55,920 --> 01:32:58,489 REVIEW BY EMPHASIZING COMMITMENT 2344 01:32:58,489 --> 01:33:01,492 TO THE CANDIDATE WITHOUT 2345 01:33:01,492 --> 01:33:05,329 CONSIDERATION OF SPONSOR AND 2346 01:33:05,329 --> 01:33:07,331 INSTITUTIONAL REPUTATION. 2347 01:33:07,331 --> 01:33:10,234 SO AND THIS IMPLEMENTATION OF 2348 01:33:10,234 --> 01:33:13,437 THIS WAS FIRST ANNOUNCED 2349 01:33:13,437 --> 01:33:18,109 RECENTLY IN APRIL 2024. 2350 01:33:18,109 --> 01:33:21,946 WHAT IS CHANGING? REVISED 2351 01:33:21,946 --> 01:33:24,181 FELLOWSHIP APPLICATION 2352 01:33:24,181 --> 01:33:25,750 STRUCTURES AND FORMS TO 2353 01:33:25,750 --> 01:33:27,384 APPLICANT AND APPLICATIONS WILL 2354 01:33:27,384 --> 01:33:30,321 BECOME SHORTER AND MORE 2355 01:33:30,321 --> 01:33:33,924 STRUCTURED ALIGNED WITH NEW 2356 01:33:33,924 --> 01:33:37,394 REVIEW CRITERIA LESS EMPHASIS 2357 01:33:37,394 --> 01:33:39,463 WILL BE GIVEN TO SPONSOR TRACK 2358 01:33:39,463 --> 01:33:41,398 RECORD AND MORE EMPHASIS ON 2359 01:33:41,398 --> 01:33:43,601 RESEARCH TRAINING PLAN AND 2360 01:33:43,601 --> 01:33:46,070 CANDIDATES PREPAREDNESS FOCUS ON 2361 01:33:46,070 --> 01:33:48,539 CANDIDATES NOT THE MENTOR. 2362 01:33:48,539 --> 01:33:50,674 DEFINE EACH SECTION THAT WILL 2363 01:33:50,674 --> 01:33:53,377 GIVE A DEFINITION WHO SHOULD 2364 01:33:53,377 --> 01:33:55,579 AUTHOR THE SECTION AND THERE 2365 01:33:55,579 --> 01:33:58,415 WILL BE ALSO UPDATED 2366 01:33:58,415 --> 01:34:00,317 INSTRUCTIONS FOR REFERENCE 2367 01:34:00,317 --> 01:34:00,584 LETTERS. 2368 01:34:00,584 --> 01:34:05,389 SO IN ADDITION TO THE 2369 01:34:05,389 --> 01:34:07,057 APPLICATION FORMS THERE WILL BE 2370 01:34:07,057 --> 01:34:10,461 REORGANIZED FELLOWSHIP CRITERIA. 2371 01:34:10,461 --> 01:34:13,597 THERE WILL BE THREE CRITERIA 2372 01:34:13,597 --> 01:34:16,167 CANDIDATES PREPAREDNESS AND 2373 01:34:16,167 --> 01:34:19,103 POTENTIAL TO BETTER IDENTIFY 2374 01:34:19,103 --> 01:34:21,005 PROMISING YOUNG SCIENTISTS. 2375 01:34:21,005 --> 01:34:24,675 THE RESEARCH TRAINING PLAN THAT 2376 01:34:24,675 --> 01:34:27,878 WILL FOCUS ON RESEARCH PROJECT 2377 01:34:27,878 --> 01:34:30,381 IN TERMS OF -- IT IS THERE TO 2378 01:34:30,381 --> 01:34:34,485 TRAINING PROMISING TO TRAIN 2379 01:34:34,485 --> 01:34:36,353 PROMISING SCIENTISTS AND 2380 01:34:36,353 --> 01:34:38,055 COMMITMENT TO CANDIDATES THAT 2381 01:34:38,055 --> 01:34:39,990 FOCUS ON SPONSORING 2382 01:34:39,990 --> 01:34:42,259 INSTITUTIONAL ENVIRONMENT 2383 01:34:42,259 --> 01:34:46,497 CONTRIBUTIONS TO THE CURRENT 2384 01:34:46,497 --> 01:34:47,898 CANDIDATES RESEARCH TRAINING 2385 01:34:47,898 --> 01:34:50,701 PLAN AND EMPHASIZE TRACK RECORD 2386 01:34:50,701 --> 01:34:52,236 AUTHOR OR IN INSTITUTION AND 2387 01:34:52,236 --> 01:34:55,005 WILL APPLY TO ALL FELLOWSHIPS, 2388 01:34:55,005 --> 01:35:00,644 AGAIN, COMING JANUARY 25, 2025. 2389 01:35:00,644 --> 01:35:04,949 FOR THE PARENTS, FELLOWSHIP 2390 01:35:04,949 --> 01:35:07,551 APPLICATIONS, IT WILL BE FOR DUE 2391 01:35:07,551 --> 01:35:10,921 DATE APRIL 8, 2025 THAT WILL BE 2392 01:35:10,921 --> 01:35:13,123 REVIEWED IN SUMMER OF 2025. 2393 01:35:13,123 --> 01:35:16,794 THIS IS, AGAIN, ONE EXAMPLE TO 2394 01:35:16,794 --> 01:35:18,195 SHOW WHAT WE HAVE CURRENTLY ON 2395 01:35:18,195 --> 01:35:20,331 THE LEFT SIDE. 2396 01:35:20,331 --> 01:35:23,300 WE HAVE CURRENTLY FIVE REVIEW 2397 01:35:23,300 --> 01:35:24,869 QUESTIONS AND FELLOWSHIP 2398 01:35:24,869 --> 01:35:27,171 APPLICATIONS THAT WILL BE 2399 01:35:27,171 --> 01:35:29,039 REORGANIZED AND WILL REMAIN IN 2400 01:35:29,039 --> 01:35:29,940 TWO ONLY. 2401 01:35:29,940 --> 01:35:32,776 AGAIN, FIRST WILL BE CANDIDATE 2402 01:35:32,776 --> 01:35:34,478 PREPAREDNESS AND POTENTIAL 2403 01:35:34,478 --> 01:35:35,679 RESEARCH TRAINING PLAN AND 2404 01:35:35,679 --> 01:35:37,348 COMMITMENT TO CANDIDATES AND 2405 01:35:37,348 --> 01:35:39,516 EVERYTHING WILL BE FOCUSED ON 2406 01:35:39,516 --> 01:35:41,318 CANDIDATE AND NO CHANGES FOR 2407 01:35:41,318 --> 01:35:45,055 ADDITIONAL REVIEW CRITERIA OR 2408 01:35:45,055 --> 01:35:46,924 REVIEW FOR FELLOWSHIP AND 2409 01:35:46,924 --> 01:35:48,058 FELLOWSHIP APPLICATION CHANGES 2410 01:35:48,058 --> 01:35:50,561 AND REVISIONS IS A SEPARATE 2411 01:35:50,561 --> 01:35:55,566 WEBPAGE WITH ALL OF THE 2412 01:35:55,566 --> 01:35:55,900 INFORMATION. 2413 01:35:55,900 --> 01:35:58,602 AND YOU CAN FIND ANYTHING THERE 2414 01:35:58,602 --> 01:36:02,840 IN QUESTIONS AND THERE IS 2415 01:36:02,840 --> 01:36:06,277 INFORMATION THERE TO GET TO 2416 01:36:06,277 --> 01:36:08,579 IMPROVE SOMEONE AND INCLUDED 2417 01:36:08,579 --> 01:36:11,415 THESE LINKS AND HYPERLINKS TO 2418 01:36:11,415 --> 01:36:15,119 THESE PAGES AND ALL OF THE 2419 01:36:15,119 --> 01:36:16,687 USEFUL INFORMATION AND FIRST 2420 01:36:16,687 --> 01:36:19,023 WEBINAR FOR WHAT FELLOWSHIP 2421 01:36:19,023 --> 01:36:22,459 APPLICANTS THAT WILL BE HELD IN 2422 01:36:22,459 --> 01:36:24,762 SEPTEMBER 19 AND REGISTRATION 2423 01:36:24,762 --> 01:36:26,597 AND ALL THESE WEBINARS ARE 2424 01:36:26,597 --> 01:36:31,735 RECORDED AND ARE AVAILABLE FOR 2425 01:36:31,735 --> 01:36:32,736 REVIEW TO WATCH LATER. 2426 01:36:32,736 --> 01:36:35,139 ON THAT, THANKS FOR YOUR 2427 01:36:35,139 --> 01:36:35,572 ATTENTION. 2428 01:36:35,572 --> 01:36:39,310 I'M HAPPY TO TAKE YOUR 2429 01:36:39,310 --> 01:36:40,144 QUESTIONS. 2430 01:36:40,144 --> 01:36:41,412 >> AUDIENCE: [APPLAUSE]. 2431 01:36:41,412 --> 01:36:51,956 >> I'M GETTING USED TO THIS NEW 2432 01:36:54,825 --> 01:36:56,260 METHOD. THANK YOU. SIMON. 2433 01:36:56,260 --> 01:36:58,128 >> THANK YOU FOR THAT OVERVIEW 2434 01:36:58,128 --> 01:36:59,630 OF THE UPCOMING CHANGES. 2435 01:36:59,630 --> 01:37:01,398 I HAD A QUESTION THAT IS RELATED 2436 01:37:01,398 --> 01:37:04,134 TO THE REPUTATIONAL BIAS ISSUES. 2437 01:37:04,134 --> 01:37:06,103 ABOUT FIVE YEARS AGO I 2438 01:37:06,103 --> 01:37:07,805 PARTICIPATED IN A THEATRE STUDY 2439 01:37:07,805 --> 01:37:11,041 TO LOOK AT BLINDED OR 2440 01:37:11,041 --> 01:37:12,242 ANONYMIZATION DURING THE REVIEW 2441 01:37:12,242 --> 01:37:16,080 PROCESS AND WONDER WHAT CAME OF 2442 01:37:16,080 --> 01:37:16,747 THE STUDY. 2443 01:37:16,747 --> 01:37:20,250 >> THE -- THAT -- TECHNICALLY, 2444 01:37:20,250 --> 01:37:24,054 THEY SAID IF -- IT IS VERY 2445 01:37:24,054 --> 01:37:26,490 DIFFICULT TO IMPLEMENT. 2446 01:37:26,490 --> 01:37:28,525 THERE IS A NEED TO SEE WHO IS 2447 01:37:28,525 --> 01:37:32,730 DOING RESEARCH; RIGHT? 2448 01:37:32,730 --> 01:37:40,637 SO THEY -- THAT PILOT WENT 2449 01:37:40,637 --> 01:37:42,272 WITHOUT ANY IMPLEMENTATION, I 2450 01:37:42,272 --> 01:37:44,274 WOULD SAY. 2451 01:37:44,274 --> 01:37:48,979 I -- I CHECKED MICHAEL'S BLOG 2452 01:37:48,979 --> 01:37:52,850 THAT HE OPENED WHEN IT WAS 2453 01:37:52,850 --> 01:37:56,120 ISSUED. 2454 01:37:56,120 --> 01:37:58,789 THERE WAS VERY VIOLENT RESPONSE 2455 01:37:58,789 --> 01:38:00,290 FROM THE COMMUNITY AND ONLY 2456 01:38:00,290 --> 01:38:04,395 THREE POSTS AND ONE WAS FROM 2457 01:38:04,395 --> 01:38:06,363 INVESTIGATOR WHO SAID MAYBE WE 2458 01:38:06,363 --> 01:38:11,435 SHOULD JUST REMOVE PIS OR 2459 01:38:11,435 --> 01:38:14,271 ENVIRONMENT FROM REVIEWS. YOU 2460 01:38:14,271 --> 01:38:18,142 KNOW, TO SEE. SO, COMPLETELY 2461 01:38:18,142 --> 01:38:18,542 [INDISCERNIBLE]. 2462 01:38:18,542 --> 01:38:18,876 >> RIGHT. 2463 01:38:18,876 --> 01:38:22,880 >> BUT IT -- IT DIDN'T GO 2464 01:38:22,880 --> 01:38:23,147 ANYWHERE. 2465 01:38:23,147 --> 01:38:24,281 THERE WAS TECHNICAL ISSUES. 2466 01:38:24,281 --> 01:38:26,450 >> I AGREE WITH CHALLENGES OF 2467 01:38:26,450 --> 01:38:28,018 DOING IT AND WOULD HAVE BEEN 2468 01:38:28,018 --> 01:38:29,787 INTERESTING TO SEE DATA 2469 01:38:29,787 --> 01:38:31,422 PUBLISHED FROM THE STUDY. 2470 01:38:31,422 --> 01:38:34,091 SAME GRANTS REVIEWED WITH 2471 01:38:34,091 --> 01:38:35,059 INVESTIGATION THERE OR 2472 01:38:35,059 --> 01:38:35,526 INFORMATION WITHOUT. 2473 01:38:35,526 --> 01:38:37,928 I WOULD BE INTERESTED TO SEE TO 2474 01:38:37,928 --> 01:38:39,863 WHAT EXTENT THE SCORE HAS 2475 01:38:39,863 --> 01:38:40,130 CHANGED. 2476 01:38:40,130 --> 01:38:40,531 >> I. 2477 01:38:40,531 --> 01:38:43,000 >> I NEVER SAW DATA PUBLISHED 2478 01:38:43,000 --> 01:38:43,600 FROM THAT. 2479 01:38:43,600 --> 01:38:47,438 >> I'M NOT AWARE OF WHERE THIS 2480 01:38:47,438 --> 01:38:48,605 DATA GOES. 2481 01:38:48,605 --> 01:38:52,509 I MEAN, PRIOR FROM 2482 01:38:52,509 --> 01:38:52,910 [INDISCERNIBLE]. 2483 01:38:52,910 --> 01:38:54,812 >> THANK YOU. 2484 01:38:54,812 --> 01:38:55,612 >> YEAH. 2485 01:38:55,612 --> 01:38:57,648 >> YES. I JUST WANT TO SAY THAT 2486 01:38:57,648 --> 01:38:59,783 I THINK THIS SEEMS LIKE A 2487 01:38:59,783 --> 01:39:01,318 FANTASTIC INITIATIVE. 2488 01:39:01,318 --> 01:39:04,254 I -- I THINK THAT SIMPLIFYING IN 2489 01:39:04,254 --> 01:39:06,490 THIS WAY MAKES SENSE TO ME, 2490 01:39:06,490 --> 01:39:06,723 ANYWAY. 2491 01:39:06,723 --> 01:39:08,592 I'M WONDERING WHAT THE THOUGHT 2492 01:39:08,592 --> 01:39:10,527 IS ABOUT EDUCATING REVIEWERS 2493 01:39:10,527 --> 01:39:11,462 ABOUT THIS. 2494 01:39:11,462 --> 01:39:15,065 I THINK THERE ARE -- THERE IS A 2495 01:39:15,065 --> 01:39:17,167 TENDENCY FOR PEOPLE TO RESHUFFLE 2496 01:39:17,167 --> 01:39:18,569 CRITERIA IN THEIR HEADS AND 2497 01:39:18,569 --> 01:39:20,237 REVIEW THE SAME WAY THAT THEY 2498 01:39:20,237 --> 01:39:23,907 ALWAYS REVIEWED AND THOUGHTS 2499 01:39:23,907 --> 01:39:25,342 ABOUT THAT? 2500 01:39:25,342 --> 01:39:27,044 >> THAT IS A GREAT POINT. 2501 01:39:27,044 --> 01:39:27,911 >> YEAH. 2502 01:39:27,911 --> 01:39:32,149 >> AND THERE IS ALWAYS A LOT OF 2503 01:39:32,149 --> 01:39:34,118 WORK FOR SCIENTIFIC 2504 01:39:34,118 --> 01:39:35,319 [INDISCERNIBLE] TO EDUCATE 2505 01:39:35,319 --> 01:39:38,922 REVIEW AND PUSH THEM AND TRAIN 2506 01:39:38,922 --> 01:39:41,158 AND PROVIDE INFORMATION AND 2507 01:39:41,158 --> 01:39:43,093 DOCUMENTS AND MAKE THEM TO, YOU 2508 01:39:43,093 --> 01:39:46,797 KNOW, USE IT, REALLY USE IT. 2509 01:39:46,797 --> 01:39:52,002 SO I WAS HERE IN NIH IN 2009 2510 01:39:52,002 --> 01:39:53,270 WHEN THERE WAS A SIGNIFICANT 2511 01:39:53,270 --> 01:39:55,839 CHANGE THAT WAS 15 YEARS LATER 2512 01:39:55,839 --> 01:39:57,708 WE ARE HERE AND CHANGING AND WE 2513 01:39:57,708 --> 01:39:58,775 ARE TRYING OUR BEST. 2514 01:39:58,775 --> 01:40:01,478 THERE WILL BE -- THERE WILL BE 2515 01:40:01,478 --> 01:40:03,147 WEBINARS AND TRAINING VIDEOS 2516 01:40:03,147 --> 01:40:06,183 THAT ARE DEVELOPED FOR REVIEWER 2517 01:40:06,183 --> 01:40:08,519 AS WELL AS INFORMATION AND 2518 01:40:08,519 --> 01:40:11,288 GUIDANCE FOR SROS TO ENFORCE 2519 01:40:11,288 --> 01:40:11,722 THOSE CHANGES. 2520 01:40:11,722 --> 01:40:13,891 WE ARE TRYING OUR BEST. 2521 01:40:13,891 --> 01:40:15,759 WE IN OUR OFFICE, IT IS BECAUSE 2522 01:40:15,759 --> 01:40:18,795 -- AS I SAID, WE HAVE SPECIAL 2523 01:40:18,795 --> 01:40:20,731 EMPHASIS PANELS AND EVERY 2524 01:40:20,731 --> 01:40:24,168 REVIEWER AND CHAIR WE HAVE TO 2525 01:40:24,168 --> 01:40:24,468 TRAIN. 2526 01:40:24,468 --> 01:40:28,205 SO WE DEVELOP CHAIR CHEAT SHEET 2527 01:40:28,205 --> 01:40:31,208 SO WHEN THEY ARE -- REVIEWERS 2528 01:40:31,208 --> 01:40:33,877 ADDRESS AND EVALUATE, WE TELL 2529 01:40:33,877 --> 01:40:35,879 THEM IF THEY DID NOT MENTION IT, 2530 01:40:35,879 --> 01:40:38,348 PLEASE ASK THEM THIS QUESTION. 2531 01:40:38,348 --> 01:40:41,385 PARTICULARLY SEX AND BIOLOGICAL 2532 01:40:41,385 --> 01:40:43,086 VARIABLES AND WHAT STUDY GROUPS 2533 01:40:43,086 --> 01:40:44,021 ARE INCLUDED AND EXCLUDING ANY 2534 01:40:44,021 --> 01:40:46,323 GROUPS AND DO THEY HAVE 2535 01:40:46,323 --> 01:40:47,558 JUSTIFICATION AND WHAT DO YOU 2536 01:40:47,558 --> 01:40:47,858 THINK? 2537 01:40:47,858 --> 01:40:51,061 WE ALWAYS TRY TO ADDRESS EVERY 2538 01:40:51,061 --> 01:40:52,429 SINGLE POINT THAT THEY ARE 2539 01:40:52,429 --> 01:40:54,131 REQUIRED TO ADDRESS. 2540 01:40:54,131 --> 01:40:55,899 >> I WILL GUESS MAYBE JUST A 2541 01:40:55,899 --> 01:40:57,367 LITTLE FEEDBACK THERE SPEAKING 2542 01:40:57,367 --> 01:40:59,770 ALSO AS A FORMER STUDY SECTION 2543 01:40:59,770 --> 01:41:00,070 CHAIR. 2544 01:41:00,070 --> 01:41:03,774 IT MIGHT NOT BE A BAD IDEA TO 2545 01:41:03,774 --> 01:41:05,776 PROVIDE THROUGH SOME MECHANISMS 2546 01:41:05,776 --> 01:41:07,611 FEEDBACK ON SOME REVIEWS THAT 2547 01:41:07,611 --> 01:41:08,779 START COMING IN. 2548 01:41:08,779 --> 01:41:10,447 THERE IS ALWAYS THE OH, YOU 2549 01:41:10,447 --> 01:41:12,282 HAVEN'T INCLUDED THIS. 2550 01:41:12,282 --> 01:41:14,718 THAT, AGAIN, TENDS TOWARDS MORE 2551 01:41:14,718 --> 01:41:15,152 INFORMATION. 2552 01:41:15,152 --> 01:41:16,753 MORE LIKE FEEDBACK, HEY, YOU 2553 01:41:16,753 --> 01:41:17,454 KNOW WHAT? 2554 01:41:17,454 --> 01:41:19,523 YOU KNOW, YOU COULD FOCUS A 2555 01:41:19,523 --> 01:41:22,092 LITTLE MORE ON THE KEY CRITERIA 2556 01:41:22,092 --> 01:41:24,161 HERE AND NOT GET LOST IN THE 2557 01:41:24,161 --> 01:41:25,963 DETAILS OR THAT TYPE OF HIGHER 2558 01:41:25,963 --> 01:41:28,298 LEVEL FEEDBACK, I THINK, COULD 2559 01:41:28,298 --> 01:41:30,467 POTENTIALLY BE REALLY HELPFUL, 2560 01:41:30,467 --> 01:41:32,603 PARTICULARLY TO EITHER YOUNG 2561 01:41:32,603 --> 01:41:34,871 REVIEWERS OR THOSE SET IN THEIR 2562 01:41:34,871 --> 01:41:35,439 WAYS, I GUESS. 2563 01:41:35,439 --> 01:41:37,541 >> GREAT IMPORTANCE. WE WILL 2564 01:41:37,541 --> 01:41:38,642 TAKE IT INTO CONSIDERATION. 2565 01:41:38,642 --> 01:41:40,877 >> THANK YOU AND JOYCE AND 2566 01:41:40,877 --> 01:41:41,278 [INDISCERNIBLE]. 2567 01:41:41,278 --> 01:41:41,945 >> THANK YOU FOR THAT. 2568 01:41:41,945 --> 01:41:43,680 IT IS NICE TO SEE THAT SOME OF 2569 01:41:43,680 --> 01:41:46,717 THE QUESTIONS ARE COMING OUT 2570 01:41:46,717 --> 01:41:48,685 FROM THE TECHNICAL REVIEWER SIDE 2571 01:41:48,685 --> 01:41:51,088 AND BEING HANDLED BY THE -- BY 2572 01:41:51,088 --> 01:41:54,291 THE SCIENTIFIC REVIEW BOARD. 2573 01:41:54,291 --> 01:41:55,892 I GUESS THE QUESTION KIND OF 2574 01:41:55,892 --> 01:41:59,429 LIKE A FOLLOWUP WHAT DR. CHERRY 2575 01:41:59,429 --> 01:42:00,731 WAS ASKING BECAUSE SINCE NOW THE 2576 01:42:00,731 --> 01:42:03,333 IDEA ABOUT INVESTIGATOR AND 2577 01:42:03,333 --> 01:42:05,435 ENVIRONMENT IS COMING BACK TO 2578 01:42:05,435 --> 01:42:08,805 YOU GUYS EFFECTIVELY, DO YOU -- 2579 01:42:08,805 --> 01:42:10,440 HAS THE THOUGHT PROCESS ABOUT 2580 01:42:10,440 --> 01:42:13,510 HOW TO EVALUATE THAT CHANGED? 2581 01:42:13,510 --> 01:42:15,979 I THINK ABOUT IT IN TERMS OF YOU 2582 01:42:15,979 --> 01:42:18,382 KNOW PROVIDING OPPORTUNITIES FOR 2583 01:42:18,382 --> 01:42:20,584 REALLY NOVEL IDEAS THAT MIGHT 2584 01:42:20,584 --> 01:42:25,155 NOT BE, YOU KNOW, TRADITIONAL 2585 01:42:25,155 --> 01:42:27,491 STATUS QUO OR YOUNG 2586 01:42:27,491 --> 01:42:29,059 INVESTIGATORS WHO, YOU KNOW, 2587 01:42:29,059 --> 01:42:31,261 MIGHT NOT BE KNOWN OR 2588 01:42:31,261 --> 01:42:32,763 INVESTIGATORS THAT PERHAPS HAVE 2589 01:42:32,763 --> 01:42:35,565 NOT MADE NAMES FOR THEMSELVES IN 2590 01:42:35,565 --> 01:42:36,767 THAT PARTICULAR FIELD AND 2591 01:42:36,767 --> 01:42:38,001 PARTICULAR STUDY SECTION AND 2592 01:42:38,001 --> 01:42:40,470 STILL HAVE REALLY GREAT IDEAS 2593 01:42:40,470 --> 01:42:42,472 THAT MIGHT BE PURSUED AND 2594 01:42:42,472 --> 01:42:44,141 THINKING ABOUT HOW NSF OFTEN 2595 01:42:44,141 --> 01:42:48,145 DEALS WITH PROPOSALS THAT GET 2596 01:42:48,145 --> 01:42:49,913 EITHER A VERY STRONG POSITIVE 2597 01:42:49,913 --> 01:42:52,115 REVIEW FROM ONE REVIEWER AND 2598 01:42:52,115 --> 01:42:55,152 VERY STRONG NEGATIVE REVIEW FROM 2599 01:42:55,152 --> 01:42:56,286 ANOTHER REVIEWER ARE USUALLY 2600 01:42:56,286 --> 01:42:57,721 ONES THEY BRING IN AND REALLY 2601 01:42:57,721 --> 01:43:00,557 THINK ABOUT, YOU KNOW, IS THIS A 2602 01:43:00,557 --> 01:43:02,793 NEW OPPORTUNITY TO, YOU KNOW, 2603 01:43:02,793 --> 01:43:06,196 REALLY FUND SOMETHING THAT IS 2604 01:43:06,196 --> 01:43:08,865 UNIQUE AND INDIVIDUAL 2605 01:43:08,865 --> 01:43:11,335 [INDISCERNIBLE] AND SPECIAL 2606 01:43:11,335 --> 01:43:11,635 CAPABILITY. 2607 01:43:11,635 --> 01:43:13,503 >> MAKING SURE THAT 2608 01:43:13,503 --> 01:43:15,172 INVESTIGATORS AND ENVIRONMENTS 2609 01:43:15,172 --> 01:43:17,307 STILL WILL BE REVIEWED BY 2610 01:43:17,307 --> 01:43:20,410 REVIEWER AND WILL NOT RECEIVE A 2611 01:43:20,410 --> 01:43:24,448 SEPARATE SCORE AND TO 2612 01:43:24,448 --> 01:43:26,350 DEEMPHASIZE FAMOUS AND PEOPLE 2613 01:43:26,350 --> 01:43:30,587 WILL FUND THE INSTITUTIONS AND 2614 01:43:30,587 --> 01:43:34,791 EVERY CHANGE HAS THE OFFICE 2615 01:43:34,791 --> 01:43:37,561 EVALUATION AND EVERY CHANGE THEY 2616 01:43:37,561 --> 01:43:40,664 GO BACK AND THEY COLLECT 2617 01:43:40,664 --> 01:43:42,399 INFORMATION AND DATA FROM 2618 01:43:42,399 --> 01:43:44,134 FEEDBACK FROM STUDY SECTION 2619 01:43:44,134 --> 01:43:46,970 MEMBERS AS WELL. 2620 01:43:46,970 --> 01:43:50,073 SO, THERE IS MIKE WHO I HAVE A 2621 01:43:50,073 --> 01:43:54,611 LINK THAT IS INCLUDED AND PUBLIC 2622 01:43:54,611 --> 01:43:59,950 -- THAT IS FEEDBACK TO HIGHER 2623 01:43:59,950 --> 01:44:05,455 UPS AND THEY READ AND LISTEN. 2624 01:44:05,455 --> 01:44:07,657 >> YES. THANK YOU VERY MUCH FOR 2625 01:44:07,657 --> 01:44:09,459 DESCRIBING AND ALL OF THE HARD 2626 01:44:09,459 --> 01:44:10,560 WORK THAT WENT INTO THIS. 2627 01:44:10,560 --> 01:44:14,464 I GUESS I HAVE A FOLLOW-UP 2628 01:44:14,464 --> 01:44:16,333 QUESTION TO WHAT DAN AND ANNE -- 2629 01:44:16,333 --> 01:44:19,035 IT IS MORE KIND OF THE FIRST 2630 01:44:19,035 --> 01:44:22,939 QUESTION OF SHOULD PROPOSED 2631 01:44:22,939 --> 01:44:24,875 RESEARCH PROJECT BE CONDUCTED. 2632 01:44:24,875 --> 01:44:26,743 DEVIL IS IN THE DETAILS. 2633 01:44:26,743 --> 01:44:29,446 HOW DO YOU RECOMMEND GETTING 2634 01:44:29,446 --> 01:44:31,214 SUBJECTIVE OUT OF THAT? 2635 01:44:31,214 --> 01:44:32,716 SOMEBODY MIGHT SAY THAT IS NOT 2636 01:44:32,716 --> 01:44:35,485 WORTH FUNDING AND DO YOU 2637 01:44:35,485 --> 01:44:36,887 RECOMMEND TO THE GRANT WRITER 2638 01:44:36,887 --> 01:44:39,556 THAT THEY USED EVIDENCE THAT IS 2639 01:44:39,556 --> 01:44:41,725 ALIGNED WITH CERTAIN ICS OR I 2640 01:44:41,725 --> 01:44:43,293 GUESS WHAT ARE YOUR THOUGHTS ON 2641 01:44:43,293 --> 01:44:44,027 THAT? 2642 01:44:44,027 --> 01:44:46,797 THAT IS REALLY QUITE SUBJECTIVE, 2643 01:44:46,797 --> 01:44:48,265 I GUESS. AND MORE KIND OF 2644 01:44:48,265 --> 01:44:51,034 INSTRUCTION THAT YOU CAN GIVE TO 2645 01:44:51,034 --> 01:44:52,369 PEOPLE SO THEY UNDERSTAND SO 2646 01:44:52,369 --> 01:44:55,405 THEY ARE NOT JUST MAKING UP 2647 01:44:55,405 --> 01:44:56,306 CRITERIA FOR THAT. 2648 01:44:56,306 --> 01:44:56,840 >> RIGHT. 2649 01:44:56,840 --> 01:44:58,508 >> I UNDERSTAND HOW PROPOSED 2650 01:44:58,508 --> 01:45:00,210 RESEARCH PROJECT COULD BE 2651 01:45:00,210 --> 01:45:01,511 CONDUCTED AND PEOPLE ARE TALKING 2652 01:45:01,511 --> 01:45:03,713 ABOUT METHODS AND PEOPLE CAN 2653 01:45:03,713 --> 01:45:04,214 AGREE ON THAT. 2654 01:45:04,214 --> 01:45:06,750 THE MORE KIND OF IS IT WORTH 2655 01:45:06,750 --> 01:45:09,853 FUNDING THAT TO ME SEEMS VERY 2656 01:45:09,853 --> 01:45:11,221 OPEN AND VAGUE. 2657 01:45:11,221 --> 01:45:13,557 >> YEAH. SO, WE WILL ALLOW 2658 01:45:13,557 --> 01:45:18,228 PEOPLE REVIEWERS TO TALK ABOUT 2659 01:45:18,228 --> 01:45:18,829 FUNDING. 2660 01:45:18,829 --> 01:45:21,064 IT IS YOUR DECISION. 2661 01:45:21,064 --> 01:45:23,800 BUT YEAH. THAT IS -- THAT IS 2662 01:45:23,800 --> 01:45:28,705 WHY IT IS VERY IMPORTANT TO 2663 01:45:28,705 --> 01:45:33,443 FOCUS WHEN SHOULD THIS BE DONE 2664 01:45:33,443 --> 01:45:36,179 BECAUSE YOU HAVE TO EVALUATE IS 2665 01:45:36,179 --> 01:45:37,180 THERE SIGNIFICANCE AND THE 2666 01:45:37,180 --> 01:45:42,285 RESULTS OF OUTCOMES WOULD BE 2667 01:45:42,285 --> 01:45:44,154 SIGNIFICANT. 2668 01:45:44,154 --> 01:45:47,090 IS THIS INNOVATIVE AND SOMETHING 2669 01:45:47,090 --> 01:45:49,359 DONE BEFORE OR REPETITION OR IS 2670 01:45:49,359 --> 01:45:54,498 IT SOMETHING NEW? 2671 01:45:54,498 --> 01:45:55,131 INNOVA 2672 01:45:55,131 --> 01:45:57,400 INNOVATION WE TRAIN AND REMIND 2673 01:45:57,400 --> 01:45:58,468 THEM INNOVATION IS NOT 2674 01:45:58,468 --> 01:45:59,669 PARTICULARLY DOING SOMETHING NEW 2675 01:45:59,669 --> 01:46:00,971 AND IF YOU HAVE -- HAVE 2676 01:46:00,971 --> 01:46:07,544 SOMETHING AND APPLY TO NEW 2677 01:46:07,544 --> 01:46:08,445 QUESTIONS WILL YOU HAVE NEW 2678 01:46:08,445 --> 01:46:12,015 OUTCOME THAT WILL BE CONSIDERED 2679 01:46:12,015 --> 01:46:15,886 INNOVATION AND IS ALWAYS A 2680 01:46:15,886 --> 01:46:17,621 STRUGGLE DEPENDING ON OBJECTIVE 2681 01:46:17,621 --> 01:46:19,189 AND SOME PEOPLE SIGNIFICANT AND 2682 01:46:19,189 --> 01:46:20,423 SOME NOT. 2683 01:46:20,423 --> 01:46:22,759 SO WE ALWAYS TELL YOU THERE 2684 01:46:22,759 --> 01:46:25,529 SHOULDN'T BE A CONSENSUS. 2685 01:46:25,529 --> 01:46:28,131 SO, IF THERE IS A DISAGREEMENT 2686 01:46:28,131 --> 01:46:29,599 IN [INDISCERNIBLE] IT WILL BE 2687 01:46:29,599 --> 01:46:32,035 DISCUSSED AND BE REFLECTED IN 2688 01:46:32,035 --> 01:46:41,478 SUMMARY STATEMENT AND IN PROGRAM 2689 01:46:41,478 --> 01:46:42,178 OFFICE 2690 01:46:42,178 --> 01:46:42,979 OFFICERS SITTING AND LISTENING 2691 01:46:42,979 --> 01:46:45,048 AND THERE WILL BE PROGRAM STUFF 2692 01:46:45,048 --> 01:46:48,184 AND YOU DECIDE ABOUT DECISIONS 2693 01:46:48,184 --> 01:46:52,622 TO [INDISCERNIBLE]. 2694 01:46:52,622 --> 01:46:56,192 >> THANK YOU. KATHY. 2695 01:46:56,192 --> 01:46:58,395 >> THANK YOU. I AGREE. THANK 2696 01:46:58,395 --> 01:47:00,196 YOU FOR ALL OF THE WORK TO PUT 2697 01:47:00,196 --> 01:47:00,864 THIS TOGETHER. 2698 01:47:00,864 --> 01:47:02,866 THESE ARE EXCITING CHANGES THAT 2699 01:47:02,866 --> 01:47:05,869 SHOULD MAKE THE REVIEW PROCESS, 2700 01:47:05,869 --> 01:47:09,205 I THINK, BETTER. 2701 01:47:09,205 --> 01:47:13,176 MY QUESTION IS TIED AROUND THAT 2702 01:47:13,176 --> 01:47:15,011 AND FUND QUESTIONS FROM EARLIER, 2703 01:47:15,011 --> 01:47:16,813 IS THERE AN EFFORT OR INTEREST 2704 01:47:16,813 --> 01:47:19,983 IN QUANTIFYING YOU HAVE GOALS 2705 01:47:19,983 --> 01:47:20,884 THAT MOTIVATED THIS CHANGE. 2706 01:47:20,884 --> 01:47:23,753 IS THERE GOING TO BE ANY 2707 01:47:23,753 --> 01:47:25,622 ANALYSIS OF QUANTITATIVE 2708 01:47:25,622 --> 01:47:26,856 ANALYSIS DID SOMETHING CHANGE? 2709 01:47:26,856 --> 01:47:28,992 DID YOU ACHIEVE GOALS YOU WERE 2710 01:47:28,992 --> 01:47:30,694 AFTER BY MAKING CHANGES? 2711 01:47:30,694 --> 01:47:33,363 WOULD IT BE PUBLISHED AND 2712 01:47:33,363 --> 01:47:33,697 AVAILABLE? 2713 01:47:33,697 --> 01:47:38,468 >> AS I SAID, CSR HAS AN OFFICE 2714 01:47:38,468 --> 01:47:40,437 OF EVALUATION. 2715 01:47:40,437 --> 01:47:43,373 THEY ARE -- THEY WILL BE DOING 2716 01:47:43,373 --> 01:47:47,243 IT AND AFTER A FEW YEARS TO 2717 01:47:47,243 --> 01:47:52,349 COLLECT DATA AND IN TERMS OF 2718 01:47:52,349 --> 01:47:53,483 PUBLICATION I HOPE THEY WILL 2719 01:47:53,483 --> 01:47:55,752 SHARE WITH US AND TELL US IF 2720 01:47:55,752 --> 01:47:57,487 THIS IS PUBLIC INFORMATION WE 2721 01:47:57,487 --> 01:47:58,455 CAN SHARE WITH YOU. 2722 01:47:58,455 --> 01:48:00,457 >> THANK YOU. ALTHOUGH SHE 2723 01:48:00,457 --> 01:48:00,957 CAN'T. 2724 01:48:00,957 --> 01:48:01,257 >> HELLO. 2725 01:48:01,257 --> 01:48:02,158 >> PUT HER. 2726 01:48:02,158 --> 01:48:06,429 >> I WILL PUT HER WHAT DO YOU 2727 01:48:06,429 --> 01:48:08,398 CALL IT, LINK? FOR HER 2728 01:48:08,398 --> 01:48:08,698 QUESTIONS. 2729 01:48:08,698 --> 01:48:12,669 >> RIGHT. I DID. THANK YOU FOR 2730 01:48:12,669 --> 01:48:14,004 GIVING THIS PRESENTATION AND 2731 01:48:14,004 --> 01:48:16,072 WORK YOU ARE DOING AND LOOKING 2732 01:48:16,072 --> 01:48:18,541 AT EVALUATION CRITERIA. MY 2733 01:48:18,541 --> 01:48:21,444 QUESTION IS ABOUT THE 2734 01:48:21,444 --> 01:48:22,479 FELLOWSHIPS. 2735 01:48:22,479 --> 01:48:25,915 PARTICULARLY, REALLY AROUND THE 2736 01:48:25,915 --> 01:48:26,950 CANDIDATE PREPAREDNESS AND 2737 01:48:26,950 --> 01:48:27,283 POTENTIAL. 2738 01:48:27,283 --> 01:48:30,854 I THINK THAT THIS IS SOMETHING 2739 01:48:30,854 --> 01:48:33,056 THAT THERE HAS BEEN TALK AROUND 2740 01:48:33,056 --> 01:48:34,858 WHAT DOES THAT ACTUALLY MEAN? 2741 01:48:34,858 --> 01:48:37,694 HOW DO WE GET AT, I WOULD SAY, 2742 01:48:37,694 --> 01:48:39,629 RIGHT, POTENTIAL, PERHAPS, MORE 2743 01:48:39,629 --> 01:48:42,098 THAN SORT OF THE NUMERICAL 2744 01:48:42,098 --> 01:48:44,601 METRICS OFTEN ASSOCIATED WITH 2745 01:48:44,601 --> 01:48:45,635 PREPAREDNESS AND WONDERED HOW 2746 01:48:45,635 --> 01:48:48,071 YOU ARE THINKING ABOUT THAT OR 2747 01:48:48,071 --> 01:48:51,074 WHAT GUIDANCE WOULD BE GIVEN TO 2748 01:48:51,074 --> 01:48:53,810 REVIEWERS AROUND PARTICULARLY 2749 01:48:53,810 --> 01:48:55,912 FELLOWSHIP APPLICATIONS. 2750 01:48:55,912 --> 01:48:58,748 >> YEAH. THE -- THAT IS A GOOD 2751 01:48:58,748 --> 01:48:59,082 POINT. 2752 01:48:59,082 --> 01:49:01,484 SO I -- WHATEVER I TOLD YOU, IT 2753 01:49:01,484 --> 01:49:02,786 WAS LIKE A BIG OVERVIEW. 2754 01:49:02,786 --> 01:49:06,022 THE MORE DETAILS ARE IN -- ON 2755 01:49:06,022 --> 01:49:07,957 THE WEB PAGE AND ARE COMING AND 2756 01:49:07,957 --> 01:49:14,264 ONE OF THE -- AS YOU SAID, 2757 01:49:14,264 --> 01:49:16,299 QUANTITATIVE QUALITATIVE 2758 01:49:16,299 --> 01:49:19,436 EDUCATION AND IN ONE CHANGE WILL 2759 01:49:19,436 --> 01:49:25,775 BE THAT THE -- THE GRIDS WILL BE 2760 01:49:25,775 --> 01:49:26,042 REMOVED. 2761 01:49:26,042 --> 01:49:27,110 >> YEAH. EXACTLY. 2762 01:49:27,110 --> 01:49:31,247 >> SO THEY WILL NOT BE -- YEAH. 2763 01:49:31,247 --> 01:49:37,153 >> THAT WILL BE ONE THING THAT 2764 01:49:37,153 --> 01:49:41,958 WILL HOPEFULLY HELP. AGAIN, THE 2765 01:49:41,958 --> 01:49:46,496 GOAL IS TO DEFAMIZE ENVIRONMENT 2766 01:49:46,496 --> 01:49:49,866 AND EMPHASIZE SPONSORS AND 2767 01:49:49,866 --> 01:49:54,070 CONSIDER WHAT HAS HAPPENED 2768 01:49:54,070 --> 01:49:55,371 BEFORE AND SOMEBODY MIGHT HAVE 2769 01:49:55,371 --> 01:49:57,373 SOMETHING IN THEIR LIFE AND 2770 01:49:57,373 --> 01:50:00,677 PARTICULARLY FOCUSING ON 2771 01:50:00,677 --> 01:50:04,280 PRESENTED RESEARCH TRAINING PLAN 2772 01:50:04,280 --> 01:50:06,783 FOR CANDIDATE AND TRAINING PLAN 2773 01:50:06,783 --> 01:50:08,952 AND NO THE THAT IS SOMETHING 2774 01:50:08,952 --> 01:50:10,286 THAT SOMEBODY KNOWS AND WHATEVER 2775 01:50:10,286 --> 01:50:14,758 IS PRESENTED FOR THIS PARTICULAR 2776 01:50:14,758 --> 01:50:15,125 CANDIDATE. 2777 01:50:15,125 --> 01:50:17,460 >> THANK YOU. 2778 01:50:17,460 --> 01:50:22,832 >> >> THANK YOU, CYNTHIA. JILL 2779 01:50:22,832 --> 01:50:26,603 IS REMINDING ME THAT DATA WAS 2780 01:50:26,603 --> 01:50:27,904 PUBLISHED, THE REDACTION. 2781 01:50:27,904 --> 01:50:32,242 WE WILL GET IT TO YOU. 2782 01:50:32,242 --> 01:50:36,112 PART OF IT WAS HARD TO 2783 01:50:36,112 --> 01:50:40,250 SUCCESSFULLY REDACT. CYNTHIA? 2784 01:50:40,250 --> 01:50:42,886 >> THANK YOU FOR YOUR WORK ON 2785 01:50:42,886 --> 01:50:44,287 THIS REALLY IMPORTANT 2786 01:50:44,287 --> 01:50:44,587 INITIATIVE. 2787 01:50:44,587 --> 01:50:46,823 I WAS WONDERING IF YOU HAVE 2788 01:50:46,823 --> 01:50:48,424 STRATEGY ON A KIND OF DIFFICULT 2789 01:50:48,424 --> 01:50:52,862 PROBLEM SOMETIMES DURING REVIEW, 2790 01:50:52,862 --> 01:50:54,464 REVIEWERS DISCUSSION AND 2791 01:50:54,464 --> 01:50:55,965 BRINGING UP THE DISCUSSION THAT 2792 01:50:55,965 --> 01:50:57,600 GOES KIND OF ON A DIRECTION THAT 2793 01:50:57,600 --> 01:51:00,937 WASN'T IN THE ORIGINAL REVIEW 2794 01:51:00,937 --> 01:51:01,738 DOCUMENTS. 2795 01:51:01,738 --> 01:51:04,240 AND THE SCORE CHANGES 2796 01:51:04,240 --> 01:51:05,775 CONSIDERABLY AND REVIEWERS ARE 2797 01:51:05,775 --> 01:51:09,012 ASKED TO -- I DON'T HEAR YOU. 2798 01:51:09,012 --> 01:51:10,079 CAN YOU SPEAK INTO -- 2799 01:51:10,079 --> 01:51:15,318 >> I'M SORRY REVIEWERS 2800 01:51:15,318 --> 01:51:17,520 DISCUSSION CHANGES AND SCORES 2801 01:51:17,520 --> 01:51:19,622 CHANGE DRAMATICALLY FROM INITIAL 2802 01:51:19,622 --> 01:51:21,925 SCORES AND REVIEWERS ARE ASKED 2803 01:51:21,925 --> 01:51:24,594 TO GO CHANGE THEIR WRITTEN 2804 01:51:24,594 --> 01:51:24,994 COMMENTS. 2805 01:51:24,994 --> 01:51:26,162 IT DOESN'T ALWAYS HAPPEN. 2806 01:51:26,162 --> 01:51:28,965 THEN YOU HAVE A SCORE AND REVIEW 2807 01:51:28,965 --> 01:51:33,670 AND WRITTEN REVIEWS THAT CARRY 2808 01:51:33,670 --> 01:51:34,003 DISCREPANCY. 2809 01:51:34,003 --> 01:51:36,406 DO YOU HAVE STRATEGIES HOW TO 2810 01:51:36,406 --> 01:51:37,574 ADDRESS THAT? 2811 01:51:37,574 --> 01:51:40,009 >> I AM DIRECTOR OF NIBIB. 2812 01:51:40,009 --> 01:51:41,511 I DO HAVE STRATEGIES. 2813 01:51:41,511 --> 01:51:44,347 WHEN WE READ AND I SEE THERE IS 2814 01:51:44,347 --> 01:51:47,617 SOMEBODY THAT GIVES SCORE EVEN 3 2815 01:51:47,617 --> 01:51:50,153 AND NO WEAKNESSES, PLEASE GIVE 2816 01:51:50,153 --> 01:51:52,055 US WHAT IS THE REASON AND WHY 3 2817 01:51:52,055 --> 01:51:54,457 IS -- 3 AND THERE IS -- AND YOU 2818 01:51:54,457 --> 01:51:57,160 ARE UNHAPPY AND YOU ARE 2819 01:51:57,160 --> 01:51:58,895 UNSATISFIED AND WHERE IS THE 2820 01:51:58,895 --> 01:51:59,229 WEAKNESSES? 2821 01:51:59,229 --> 01:52:01,030 I WILL TELL REVIEWERS TO IMAGINE 2822 01:52:01,030 --> 01:52:02,832 YOU ARE IN -- YOU RECEIVE A 2823 01:52:02,832 --> 01:52:04,901 SCORE AND YOU ARE NOT SUCCESSFUL 2824 01:52:04,901 --> 01:52:07,837 AND HOW ARE YOU GOING TO ADDRESS 2825 01:52:07,837 --> 01:52:09,606 AND HOW WILL YOU FIX THIS IF YOU 2826 01:52:09,606 --> 01:52:12,041 DON'T GIVE -- YOU ARE NOT GIVEN 2827 01:52:12,041 --> 01:52:12,709 FEEDBACK? 2828 01:52:12,709 --> 01:52:15,645 SO WE DO HAVE STRATEGIES. 2829 01:52:15,645 --> 01:52:18,248 I CANNOT ANSWER FOR SATISFACTION 2830 01:52:18,248 --> 01:52:19,649 AND WHEN SOMEBODY BRINGS 2831 01:52:19,649 --> 01:52:21,584 ATTENTION TO THEM, THEY SAY WE 2832 01:52:21,584 --> 01:52:24,020 HAVE LOTS OF APPLICATIONS AND 2833 01:52:24,020 --> 01:52:25,855 CAN'T UPLOAD -- YOU KNOW, REACH 2834 01:52:25,855 --> 01:52:28,391 OUT TO EVERY REVIEWER. 2835 01:52:28,391 --> 01:52:29,826 SO, THAT IS IT. 2836 01:52:29,826 --> 01:52:33,229 I CAN'T DO THAT FOR THEM BUT WE 2837 01:52:33,229 --> 01:52:35,031 HAVE STRATEGY AND WE -- YOU 2838 01:52:35,031 --> 01:52:39,035 WON'T SEE IN OUR SUMMARY 2839 01:52:39,035 --> 01:52:39,369 STATEMENT. 2840 01:52:39,369 --> 01:52:41,070 >> THANK YOU. WE WILL CONCLUDE 2841 01:52:41,070 --> 01:52:43,506 THEN WITH THE QUESTIONS. 2842 01:52:43,506 --> 01:52:46,676 THANK YOU, MAN ANA. 2843 01:52:46,676 --> 01:52:47,410 >> THANK YOU. 2844 01:52:47,410 --> 01:52:50,380 >> AND COUNCIL MEMBERS FOR YOUR 2845 01:52:50,380 --> 01:52:51,314 EXCELLENT QUESTIONS. 2846 01:52:51,314 --> 01:52:51,848 >> AUDIENCE: [APPLAUSE]. 2847 01:52:51,848 --> 01:52:54,150 >> AT THIS TIME WE ARE SCHEDULED 2848 01:52:54,150 --> 01:52:55,051 FOR A BREAK. 2849 01:52:55,051 --> 01:52:58,454 LET'S BREAK FOR 30 MINUTES AS 2850 01:52:58,454 --> 01:53:02,892 PLANNED AND RECONVENE AT 11:30. 2851 01:53:02,892 --> 01:53:09,656 THANK YOU! 2852 01:53:09,656 --> 01:53:19,199 THE RIGHT ONE. ALL RIGHT. 2853 01:53:19,199 --> 01:53:20,000 >> AUDIENCE: [APPLAUSE]. 2854 01:53:20,000 --> 01:53:21,935 >> THIS ONE IS PARTICULARLY 2855 01:53:21,935 --> 01:53:24,004 DIFFICULT FOR ME. I BELIEVE 2856 01:53:24,004 --> 01:53:26,573 GILDA AND I HAVE BEEN ON SOME 2857 01:53:26,573 --> 01:53:29,343 KIND OF COUNCIL OR ADVISORY 2858 01:53:29,343 --> 01:53:32,179 BOARD FOR MAYBE LIKE 10 YEARS IN 2859 01:53:32,179 --> 01:53:36,617 A ROW, SO, YOU ARE ALWAYS ON 2860 01:53:36,617 --> 01:53:45,125 CALL TO COUNCIL. GILDA 2861 01:53:45,125 --> 01:53:45,559 HARABINO. 2862 01:53:45,559 --> 01:53:46,360 >> AUDIENCE: [APPLAUSE]. 2863 01:53:46,360 --> 01:53:56,904 >> OH, I'M GETTING -- I WANT TO 2864 01:54:04,912 --> 01:54:07,981 MENTION, BRUCE, OWL TRADITION IS 2865 01:54:07,981 --> 01:54:11,184 TO SAY GOOD-BYE AT MAY COUNCIL 2866 01:54:11,184 --> 01:54:13,086 DEPARTING MEMBERS KINDLY AGREED 2867 01:54:13,086 --> 01:54:14,855 TO CONTINUE SHOULD THE NEXT 2868 01:54:14,855 --> 01:54:16,490 CLASS BE NOT APPOINTED IN TIME. 2869 01:54:16,490 --> 01:54:19,326 IT SEEMS TO BE A TRADITION. 2870 01:54:19,326 --> 01:54:19,893 THANK YOU. 2871 01:54:19,893 --> 01:54:20,527 >> NO. 2872 01:54:20,527 --> 01:54:23,997 >> THANK YOU SO MUCH. 2873 01:54:23,997 --> 01:54:24,731 >> AUDIENCE: [LAUGHING]. 2874 01:54:24,731 --> 01:54:28,602 >> THERE IS A MYSTERY TO THAT 2875 01:54:28,602 --> 01:54:30,571 PROCESS THAT NONE OF US TRULY 2876 01:54:30,571 --> 01:54:31,939 UNDERSTAND. WE KNOW IT IS 2877 01:54:31,939 --> 01:54:32,906 ALWAYS THE WAY. 2878 01:54:32,906 --> 01:54:35,075 STICKING WITH THAT, WE WILL SEE 2879 01:54:35,075 --> 01:54:38,645 YOU AT NEXT COUNCIL. 2880 01:54:38,645 --> 01:54:40,280 THANK YOU SO MUCH. 2881 01:54:40,280 --> 01:54:42,983 NOW IS A GREAT TIME, ALSO, FOR 2882 01:54:42,983 --> 01:54:47,020 ME TO WELCOME NEW NIBIB STAFF. 2883 01:54:47,020 --> 01:54:49,790 YOU KNOW, OUR NEW STAFF IS JUST 2884 01:54:49,790 --> 01:54:50,123 INCREDIBLE. 2885 01:54:50,123 --> 01:54:53,794 THEY ARE -- THEY ARE REFLECTIVE 2886 01:54:53,794 --> 01:54:55,062 OF EXCELLENCE OF OUR EXISTING 2887 01:54:55,062 --> 01:54:57,064 STAFF. I WILL GO THROUGH EACH 2888 01:54:57,064 --> 01:54:58,031 ONE VERY BRIEFLY. 2889 01:54:58,031 --> 01:55:00,434 IF YOU COULD JUST STAND AND WAVE 2890 01:55:00,434 --> 01:55:03,203 AND, YOU KNOW, WE WILL THANK YOU 2891 01:55:03,203 --> 01:55:06,106 FOR COMING ON BOARD. 2892 01:55:06,106 --> 01:55:08,241 MARTIN, I WILL SAY A FEW WORDS 2893 01:55:08,241 --> 01:55:10,577 ABOUT EVERYONE BRIEFLY. 2894 01:55:10,577 --> 01:55:13,747 MARTIN? 2895 01:55:13,747 --> 01:55:15,716 MAR CONTINUE WAS PREVIOUSLY 2896 01:55:15,716 --> 01:55:19,286 ASSOCIATE PROFESSOR OF 2897 01:55:19,286 --> 01:55:20,887 BIOMEDICAL ENGINEERING AT DUKE 2898 01:55:20,887 --> 01:55:23,156 AND HAS ALL EXPERIENCE IN 2899 01:55:23,156 --> 01:55:24,758 IMAGING INTERSECTING WITH MARTIN 2900 01:55:24,758 --> 01:55:26,560 OVER COURSE OF OUR YEARS IF YOU 2901 01:55:26,560 --> 01:55:30,130 HAVE BEEN IN IMAGING HE DOES 2902 01:55:30,130 --> 01:55:34,935 NUCLEAR AND X-RAY-BASED IMAGING 2903 01:55:34,935 --> 01:55:38,171 AND PET RI AND COMBINATION AND 2904 01:55:38,171 --> 01:55:40,741 IN COMBINED MODALITIES AND IS AN 2905 01:55:40,741 --> 01:55:43,343 ENTREPRENEUR AND START-UP IN CT 2906 01:55:43,343 --> 01:55:45,979 IMAGING AND BREAST CANCER AND 2907 01:55:45,979 --> 01:55:51,018 ONE AREA OF EXPERTISE AND MARTIN 2908 01:55:51,018 --> 01:55:54,154 TRAINED WITH JERRY IN THE UCLA 2909 01:55:54,154 --> 01:55:57,524 DAYS AT CRUMP INSTITUTE THAT I 2910 01:55:57,524 --> 01:55:59,993 HAD A CHANCE TO VISIT A FEW 2911 01:55:59,993 --> 01:56:00,994 TIMES. 2912 01:56:00,994 --> 01:56:06,466 WELCOME. WE ARE SO GLAD TO HAVE 2913 01:56:06,466 --> 01:56:06,867 YOU. 2914 01:56:06,867 --> 01:56:09,102 >> AUDIENCE: [APPLAUSE]. 2915 01:56:09,102 --> 01:56:14,341 >> NEXT PERSON I WOULD LIKE TO 2916 01:56:14,341 --> 01:56:16,877 INTRODUCE TODAY IS 2917 01:56:16,877 --> 01:56:18,011 [INDISCERNIBLE] A GRANTS 2918 01:56:18,011 --> 01:56:21,114 SPECIALIST IN OFFICE OF GRANTS 2919 01:56:21,114 --> 01:56:24,017 MANAGEMENT WHO HAS ENORMOUS 2920 01:56:24,017 --> 01:56:25,986 LEADERSHIP AND EXPERTISE IN THAT 2921 01:56:25,986 --> 01:56:29,122 AREA THAT WAS BUILT BEING A 2922 01:56:29,122 --> 01:56:31,391 SUPERVISOR TEAM LEAD AT NCI AND 2923 01:56:31,391 --> 01:56:34,227 SHE MANAGED AN OPERATION THAT 2924 01:56:34,227 --> 01:56:37,130 INCLUDED THINGS LIKE NCI'S 2925 01:56:37,130 --> 01:56:39,232 CANCER MOONSHOT AND PROGRAMS 2926 01:56:39,232 --> 01:56:43,036 RELATED TO THAT AND PRIOR THAT A 2927 01:56:43,036 --> 01:56:46,907 LEAD GRANT SPECIALIST AT NYA. 2928 01:56:46,907 --> 01:56:51,011 HER EDUCATION IS REALLY 2929 01:56:51,011 --> 01:56:51,411 IMPRESSIVE. 2930 01:56:51,411 --> 01:56:54,014 SHE HAS BACKGROUND WITH A 2931 01:56:54,014 --> 01:56:56,016 BACHELORS IN BEHAVIORAL SOCIAL 2932 01:56:56,016 --> 01:56:58,318 SCIENCE FROM UNIVERSITY OF 2933 01:56:58,318 --> 01:57:00,954 MARYLAND AND MASTERS IN PUBLIC 2934 01:57:00,954 --> 01:57:02,889 ADMINISTRATION FROM GEORGE 2935 01:57:02,889 --> 01:57:03,323 MASON. 2936 01:57:03,323 --> 01:57:05,926 SHE HAS ALSO COMPLETED MID-LEVEL 2937 01:57:05,926 --> 01:57:10,430 NIH EXECUTIVE TRAINING PROGRAM. 2938 01:57:10,430 --> 01:57:11,131 WELCOME. 2939 01:57:11,131 --> 01:57:14,634 >> AUDIENCE: [APPLAUSE]. 2940 01:57:14,634 --> 01:57:18,238 >> JENNA HARRISON PETERS, IS 2941 01:57:18,238 --> 01:57:19,039 JENNA HERE? 2942 01:57:19,039 --> 01:57:20,173 >> I DON'T THINK SO. 2943 01:57:20,173 --> 01:57:24,044 >> POSSIBLY IN THE OTHER ROOM? 2944 01:57:24,044 --> 01:57:24,778 OKAY. BUT. 2945 01:57:24,778 --> 01:57:25,145 >> ZOOM. 2946 01:57:25,145 --> 01:57:28,148 >> SHE IS ON ZOOM, TERRIFIC. 2947 01:57:28,148 --> 01:57:31,685 JENNA, IF ON ZOOM, STAND UP. 2948 01:57:31,685 --> 01:57:32,652 >> SHE IS ON. 2949 01:57:32,652 --> 01:57:35,322 >> JENNA HAS TAKEN ON POSITION 2950 01:57:35,322 --> 01:57:37,357 AS GRANT MANAGEMENT SPECIALIST 2951 01:57:37,357 --> 01:57:39,426 AND AGAIN OFFICE OF GRANTS 2952 01:57:39,426 --> 01:57:39,726 MANAGEMENT. 2953 01:57:39,726 --> 01:57:41,828 SHE HAD A POSITION THAT WAS 2954 01:57:41,828 --> 01:57:45,098 SIMILAR TO THIS FOR TWO YEARS AT 2955 01:57:45,098 --> 01:57:50,637 NIAD THAT I UNDERSKO R -- 2956 01:57:50,637 --> 01:57:53,740 UNDERSCORE IS SECOND OR BIGGEST 2957 01:57:53,740 --> 01:57:56,309 DEPENDING HOW YOU COUNT NIH 2958 01:57:56,309 --> 01:57:58,945 INSTITUTES AND IS CONCENTRATED 2959 01:57:58,945 --> 01:58:01,148 IN A MORE I GUESS LESS 2960 01:58:01,148 --> 01:58:02,649 WELL-FUNDED BUT VERY COHERENT 2961 01:58:02,649 --> 01:58:04,317 AND COLLABORATIVE INSTITUTE. WE 2962 01:58:04,317 --> 01:58:06,419 ARE SO GLAD TO HAVE HER ON 2963 01:58:06,419 --> 01:58:06,653 BOARD. 2964 01:58:06,653 --> 01:58:09,256 SHE BRINGS A REALLY INTERESTING 2965 01:58:09,256 --> 01:58:09,556 BACKGROUND. 2966 01:58:09,556 --> 01:58:11,992 HER MASTERS IS IN PUBLIC HEALTH 2967 01:58:11,992 --> 01:58:14,494 AND EPIDEMIOLOGY FROM THE 2968 01:58:14,494 --> 01:58:15,729 UNIVERSITY OF MARYLAND. 2969 01:58:15,729 --> 01:58:18,965 SHE HAS BEEN A PATHWAY'S INTERN 2970 01:58:18,965 --> 01:58:24,004 AT NIHNIAD. 2971 01:58:24,004 --> 01:58:26,406 LET'S WELCOME JENNA. 2972 01:58:26,406 --> 01:58:27,007 FINALLY, JOSH. 2973 01:58:27,007 --> 01:58:30,610 WILL YOU HAVE TO HELP ME WITH 2974 01:58:30,610 --> 01:58:32,179 YOUR LAST NAME. 2975 01:58:32,179 --> 01:58:34,181 OKAY. IT IS JUST LIKE IT IS 2976 01:58:34,181 --> 01:58:34,447 SPELLED. 2977 01:58:34,447 --> 01:58:36,116 IT IS REALLY EASY. 2978 01:58:36,116 --> 01:58:38,385 HE IS A GRANTS MANAGEMENT 2979 01:58:38,385 --> 01:58:42,155 SPECIALIST AT NIBIB. YOU SHOULD 2980 01:58:42,155 --> 01:58:44,791 BE HAPPY WE ARE HIRING GRANTS 2981 01:58:44,791 --> 01:58:45,992 MANAGEMENT SPECIALISTS. 2982 01:58:45,992 --> 01:58:47,928 THIS IS A GOOD SIGN. 2983 01:58:47,928 --> 01:58:50,163 THEY ARE SO EXPERIENCED AND 2984 01:58:50,163 --> 01:58:52,332 TALENTED AND STARTED FEDERAL 2985 01:58:52,332 --> 01:58:56,336 CAREER AT NIH AT NIAD IN 2020. 2986 01:58:56,336 --> 01:58:59,439 HE HAD PRIOR GOVERNMENT 2987 01:58:59,439 --> 01:59:01,141 EXPERIENCE IN DEPARTMENT OF 2988 01:59:01,141 --> 01:59:03,009 HOMELAND SECURITY AND THAT IS 2989 01:59:03,009 --> 01:59:04,811 ALWAYS A REALLY INTERESTING 2990 01:59:04,811 --> 01:59:06,346 PLACE TO WORK AND I'M LOOKING 2991 01:59:06,346 --> 01:59:08,048 FORWARD TO HEARING STORIES ABOUT 2992 01:59:08,048 --> 01:59:11,051 THAT WHERE HE WAS A TEAM LEAD 2993 01:59:11,051 --> 01:59:12,919 AND FINANCIAL ANALYST AND AGAIN 2994 01:59:12,919 --> 01:59:14,921 REALLY INCREDIBLE TRAINING. 2995 01:59:14,921 --> 01:59:17,390 WAS AN UNDERGRADUATE AT 2996 01:59:17,390 --> 01:59:19,526 UNIVERSITY OF MARYLAND AND 2997 01:59:19,526 --> 01:59:21,928 BACHELOR BS IS IN COMPUTER 2998 01:59:21,928 --> 01:59:22,796 INFORMATION TECHNOLOGY AND 2999 01:59:22,796 --> 01:59:25,198 GRADUATE EDUCATION AN MBA FROM 3000 01:59:25,198 --> 01:59:27,133 UNIVERSITY OF MARYLAND AND SO 3001 01:59:27,133 --> 01:59:29,202 GLAD TO WELCOME YOU HERE AND 3002 01:59:29,202 --> 01:59:35,842 BRING THAT EXPERTISE TO OUR 3003 01:59:35,842 --> 01:59:36,443 COMMUN 3004 01:59:36,443 --> 01:59:37,577 COMMUNITY. 3005 01:59:37,577 --> 01:59:39,946 IN THE BUILD, I DON'T HAVE ROOM 3006 01:59:39,946 --> 01:59:43,617 FOR ALL OF THE PICTURES OF ALL 3007 01:59:43,617 --> 01:59:47,287 OUR CORE, OUR STAFF AND EVERYONE 3008 01:59:47,287 --> 01:59:49,189 INVOLVED IN ALL OF OUR DIFFERENT 3009 01:59:49,189 --> 01:59:49,489 OFFICES. 3010 01:59:49,489 --> 01:59:53,026 THIS IS TO REMIND YOU THAT WHEN 3011 01:59:53,026 --> 01:59:57,664 YOU HAVE FOUR MAJOR DIVISIONS I 3012 01:59:57,664 --> 01:59:58,899 WAS MYSTIFIED BY STRUCTURE AND 3013 01:59:58,899 --> 02:00:00,200 WHERE IS EVERYBODY GOING AND HOW 3014 02:00:00,200 --> 02:00:02,836 ARE ALL OF THE OFFICES AND 3015 02:00:02,836 --> 02:00:05,038 GROUPS THAT ARE INTERCONNECTED 3016 02:00:05,038 --> 02:00:06,706 AND OFFICE OF RESEARCH AND 3017 02:00:06,706 --> 02:00:08,575 ADMINISTRATION AND OFFICE OF 3018 02:00:08,575 --> 02:00:11,978 ADMINISTRATIVE MANAGEMENT AND 3019 02:00:11,978 --> 02:00:14,848 EXTRAMURAL PROGRAM AND 3020 02:00:14,848 --> 02:00:16,149 INTRAMURAL RESEARCH PROGRAM. 3021 02:00:16,149 --> 02:00:18,251 THANKS TO ALL OF YOU. I WON'T 3022 02:00:18,251 --> 02:00:19,653 MAKE YOU ALL STAND BUT LET'S 3023 02:00:19,653 --> 02:00:23,990 GIVE A ROUND OF APPLAUSE FOR OUR 3024 02:00:23,990 --> 02:00:25,926 COMMUNITY. 3025 02:00:25,926 --> 02:00:29,129 ONE ANNOUNCEMENT THAT PROBABLY 3026 02:00:29,129 --> 02:00:31,064 EVERYONE SAW AND I DO WANT TO 3027 02:00:31,064 --> 02:00:35,201 REALLY RE-ENFORCE THE 3028 02:00:35,201 --> 02:00:36,569 CONGRATULATIONS HERE. 3029 02:00:36,569 --> 02:00:38,872 OUR COUNCIL MEMBER WAS ELECTED 3030 02:00:38,872 --> 02:00:40,874 IN THIS RECENT CLASS TO NATIONAL 3031 02:00:40,874 --> 02:00:47,080 ACADEMY OF ENGINEERING AND BROWN 3032 02:00:47,080 --> 02:00:50,917 DEAN OF ENGINEERING AND NIBIB 3033 02:00:50,917 --> 02:00:53,053 COUNCIL MEMBER. HER CITATION 3034 02:00:53,053 --> 02:00:54,421 FOR HER ELECTION AND 3035 02:00:54,421 --> 02:00:57,223 DISTINGUISHED CONTRIBUTIONS TO 3036 02:00:57,223 --> 02:00:59,292 ENGINEERING OR NANOFABRICATED 3037 02:00:59,292 --> 02:01:03,730 MATERIALS TO CONTROL BIOLOGICS 3038 02:01:03,730 --> 02:01:06,132 DELIVERY AND LEADERSHIP IN FIELD 3039 02:01:06,132 --> 02:01:08,902 OF [INDISCERNIBLE]. 3040 02:01:08,902 --> 02:01:09,302 CONGRATULATIONS. 3041 02:01:09,302 --> 02:01:11,204 >> THANK YOU. SORRY I COULDN'T 3042 02:01:11,204 --> 02:01:13,173 BE THERE. I MISS YOU ALL. 3043 02:01:13,173 --> 02:01:15,241 >> WE DO MISS YOU AND HOPE TO 3044 02:01:15,241 --> 02:01:17,477 SEE YOU IN SEPTEMBER. 3045 02:01:17,477 --> 02:01:18,311 >> ABSOLUTELY. 3046 02:01:18,311 --> 02:01:18,578 >> YEAH. 3047 02:01:18,578 --> 02:01:21,114 >> MULTIPLE PLACES, EXACTLY. 3048 02:01:21,114 --> 02:01:22,615 >> YEAH. YEAH. 3049 02:01:22,615 --> 02:01:25,385 SO JUST TO -- EVERYONE, OF 3050 02:01:25,385 --> 02:01:27,120 COURSE, IS FAMILIAR WITH THE 3051 02:01:27,120 --> 02:01:29,656 FINAL PASSING OF THE FEDERAL 3052 02:01:29,656 --> 02:01:29,889 BUDGET. 3053 02:01:29,889 --> 02:01:33,727 AND JUST A FEW POINTS TO 3054 02:01:33,727 --> 02:01:34,027 HIGHLIGHT. 3055 02:01:34,027 --> 02:01:35,962 OF COURSE, THERE WAS EFFECTIVELY 3056 02:01:35,962 --> 02:01:38,598 NO CHANGE AND ACROSS THE FEDERAL 3057 02:01:38,598 --> 02:01:41,901 BUDGET, NO CHANGE WITH NIBIB 3058 02:01:41,901 --> 02:01:42,168 BUDGET. 3059 02:01:42,168 --> 02:01:44,237 WE HAD TO SPEND ALL OF THAT TIME 3060 02:01:44,237 --> 02:01:46,072 THEN FIGURING OUT HOW TO LOCK IN 3061 02:01:46,072 --> 02:01:47,507 ON THE PAY LINE. 3062 02:01:47,507 --> 02:01:50,176 PAY LINE FOR THE PARENT RO1S, 3063 02:01:50,176 --> 02:01:51,845 JUST TO RE-ENFORCE THIS, I THINK 3064 02:01:51,845 --> 02:01:54,047 THAT MANY OF YOU MAY KNOW 3065 02:01:54,047 --> 02:01:56,282 ALREADY THAT IT IS 16 3066 02:01:56,282 --> 02:01:56,583 PERCENTILE. 3067 02:01:56,583 --> 02:02:00,353 THIS INCREASES WITH NEW 3068 02:02:00,353 --> 02:02:02,422 INVESTIGATORS THIS YEAR ONLY TO 3069 02:02:02,422 --> 02:02:05,859 21 PERCENTILE AND 29 PERCENTILE 3070 02:02:05,859 --> 02:02:07,527 FOR EARLY-STAGE INVESTIGATORS 3071 02:02:07,527 --> 02:02:10,163 THAT IS, AGAIN, THIS YEAR ONLY. 3072 02:02:10,163 --> 02:02:12,098 THESE PAY LINES ARE REALLY 3073 02:02:12,098 --> 02:02:15,135 STRUCTURED IN ORDER TO SORT OF 3074 02:02:15,135 --> 02:02:17,203 DRIVE TWO MAJOR PHILOSOPHICAL 3075 02:02:17,203 --> 02:02:17,771 POINTS. 3076 02:02:17,771 --> 02:02:21,041 WE WANT TO SUSTAIN COMPETING 3077 02:02:21,041 --> 02:02:22,842 RO1S ABOUT SAME LEVEL THEY HAVE 3078 02:02:22,842 --> 02:02:25,945 BEEN OVER SEVERAL YEARS NOW. 3079 02:02:25,945 --> 02:02:27,881 ULTIMATELY WHEN WE ANNOUNCE 3080 02:02:27,881 --> 02:02:30,150 FINAL NUMBERS OF R01S WE ARE 3081 02:02:30,150 --> 02:02:31,985 CONFIDENT THEY WILL BE ABOUT THE 3082 02:02:31,985 --> 02:02:34,054 SAME IF THEY WERE LAST YEAR AND 3083 02:02:34,054 --> 02:02:36,890 PREVIOUS YEAR AND DIDN'T WANT TO 3084 02:02:36,890 --> 02:02:37,791 JEOPARDIZE THAT. 3085 02:02:37,791 --> 02:02:39,125 SECOND, SOMETHING THAT HAS BEEN 3086 02:02:39,125 --> 02:02:41,294 OBSERVED ACROSS THE NIH AS 3087 02:02:41,294 --> 02:02:43,329 FUNDING LEVELS ARE MORE 3088 02:02:43,329 --> 02:02:44,664 DIFFICULT TO GET AND DRAW EARLY 3089 02:02:44,664 --> 02:02:48,034 STAGE INVESTIGATORS TEND TO 3090 02:02:48,034 --> 02:02:49,436 SUFFER THE MOST. 3091 02:02:49,436 --> 02:02:51,071 WE WANT TO CONSERVE GRANTS 3092 02:02:51,071 --> 02:02:53,940 ISSUED TO ESIS AND WHY WE WENT 3093 02:02:53,940 --> 02:02:57,077 UP TO 29TH PERCENTILE FOR ESIS 3094 02:02:57,077 --> 02:02:58,711 AND ONLY THIS YEAR AND 3095 02:02:58,711 --> 02:02:59,712 REFLECTING THE FACT THAT THESE 3096 02:02:59,712 --> 02:03:01,581 NUMBERS ARE NOT WRITTEN IN STONE 3097 02:03:01,581 --> 02:03:03,883 BUT DESIGNED TO HELP SUPPORT 3098 02:03:03,883 --> 02:03:05,185 WHAT WE BELIEVE FROM YOUR 3099 02:03:05,185 --> 02:03:06,619 FEEDBACK AND INTERACTING WITH 3100 02:03:06,619 --> 02:03:08,521 THE COMMUNITY AND WHAT THE 3101 02:03:08,521 --> 02:03:10,023 COMMUNITY NEEDS THE MOST. 3102 02:03:10,023 --> 02:03:12,225 TO KIND OF DO THAT, YOU KNOW, 3103 02:03:12,225 --> 02:03:16,496 THIS IS A CONSERVATION OF ENERGY 3104 02:03:16,496 --> 02:03:17,964 CONSERVATION AND MASS PROBLEM. 3105 02:03:17,964 --> 02:03:20,366 WE HAD TO MAKE ADMINISTRATIVE 3106 02:03:20,366 --> 02:03:20,767 CUTS. 3107 02:03:20,767 --> 02:03:23,036 THE ADMINISTRATIVE CUTS WE 3108 02:03:23,036 --> 02:03:26,673 INVOKED RUN LIKE PRIOR YEARS IN 3109 02:03:26,673 --> 02:03:28,708 BUDGET TIMES AND YOU WILL SEE 3110 02:03:28,708 --> 02:03:30,143 PRECEDENT FOR THESE AND ALSO 3111 02:03:30,143 --> 02:03:31,911 FROM OTHER INSTITUTES. 3112 02:03:31,911 --> 02:03:35,115 SO THAT IS 24% TO R01S THAT WILL 3113 02:03:35,115 --> 02:03:38,818 GO TO NON-ESIS WITH NON-MODULAR 3114 02:03:38,818 --> 02:03:40,720 BUDGETS THAT IS KIND OF SOMEWHAT 3115 02:03:40,720 --> 02:03:43,723 CODE LANGUAGE FOR LARGEST BUDGET 3116 02:03:43,723 --> 02:03:46,893 R01S FROM MOST EXPERIENCE AND 3117 02:03:46,893 --> 02:03:48,228 SUCCESSFUL INVESTIGATORS AND 15% 3118 02:03:48,228 --> 02:03:50,663 TO U0 ONES THAT ARE 3119 02:03:50,663 --> 02:03:52,799 BIOENGINEERING PARTNERSHIPS WITH 3120 02:03:52,799 --> 02:03:56,703 INDUSTRY AND BPI AWARDS AND 10% 3121 02:03:56,703 --> 02:03:59,239 TO K4 ONES IN FIRST YEAR ONLY 3122 02:03:59,239 --> 02:04:02,008 AND SUBSEQUENT YEARS THAT CUT 3123 02:04:02,008 --> 02:04:04,677 DISAPPEARS AND 10% TO R2 ONES 3124 02:04:04,677 --> 02:04:07,113 THAT ARE IN THE PARENT. 3125 02:04:07,113 --> 02:04:10,517 SO THAT WOULD NOT BE TO THE 3126 02:04:10,517 --> 02:04:11,251 TRAILBLAZER AWARD AND ONLY 3127 02:04:11,251 --> 02:04:12,852 PARENT R2 ONES. 3128 02:04:12,852 --> 02:04:17,190 AS OTHER ICS ARE DOING, IN ORDER 3129 02:04:17,190 --> 02:04:20,994 TO CREATE ROOM IN THE BUDGET AND 3130 02:04:20,994 --> 02:04:22,996 BULK OF RESEARCH BUDGET IS 3131 02:04:22,996 --> 02:04:24,964 SOMEWHERE AROUND 2/3 OR SO GOES 3132 02:04:24,964 --> 02:04:27,066 TO COMPETING AWARDS. 3133 02:04:27,066 --> 02:04:31,671 SMALL REDUCTION, 2% IN COMPETING 3134 02:04:31,671 --> 02:04:34,040 R01S AND OTHER ICS FOR 3135 02:04:34,040 --> 02:04:36,709 COMPARISON IN 3 TO 5% AND RAIN 3136 02:04:36,709 --> 02:04:37,544 INITIATIVE AS I THINK MANY OF 3137 02:04:37,544 --> 02:04:41,314 YOU HAVE FOLLOWED THE 2 FIRST 3138 02:04:41,314 --> 02:04:42,916 CENTURY CARES ACT REDUCTION OR 3139 02:04:42,916 --> 02:04:45,818 LACK OF SUPPORT IN THIS CURRENT 3140 02:04:45,818 --> 02:04:46,252 YEAR. 3141 02:04:46,252 --> 02:04:50,323 IT IS A 10% REDUCTION IN THOSE 3142 02:04:50,323 --> 02:04:54,394 COMPETING R01S THAT HAS HELPED 3143 02:04:54,394 --> 02:04:56,462 US MAINTAIN PAY LINE AND R01S AS 3144 02:04:56,462 --> 02:04:59,265 WE HOPED AND ENORMOUS AMOUNT OF 3145 02:04:59,265 --> 02:05:01,801 WORK. THANK YOU SO MUCH TO OUR 3146 02:05:01,801 --> 02:05:03,536 BUDGET OFFICE AND LEADERSHIP 3147 02:05:03,536 --> 02:05:05,305 TEAM OF DAVID AND JILL. 3148 02:05:05,305 --> 02:05:06,706 WE APPRECIATE MODELING THAT YOU 3149 02:05:06,706 --> 02:05:08,908 HAVE DONE THAT IS REALLY 3150 02:05:08,908 --> 02:05:10,476 TRANSFORMATIONAL FOR US AND 3151 02:05:10,476 --> 02:05:12,645 ALLOWS US TO MAKE THESE 3152 02:05:12,645 --> 02:05:13,012 DECISIONS. 3153 02:05:13,012 --> 02:05:15,648 ON THAT NOTE, I MEAN, THIS 3154 02:05:15,648 --> 02:05:17,350 REALLY ILLUSTRATES THE STARK 3155 02:05:17,350 --> 02:05:19,586 REALITY OF WHAT HAS HAPPENED 3156 02:05:19,586 --> 02:05:22,555 WITH 21ST CENTURY CURES FUNDING. 3157 02:05:22,555 --> 02:05:24,691 YOU HAVE SEEN THAT ENACTED 3158 02:05:24,691 --> 02:05:28,494 BUDGET FOR BRAIN INITIATIVE IS 3159 02:05:28,494 --> 02:05:30,363 SIGNIFICANTLY LOWER THAN WHAT 3160 02:05:30,363 --> 02:05:33,166 HAD BEEN ENACTED IN THE PREVIOUS 3161 02:05:33,166 --> 02:05:33,967 YEAR. 3162 02:05:33,967 --> 02:05:36,169 AND IF YOU SPEAK WITH JOHN WHO 3163 02:05:36,169 --> 02:05:38,871 IS HEAD OF THE INITIATIVE AND 3164 02:05:38,871 --> 02:05:41,574 HAS BIN CREDIBLY CREATIVE AND 3165 02:05:41,574 --> 02:05:43,309 VERY, VERY BUSY AND TRYING TO 3166 02:05:43,309 --> 02:05:47,080 FIGURE OUT HOW TO PRIORITIZE AND 3167 02:05:47,080 --> 02:05:49,649 RANK APPLICATIONS TO BRING AND 3168 02:05:49,649 --> 02:05:52,118 HOW TO I THINK CREATIVELY BRING 3169 02:05:52,118 --> 02:05:54,187 IN NEW RESOURCES FROM OTHER 3170 02:05:54,187 --> 02:05:55,922 INSTITUTES AND FROM ALL OF THE 3171 02:05:55,922 --> 02:05:59,025 BRAIN INSTITUTES TO MAKE UP SOME 3172 02:05:59,025 --> 02:06:06,633 OF THAT SIGNIFICANT SHORTFALL IN 3173 02:06:06,633 --> 02:06:09,135 BRAIN AND PIVOTING OPTIMISTIC 3174 02:06:09,135 --> 02:06:10,103 FUNDING OPPORTUNITIES WHERE WE 3175 02:06:10,103 --> 02:06:13,473 KNOW FUNDING WILL BE ISSUED. 3176 02:06:13,473 --> 02:06:15,908 FIRST ONE, OF COURSE, TYING INTO 3177 02:06:15,908 --> 02:06:17,844 DR. CLAYTON'S INCREDIBLE 3178 02:06:17,844 --> 02:06:19,712 PRESENTATION THIS MORNING, WE 3179 02:06:19,712 --> 02:06:21,514 THINK IT WILL BE AN EXPANDING 3180 02:06:21,514 --> 02:06:24,784 SET OF RESOURCES AND AN ENORMOUS 3181 02:06:24,784 --> 02:06:26,819 AMOUNT OF INTEREST GENERATED IN 3182 02:06:26,819 --> 02:06:30,290 WOMEN'S HEALTH OPPORTUNITIES AS 3183 02:06:30,290 --> 02:06:32,959 JANINE TALKED ABOUT WOMEN'S 3184 02:06:32,959 --> 02:06:34,127 EXECUTIVE ORDER FROM PRESIDENT 3185 02:06:34,127 --> 02:06:35,695 BIDEN CAME IN MARCH THIS YEAR 3186 02:06:35,695 --> 02:06:38,498 AND IS A PHOTO THAT DR. CLAYTON 3187 02:06:38,498 --> 02:06:42,302 ALSO SHOWED WITH HER MONICA BER 3188 02:06:42,302 --> 02:06:46,105 TAN OELI NIH DIRECTOR AND TARA A 3189 02:06:46,105 --> 02:06:48,508 DEBUTY DIRECTOR OF NIH WHO IS IN 3190 02:06:48,508 --> 02:06:51,878 THAT PICTURE AS WELL AND RENÉ 3191 02:06:51,878 --> 02:06:58,618 FROM ARPAH AND NIBIB IS SIGNED 3192 02:06:58,618 --> 02:07:01,754 ON TO ALL NWH LED OPPORTUNITIES 3193 02:07:01,754 --> 02:07:03,523 NOT JUST IN RESEARCH BUT IN 3194 02:07:03,523 --> 02:07:05,491 TRAINING AND CAREER ADVANCEMENT 3195 02:07:05,491 --> 02:07:07,894 AND RECOMMEND THAT YOU TAKE A 3196 02:07:07,894 --> 02:07:09,329 LOOK AT THESE. 3197 02:07:09,329 --> 02:07:11,998 CONTACT TINA ON THE FIRST ROW 3198 02:07:11,998 --> 02:07:14,400 AND PEOPLE SHOULD CONNECT WITH 3199 02:07:14,400 --> 02:07:17,236 HER AND DAVID. 3200 02:07:17,236 --> 02:07:20,840 IF YOU HAVE QUESTIONS, HE IS 3201 02:07:20,840 --> 02:07:21,941 NEXT DOOR. 3202 02:07:21,941 --> 02:07:25,812 TINA IS POINTING OVER THERE. 3203 02:07:25,812 --> 02:07:27,980 WE ARE HOPEFUL TO BE AT THE 3204 02:07:27,980 --> 02:07:29,415 CENTER PART OF THE DRIVING FORCE 3205 02:07:29,415 --> 02:07:32,218 OF FUNDING AND PROMOTING SEVERAL 3206 02:07:32,218 --> 02:07:34,921 OF THESE OPPORTUNITIES. 3207 02:07:34,921 --> 02:07:39,125 JANINE MENTIONED THE ACT ENDO 3208 02:07:39,125 --> 02:07:40,660 CHALLENGE THAT IS HOT. SHE 3209 02:07:40,660 --> 02:07:43,296 DIDN'T KNOW IT HERSELF AND I 3210 02:07:43,296 --> 02:07:44,564 CENTERED THESE TWO SLIDES. 3211 02:07:44,564 --> 02:07:47,367 AS MANY OF YOU KNOW, WE HAVE A 3212 02:07:47,367 --> 02:07:50,269 STRONG PARTNERSHIP WITH NIH AND 3213 02:07:50,269 --> 02:07:52,171 NICHD ON MANY DIFFERENT AREAS 3214 02:07:52,171 --> 02:07:55,375 AND ONE IS IN THE RAD X TECH FOR 3215 02:07:55,375 --> 02:07:56,976 MATERNAL HEALTH AND WE PARTNER 3216 02:07:56,976 --> 02:07:59,612 WITH THEM AND ORWH. 3217 02:07:59,612 --> 02:08:02,181 SO NICHD, WHEN THEY HAD TO 3218 02:08:02,181 --> 02:08:05,218 REALLY THINK ABOUT HOW TO PULL 3219 02:08:05,218 --> 02:08:07,453 OFF A FAST, EFFECTIVE AND 3220 02:08:07,453 --> 02:08:09,622 IMPACTFUL PROGRAM, THEY HAD 3221 02:08:09,622 --> 02:08:11,057 ANNOUNCED ALREADY THE PROGRAM 3222 02:08:11,057 --> 02:08:14,093 BUT HADN'T REALLY SETTLED ON A 3223 02:08:14,093 --> 02:08:14,560 FUNDING MECHANISM. 3224 02:08:14,560 --> 02:08:16,596 THEY HAVE NOW RESOLVED THAT. 3225 02:08:16,596 --> 02:08:23,202 THEY WILL DO SOMETHING VERY S 3226 02:08:23,202 --> 02:08:33,713 SIMILAR TO IT CH. 3227 02:09:49,655 --> 02:09:53,159 >> LONGER TIME SPANS REALLY 3228 02:09:53,159 --> 02:09:55,895 PIONEERED BY NIA THAT OF COURSE 3229 02:09:55,895 --> 02:09:56,996 IS INTERESTED IN TIME BOTH 3230 02:09:56,996 --> 02:10:03,202 FORWARD AND REVERSE HOPEFULLY 3231 02:10:03,202 --> 02:10:07,907 PROGRESS 3232 02:10:07,907 --> 02:10:08,241 PROGRESSIONS. 3233 02:10:08,241 --> 02:10:09,242 YOU CAN CONTACT COLLEAGUES ON 3234 02:10:09,242 --> 02:10:11,644 THIS THIS IS DEVELOPMENT AND AIM 3235 02:10:11,644 --> 02:10:13,813 IN HYPOTHESIS TESTING AND SOME 3236 02:10:13,813 --> 02:10:15,348 CONSTRAINTS THIS IS AN 3237 02:10:15,348 --> 02:10:16,849 INTERESTING ONE. 3238 02:10:16,849 --> 02:10:21,921 I'M REALLY CURIOUS, INCLUDING 3239 02:10:21,921 --> 02:10:23,689 TWO TIME POINTS MEANINGFULLY 3240 02:10:23,689 --> 02:10:24,991 SEPARATED IN TIME. 3241 02:10:24,991 --> 02:10:28,327 HOW CAN YOU BANK THE MONEY AND 3242 02:10:28,327 --> 02:10:31,397 PULL IT OUT WHEN YOUR SUBJECT 3243 02:10:31,397 --> 02:10:33,032 ENTERS MIDDLE AGE WHEN YOU START 3244 02:10:33,032 --> 02:10:35,234 THE STUDY WHEN THEY ARE LET'S 3245 02:10:35,234 --> 02:10:37,670 SAY A TEENAGER OR SOMETHING LIKE 3246 02:10:37,670 --> 02:10:39,872 THAT. 3247 02:10:39,872 --> 02:10:45,177 HOW DOES THIS WORK? 3248 02:10:45,177 --> 02:10:55,655 >> TO HAVE A COMPARISON OF 3249 02:10:58,291 --> 02:10:59,825 DIFFERENT LIFE POINT AND 3250 02:10:59,825 --> 02:11:01,227 LONGITUDINALLY AND MEASURING 3251 02:11:01,227 --> 02:11:01,494 THEM. 3252 02:11:01,494 --> 02:11:04,597 I THINK THAT, YOU KNOW, BECAUSE 3253 02:11:04,597 --> 02:11:07,266 IT IS A SORT OF -- THERE IS A 3254 02:11:07,266 --> 02:11:10,002 FIRST STEP OF COMPREHENSIVE 3255 02:11:10,002 --> 02:11:11,771 EFFORTS THAT QUITE A NUMBER OF 3256 02:11:11,771 --> 02:11:14,073 INSTITUTES HAVE BEEN THINKING 3257 02:11:14,073 --> 02:11:14,440 ABOUT. 3258 02:11:14,440 --> 02:11:16,275 AT THIS POINT, I THINK IT IS, 3259 02:11:16,275 --> 02:11:20,112 YOU KNOW, INSTEAD OF HAVING 3260 02:11:20,112 --> 02:11:21,781 POINTS THAT I THINK WILL ANSWER 3261 02:11:21,781 --> 02:11:24,617 SORT OF INITIAL STEPS AND WE ARE 3262 02:11:24,617 --> 02:11:26,919 THINKING OF HAVING TWO POINTS 3263 02:11:26,919 --> 02:11:28,588 AND COMPARING THEM. 3264 02:11:28,588 --> 02:11:31,390 REALLY, TO ENCOURAGE THE 3265 02:11:31,390 --> 02:11:34,360 COMMUNITY TO THINK ABOUT THE 3266 02:11:34,360 --> 02:11:36,629 LIFESPAN AND RESEARCH AND ISSUES 3267 02:11:36,629 --> 02:11:37,964 INSTEAD OF LOOKING AT 3268 02:11:37,964 --> 02:11:38,931 [INDISCERNIBLE] POINTS. 3269 02:11:38,931 --> 02:11:39,699 >> YEAH, YEAH. 3270 02:11:39,699 --> 02:11:40,399 >> YEAH. 3271 02:11:40,399 --> 02:11:41,734 >> SO THERE IS -- YEAH. 3272 02:11:41,734 --> 02:11:43,169 >> THERE IS A LOT THAT NEEDS TO 3273 02:11:43,169 --> 02:11:46,939 BE WORKED OUT AND WE WORK REALLY 3274 02:11:46,939 --> 02:11:49,976 AND EXCITED TO SEE HOW THE 3275 02:11:49,976 --> 02:11:50,843 COMMUNITY RESPONDS TO THIS. 3276 02:11:50,843 --> 02:11:52,845 >> YES. THANK YOU. I MEAN, 3277 02:11:52,845 --> 02:11:54,647 THIS IS REALLY EXCITING. 3278 02:11:54,647 --> 02:11:56,983 IT IS KIND OF YOU KNOW WHEN WE 3279 02:11:56,983 --> 02:11:58,951 ARE TOGETHER TALKING ABOUT WHAT 3280 02:11:58,951 --> 02:12:01,053 ARE MOST LOGICAL WAYS TO LOOK AT 3281 02:12:01,053 --> 02:12:03,322 AGING AND REVERSAL, YOU KNOW, WE 3282 02:12:03,322 --> 02:12:05,458 WOULD LIKE TO SEE CONTINUOUS 3283 02:12:05,458 --> 02:12:06,726 LONGITUDINAL STUDIES WITH 3284 02:12:06,726 --> 02:12:08,928 APPLICATION OF VARIETY OF 3285 02:12:08,928 --> 02:12:10,329 DIFFERENT TECHNOLOGIES AND 3286 02:12:10,329 --> 02:12:11,697 APPROACHES AND PRACTICE, OF 3287 02:12:11,697 --> 02:12:13,432 COURSE, OF MEDICINE IS FAR FROM 3288 02:12:13,432 --> 02:12:13,733 THAT. 3289 02:12:13,733 --> 02:12:16,535 THIS IS AN EXCITING OPPORTUNITY 3290 02:12:16,535 --> 02:12:19,338 AND PLEASE CONNECT WITH GOYING 3291 02:12:19,338 --> 02:12:21,641 TO FIGURE OUT HOW WE CAN MOST 3292 02:12:21,641 --> 02:12:23,442 CAPITALIZE ON THAT. 3293 02:12:23,442 --> 02:12:26,946 THANK YOU GOYING. 3294 02:12:26,946 --> 02:12:29,682 NOW I HAVE A SERIES OF 3295 02:12:29,682 --> 02:12:30,683 SUPPLEMENTAL FUNDING 3296 02:12:30,683 --> 02:12:31,584 OPPORTUNITIES THAT ARE DRIVEN BY 3297 02:12:31,584 --> 02:12:33,686 THE OFFICE OF DATA SCIENCE AND, 3298 02:12:33,686 --> 02:12:36,389 OF COURSE, WE ARE SO INTIMATELY 3299 02:12:36,389 --> 02:12:39,959 AND STRONGLY CONNECTED WITH 3300 02:12:39,959 --> 02:12:44,697 THAT. 3301 02:12:44,697 --> 02:12:45,865 QI. 3302 02:12:45,865 --> 02:12:47,867 DUAN IS CONTACT PERSON FOR THIS 3303 02:12:47,867 --> 02:12:50,302 AND FIRST IS USE OF CLOUD 3304 02:12:50,302 --> 02:12:53,839 SERVICES AND CLOUD RESOURCES IN 3305 02:12:53,839 --> 02:12:54,974 NIH-SUPPORTED RESEARCH. 3306 02:12:54,974 --> 02:12:57,176 AGAIN, THESE ARE COMPETITIVE 3307 02:12:57,176 --> 02:13:01,247 REVISIONS TO YOUR EXISTING 3308 02:13:01,247 --> 02:13:01,480 AWARDS. 3309 02:13:01,480 --> 02:13:04,550 AND THE NIH CLOUD LAB HAS OPENED 3310 02:13:04,550 --> 02:13:06,285 UP. 3311 02:13:06,285 --> 02:13:10,456 IT IS ACTUALLY REALLY IN TRYING 3312 02:13:10,456 --> 02:13:15,227 TO INSPIRE SIGNIFICANT USE FROM 3313 02:13:15,227 --> 02:13:16,595 INTRAMURAL AND EXTRAMURAL 3314 02:13:16,595 --> 02:13:18,431 COMMUNITY AND YOU CAN LOOK ON 3315 02:13:18,431 --> 02:13:20,633 THEIR WEBSITE. I NOTICE THERE 3316 02:13:20,633 --> 02:13:23,969 IS A $500 CREDIT FOR ACTUALLY 3317 02:13:23,969 --> 02:13:25,538 SIGNING UP AND GETTING STARTED 3318 02:13:25,538 --> 02:13:27,373 WITH THE NIH CLOUD LAB. 3319 02:13:27,373 --> 02:13:29,709 OF COURSE, I'M SURE THAT IS ONE 3320 02:13:29,709 --> 02:13:32,011 OF THE CLASSIC ADDICTIONS YOU 3321 02:13:32,011 --> 02:13:33,979 GET STARTED WITH 3500 AND BEFORE 3322 02:13:33,979 --> 02:13:35,715 YOU KNOW IT, I WON'T COMPLETE 3323 02:13:35,715 --> 02:13:36,682 THE SENTENCE. 3324 02:13:36,682 --> 02:13:38,184 YOU KNOW WHERE I'M GOING WITH 3325 02:13:38,184 --> 02:13:38,384 THAT. 3326 02:13:38,384 --> 02:13:40,419 THIS IS A REALLY, REALLY 3327 02:13:40,419 --> 02:13:42,421 IMPORTANT WAY FOR OUR COMMUNITY 3328 02:13:42,421 --> 02:13:43,489 TO COME TOGETHER AND GIVE 3329 02:13:43,489 --> 02:13:46,525 FEEDBACK ON WHAT WORKS IN THE 3330 02:13:46,525 --> 02:13:48,227 TECHNOLOGY DEVELOPMENT SPACE. 3331 02:13:48,227 --> 02:13:49,361 THIS IS ONE. 3332 02:13:49,361 --> 02:13:55,034 A SECOND IS, AS YOU KNOW, I 3333 02:13:55,034 --> 02:13:57,770 THINK MORE IN THE MEDICAL 3334 02:13:57,770 --> 02:13:58,070 COMMUNITY. 3335 02:13:58,070 --> 02:14:00,473 THE BROADER MEDICAL COMMUNITY, 3336 02:14:00,473 --> 02:14:03,008 THERE IS A HOPE THAT AT LEAST 3337 02:14:03,008 --> 02:14:04,543 CERTAINLY FOR PEOPLE NOT 3338 02:14:04,543 --> 02:14:05,644 DEVELOPING NEW TECHNOLOGIES ALL 3339 02:14:05,644 --> 02:14:06,479 THE TIME. 3340 02:14:06,479 --> 02:14:09,815 THERE IS A HOPE THAT EXISTING 3341 02:14:09,815 --> 02:14:12,118 DATA AS IT BECOMES AVAILABLE CAN 3342 02:14:12,118 --> 02:14:14,820 BE PUT INTO A STRUCTURE AND THEN 3343 02:14:14,820 --> 02:14:16,255 REUSED TO DRIVE NEW DISCOVERY 3344 02:14:16,255 --> 02:14:19,725 ALMOST AS IF IT IS A NEW 3345 02:14:19,725 --> 02:14:21,260 TECHNOLOGY THAT WERE CREATED BY 3346 02:14:21,260 --> 02:14:23,963 OUR COMMUNITY THAT IS GENERATING 3347 02:14:23,963 --> 02:14:25,598 ENTIRELY NEW WAYS TO MEASURE 3348 02:14:25,598 --> 02:14:25,865 THINGS. 3349 02:14:25,865 --> 02:14:28,167 THIS IS PROBABLY THE BULK OF 3350 02:14:28,167 --> 02:14:31,036 THE ASPIRATIONAL GOALS OF ALL 3351 02:14:31,036 --> 02:14:32,104 INSTITUTES ACROSS NIH. 3352 02:14:32,104 --> 02:14:35,441 WE ARE SORT OF OUTLIARS SAYING 3353 02:14:35,441 --> 02:14:37,743 WE NEED NEW TECHNOLOGY AND 3354 02:14:37,743 --> 02:14:39,245 MEASUREMENTS AND WAYS TO SEE 3355 02:14:39,245 --> 02:14:39,478 THINGS. 3356 02:14:39,478 --> 02:14:41,947 WE AS A COMMUNITY HAVE TO REALLY 3357 02:14:41,947 --> 02:14:43,883 RESPOND TO THIS KIND OF APPROACH 3358 02:14:43,883 --> 02:14:45,551 TO BOTH HELP TO CONTINUE TO 3359 02:14:45,551 --> 02:14:47,353 PROMOTE THE ROLE OF NEW 3360 02:14:47,353 --> 02:14:49,822 TECHNOLOGIES BUT POWER OF DATA 3361 02:14:49,822 --> 02:14:50,055 REUSE. 3362 02:14:50,055 --> 02:14:52,758 THIS IS, AGAIN, A COMPETITIVE 3363 02:14:52,758 --> 02:14:54,794 REVISION TYPE OF APPLICATION. 3364 02:14:54,794 --> 02:14:58,030 AND I ENCOURAGE YOU TO TALK TO 3365 02:14:58,030 --> 02:14:58,397 QI. 3366 02:14:58,397 --> 02:15:01,233 AWARD SIZES ARE LIMITED AND 3367 02:15:01,233 --> 02:15:05,504 TOTAL AMOUNT IS $275,000 DIRECT. 3368 02:15:05,504 --> 02:15:09,074 BUT, UP TO 200,000 DOLLARS IN 3369 02:15:09,074 --> 02:15:10,442 CAP FOR ANY GIVEN YEAR. 3370 02:15:10,442 --> 02:15:13,279 TAKE A LOOK AT DETAILS OF THAT. 3371 02:15:13,279 --> 02:15:15,414 AND THEN IF YOU HAVE NOT HAD 3372 02:15:15,414 --> 02:15:18,417 ENOUGH OF DATA YET, HERE IS YET 3373 02:15:18,417 --> 02:15:19,852 ANOTHER EXCITING INITIATIVE THAT 3374 02:15:19,852 --> 02:15:22,855 IS LED BY OUR -- IN FACT, DID WE 3375 02:15:22,855 --> 02:15:26,859 GET ALL OUR DATA SCIENCE EXPERTS 3376 02:15:26,859 --> 02:15:29,695 HERE ON THIS SLIDE? 3377 02:15:29,695 --> 02:15:31,897 MO AND QI AND BRAD IF YOU COULD 3378 02:15:31,897 --> 02:15:34,900 STAND. BRAD IS PROBABLY IN 3379 02:15:34,900 --> 02:15:37,369 NOVRJ CAROLINA BUT YEAH. SO 3380 02:15:37,369 --> 02:15:38,204 PLEASE CONNECT WITH THEM. 3381 02:15:38,204 --> 02:15:40,673 THIS IS A REALLY EXCITING 3382 02:15:40,673 --> 02:15:43,175 INITIATIVE AND MULTIMODAL AI IS 3383 02:15:43,175 --> 02:15:44,610 KIND OF OUR NATURAL SET POINT IN 3384 02:15:44,610 --> 02:15:46,178 OUR COMMUNITY WHETHER YOU ARE 3385 02:15:46,178 --> 02:15:47,780 USING A COMBINATION OF 3386 02:15:47,780 --> 02:15:50,182 APPROACHES WHERE, YOU KNOW, YOU 3387 02:15:50,182 --> 02:15:54,119 ARE KIND OF THE BASIS OF A 3388 02:15:54,119 --> 02:15:57,556 PHYSICS MODEL OR SIM BIOLOGIC 3389 02:15:57,556 --> 02:16:00,059 TROOPS TO DO MECHANISTIC AI 3390 02:16:00,059 --> 02:16:03,028 BASED APPROACHES OR USING 3391 02:16:03,028 --> 02:16:04,296 MULTIPLE MODALITIES WITHIN AI 3392 02:16:04,296 --> 02:16:05,598 ITSELF AND COMBINATIONS OF 3393 02:16:05,598 --> 02:16:06,866 DIFFERENT LEARNING PROCESS. 3394 02:16:06,866 --> 02:16:08,067 THAT IS WHAT WE DO. 3395 02:16:08,067 --> 02:16:10,302 I THINK THAT THE BROADER 3396 02:16:10,302 --> 02:16:12,004 COMMUNITY NEEDS TO REALLY SEE 3397 02:16:12,004 --> 02:16:13,572 POWERFUL APPROACHES AND THINK IF 3398 02:16:13,572 --> 02:16:15,474 YOU ARE HOPEFULLY APPLYING AND 3399 02:16:15,474 --> 02:16:19,211 WE ARE GETTING PRETTY GOOD 3400 02:16:19,211 --> 02:16:20,779 RESPONSE TO THIS. 3401 02:16:20,779 --> 02:16:28,454 QI, WHAT IS YOUR -- IS THAT -- 3402 02:16:28,454 --> 02:16:32,992 >> YES. YES. THIS WILL 3403 02:16:32,992 --> 02:16:34,793 PROBABLY COME AROUND AGAIN. 3404 02:16:34,793 --> 02:16:37,963 THIS WILL PROBABLY COME AROUND 3405 02:16:37,963 --> 02:16:38,364 AGAIN. 3406 02:16:38,364 --> 02:16:41,734 IT IS -- I THINK OR YOU THINK 3407 02:16:41,734 --> 02:16:45,170 THIS WILL BE A ONE YEAR KIND OF 3408 02:16:45,170 --> 02:16:48,574 INITIATIVE? I'M PUTTING YOU ON 3409 02:16:48,574 --> 02:16:52,311 THE SPOT. YEAH. WITH ENORMOUS 3410 02:16:52,311 --> 02:16:54,413 AMOUNT OF INTEREST IN AI, SOME 3411 02:16:54,413 --> 02:16:56,582 OF YOU NOW THAT YOU ARE INSIDE 3412 02:16:56,582 --> 02:16:59,985 OF THE BELTWAY YOU ARE PROBABLY 3413 02:16:59,985 --> 02:17:03,322 FOLLOWING SENATOR SHOOUM AR'S AI 3414 02:17:03,322 --> 02:17:04,390 RECOMMENDATIONS THAT CAME OUT 3415 02:17:04,390 --> 02:17:04,857 YESTERDAY. 3416 02:17:04,857 --> 02:17:07,993 I ALONG WITH JONI AND ASSIST 3417 02:17:07,993 --> 02:17:09,895 YANTD DIRECTOR HAVE DONE SEVERAL 3418 02:17:09,895 --> 02:17:12,498 CONGRESSIONAL BRIEFINGS ON AI 3419 02:17:12,498 --> 02:17:13,866 AND WE HAVE ANOTHER ONE COMING 3420 02:17:13,866 --> 02:17:14,800 UP NEXT WEEK. 3421 02:17:14,800 --> 02:17:17,136 THERE IS ENORMOUS INTEREST AS 3422 02:17:17,136 --> 02:17:20,105 NIH AND ALTHOUGH WE ARE NOT AN 3423 02:17:20,105 --> 02:17:21,307 OFFICIAL FOUNDING AGENCY WITHIN 3424 02:17:21,307 --> 02:17:23,709 THE NATIONAL AI RESEARCH 3425 02:17:23,709 --> 02:17:26,312 RESOURCE, WE ARE THE GO-TO 3426 02:17:26,312 --> 02:17:28,447 AGENCY FOR HELP WITH BOTH 3427 02:17:28,447 --> 02:17:31,150 RESPECT TO NEW METHODS AND THEIR 3428 02:17:31,150 --> 02:17:33,385 DEVELOPMENTS AND APPLICATIONS 3429 02:17:33,385 --> 02:17:35,988 AND FOR ALSO GUIDELINES TO 3430 02:17:35,988 --> 02:17:37,523 IDENTIFY AND OPTIMIZE USE AND OF 3431 02:17:37,523 --> 02:17:39,658 COURSE CONGRESS IS VERY, VERY 3432 02:17:39,658 --> 02:17:42,094 INTERESTED IN REGULATING ITS 3433 02:17:42,094 --> 02:17:42,294 USE. 3434 02:17:42,294 --> 02:17:46,165 WE HAVE TO BE REALLY DEEPLY 3435 02:17:46,165 --> 02:17:47,132 ENGAGED IN THAT CONSTRUCTION FOR 3436 02:17:47,132 --> 02:17:48,734 THAT CONVERSATION AND THIS IS 3437 02:17:48,734 --> 02:17:50,202 ONE OF THOSE OPPORTUNITIES FOR 3438 02:17:50,202 --> 02:17:51,770 OUR COMMUNITY. 3439 02:17:51,770 --> 02:17:55,674 THANK YOU, YOU GUYS. 3440 02:17:55,674 --> 02:17:57,910 SO ANOTHER ADMINISTRATIVE 3441 02:17:57,910 --> 02:17:59,445 SUPPLEMENT OPPORTUNITY THAT WE 3442 02:17:59,445 --> 02:18:01,046 HAVE I THINK BEEN FORESHADOWING 3443 02:18:01,046 --> 02:18:02,548 THIS FOR A WHILE. 3444 02:18:02,548 --> 02:18:05,617 WE HAVE OUR IMAGING PHANTOM 3445 02:18:05,617 --> 02:18:07,987 LIBRARY AND OUR LENDING LIBRARY 3446 02:18:07,987 --> 02:18:10,255 THAT WE HAVE EXPANDED THAT TO 3447 02:18:10,255 --> 02:18:11,957 INCLUDE SOME OPTICAL 3448 02:18:11,957 --> 02:18:13,726 TECHNOLOGIES INCLUDING OPTICAL 3449 02:18:13,726 --> 02:18:15,194 [INDISCERNIBLE] AND SXABDING 3450 02:18:15,194 --> 02:18:15,995 COLLABORATIONS THERE. 3451 02:18:15,995 --> 02:18:17,196 THIS IS ADMINISTRATIVE 3452 02:18:17,196 --> 02:18:19,665 SUPPLEMENT THAT SUPPORTS 3453 02:18:19,665 --> 02:18:21,433 OPTIMIZATION, CALIBRATION, 3454 02:18:21,433 --> 02:18:23,202 DISSEMINATION OF IMAGING 3455 02:18:23,202 --> 02:18:25,437 PHANTOMS AS PART OF YOUR PARENT 3456 02:18:25,437 --> 02:18:25,671 AWARD. 3457 02:18:25,671 --> 02:18:27,906 THIS IS DESIGNED TO REALLY 3458 02:18:27,906 --> 02:18:29,675 IMPROVE QUALITY ASSURANCE AND 3459 02:18:29,675 --> 02:18:31,643 PERFORMANCE DURING TECHNICAL 3460 02:18:31,643 --> 02:18:33,178 DEVELOPMENT DURING IMAGING 3461 02:18:33,178 --> 02:18:35,481 TECHNOLOGIES AS WELL AS TO TRY 3462 02:18:35,481 --> 02:18:37,983 TO ACCELERATE DATA SHARING AND 3463 02:18:37,983 --> 02:18:38,484 REGULATORY CLEARANCES. 3464 02:18:38,484 --> 02:18:40,986 WE THINK, YOU KNOW, THESE ARE -- 3465 02:18:40,986 --> 02:18:42,955 THEY CLEARLY PLAY A VERY 3466 02:18:42,955 --> 02:18:44,490 IMPORTANT ROLE AND IS AN 3467 02:18:44,490 --> 02:18:46,859 OPPORTUNITY TO REALLY ADVANCE 3468 02:18:46,859 --> 02:18:47,526 [INDISCERNIBLE] AND ANDERSON IS 3469 02:18:47,526 --> 02:18:48,961 THE LEAD ON THIS ONE. 3470 02:18:48,961 --> 02:18:50,763 SO HOPEFULLY MANY OF YOU HAVE 3471 02:18:50,763 --> 02:18:51,797 TALKED TO HER ABOUT THIS AND 3472 02:18:51,797 --> 02:18:57,202 WILL BE ABLE TO RESPOND TO THIS 3473 02:18:57,202 --> 02:18:59,038 INITIATIVE. 3474 02:18:59,038 --> 02:19:00,539 SO IT IS ACTUALLY SURPRISING 3475 02:19:00,539 --> 02:19:02,741 THAT THIS IS -- NOW WE ARE 3476 02:19:02,741 --> 02:19:06,512 ANNOUNCING THE REAPPEARANCE OF 3477 02:19:06,512 --> 02:19:12,017 THE BETA, THE BEI AND BIOMEDICAL 3478 02:19:12,017 --> 02:19:13,852 IMAGING TECHNOLOGY ACCELERATION 3479 02:19:13,852 --> 02:19:16,655 INITIATIVE AT HBCU AND HAD FIRST 3480 02:19:16,655 --> 02:19:17,956 ROUND OF APPLICATION END OF 3481 02:19:17,956 --> 02:19:19,858 JANUARY AND THEY ARE NOW IN 3482 02:19:19,858 --> 02:19:20,159 REVIEW. 3483 02:19:20,159 --> 02:19:22,027 BY THE TIME THAT THESE 3484 02:19:22,027 --> 02:19:23,028 APPLICATIONS ARE DUE WHEN WE 3485 02:19:23,028 --> 02:19:26,799 UPDATE YOU IN THE -- IN COUNCIL 3486 02:19:26,799 --> 02:19:29,601 IN SEPTEMBER AND HOPEFULLY WILL 3487 02:19:29,601 --> 02:19:31,703 BE ABLE TO ANNOUNCE WINNERS OF 3488 02:19:31,703 --> 02:19:33,605 THAT FIRST ROUND AND A SECOND 3489 02:19:33,605 --> 02:19:35,240 OPPORTUNITY IS NOW COMING UP. 3490 02:19:35,240 --> 02:19:38,110 THESE DUE DATES ARE AT THE END 3491 02:19:38,110 --> 02:19:40,412 OF SEPTEMBER THIS YEAR AND END 3492 02:19:40,412 --> 02:19:43,482 OF SEPTEMBER THE FOLLOWING YEAR 3493 02:19:43,482 --> 02:19:45,451 AND THAT WILL HAVE BEEN THREE 3494 02:19:45,451 --> 02:19:47,686 FULL APPLICATION DUE DATES FOR 3495 02:19:47,686 --> 02:19:49,455 THIS AWARD AND ARE EXCITED TO 3496 02:19:49,455 --> 02:19:51,757 SEE OUTCOMES ENCOURAGING PEOPLE 3497 02:19:51,757 --> 02:19:55,060 TO APPLY FOR THIS AND IT IS 3498 02:19:55,060 --> 02:19:59,198 AWARD UG3UH3 IN TERMS OF PHASE 2 3499 02:19:59,198 --> 02:20:01,667 AND ALBERT ALVILLA IS OUR 3500 02:20:01,667 --> 02:20:02,634 CONTACT FOR THAT. 3501 02:20:02,634 --> 02:20:06,972 NOW, A FEW PROGRAM UPDATES. 3502 02:20:06,972 --> 02:20:11,143 WE HAD A SPECTACULAR WORKSHOP 3503 02:20:11,143 --> 02:20:14,913 AND IF YOU CAN DO A Q.R. CODE 3504 02:20:14,913 --> 02:20:16,515 AND SCAN FROM YOUR REMOTE 3505 02:20:16,515 --> 02:20:19,251 LOCATION WE WILL HAVE PDF SLIDE 3506 02:20:19,251 --> 02:20:21,186 THAT WE WILL UPLOAD THAT YOU CAN 3507 02:20:21,186 --> 02:20:24,523 GET ACCESS TO AND TALKED IN THE 3508 02:20:24,523 --> 02:20:25,824 MIDRC SESSION THAT ARE AMONGST 3509 02:20:25,824 --> 02:20:27,860 BEST TALKS I HAVE SEEN COVERING 3510 02:20:27,860 --> 02:20:29,862 ISSUES AND CHALLENGES OF AI. 3511 02:20:29,862 --> 02:20:31,663 NOT JUST TECHNICAL ONES BUT KIND 3512 02:20:31,663 --> 02:20:35,134 OF THE BROAD OVERVIEW OF HOW YOU 3513 02:20:35,134 --> 02:20:38,737 STRUCTURE MULTIPLE DATABASES IN 3514 02:20:38,737 --> 02:20:41,640 A CONNECT THE NETWORK AND DATA 3515 02:20:41,640 --> 02:20:43,509 FABRIC SO-TO-SPEAK THAT SPANS 3516 02:20:43,509 --> 02:20:45,777 ACROSS MULTIPLE DOMAINS. 3517 02:20:45,777 --> 02:20:47,946 THIS IS NOW AVAILABLE TO THE 3518 02:20:47,946 --> 02:20:51,016 PUBLIC AND NOW ON MIDRC WEBSITE. 3519 02:20:51,016 --> 02:20:53,485 IT WAS A VERY, VERY PRODUCTIVE 3520 02:20:53,485 --> 02:20:56,388 MEETING AND QUICK UPDATES ON 3521 02:20:56,388 --> 02:20:57,089 MIDRC. 3522 02:20:57,089 --> 02:21:00,759 WE TALKED ABOUT HOW MIDRC ITSELF 3523 02:21:00,759 --> 02:21:04,530 IS PART OF ARPA H'S DATA FABRIC 3524 02:21:04,530 --> 02:21:06,498 AND HAD A NUMBER OF SPECIFIC 3525 02:21:06,498 --> 02:21:08,000 GOALS AND DELIVERABLES THAT IS 3526 02:21:08,000 --> 02:21:09,468 PART OF THAT AND SOME HIGHLIGHTS 3527 02:21:09,468 --> 02:21:11,603 WHAT THEY HAVE BEEN ABLE TO 3528 02:21:11,603 --> 02:21:11,904 ACCOMPLISH. 3529 02:21:11,904 --> 02:21:14,239 WE ARE I HAVE BIASED AND BELIEVE 3530 02:21:14,239 --> 02:21:15,174 THESE ARE MOST IMPORTANT GOALS 3531 02:21:15,174 --> 02:21:17,176 AND ARE DOING A REALLY GOOD JOB 3532 02:21:17,176 --> 02:21:19,111 OF DELIVERING ON THOSE. 3533 02:21:19,111 --> 02:21:23,482 IT IS A METAINDEXING OF MIDRC 3534 02:21:23,482 --> 02:21:27,753 INSIDE OF IMAGING DATA COMMONS 3535 02:21:27,753 --> 02:21:29,922 IN THIS DATA FABRIC IMAGING HUB 3536 02:21:29,922 --> 02:21:31,490 AND THAT SOUNDS VERY DIFFICULT 3537 02:21:31,490 --> 02:21:32,591 TO UNDERSTAND LANGUAGE. 3538 02:21:32,591 --> 02:21:38,830 IF YOU DO TAKE A LOOK AT THIS 3539 02:21:38,830 --> 02:21:40,599 YOUTUBE VIDEOCAST, YOU WILL KIND 3540 02:21:40,599 --> 02:21:43,068 OF UNDERSTAND THE IDEA OF THE 3541 02:21:43,068 --> 02:21:46,271 DATA BASES AND DATA FABRIC AND 3542 02:21:46,271 --> 02:21:46,705 DATA HUB. 3543 02:21:46,705 --> 02:21:51,743 THIS IS ALL HOSTED ON THE JENTRY 3544 02:21:51,743 --> 02:21:53,645 PLATFORM THAT HAS SOMETHING LIKE 3545 02:21:53,645 --> 02:21:55,781 18 SEPARATE DATA BASES THAT ARE 3546 02:21:55,781 --> 02:21:57,015 ON DIFFERENT TOPICS. 3547 02:21:57,015 --> 02:21:59,418 BECAUSE IT IS ON A SINGLE 3548 02:21:59,418 --> 02:22:02,521 PLATFORM, YOU ARE ACTUALLY ABLE 3549 02:22:02,521 --> 02:22:04,957 TO INTERCONNECT AND INTEROPERATE 3550 02:22:04,957 --> 02:22:06,992 BETWEEN THESE DATA RESOURCES. 3551 02:22:06,992 --> 02:22:09,861 WHAT IS INTERESTING FOR MIDRC IS 3552 02:22:09,861 --> 02:22:12,264 THEY HAVE THOUSANDS OF PATIENTS 3553 02:22:12,264 --> 02:22:14,399 IN COMMON WITH DATA BASES HOSTED 3554 02:22:14,399 --> 02:22:18,971 ON GEN3 AND DATA COMMONS AND IS 3555 02:22:18,971 --> 02:22:20,305 AN ENORMOUS OPPORTUNITY THAT IS 3556 02:22:20,305 --> 02:22:23,141 A ROADMAP FOR HOW DATA BASES 3557 02:22:23,141 --> 02:22:24,643 WILL EVOLVE INTO THIS KIND OF 3558 02:22:24,643 --> 02:22:27,312 FABRIC THAT IS ENVISIONED BY 3559 02:22:27,312 --> 02:22:29,248 ARPAH AND MANY OTHERS AND IS A 3560 02:22:29,248 --> 02:22:31,483 VERY IMPORTANT ACHIEVEMENT AND 3561 02:22:31,483 --> 02:22:34,720 ARE PRACTICAL TOOLS THAT MIDRC 3562 02:22:34,720 --> 02:22:36,421 HAS CONTRIBUTED TO THE DATA 3563 02:22:36,421 --> 02:22:37,990 FABRIC IS DIVERSITY CALCULATOR 3564 02:22:37,990 --> 02:22:40,759 THAT ALLOWS YOU TO COMPARE DATA 3565 02:22:40,759 --> 02:22:43,729 SETS YOU HAVE ACQUIRED WITH US 3566 02:22:43,729 --> 02:22:45,731 CENSUS DATA TO SEE HOW CLOSELY 3567 02:22:45,731 --> 02:22:47,099 YOU ARE MATCHING AND 3568 02:22:47,099 --> 02:22:48,433 REPRESENTING THE POPULATION IN 3569 02:22:48,433 --> 02:22:49,334 YOUR DATA SET. 3570 02:22:49,334 --> 02:22:51,870 I HAVE TALKED ABOUT THE BIAS 3571 02:22:51,870 --> 02:22:53,672 AWARENESS TOOLS THAT I THINK ARE 3572 02:22:53,672 --> 02:22:54,773 REALLY UNEQUAL. 3573 02:22:54,773 --> 02:22:57,476 THEY ARE DEVELOPED BY MIDRC. 3574 02:22:57,476 --> 02:23:00,479 THEY ARE ALL AVAILABLE ON THE 3575 02:23:00,479 --> 02:23:03,148 MIDRC WEBSITE AND NOW IN 3576 02:23:03,148 --> 02:23:07,219 BIOMEDICAL DATA FABRIC UNIVERSE, 3577 02:23:07,219 --> 02:23:08,520 SO-TO-SPEAK. 3578 02:23:08,520 --> 02:23:10,322 MIDRC DEVELOPED A TEXT 3579 02:23:10,322 --> 02:23:12,124 DEIDENTIFICATION TOOL THAT WORKS 3580 02:23:12,124 --> 02:23:15,060 BETTER OR ON PAR WITH 3581 02:23:15,060 --> 02:23:17,529 UNPUBLISHED ALGORITHMS AND 3582 02:23:17,529 --> 02:23:18,864 ULTIMATELY THE EXPECTATION IS 3583 02:23:18,864 --> 02:23:22,434 THAT THESE KINDS OF DATA 3584 02:23:22,434 --> 02:23:23,268 APPROACHES NEED TO TAKE 3585 02:23:23,268 --> 02:23:26,004 ADVANTAGE OF FEDERATED LEARNING 3586 02:23:26,004 --> 02:23:27,773 OPPORTUNITIES AND YOU NEED THE 3587 02:23:27,773 --> 02:23:29,341 PROPER STRUCTURE WITH EDGE NODES 3588 02:23:29,341 --> 02:23:30,842 THAT ARE DEVELOPED IN CONNECTION 3589 02:23:30,842 --> 02:23:32,811 WITH THIS FABRIC AND THINK THAT 3590 02:23:32,811 --> 02:23:33,945 YOU GET AN APPRECIATION FOR THIS 3591 02:23:33,945 --> 02:23:37,149 IF YOU LOOK AT THE VIDEO WHERE 3592 02:23:37,149 --> 02:23:39,985 BOB GROSSMAN PRESENTS OVERALL 3593 02:23:39,985 --> 02:23:41,853 CONCEPTUAL FRAMEWORK FOR THESE 3594 02:23:41,853 --> 02:23:44,990 ARCHITECTURES AND BOTTOM LINE IS 3595 02:23:44,990 --> 02:23:48,560 THAT MIDRC AND RELATED DATA 3596 02:23:48,560 --> 02:23:51,029 BASES ARE IN IDEAL POSITION TO 3597 02:23:51,029 --> 02:23:52,431 BEGIN ENGAGING AND DRIVE 3598 02:23:52,431 --> 02:23:53,565 FEDERATED LEARNING APPROACHES 3599 02:23:53,565 --> 02:23:55,367 THAT WILL DRAMATICALLY EXPAND 3600 02:23:55,367 --> 02:23:57,636 THE IMPACT OF DATA BASES IN 3601 02:23:57,636 --> 02:23:59,338 DIFFERENT SITES ALL OVER THE 3602 02:23:59,338 --> 02:24:01,373 COUNTRY AND POTENTIALLY HELP 3603 02:24:01,373 --> 02:24:03,041 PLACES GET OVER WHATEVER 3604 02:24:03,041 --> 02:24:04,242 POLICIES THEY MIGHT HAVE ABOUT 3605 02:24:04,242 --> 02:24:07,579 DATA SHARING INTO A SINGLE DATA 3606 02:24:07,579 --> 02:24:07,913 REPOSITORY. 3607 02:24:07,913 --> 02:24:09,581 LOTS OF THOUGHTFUL CONSTRUCTION 3608 02:24:09,581 --> 02:24:11,383 GOING ON AND LOTS OF GREAT 3609 02:24:11,383 --> 02:24:11,650 DIALOGUE. 3610 02:24:11,650 --> 02:24:15,020 LAST THING I WOULD LIKE TO SAY 3611 02:24:15,020 --> 02:24:19,124 ABOUT MIDRC IS THAT IT IS KIND 3612 02:24:19,124 --> 02:24:21,226 OF ALMOST LIKE ONE OF THE 3613 02:24:21,226 --> 02:24:23,662 ULTIMATE BADGES OF RECOGNITION 3614 02:24:23,662 --> 02:24:25,197 AND HONOR THAT IS GETTING CALLED 3615 02:24:25,197 --> 02:24:27,599 OUT BY THE FDA FOR DOING 3616 02:24:27,599 --> 02:24:28,667 SOMETHING THAT THEY WANT 3617 02:24:28,667 --> 02:24:30,435 EVERYBODY ELSE TO DO. 3618 02:24:30,435 --> 02:24:33,739 SO, MIDRC HAS THIS DECISION TREE 3619 02:24:33,739 --> 02:24:39,077 FOR MEDICAL IMAGING AND AI ML 3620 02:24:39,077 --> 02:24:39,778 CLASSIFICATION METHODS. 3621 02:24:39,778 --> 02:24:42,981 THE FDA HAS NOW PUBLISHED THIS 3622 02:24:42,981 --> 02:24:45,183 IN THEIR GUIDE FOR HOW TO DO 3623 02:24:45,183 --> 02:24:47,452 MEDICAL IMAGE CLASSIFICATION. 3624 02:24:47,452 --> 02:24:50,255 AND IT COVERS MANY DIFFERENT FDA 3625 02:24:50,255 --> 02:24:50,956 PRODUCT CODES. 3626 02:24:50,956 --> 02:24:53,759 IT IS NOT JUST COVID DIAGNOSTIC 3627 02:24:53,759 --> 02:24:55,994 AS MIDRC WAS DEVELOPED FOR IN 3628 02:24:55,994 --> 02:24:58,363 THE FIRST PLACE BUT COVERS A 3629 02:24:58,363 --> 02:24:59,531 VARIETY OF DIFFERENT 3630 02:24:59,531 --> 02:24:59,998 APPLICATIONS BASIS. 3631 02:24:59,998 --> 02:25:03,001 YOU CAN GO ON TO THE MIDRC 3632 02:25:03,001 --> 02:25:07,139 WEBSITE AND SEE THE MIDRC METRIC 3633 02:25:07,139 --> 02:25:09,608 TREE FOR CLASSIFICATION DETECTOR 3634 02:25:09,608 --> 02:25:11,476 LOCALIZATION SEGMENTATION AND 3635 02:25:11,476 --> 02:25:12,577 TIME FOR [INDISCERNIBLE] 3636 02:25:12,577 --> 02:25:14,780 ANALYSIS AND REALLY INCREDIBLE 3637 02:25:14,780 --> 02:25:16,448 TOOLS AND IF DOING IMAGING AT 3638 02:25:16,448 --> 02:25:18,116 ANY SCALE AND YOU WANT TO 3639 02:25:18,116 --> 02:25:20,619 SEGMENT AND CLASSIFY AND DO 3640 02:25:20,619 --> 02:25:22,888 ANYTHING IN A KIND OF AUTOMATED 3641 02:25:22,888 --> 02:25:25,023 WAY, THIS IS VERY, VERY 3642 02:25:25,023 --> 02:25:25,290 POWERFUL. 3643 02:25:25,290 --> 02:25:28,126 I ENCOURAGE EVERYONE TO TAKE A 3644 02:25:28,126 --> 02:25:29,561 LOOK AT THAT. 3645 02:25:29,561 --> 02:25:33,799 SO NOW JUST A FEW QUICK UPDATES 3646 02:25:33,799 --> 02:25:34,766 ABOUT RAD X. 3647 02:25:34,766 --> 02:25:41,039 WE ARE UP TO 8 DIFFERENT RAD X 3648 02:25:41,039 --> 02:25:43,375 PROJECTS THAT ARE GOING ON RIGHT 3649 02:25:43,375 --> 02:25:48,880 NOW AND RAD X FOR ENDOMETRIOSIS 3650 02:25:48,880 --> 02:25:50,849 THAT IS 8 AND CARE AND VIRAL 3651 02:25:50,849 --> 02:25:53,418 LOAD DIAGNOSTICS THIS IS A NEW 3652 02:25:53,418 --> 02:25:57,456 LOAD EFFORT WITH SUBSTANTIAL NEW 3653 02:25:57,456 --> 02:25:59,057 INVESTMENT LED BY SEAN MUL VAINY 3654 02:25:59,057 --> 02:26:01,426 WHO HAS MANAGED TO WORK VERY 3655 02:26:01,426 --> 02:26:03,161 CLOSELY WITH OFFICE OF AIDS 3656 02:26:03,161 --> 02:26:05,330 RESEARCH AND NIAD. 3657 02:26:05,330 --> 02:26:09,901 I WAS VERY SURPRISED TO SEE 3658 02:26:09,901 --> 02:26:12,003 THEIR COMMITMENT IT IS NOW A 10 3659 02:26:12,003 --> 02:26:14,339 MILLION DOLLAR PROGRAM THAT WILL 3660 02:26:14,339 --> 02:26:16,641 PROVIDE SIGNIFICANT SUPPORT TO 3661 02:26:16,641 --> 02:26:18,043 PERFORMERS DEVELOPING 3662 02:26:18,043 --> 02:26:20,011 DIAGNOSTICS AND GOAL IS TO GET 3663 02:26:20,011 --> 02:26:22,247 TO QUANTITATIVE TESTS AT POINT 3664 02:26:22,247 --> 02:26:25,217 OF CARE LESS THAN 1,000 COPIES 3665 02:26:25,217 --> 02:26:28,253 PER MILL AND IDEALLY LIMITS 3666 02:26:28,253 --> 02:26:32,457 DETECTION THAT IS 200 COPIES PER 3667 02:26:32,457 --> 02:26:34,259 MILL. IF A COUPLE HUNDRED 3668 02:26:34,259 --> 02:26:34,993 COPIES PER MILL AND ON TREATMENT 3669 02:26:34,993 --> 02:26:37,529 YOU ARE CONSIDERED TO BE NOT 3670 02:26:37,529 --> 02:26:39,998 CONTAGIOUS AND IS AN IMPORTANT 3671 02:26:39,998 --> 02:26:42,501 FACTOR AND DON'T KNOW HOW COPY 3672 02:26:42,501 --> 02:26:44,336 NUMBERS FLUCTUATE OVER TIME AND 3673 02:26:44,336 --> 02:26:46,104 POINT OF CARE AND OVER COUNTER 3674 02:26:46,104 --> 02:26:48,106 TYPES OF APPROACHES WOULD ALLOW 3675 02:26:48,106 --> 02:26:50,275 US TO VISUALIZE DYNAMICS OF THAT 3676 02:26:50,275 --> 02:26:53,712 AND DO A BETTER JOB COUPLING 3677 02:26:53,712 --> 02:26:56,014 TREATMENT AND DIAGNOSIS AND 3678 02:26:56,014 --> 02:26:59,684 PRECISION-LED DIAGNOSTICS THAT 3679 02:26:59,684 --> 02:27:01,386 REALLY BUILDS ON PUCK TURN 3680 02:27:01,386 --> 02:27:03,021 PROGRAM AND STRENGTHENS 3681 02:27:03,021 --> 02:27:03,889 CONNECTIONS AND MULTIPLE 3682 02:27:03,889 --> 02:27:06,925 SUBJECTS WILL BE LOOKED AT AT 3683 02:27:06,925 --> 02:27:08,593 JOHNS HOPKINS AND CLINICAL 3684 02:27:08,593 --> 02:27:10,529 CAPABILITY STUDIES AND 3685 02:27:10,529 --> 02:27:12,197 MARKETPLACE LANDSCAPE AND 3686 02:27:12,197 --> 02:27:14,499 ANALYSIS AND SUBJECT MATTER 3687 02:27:14,499 --> 02:27:16,001 EXPERTS FROM NORTHWESTERN ARE 3688 02:27:16,001 --> 02:27:18,069 DEEPLY ENGAGED AND ANALYTICAL 3689 02:27:18,069 --> 02:27:19,471 TESTING AND HOME LABS EVALUATION 3690 02:27:19,471 --> 02:27:24,009 THAT IS ONGOING AND RAD X 3691 02:27:24,009 --> 02:27:25,710 PROJECTS APP KNEE CENTER AT 3692 02:27:25,710 --> 02:27:27,178 [INDISCERNIBLE] ARE PART OF 3693 02:27:27,178 --> 02:27:28,313 THIS. 3694 02:27:28,313 --> 02:27:30,181 SUPPORT TO REMIND EVERYONE WHEN 3695 02:27:30,181 --> 02:27:33,218 AT A PROGRAM IT IS NOT JUST 3696 02:27:33,218 --> 02:27:35,587 DOLLAR SUPPORT BUT THERE IS 3697 02:27:35,587 --> 02:27:37,722 ENORMOUS IN KIND RESOURCES WITH 3698 02:27:37,722 --> 02:27:39,724 PROFESSIONALS AND EXPERTS IN THE 3699 02:27:39,724 --> 02:27:42,861 SPACE DESIGNED TO HELP BOTH ON 3700 02:27:42,861 --> 02:27:44,195 TECHNOLOGY AND CLINICAL 3701 02:27:44,195 --> 02:27:45,397 APPLICATIONS AND CLINICAL TRIALS 3702 02:27:45,397 --> 02:27:47,198 AND MARKETS AND UNDERSTANDING 3703 02:27:47,198 --> 02:27:48,033 THOSE. 3704 02:27:48,033 --> 02:27:50,802 OF COURSE, THEN, COUPLING 3705 02:27:50,802 --> 02:27:52,203 STRONGLY INTO REGULATORY PATHWAY 3706 02:27:52,203 --> 02:27:54,039 THAT IS AN ULTIMATE GOAL AND YOU 3707 02:27:54,039 --> 02:27:59,077 WANT THESE THINGS TO GET OUT 3708 02:27:59,077 --> 02:28:03,014 INTO THE HANDS OF THE PUBLIC AS 3709 02:28:03,014 --> 02:28:04,115 QUICK AS POSSIBLE. 3710 02:28:04,115 --> 02:28:06,585 INTERESTING AND ASTOUNDING 3711 02:28:06,585 --> 02:28:07,819 STATISTIC EMERGING IN 3712 02:28:07,819 --> 02:28:09,087 NEURODISCUSSIONS IN WEEKLY 3713 02:28:09,087 --> 02:28:10,622 FUNDING PANEL MEETINGS IF YOU 3714 02:28:10,622 --> 02:28:13,358 HAVE USED -- HOW MANY HAVE USED 3715 02:28:13,358 --> 02:28:19,130 A COVID FLU MULTIPLEX TEST? 3716 02:28:19,130 --> 02:28:24,836 OKAY. ONLY HARDCORE. 3717 02:28:24,836 --> 02:28:27,572 100% OF TESTS ON MARKET AS OF 3718 02:28:27,572 --> 02:28:29,641 THIS DATE FROM THESE 3719 02:28:29,641 --> 02:28:31,142 MANUFACTURERS BOTH OVER THE 3720 02:28:31,142 --> 02:28:33,244 COUNTER AS WELL AS POINT OF CARE 3721 02:28:33,244 --> 02:28:35,146 HAVE GONE THROUGH THE RAD X 3722 02:28:35,146 --> 02:28:37,215 PROCESS AND CAPACITY FOR ALL OF 3723 02:28:37,215 --> 02:28:41,086 THESE TESTS IS UP TO 46 MILLION 3724 02:28:41,086 --> 02:28:42,554 TESTS PER WEEK AND A FEW OTHERS 3725 02:28:42,554 --> 02:28:45,190 ARE IN THE PIPELINE AND IT GETS 3726 02:28:45,190 --> 02:28:50,061 US UP TO 60 OR 65 MILLION PER 3727 02:28:50,061 --> 02:28:50,261 WEEK. 3728 02:28:50,261 --> 02:28:52,497 THIS IS AMAZING AND WE HAVE A 3729 02:28:52,497 --> 02:28:54,399 MOMENT IN TIME WITH BRAGGING 3730 02:28:54,399 --> 02:28:58,670 RIGHTS IN A SENSE FOR SUCH AN 3731 02:28:58,670 --> 02:29:01,206 IMPACTFUL I DON'T KNOW, 3732 02:29:01,206 --> 02:29:03,942 CONTRIBUTION TO TESTING AND 3733 02:29:03,942 --> 02:29:04,909 DIAGNOSTIC MARKET. 3734 02:29:04,909 --> 02:29:07,178 IT UNDERSCORES AMAZING WORK THAT 3735 02:29:07,178 --> 02:29:10,915 RAD X TEAMS ARE DOG AND THIS 3736 02:29:10,915 --> 02:29:14,285 WILL ULTIMATELY WE HOPE BECOME 3737 02:29:14,285 --> 02:29:16,621 MUCH MORE WIDELY DISSEMINATED IN 3738 02:29:16,621 --> 02:29:18,657 TEST TREAT PARADIGMS AND ONE 3739 02:29:18,657 --> 02:29:20,692 THING I DIDN'T MENTION IS THIS 3740 02:29:20,692 --> 02:29:22,460 IS FOR THIS FLU SEASON AND TESTS 3741 02:29:22,460 --> 02:29:25,030 HAVE BEEN AUTHORIZED IN PREVIOUS 3742 02:29:25,030 --> 02:29:26,297 FLU SEASONS AND THIS FLU SEASON 3743 02:29:26,297 --> 02:29:29,968 THIS IS 100% OF THE MULTIPLEX 3744 02:29:29,968 --> 02:29:30,335 TESTS. 3745 02:29:30,335 --> 02:29:32,203 IN THE SORT OF REOCCURRING 3746 02:29:32,203 --> 02:29:35,407 DISCUSSION THAT WE HAVE ABOUT IF 3747 02:29:35,407 --> 02:29:39,444 YOU TEST AND YOU ARE POSITIVE, 3748 02:29:39,444 --> 02:29:42,247 YOU WANT TO TREAT RIGHT AWAY AND 3749 02:29:42,247 --> 02:29:45,216 THIS PROGRAM TEST TO TREAT AND 3750 02:29:45,216 --> 02:29:47,585 TEFLT TO TREAT PILOT PROGRAM HAS 3751 02:29:47,585 --> 02:29:49,721 WRAPPED UP WITH ENORMOUS 3752 02:29:49,721 --> 02:29:49,988 SUCCESS. 3753 02:29:49,988 --> 02:29:52,624 WHAT IS REALLY INTERESTING, WE 3754 02:29:52,624 --> 02:29:55,360 HAD THESE TARGET IN 60,000. 3755 02:29:55,360 --> 02:29:58,430 WE HIT OVER 80,000. 3756 02:29:58,430 --> 02:30:00,765 WE HAD TELEHEALTH VISITS AND 3757 02:30:00,765 --> 02:30:03,301 AGAIN TARGETS BETWEEN 5 AND 3758 02:30:03,301 --> 02:30:05,704 6,000 AND 8600 TARGET VISITS 3759 02:30:05,704 --> 02:30:08,239 THAT WERE ACTUALLY ACHIEVED. 3760 02:30:08,239 --> 02:30:10,508 EXCEEDING ALL THE EXPECTED 3761 02:30:10,508 --> 02:30:12,077 PROJECTED GOALS AND TARGETS WITH 3762 02:30:12,077 --> 02:30:14,145 A REALLY INTERESTING SURGE THAT 3763 02:30:14,145 --> 02:30:15,980 TOOK PLACE IN APRIL AND ANDREW 3764 02:30:15,980 --> 02:30:18,416 HAS ANALYZED THIS DATA VERY 3765 02:30:18,416 --> 02:30:20,085 CAREFULLY AND ANDREW IF YOU CAN 3766 02:30:20,085 --> 02:30:21,886 STAND UP AND I DON'T KNOW IF 3767 02:30:21,886 --> 02:30:23,588 PEOPLE HAVE QUESTIONS THIS IS AN 3768 02:30:23,588 --> 02:30:24,456 AMAZING PROGRAM. 3769 02:30:24,456 --> 02:30:28,226 WE ARE TOTALLY OUT OF OUR SWIM 3770 02:30:28,226 --> 02:30:30,595 LANE HERE IN SOME SENSE AND 3771 02:30:30,595 --> 02:30:31,629 ANDREW AND COLLEAGUES HAVE BUILT 3772 02:30:31,629 --> 02:30:33,932 UP THIS PARTNERSHIP WITH 3773 02:30:33,932 --> 02:30:35,467 MULTIPLE FEDERAL AGENCIES THAT 3774 02:30:35,467 --> 02:30:37,702 ARE VERY INTERESTED IN DIFFERENT 3775 02:30:37,702 --> 02:30:39,104 FACETS OF PROBLEM. 3776 02:30:39,104 --> 02:30:40,872 FROM OUR PERSPECTIVE WE CHECKED 3777 02:30:40,872 --> 02:30:43,475 ALL OF THE BOXES ON TECHNICAL 3778 02:30:43,475 --> 02:30:44,542 FEASIBILITY AND KNOW THIS CAN BE 3779 02:30:44,542 --> 02:30:48,012 DONE AND CAN BE DONE WITH 3780 02:30:48,012 --> 02:30:51,983 NUCLEIC ACID TESTS THIS IS 3781 02:30:51,983 --> 02:30:55,553 LOSERA OVER THE COUNTER NUCLEIC 3782 02:30:55,553 --> 02:30:58,323 ACID TESTS AND ANDREW CAN YOU 3783 02:30:58,323 --> 02:30:59,724 HELP INTERPRET AT THE TOP HERE 3784 02:30:59,724 --> 02:31:01,993 IS A LITTLE NEWS STORY FROM 3785 02:31:01,993 --> 02:31:03,461 FORBES AND WILL TURN IT OVER TO 3786 02:31:03,461 --> 02:31:07,999 YOU TO TELL A LITTLE ABOUT THE 3787 02:31:07,999 --> 02:31:10,368 STO 3788 02:31:10,368 --> 02:31:10,769 STORY. 3789 02:31:10,769 --> 02:31:14,672 IT IS A NEW MEASURE OF SUCCESS. 3790 02:31:14,672 --> 02:31:16,508 >> THANK YOU, BRUCE. 3791 02:31:16,508 --> 02:31:18,710 YEAH. WE ALWAYS ADVERTIZED THIS 3792 02:31:18,710 --> 02:31:20,779 PROGRAM AS A PILOT. 3793 02:31:20,779 --> 02:31:22,914 MOSTLY REALLY DUE TO LIMITED 3794 02:31:22,914 --> 02:31:24,249 FUNDING AND HAD ALSO OUR 3795 02:31:24,249 --> 02:31:26,084 RESEARCH GOALS WE WANTED TO MEET 3796 02:31:26,084 --> 02:31:29,954 AT NIH AND PARTNERED WITH CDC 3797 02:31:29,954 --> 02:31:32,090 WHO OF COURSE HAD THE PUBLIC 3798 02:31:32,090 --> 02:31:33,725 HEALTH DRIVE FOR DOING THIS. 3799 02:31:33,725 --> 02:31:36,161 UPON REALLY MAKING A FORMAL 3800 02:31:36,161 --> 02:31:37,562 ANNOUNCEMENT THAT THE PROGRAM 3801 02:31:37,562 --> 02:31:40,532 WAS SHUTTING DOWN AND THERE WAS 3802 02:31:40,532 --> 02:31:42,500 AN ALMOST SUPPORT AND WE WERE 3803 02:31:42,500 --> 02:31:43,935 CONTACTED BY FORBES ABOUT WHY 3804 02:31:43,935 --> 02:31:45,904 WAS THIS HAPPENING AND THERE WAS 3805 02:31:45,904 --> 02:31:49,440 A LOT OF ORGANIZATIONS AND THERE 3806 02:31:49,440 --> 02:31:51,276 WAS ACTUALLY LOOKS LIKE A LETTER 3807 02:31:51,276 --> 02:31:53,545 BEING WRITTEN AND SUBMIT TODAY 3808 02:31:53,545 --> 02:31:55,814 NIH DIRECTOR ASKING TO KEEP 3809 02:31:55,814 --> 02:31:58,082 PROGRAM GOING THAT HAS 200 3810 02:31:58,082 --> 02:31:59,184 SIGNATURES AND 20 COMPANIES ON 3811 02:31:59,184 --> 02:31:59,417 BOARD. 3812 02:31:59,417 --> 02:32:01,719 YOU KNOW, THERE IS A NEED FOR 3813 02:32:01,719 --> 02:32:03,221 THESE TYPES OF PROGRAMS AND WE 3814 02:32:03,221 --> 02:32:06,191 ARE IN DISCUSSIONS WITH CDC AND 3815 02:32:06,191 --> 02:32:07,859 HAVING THEM MAYBE PICK THIS UP 3816 02:32:07,859 --> 02:32:09,661 AND CONTINUE WITH OTHER PROGRAMS 3817 02:32:09,661 --> 02:32:11,996 AND THIS CALENDAR YEAR THERE IS 3818 02:32:11,996 --> 02:32:13,731 STILL SOME OTHER SUBSIDIES IN 3819 02:32:13,731 --> 02:32:17,335 PLACE FOR UNINSURED INDIVIDUALS 3820 02:32:17,335 --> 02:32:19,237 AND SCOPE TO ACCESS SERVICES AND 3821 02:32:19,237 --> 02:32:21,406 END OF PUBLIC HEALTH EMERGENCY 3822 02:32:21,406 --> 02:32:23,474 AND THIS IS NOW SLOWLY GOING 3823 02:32:23,474 --> 02:32:24,809 AWAY AND NEED IS THERE AND 3824 02:32:24,809 --> 02:32:26,077 PEOPLE WANT IT AND IT WAS GREAT 3825 02:32:26,077 --> 02:32:28,313 TO SEE THAT INTEREST FROM THE 3826 02:32:28,313 --> 02:32:30,014 COMMUNITY OVER THE NEXT 6 MONTHS 3827 02:32:30,014 --> 02:32:32,984 IS WE COLLECTED DATA ANALYSIS 3828 02:32:32,984 --> 02:32:34,586 PROGRAM THAT ENDED A FEW WEEKS 3829 02:32:34,586 --> 02:32:36,888 AGO AND LOOK OUT IN THE NEXT FEW 3830 02:32:36,888 --> 02:32:38,690 MONTHS FOR FINDINGS BEING 3831 02:32:38,690 --> 02:32:39,958 PUBLISHED IN TRADITIONAL 3832 02:32:39,958 --> 02:32:43,027 ACADEMIC JOURNALS AND WE HAD A 3833 02:32:43,027 --> 02:32:44,529 GRASSROOTS WORK WITH THE 3834 02:32:44,529 --> 02:32:45,830 COMMUNITY FOR RECRUITING PEOPLE 3835 02:32:45,830 --> 02:32:48,733 IN THE PROGRAM AND WILL BE 3836 02:32:48,733 --> 02:32:50,001 DISSEMINATING FINDINGS THROUGH 3837 02:32:50,001 --> 02:32:51,970 THOSE KIND OF MORE GRASSROOTS 3838 02:32:51,970 --> 02:32:53,037 COMMUNITY CHANNELS. 3839 02:32:53,037 --> 02:32:54,205 >> THANK YOU ANDREW. 3840 02:32:54,205 --> 02:32:57,141 WHAT IS AMAZING TO ME IS WE ARE 3841 02:32:57,141 --> 02:33:00,011 VERY COMFORTABLE IN WORKING ON 3842 02:33:00,011 --> 02:33:01,512 TECHNICAL PROBLEMS AND WORKING 3843 02:33:01,512 --> 02:33:03,748 ON SYMPTOMS AND WILL HAVE A 3844 02:33:03,748 --> 02:33:05,483 DISCOVERY ABOUT SOMETHING THAT 3845 02:33:05,483 --> 02:33:07,285 IS REALLY INTERESTING AND TELL 3846 02:33:07,285 --> 02:33:08,686 FRIENDS AND MAYBE WILL STOP THAT 3847 02:33:08,686 --> 02:33:11,122 PROGRAM AND, YOU KNOW, A 3848 02:33:11,122 --> 02:33:12,557 COLLEAGUE MAYBE WILL SAY SAD TO 3849 02:33:12,557 --> 02:33:15,126 SEE YOU ENDED THAT RESEARCH 3850 02:33:15,126 --> 02:33:15,326 LINE. 3851 02:33:15,326 --> 02:33:17,896 IT IS NOT VERY -- NO ONE REALLY 3852 02:33:17,896 --> 02:33:18,696 CARES THAT MUCH. 3853 02:33:18,696 --> 02:33:20,298 YOU KNOW? 3854 02:33:20,298 --> 02:33:22,133 IT IS SO NARROW COMMUNITY AND 3855 02:33:22,133 --> 02:33:25,003 WHEN WE STEPPED OUT SORT OF INTO 3856 02:33:25,003 --> 02:33:26,271 THIS INTERSECTION BETWEEN A 3857 02:33:26,271 --> 02:33:28,506 STRONG PUBLIC HEALTH NEED AND 3858 02:33:28,506 --> 02:33:32,777 PROVIDING A SERVICE, THEN WE 3859 02:33:32,777 --> 02:33:34,479 REALLY SAW THIS RESPONSE WHERE 3860 02:33:34,479 --> 02:33:36,314 ARTICLES ARE COMING OUT AND 3861 02:33:36,314 --> 02:33:37,215 PEOPLE ARE VERY DISAPPOINTED 3862 02:33:37,215 --> 02:33:39,350 THAT WE ARE ENDING THIS PROGRAM 3863 02:33:39,350 --> 02:33:41,386 AND OUR GOAL WITH THE PROGRAM 3864 02:33:41,386 --> 02:33:43,821 WAS TO UNDERSTAND TECHNICAL GOAL 3865 02:33:43,821 --> 02:33:45,123 AND FEASIBILITY. 3866 02:33:45,123 --> 02:33:47,592 IT IS KIND OF OPENED MY EYES UP 3867 02:33:47,592 --> 02:33:49,527 TO DIFFERENT POTENTIAL IMPACTS 3868 02:33:49,527 --> 02:33:51,195 WE HAVE IN PUBLIC HEALTH. 3869 02:33:51,195 --> 02:33:55,667 >> THANKS, ANDREW. 3870 02:33:55,667 --> 02:34:00,371 >> SO SWITCHING TO THE TRAINING 3871 02:34:00,371 --> 02:34:02,707 AND DISSEMINATION TOPIC AND OF 3872 02:34:02,707 --> 02:34:04,575 COURSE YOU KNOW FOR THOSE OF YOU 3873 02:34:04,575 --> 02:34:06,577 WHO ARE SUPPORTING TRAINEES, 3874 02:34:06,577 --> 02:34:09,180 THIS IS A REALLY BIG, BIG ITEM 3875 02:34:09,180 --> 02:34:11,482 THAT HAS CUT ACROSS ALL OF NIH 3876 02:34:11,482 --> 02:34:15,153 AND ALL ACROSS THE FEDERAL 3877 02:34:15,153 --> 02:34:16,754 SPACE. 3878 02:34:16,754 --> 02:34:18,990 NRSA PAY LEVEL INCREASES AND HOW 3879 02:34:18,990 --> 02:34:21,359 YOU WILL MANAGE AND TRACK THAT 3880 02:34:21,359 --> 02:34:24,796 WITHIN YOUR GRANT PORTFOLIOS AND 3881 02:34:24,796 --> 02:34:26,998 IMPACT ON YOU AS AN INVESTIGATOR 3882 02:34:26,998 --> 02:34:29,167 I REALLY ENCOURAGE YOU TO GET IN 3883 02:34:29,167 --> 02:34:32,837 TOUCH WITH DANA AND TINA AND 3884 02:34:32,837 --> 02:34:34,706 DAVE TO THINK THROUGH THAT. 3885 02:34:34,706 --> 02:34:36,641 WE WILL SEE ANOTHER STAGE AND 3886 02:34:36,641 --> 02:34:38,943 CURRENTLY HAVE 4% AND 8 3887 02:34:38,943 --> 02:34:40,244 INCREASES IN PRE AND POST 3888 02:34:40,244 --> 02:34:42,380 DOCTORAL FELLOWS THAT ARE IN THE 3889 02:34:42,380 --> 02:34:42,947 CURRENT YEAR. 3890 02:34:42,947 --> 02:34:46,451 WE ARE GOING TO SEE MORE 3891 02:34:46,451 --> 02:34:47,418 INCREASES TO COME WITH THE 3892 02:34:47,418 --> 02:34:51,990 ADVISORY COUNCIL TO THE DIRECTOR 3893 02:34:51,990 --> 02:34:55,193 REALLY SUGGESTING AROUND A 3894 02:34:55,193 --> 02:34:57,128 $70,000 PAY LEVEL FOR POST 3895 02:34:57,128 --> 02:34:58,196 DOCTORAL FELLOWS AND IS A 3896 02:34:58,196 --> 02:35:02,033 TARGETED STRATEGY TO GET TO THAT 3897 02:35:02,033 --> 02:35:03,568 COMING FROM NIH. 3898 02:35:03,568 --> 02:35:07,071 THAT WILL HAPPEN OVER TIME. 3899 02:35:07,071 --> 02:35:11,943 AND JUST AS A REMINDER OF THE 3900 02:35:11,943 --> 02:35:14,746 ENORMITY OF THIS THERE IS 100 -- 3901 02:35:14,746 --> 02:35:16,714 17 THOUSAND NSA SCHOLARS ACROSS 3902 02:35:16,714 --> 02:35:20,518 THE NIH AND 180 WITHIN NIBIB. 3903 02:35:20,518 --> 02:35:26,057 SO WE REISSUED THE ESTEEMED AND 3904 02:35:26,057 --> 02:35:27,959 TEAM-BASED DESIGN PROGRAMS. 3905 02:35:27,959 --> 02:35:29,427 THESE HAVE GROWN OVER THE LAST 3906 02:35:29,427 --> 02:35:31,496 SEVERAL YEARS AND WE ARE REALLY 3907 02:35:31,496 --> 02:35:33,798 PROUD OF THEM AND ESTEEMED 3908 02:35:33,798 --> 02:35:35,800 PROGRAM HAS 16 BOARDS INCLUDING 3909 02:35:35,800 --> 02:35:39,003 A NEW AWARD AT LOUISIANA STATE 3910 02:35:39,003 --> 02:35:42,373 UNIVERSITY AND RENEWAL OF UP SAN 3911 02:35:42,373 --> 02:35:45,209 ANTONIO PROGRAM AND TEAM BASED 3912 02:35:45,209 --> 02:35:48,513 DESIGN IS ANOTHER R25 AND ARE 19 3913 02:35:48,513 --> 02:35:50,915 PROGRAMS NOW WITH 4 PENDING 3914 02:35:50,915 --> 02:35:51,215 AWARDS. 3915 02:35:51,215 --> 02:35:53,885 SO PLEASE CONTACT TINA AND DAVE. 3916 02:35:53,885 --> 02:35:55,820 WE ARE REALLY HOPEFUL TO BE ABLE 3917 02:35:55,820 --> 02:35:57,755 TO CONTINUE TO GROW THIS NETWORK 3918 02:35:57,755 --> 02:36:00,391 AND THINK IT PLAYS A VERY, VERY 3919 02:36:00,391 --> 02:36:02,527 IMPORTANT ROLE IN EXPANDING OUR 3920 02:36:02,527 --> 02:36:03,995 COMMUNITY AND PIPELINE AND 3921 02:36:03,995 --> 02:36:07,198 OPPORTUNITIES FOR OUR 3922 02:36:07,198 --> 02:36:08,166 INVESTIGATORS. 3923 02:36:08,166 --> 02:36:09,901 RELATED TO THAT AND WE TALKED 3924 02:36:09,901 --> 02:36:12,603 ABOUT THIS A LITTLE WITH DR. 3925 02:36:12,603 --> 02:36:15,206 CLAYTON BEING HERE IS KIND OF 3926 02:36:15,206 --> 02:36:17,675 OUR CORE CURRICULUM IN A SENSE. 3927 02:36:17,675 --> 02:36:19,110 THERE IS THE DESIGN PROJECTS 3928 02:36:19,110 --> 02:36:21,546 THAT STUDENTS ARE ALL ENGAGED IN 3929 02:36:21,546 --> 02:36:24,048 AND ANNOUNCING THIS AGAIN AND 3930 02:36:24,048 --> 02:36:26,384 REMINDING EVERYONE OF THE MAY 3931 02:36:26,384 --> 02:36:28,152 31ST SUBMISSION DATE WE HOPE TO 3932 02:36:28,152 --> 02:36:30,721 SEE LOTS OF APPLICATIONS AND 3933 02:36:30,721 --> 02:36:33,724 160,$160,000 IN PRIZES THIS YEAD 3934 02:36:33,724 --> 02:36:36,194 MANY INSTITUTES ARE PART OF 3935 02:36:36,194 --> 02:36:36,594 THIS. 3936 02:36:36,594 --> 02:36:41,265 THERE IS $120,000 FIRST PRICE 3937 02:36:41,265 --> 02:36:47,071 AND $815,000 PRIZES AND WORKING 3938 02:36:47,071 --> 02:36:49,173 THE IMAGINE OUT STUDENTS HAVE 3939 02:36:49,173 --> 02:36:51,209 PRETTY GOOD ODDS TO GET ONE OF 3940 02:36:51,209 --> 02:36:55,379 THESE AWARDS AND THERE IS A 3941 02:36:55,379 --> 02:36:55,880 $10, 3942 02:36:55,880 --> 02:36:59,283 $100,005,000 PRIZE AND $15,000 3943 02:36:59,283 --> 02:37:00,318 HONORABLE PRIZE AND FAIR AMOUNT 3944 02:37:00,318 --> 02:37:02,153 OF MONEY GOING DIRECTLY INTO 3945 02:37:02,153 --> 02:37:03,988 BANK ACCOUNT OF STUDENTS AND 3946 02:37:03,988 --> 02:37:05,523 THEY SHOULD BE EXCITED ABOUT 3947 02:37:05,523 --> 02:37:05,890 THAT. 3948 02:37:05,890 --> 02:37:07,992 THERE IS ENORMOUS SUCCESS WITH 3949 02:37:07,992 --> 02:37:09,694 STUDENTS THAT I WILL PULL OUT 3950 02:37:09,694 --> 02:37:12,497 THIS 20202 DEBUT CHALLENGE 3951 02:37:12,497 --> 02:37:15,199 AWARDEE SUPPORTED BY NCI AND WAS 3952 02:37:15,199 --> 02:37:17,869 THEIR TOP AWARD AND $15,000 3953 02:37:17,869 --> 02:37:20,338 AWARD FROM NATIONAL CANS 3954 02:37:20,338 --> 02:37:24,375 INSTITUTE FROM TECHNO WILLING TO 3955 02:37:24,375 --> 02:37:26,978 STABILIZE SKULL AND NEUROSURGERY 3956 02:37:26,978 --> 02:37:29,780 PARTICULARLY NEUROSURGERY FOR 3957 02:37:29,780 --> 02:37:31,349 TUMORS AAND THAT COMPANY WAS 3958 02:37:31,349 --> 02:37:34,919 LAUNCHED AND WENT THROUGH C3I 3959 02:37:34,919 --> 02:37:36,487 BOOT CAMP AND CHALLENGE AND HERE 3960 02:37:36,487 --> 02:37:38,689 WE HAVE ACTUALLY ALL STUCK WITH 3961 02:37:38,689 --> 02:37:38,956 IT. 3962 02:37:38,956 --> 02:37:43,094 THEY -- IN MED SCHOOL AND GRAD 3963 02:37:43,094 --> 02:37:48,366 SCHOOL. HERE IS ALLIE THEY 3964 02:37:48,366 --> 02:37:50,768 RENAMED COMPANY XANDER MEDICAL 3965 02:37:50,768 --> 02:37:54,639 IS RENAMED AND SHE IS A GRADUATE 3966 02:37:54,639 --> 02:37:55,840 AT NORTHEASTERN WORKING ON 3967 02:37:55,840 --> 02:37:59,577 ADVANCING AND DEVELOPING AND 3968 02:37:59,577 --> 02:38:00,411 COMMERCIALIZING THIS TECHNOLOGY 3969 02:38:00,411 --> 02:38:03,514 WITH UPDATED PROTOTYPES AND AS 3970 02:38:03,514 --> 02:38:05,650 YOU KNOW STUDENTS GET HOOKED ON 3971 02:38:05,650 --> 02:38:07,518 THESE THINGS AT EARLY STAGES IN 3972 02:38:07,518 --> 02:38:09,620 THEIR CAREER AND ARE LESSONS 3973 02:38:09,620 --> 02:38:10,922 THEY LEARN AND CONTINUE TO WORK 3974 02:38:10,922 --> 02:38:13,624 ON AS THEY PROGRESS IN WHATEVER 3975 02:38:13,624 --> 02:38:15,226 TRAINING OPPORTUNITY THAT THEY 3976 02:38:15,226 --> 02:38:16,727 ARE PURSUING. 3977 02:38:16,727 --> 02:38:19,997 WE HAVE A NEW CONFERENCE AWARD 3978 02:38:19,997 --> 02:38:22,733 PROGRAM LAUNCHED BY ALBERT 3979 02:38:22,733 --> 02:38:25,002 AVILLA AND ARE HOPING TO MAKE 3980 02:38:25,002 --> 02:38:26,637 SOMEWHERE BETWEEN 20 AND 40 3981 02:38:26,637 --> 02:38:28,940 AWARDS PER YEAR AND IT IS NOT AN 3982 02:38:28,940 --> 02:38:30,374 ENORMOUS AMOUNT OF MONEY FOR 3983 02:38:30,374 --> 02:38:33,377 EACH STUDENT AND IT IS WHAT WE 3984 02:38:33,377 --> 02:38:35,346 CAN AFFORD AND IS REASONABLE FOR 3985 02:38:35,346 --> 02:38:38,115 CONFERENCES THAT IS UP TO $1500 3986 02:38:38,115 --> 02:38:39,584 IN SUPPORT. 3987 02:38:39,584 --> 02:38:42,220 IDEA IS TO GET STUDENTS TO 3988 02:38:42,220 --> 02:38:45,056 CONFERENCES AND WE HAVE SORT OF 3989 02:38:45,056 --> 02:38:46,757 SUGGESTED FOUR MAJOR ONES OVER 3990 02:38:46,757 --> 02:38:49,827 COURSE OF YEAR AND BMES MEETING 3991 02:38:49,827 --> 02:38:53,130 AND PLATONICS WEST AND MEDICAL 3992 02:38:53,130 --> 02:38:54,699 IMAGING MEETING AND SOCIETY 3993 02:38:54,699 --> 02:38:56,500 PROVIDING MATERIALS AND ARE NOT 3994 02:38:56,500 --> 02:38:58,436 CONSTRAINING IT TO THESE. 3995 02:38:58,436 --> 02:38:59,370 WE SUGGESTED THESE BECAUSE THESE 3996 02:38:59,370 --> 02:39:02,573 ARE WHERE NIBIB PROGRAM FOLKS GO 3997 02:39:02,573 --> 02:39:04,542 AND GOAL IS NOT JUST TO GET 3998 02:39:04,542 --> 02:39:07,745 STUDENTS TO CONFERENCES TO SEE 3999 02:39:07,745 --> 02:39:09,113 SCIENTIFIC CONTENT AND ENGAGED. 4000 02:39:09,113 --> 02:39:11,349 THAT IS PART OF IT AND IT IS TO 4001 02:39:11,349 --> 02:39:14,619 MEET WITH NIBIB PROGRAM FOLKS 4002 02:39:14,619 --> 02:39:17,555 AND PARTICIPANTS AT THAT 4003 02:39:17,555 --> 02:39:19,090 CONFERENCE AND GET EXCLUSIVE 4004 02:39:19,090 --> 02:39:20,591 ATTENTION ABOUT WHERE CAN I GO 4005 02:39:20,591 --> 02:39:23,127 AND WHERE ARE OPPORTUNITIES AND 4006 02:39:23,127 --> 02:39:25,229 HOW DO YOU GET FUNDING AT 4007 02:39:25,229 --> 02:39:26,597 DIFFERENT STAGES IN YOUR CAREER 4008 02:39:26,597 --> 02:39:29,233 TO BEGIN THAT DIALOGUE AND THIS 4009 02:39:29,233 --> 02:39:32,003 IS DESIGNED TO BE STIMULATORY TO 4010 02:39:32,003 --> 02:39:35,139 OUR COMMUNITY TO HELP, AGAIN, 4011 02:39:35,139 --> 02:39:36,474 ACCELERATE THAT PIPELINE AND ARE 4012 02:39:36,474 --> 02:39:38,142 INTERESTED IN YOUR THOUGHTS ON 4013 02:39:38,142 --> 02:39:39,977 THAT AND HOPEFULLY YOU WILL 4014 02:39:39,977 --> 02:39:41,479 NOMINATE AND POINT THIS OUT TO 4015 02:39:41,479 --> 02:39:42,546 VARIOUS STUDENTS. 4016 02:39:42,546 --> 02:39:46,350 WE ARE EXCITED TO GET THIS 4017 02:39:46,350 --> 02:39:48,019 PROGRAM LAUNCHED. 4018 02:39:48,019 --> 02:39:50,721 BIOMEDICAL ENGINEERING SUMMER 4019 02:39:50,721 --> 02:39:54,892 INTERN SHL PROGRAM AND MANU 4020 02:39:54,892 --> 02:39:57,728 REALLY EXPANDED SCOPE OF THIS 4021 02:39:57,728 --> 02:40:00,798 AND IS EXCITING AND FRUSTRATING 4022 02:40:00,798 --> 02:40:03,434 IN WAY TO SEE MORE THAN 200 4023 02:40:03,434 --> 02:40:04,802 APPLICATIONS WERE RECEIVED AND 4024 02:40:04,802 --> 02:40:07,371 THANKS TO YOU AND OUR COMMUNITY 4025 02:40:07,371 --> 02:40:09,373 FOR GETTING WORD OUT AND WE ARE 4026 02:40:09,373 --> 02:40:11,242 EXPANDING BEYOND BIOMEDICAL 4027 02:40:11,242 --> 02:40:13,411 ENGINEERING STUDENTS GOING INTO 4028 02:40:13,411 --> 02:40:14,945 MANY DIFFERENT AREAS. 4029 02:40:14,945 --> 02:40:22,286 THERE IS 2 24 INTERNS THAT HAVE 4030 02:40:22,286 --> 02:40:23,721 BEEN SELECTED THAT IS UP 16 FROM 4031 02:40:23,721 --> 02:40:26,057 LAST YEAR AND WOULD LIKE THAT 4032 02:40:26,057 --> 02:40:27,525 ACCEPTANCE RATE UP HIGHER IF WE 4033 02:40:27,525 --> 02:40:28,025 CAN. 4034 02:40:28,025 --> 02:40:30,161 WE ARE COMMITTED TO THAT. 4035 02:40:30,161 --> 02:40:32,063 WE ARE CERTAINLY HAPPY TO GO 4036 02:40:32,063 --> 02:40:33,731 AROUND TO OTHER INSTITUTES AND 4037 02:40:33,731 --> 02:40:35,933 CENTERS AND SEE IF THEY CAN 4038 02:40:35,933 --> 02:40:38,369 CONTRIBUTE TO THE SUPPORT AND, 4039 02:40:38,369 --> 02:40:40,271 AGAIN, AS I MENTIONED 4040 02:40:40,271 --> 02:40:43,107 ELIGIBILITY IS OPEN TO ALL 4041 02:40:43,107 --> 02:40:45,142 UNDERGRADUATE STUDENTS AND BME 4042 02:40:45,142 --> 02:40:47,044 AND STEM MAJORS AND 4043 02:40:47,044 --> 02:40:48,112 REPRESENTATION FROM 21 DIFFERENT 4044 02:40:48,112 --> 02:40:49,647 COLLEGES AND UNIVERSITIES AND 4045 02:40:49,647 --> 02:40:52,183 THIS IS REALLY EXCITING AND SO 4046 02:40:52,183 --> 02:40:54,785 IT IS STARTING AT THE BEGINNING 4047 02:40:54,785 --> 02:40:55,519 OF JUNE. 4048 02:40:55,519 --> 02:40:57,621 ANOTHER PROGRAM THAT WE HAVE 4049 02:40:57,621 --> 02:40:59,724 BEEN TALKING ABOUT AND THATMONA 4050 02:40:59,724 --> 02:41:02,293 HAS BEEN INSTRUMENTAL IN GETTING 4051 02:41:02,293 --> 02:41:04,628 THIS LAUNCHED IS SO HAS ANNE AND 4052 02:41:04,628 --> 02:41:07,798 EXECUTIVE OFFICER AND WHOLE 4053 02:41:07,798 --> 02:41:08,799 ADMINISTRATIVE MANAGEMENT TEAM. 4054 02:41:08,799 --> 02:41:11,702 THIS IS A COMPLEX MOVE AND SOME 4055 02:41:11,702 --> 02:41:13,738 KNOW THAT NSF HAS GRADUATE 4056 02:41:13,738 --> 02:41:15,339 INTERN PROGRAMS AND IF YOU ARE 4057 02:41:15,339 --> 02:41:18,142 AN NSF SUPPORTED GRADUATE 4058 02:41:18,142 --> 02:41:19,977 STUDENT ON A PI'S GRANT OR IF 4059 02:41:19,977 --> 02:41:22,213 YOU HAVE OWN GRADUATE RESEARCH 4060 02:41:22,213 --> 02:41:24,615 FELLOWSHIP YOU CAN DO AN 4061 02:41:24,615 --> 02:41:27,551 INTERNSHIP FOR 6 MONTHS PAID AT 4062 02:41:27,551 --> 02:41:28,819 NATIONAL LABS AROUND THE 4063 02:41:28,819 --> 02:41:29,820 COUNTRY. 4064 02:41:29,820 --> 02:41:31,555 OKAY. WE ARE A NATIONAL LAB 4065 02:41:31,555 --> 02:41:33,724 HERE AT NIH. 4066 02:41:33,724 --> 02:41:35,693 SO, WE THOUGHT THAT WE NEEDED TO 4067 02:41:35,693 --> 02:41:38,162 REALLY KIND OF GET ENGAGED IN 4068 02:41:38,162 --> 02:41:38,596 THIS. 4069 02:41:38,596 --> 02:41:40,698 OF COURSE SUSAN OUR CLOSE 4070 02:41:40,698 --> 02:41:42,566 COLLEAGUE HEAD OF NSF 4071 02:41:42,566 --> 02:41:44,468 ENGINEERING DIRECTOR WORKED WITH 4072 02:41:44,468 --> 02:41:46,237 US TO MAKE THIS HAPPEN. 4073 02:41:46,237 --> 02:41:48,572 OVER THE NEXT COUPLE OF YEARS, 4074 02:41:48,572 --> 02:41:51,242 WE WILL PARTNER WITH THEM AND 4075 02:41:51,242 --> 02:41:53,644 HOPE TO FUND ANYWHERE BETWEEN 8 4076 02:41:53,644 --> 02:41:55,079 AND 10 INTERNSHIPS OVER THIS 4077 02:41:55,079 --> 02:41:55,980 PERIOD OF TIME. 4078 02:41:55,980 --> 02:41:58,249 AS YOU HAVE PROBABLY HEARD 4079 02:41:58,249 --> 02:42:00,418 ALREADY FROM MANU, YOU KNOW, HE 4080 02:42:00,418 --> 02:42:02,586 HAS GONE AROUND AND ORGANIZED 4081 02:42:02,586 --> 02:42:03,687 THESE EVENTS AND TRIED TO 4082 02:42:03,687 --> 02:42:04,655 UNDERSTAND WHAT PEOPLE ARE 4083 02:42:04,655 --> 02:42:07,992 LOOKING FOR IN THE IRP AND MANU, 4084 02:42:07,992 --> 02:42:09,927 I DON'T WANT TO -- YOU SHOULD 4085 02:42:09,927 --> 02:42:10,127 TELL. 4086 02:42:10,127 --> 02:42:15,232 WHAT ARE PEOPLE LOOKING FOR. 4087 02:42:15,232 --> 02:42:21,238 >> [INDISCERNIBLE]. 4088 02:42:21,238 --> 02:42:23,908 >> LOOKING FOR EVERYTHING. 4089 02:42:23,908 --> 02:42:25,810 GREAT ANSWER. IF YOU CAN 4090 02:42:25,810 --> 02:42:27,778 IMAGINE GREAT SPONSOR FROM DATA 4091 02:42:27,778 --> 02:42:29,280 CENTER AND LOOKING FOR PEOPLE 4092 02:42:29,280 --> 02:42:31,415 DOING IMAGE ANALYSIS AND 4093 02:42:31,415 --> 02:42:33,017 PROCESSING AND AI AND MACHINE 4094 02:42:33,017 --> 02:42:34,618 LEARNING AND LOOKING FOR PEOPLE 4095 02:42:34,618 --> 02:42:37,087 DOING SOFT BIOMATERIALS AND 4096 02:42:37,087 --> 02:42:41,592 CENSUS AND GREAT MRI PEOPLE ON 4097 02:42:41,592 --> 02:42:45,162 KAN ZAGS SDAS AND PROCESSING 4098 02:42:45,162 --> 02:42:46,931 IMAGES LOOKING FOR EVERYTHING. 4099 02:42:46,931 --> 02:42:50,234 AGAIN, ALL THINGS WE DO THEN 4100 02:42:50,234 --> 02:42:51,802 THAT IS WHAT IR INVESTIGATORS 4101 02:42:51,802 --> 02:42:54,605 ARE LOOKING FOR AND SEND 4102 02:42:54,605 --> 02:42:55,973 STUDENTS WE HAVE SEEN NUMBER 4103 02:42:55,973 --> 02:42:57,041 INQUIRIES ALREADY AND THIS IS AN 4104 02:42:57,041 --> 02:42:59,009 EXCITING LAUNCH THAT WE ARE 4105 02:42:59,009 --> 02:43:00,444 TRYING TO MANAGE. 4106 02:43:00,444 --> 02:43:01,645 >> THANK YOU MANU. 4107 02:43:01,645 --> 02:43:03,881 I MEAN, THAT -- I THINK THAT 4108 02:43:03,881 --> 02:43:06,517 REALLY UNDERSCORES KIND OF WHAT 4109 02:43:06,517 --> 02:43:08,052 WE HAVE ALL FELT VERY STRONGLY 4110 02:43:08,052 --> 02:43:10,855 AND WE THINK THIS IS A KIND OF A 4111 02:43:10,855 --> 02:43:12,823 FAST TRACK TO BEING ABLE TO HELP 4112 02:43:12,823 --> 02:43:15,726 CHANGE THE CULTURE A LITTLE BIT 4113 02:43:15,726 --> 02:43:17,995 WITHIN THE IRP PROGRAM TO BRING 4114 02:43:17,995 --> 02:43:20,297 IN A BUNCH OF ENGINEERING AND 4115 02:43:20,297 --> 02:43:22,967 PHYSICAL SCIENCE STUDENTS INTO 4116 02:43:22,967 --> 02:43:26,804 OUR UNIVERSE YEAR AND HELP WITH 4117 02:43:26,804 --> 02:43:28,839 ACCELERATING TRAINING AND 4118 02:43:28,839 --> 02:43:30,641 BIOMEDICAL PROBLEMS IN A UNIQUE 4119 02:43:30,641 --> 02:43:32,810 ENVIRONMENT WITH CLINICAL CENTER 4120 02:43:32,810 --> 02:43:34,211 AND COLLABORATIVE OPPORTUNITIES 4121 02:43:34,211 --> 02:43:35,980 AND ARE PRETTY GOOD AWARDS AND 4122 02:43:35,980 --> 02:43:40,017 IS UP TO $55,000 PER STUDENT OR 4123 02:43:40,017 --> 02:43:42,152 6 MONTH FELLOWSHIP PERIOD. 4124 02:43:42,152 --> 02:43:44,321 AGAIN, IT IS STRUCTURED EXACTLY 4125 02:43:44,321 --> 02:43:46,423 LIKE THE NSF INTERNSHIP PROGRAM 4126 02:43:46,423 --> 02:43:48,325 THAT YOU HAVE SEEN IF YOU GO TO 4127 02:43:48,325 --> 02:43:49,493 THE NSF WEBSITE. 4128 02:43:49,493 --> 02:43:52,730 WE HAVE A PIECE OF THAT WEB SITE 4129 02:43:52,730 --> 02:43:53,731 WITH THIS DEAR COLLEAGUE LETTER 4130 02:43:53,731 --> 02:43:57,601 THAT IS EXCITING TO SEE. 4131 02:43:57,601 --> 02:44:01,472 RELATED, AGAIN, TO SORT OF THE 4132 02:44:01,472 --> 02:44:03,240 COMMUNITY BUILDING AND SO MANU 4133 02:44:03,240 --> 02:44:06,777 AND TEAM ARE -- THEY HAVE COME 4134 02:44:06,777 --> 02:44:09,547 UP WITH AN IDEA TO HAVE A 4135 02:44:09,547 --> 02:44:11,949 SATELLITE MEETING TO BME 4136 02:44:11,949 --> 02:44:14,051 CONFERENCE DAY BEFORE BMES 4137 02:44:14,051 --> 02:44:16,387 CONFERENCE AND THIS IS REALLY 4138 02:44:16,387 --> 02:44:18,422 ABOUT KIND OF A BROAD TOPIC OF 4139 02:44:18,422 --> 02:44:21,191 HOW DO WE BUILD BRIDGES ACROSS 4140 02:44:21,191 --> 02:44:24,395 NIH AND BROADER ENGINEERING AND 4141 02:44:24,395 --> 02:44:25,095 TECHNOLOGY DEVELOPMENT 4142 02:44:25,095 --> 02:44:25,462 COMMUNITY. 4143 02:44:25,462 --> 02:44:29,066 SO, WE ARE HOPING TO INCLUDE OUR 4144 02:44:29,066 --> 02:44:30,935 INTRAMURAL INVESTIGATORS AND 4145 02:44:30,935 --> 02:44:34,238 NEEDS AND THINGS THAT MANU JUST 4146 02:44:34,238 --> 02:44:36,006 ARTICULATED AND ADVERTISE SOME 4147 02:44:36,006 --> 02:44:37,408 PROGRAMS AND BUILD COMMUNITY AND 4148 02:44:37,408 --> 02:44:39,977 GET PEOPLE TALKING AND HELP TO 4149 02:44:39,977 --> 02:44:41,779 ENCOURAGE AND DRIVE 4150 02:44:41,779 --> 02:44:43,047 COLLABORATIONS AND WE CAN SEE 4151 02:44:43,047 --> 02:44:46,383 NEW PROGRAMS AND OPPORTUNITIES 4152 02:44:46,383 --> 02:44:48,452 AND I'M PRETTY SURE THAT WE 4153 02:44:48,452 --> 02:44:50,521 DON'T HAVE THE FINAL 4154 02:44:50,521 --> 02:44:52,957 CONFIRMATION FROM DR. BER TAN 4155 02:44:52,957 --> 02:44:54,058 OELI'S OFFICE YET. 4156 02:44:54,058 --> 02:44:56,760 SHE HAS IT ON HER CALENDAR AND I 4157 02:44:56,760 --> 02:44:58,329 EXPECT SHE WILL BE ABLE TO COME 4158 02:44:58,329 --> 02:44:59,797 TO THAT EVENT THAT DAY AND 4159 02:44:59,797 --> 02:45:01,332 TALKING ABOUT A VARIETY OF 4160 02:45:01,332 --> 02:45:02,900 DIFFERENT OTHER EVENTS THAT WILL 4161 02:45:02,900 --> 02:45:05,002 BE HELD WITH INTERESTING 4162 02:45:05,002 --> 02:45:06,303 SPEAKERS AND ENGAGEMENT AND 4163 02:45:06,303 --> 02:45:07,271 PARTICIPATION AND ARE LOOKING 4164 02:45:07,271 --> 02:45:10,541 FORWARD TO YOUR FEEDBACK ON THAT 4165 02:45:10,541 --> 02:45:11,809 AS WELL. 4166 02:45:11,809 --> 02:45:14,078 SO IF YOU ARE FAMILIAR WITH 4167 02:45:14,078 --> 02:45:16,347 SPEAKING OF AI AND WE ACTUALLY I 4168 02:45:16,347 --> 02:45:20,150 THINK IT IS A MANDATORY 4169 02:45:20,150 --> 02:45:21,085 REQUIREMENT THAT LIKE SOME 4170 02:45:21,085 --> 02:45:22,820 FRACTION OF OUR SLIDE PATH TO 4171 02:45:22,820 --> 02:45:24,855 COVER AI AND MACHINE LEARNING 4172 02:45:24,855 --> 02:45:26,490 AND COMPUTATION AND MODELING AND 4173 02:45:26,490 --> 02:45:27,257 SO FORTH. 4174 02:45:27,257 --> 02:45:30,761 BRIDGE TO AI PROGRAM AND I SEE 4175 02:45:30,761 --> 02:45:32,062 THAT GRACE IS HERE WHO WAS 4176 02:45:32,062 --> 02:45:34,598 LEADING OUR EFFORTS ON THIS. 4177 02:45:34,598 --> 02:45:37,101 GRACE I WILL ASK YOU A HARD 4178 02:45:37,101 --> 02:45:38,736 QUESTION IN A MINUTE. 4179 02:45:38,736 --> 02:45:41,939 JUST RECENTLY HAVE HAD THEIR 4180 02:45:41,939 --> 02:45:43,974 FIRST MEETING OPEN HOUSE WITH 4181 02:45:43,974 --> 02:45:46,243 OVER 100 PEOPLE PUBLIC 4182 02:45:46,243 --> 02:45:47,645 PARTICIPATION COVERING ALL OF 4183 02:45:47,645 --> 02:45:50,347 THE KINDS OF APPROACHES TO AI 4184 02:45:50,347 --> 02:45:52,016 COLLABORATIVE APPROACHES AND 4185 02:45:52,016 --> 02:45:53,851 ETHICAL CONSIDERATIONS THAT IS A 4186 02:45:53,851 --> 02:45:55,552 HUGE FOUNDATIONAL ELEMENT OF 4187 02:45:55,552 --> 02:45:57,655 BRIDGE TO AI. 4188 02:45:57,655 --> 02:45:59,857 THERE ARE VERY BEAUTIFUL DATA 4189 02:45:59,857 --> 02:46:02,860 SETS THAT COVER A WIDE VARIETY 4190 02:46:02,860 --> 02:46:05,462 OF TOPICS AND GRACE IF YOU CAN 4191 02:46:05,462 --> 02:46:07,998 SORT OF COVER WHAT THOSE DATA 4192 02:46:07,998 --> 02:46:08,432 SETS ARE. 4193 02:46:08,432 --> 02:46:12,036 IF YOU CAN SCAN THE Q.R. CODE, I 4194 02:46:12,036 --> 02:46:14,571 WILL ALSO ADVERTIZE A REALLY 4195 02:46:14,571 --> 02:46:16,907 KIND OF -- WE LIKE WEIRD AND 4196 02:46:16,907 --> 02:46:18,409 OBSCURE THINGS AND IF YOU LOOK 4197 02:46:18,409 --> 02:46:20,477 AT THE BRIDGE TO AI WEBSITE 4198 02:46:20,477 --> 02:46:21,979 THERE IS A THEME SONG ON THERE 4199 02:46:21,979 --> 02:46:26,817 AS WELL WHICH IS A NERDY CHEESY 4200 02:46:26,817 --> 02:46:29,153 THEME SONG THAT I THINK YOU WILL 4201 02:46:29,153 --> 02:46:30,554 ALL APPRECIATE IT. 4202 02:46:30,554 --> 02:46:32,389 IS THAT THEME SONG HUMAN 4203 02:46:32,389 --> 02:46:36,727 GENERATED OR AI GENERATED OR 4204 02:46:36,727 --> 02:46:37,695 COLLABORATION BETWEEN THEM? 4205 02:46:37,695 --> 02:46:39,029 >> I BELIEVE A COLLABORATION 4206 02:46:39,029 --> 02:46:41,265 BETWEEN THE TWO AND ACTUALLY A 4207 02:46:41,265 --> 02:46:43,200 PRETTY STRONG COMPETITION OF 4208 02:46:43,200 --> 02:46:45,402 MULTIPLE THEME SONG SUBMISSIONS. 4209 02:46:45,402 --> 02:46:47,171 >> ALL RIGHT. NOW THAT I 4210 02:46:47,171 --> 02:46:49,139 CONFUSED EVERYONE WITH IT WE 4211 02:46:49,139 --> 02:46:51,275 DON'T WANT TO HEAR THEME SONGS 4212 02:46:51,275 --> 02:46:54,211 BLARING ON PHONES NOW BUT AT 4213 02:46:54,211 --> 02:46:55,446 NEXT. GRACE IF YOU CAN 4214 02:46:55,446 --> 02:47:00,017 SUMMARIZE DATA SETS ARE 4215 02:47:00,017 --> 02:47:01,752 EXTRAORDI 4216 02:47:01,752 --> 02:47:02,119 EXTRAORDINARY. 4217 02:47:02,119 --> 02:47:03,287 >> I ENCOURAGE ALL OF YOU THANK 4218 02:47:03,287 --> 02:47:06,123 YOU FOR TIME TO GO TO OPEN HOUSE 4219 02:47:06,123 --> 02:47:09,693 RECORDING AND BRIDGE TO AI 4220 02:47:09,693 --> 02:47:13,931 PROGRAM IS REALLY FOCUSED ON 4221 02:47:13,931 --> 02:47:18,268 AREA OF THINKING ABOUT ETHICAL 4222 02:47:18,268 --> 02:47:22,106 CREATING A CULTURE OF ETHICS 4223 02:47:22,106 --> 02:47:25,375 INQUIRY THROUGHOUT ENTIRE DATA 4224 02:47:25,375 --> 02:47:26,610 PREPARATION PROCESS AND NOT JUST 4225 02:47:26,610 --> 02:47:28,412 COMPLIANCE AND YOU WILL HEAR A 4226 02:47:28,412 --> 02:47:32,750 LOT OF LEGAL EXPERTS TALKING AS 4227 02:47:32,750 --> 02:47:37,154 WELL AS ANTHROPOLOGISTS AND 4228 02:47:37,154 --> 02:47:38,255 PHILOSOPHERS TALKING ABOUT 4229 02:47:38,255 --> 02:47:39,957 ISSUES THEY ARE DEALING WITH IN 4230 02:47:39,957 --> 02:47:42,993 TERMS OF RELEASE AND IS FIRST 4231 02:47:42,993 --> 02:47:47,297 PUBLIC RELEASE OF DATA AND UP TO 4232 02:47:47,297 --> 02:47:48,832 RELEASE THERE WAS A HUGE 4233 02:47:48,832 --> 02:47:50,200 DISCUSSION BETWEEN ETHICS AND 4234 02:47:50,200 --> 02:47:52,202 DATA SCIENCE FOLKS IN TERMS HOW 4235 02:47:52,202 --> 02:47:54,972 THEY WOULD RELEASE DATA AND 4236 02:47:54,972 --> 02:47:56,940 CONSENT OPEN HOUSE PARTICIPANTS 4237 02:47:56,940 --> 02:48:02,079 TO ACTUALLY USE DATA IN AN 4238 02:48:02,079 --> 02:48:05,048 ETHICAL WAY YOU WILL SEE HOW 4239 02:48:05,048 --> 02:48:07,184 THEY PREPARE THIS DATA FOR THIS 4240 02:48:07,184 --> 02:48:08,619 RELEASE SO GRAND CHALLENGE THAT 4241 02:48:08,619 --> 02:48:14,324 THIS IS ELUDING TO WE HAVE 4 4242 02:48:14,324 --> 02:48:24,868 CHALLENGES AND ONE IS FOR VOICE 4243 02:48:32,075 --> 02:48:34,912 MOST OF THEM AND WE HAVE 4244 02:48:34,912 --> 02:48:37,181 FUNCTIONAL GENOMICS DATA AND NOT 4245 02:48:37,181 --> 02:48:40,484 HUMAN DATA AND LAST ONE IS 4246 02:48:40,484 --> 02:48:41,652 [INDISCERNIBLE] GRAND CHALLENGE 4247 02:48:41,652 --> 02:48:47,391 THAT IS IDEA OF LOOKING AT HOW 4248 02:48:47,391 --> 02:48:50,160 ONE GOES FROM A HEALTHY STATE OR 4249 02:48:50,160 --> 02:48:53,864 GOING FROM DISEASE BACKED STATE 4250 02:48:53,864 --> 02:49:04,141 TO HEALTHY STATE